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STM Scanning tunneling 
microscope 
T Temperature 
t time 
t1/2 half life 
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Z atomic number 
Z Generic heteroatom 
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ΔGǂ Gibbs’ free energy of 
activation 
ΔHǂ Enthalpy of activation 
ΔSǂ Entropy of activation 
Δε Molar circular dichroism 
ε extinction coefficient 
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λ wavelength 
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(UV/Vis) 
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1 Introduction 
1.1 Gold catalysis 
For over a century, transition metals have proven to be integral to a variety of widely adopted 
catalytic reactions, featuring in important industrial processes such as the Fischer-Tropsch 
conversion of carbon monoxide and hydrogen into liquid hydrocarbons, the Haber-Bosch 
fixation of nitrogen and the Ziegler-Natta polymerization of alkenes into plastics.[1,2] Towards 
the latter half of the 20th century, homogenous transition metal-based catalysts[2] were widely 
adopted in enantioselective catalysis, which based upon broadly applicable chiral scaffolds 
such as those developed by Noyori,[3] Knowles[4] or Sharpless[5] enabled a number of 
industrially scalable asymmetric processes with high efficiency, selectivity, atom economy 
and functional group tolerance. 
Catalytic applications of gold, however, developed at a much slower place. Despite exhibiting 
a rich coordination chemistry,[6] gold was deemed to be largely catalytically inactive by the 
chemical community.[7] Gold has been, nevertheless, valued for millennia by mankind for its 
use in coins, jewellery and other items of value. Due to its high ductility and durability against 
degradation to chemicals or light, it is also a suitable material in areas such as medical 
implants and electronics.[8] Much of this stems from the noble character of gold, with is 
defined as a reluctance to chemically bond with many elements, and a high oxidation 
potential. In fact, gold has the highest oxidation potential and electronegativity of any metal,[8] 
and its reluctance to cycle between oxidation states and participate in the elementary steps 
of otherwise standard transition metal catalyzed reactions contributed to the notion of its 
catalytic inactivity.  
This perspective however, gradually started to change, first of all with reports of 
heterogeneous gold catalysts in the hydrogenation of olefins in 1973[9] and a decade later 
with the oxidation of CO[10] and the hydrochlorination of alkynes,[11] where gold outperformed 
other catalysts. Around the same time, the first report of homogenous gold catalysis was 
described by Ito et al, of the gold catalyzed aldol reaction between aldehydes and 
isocyanates to form oxazolines. Impressively, this was also the first report of asymmetric gold 
catalysis.[12] 
However, the specialty of gold lies in its activity as a carbophilic, soft Lewis acid, and it has 
been widely applied within the arena of π-acid catalysis alongside metals such as 
platinum.[13,14] Reports of gold in this regard began with the seminal work by Fukuda, Utimoto 
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and Nozaki,[15] where the Au(III) catalyzed hydroamination of alkynes was described 
(Scheme 1).  
 
Scheme 1. Au(III)-catalyzed hydroamination of alkyne 1. Reagents and conditions: (a) AuCl4·2H2O (5 mol%), 
MeCN, rt, 12 h. 
This was followed by other important studies, such as the gold catalyzed activation of 
alkynes to nucleophilic addition by water[16] and alcohols,[16,17] and later the activation of 
alkenes and alkynes[18] and the synthesis of phenols through cycloisomerization reactions.[19] 
Gold proved highly active and selective in these reactions, where its noble properties, 
namely a low oxo-philicitiy and redox activity, were highly advantageous. This sparked a 
huge interest in the field of gold catalyzed carbophilic activation, so-called the chemists "gold 
rush",[20] which became one of the most intensively studied fields of chemistry of the 21st 
century.[7,14,21] 
1.1.1 General properties of gold 
Gold is located in group 11 of the periodic table, in the 3rd row of the transition metals and 
exists most commonly in the oxidation states +1 and +3. Gold(III) complexes tend to have a 
square planar geometry, while gold(I) complexes a predominantly linear geometry. In 
addition, gold can form strong aurophilic interactions, and a variety of gold clusters have 
been described.[22]  
The qualities of gold as a noble metal can be attributed to relativistic effects. Because of the 
large gold nucleus, a large enough force is exerted on the orbiting electrons to bring their 
speed close to the speed of light. A relativistic consequence of this is that the mass of 
electrons approaching this speed increases. This can be described using the following 
equation:  
𝑚 =
𝑚0
√[1 − (
𝑣
𝑐)
2
]
 
where m is the corrected mass, m0 is the non-relativistic mass, v is the velocity and c is the 
speed of light. The Bohr radius of an electron is inversely proportional to its mass, therefore if 
the mass increases, the orbital housing that electron will also contract.[23] Gold is unique in 
having appreciably larger relativistic effects than its neighbors. This can be visualized by 
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comparing the ratio between the calculated radius of the 6s orbital, when relativistic effects 
are or are not taken into account (Figure 1).[24]  
 
Figure 1. The ratio of non-relativistic and relativistic radii for the 6s orbital for the elements of Z = 55-100. Figure 
taken from P. Pyykkö, Angew. Chem. Int. Ed. 2004, 43, 4412.[24] 
Relativistic effects account for some large differences between gold and silver, with which it 
shares group 11. For example, the first ionization energy of gold is much larger (9.22 eV vs 
7.57 eV), as well as the electronegativity (2.4 vs 1.9).[23] This also leads to generally stronger 
metal ligand bonds for gold complexes over silver complexes due a bond length 
contraction.[23]  
 
Figure 2. Calculated relativistic (R) and non-relativistic (NR) molecular orbital energies of AuH and AgH. Figure 
taken from P. Pyykkö, Angew. Chem. Int. Ed. 2004, 43, 4412.[24] 
While the s and p orbitals of gold experience a large relativistic contraction, the d orbitals 
become destabilized and expand due to better shielding from the nuclear charge. This effect 
can be observed for the mononuclear complexes AuH and AgH (Figure 2). When the 
energies of the 6sσ and 5d orbitals for AuH and AgH are calculated without taking relativistic 
effects into consideration (NR in Figure 2), the orbital energies of the two compounds are 
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comparable. However, when relativistic effects are considered (R in Figure 2), the 6sσ 
orbitals decrease in energy and the 5d orbitals increase in energy. This effect is more 
pronounced for AuH over AgH.[24]. A consequence of these effects is that gold is a chemically 
soft, carbophilic Lewis acid, due its low lying, large and polarizable empty orbitals. Another 
consequence is the stability of gold(I) compounds towards redox processes, and although 
this closed off gold for many years from conventional transition metal catalysed reactions 
where the metal fluctuates between two oxidation states separated by two electrons, it 
opened new avenues in reactivity for π-acid catalysis, where gold demonstrates sometimes 
exquisite selectivity and orthogonality to other conventional redox reactions. 
1.1.2 Gold as a carbophilic Lewis acid 
The basic reaction mechanism of transformations catalyzed by a gold center is outlined in 
Figure 3.[25,26] This will be discussed in detail over the course of this chapter with an aim to 
account for the exceptional properties of gold as a soft Lewis acid catalyst. In general, gold 
activates an incoming π-system towards nucleophilic attack, which results in the formation of 
the anti vinyl gold species D. Protodemetalation or other trapping reactions of the latter with 
an electrophile gives the product and regenerates the active gold species. 
 
Figure 3. General gold catalysis mechanism of the activation of π-systems toward nucleophilic attack. 
Many reactions in gold catalysis utilize gold(I) complexes of type (L·AuX), due to their 
stability and tuneability through the ancillary ligand L, although AuCl3 is also a popular 
catalyst in cases where higher Lewis acidity may be required. When X is a non-coordinating 
counterion, for example triflamide, these complexes can be directly used in catalysis, as the 
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gold has a coordination vacancy. The corresponding cationic gold(I) complex can also be 
stabilized through neutral donors, such as acetonitrile or toluene, which are then easily 
displaced under catalytic conditions. Another approach is to remove the anion X in situ. This 
is commonly achieved, either by protonation with one equivalent of a Brønsted acid, for 
example when X = CH3, or by silver-mediated abstraction, when X = Cl. In this case the 
gold(I) precatalyst is commonly administered with a silver salt, which forms insoluble silver 
chloride and the active gold species.[25] In many gold-catalyzed reactions, silver plays a non-
innocent role and this has deserved comment in the chemical literature.[27]  
The coordination vacancy of gold is then filled by formation of a π-complex with a suitable 
donor, such as an alkyne, allene or alkene.[24] The bonding situation between transition metal 
complexes and carbon-carbon multiple bonds can be interpreted using the Dewar-Chatt-
Duncanson model (DCD),[28] which considers the bond as a donor acceptor interaction 
between two closed shell fragments. In general, a σ-bond is formed by donation of the π-
system into empty, low lying orbitals on the metal of appropriate symmetry and π-back-
donation occurs from filled metal orbitals into the π*-orbital of the unsaturated ligand. In 
addition, a substantial electrostatic contribution has been calculated to exist between the two 
centers, with calculations for gold-acetylene and gold-ethylene predicting that this accounts 
for approximately half of the bond energy.[24] As an example, the four predicted interactions 
between an alkyne and a metal are shown in Figure 4.  
 
Figure 4. Schematic diagram showing bonding model between metal and an alkyne ligand. Figure taken from A. 
Fürstner, P. W. Davies, Angew. Chem. Int. Ed. 2007, 46, 3410.[14] 
Firstly, the alkyne can form a M←L σ-complex through donation of its filled in-plane π orbital 
into the empty dz2 metal orbital; additionally M→L π* back-donation can occur between the 
filled metal dxz orbital and the in-plane π* orbital of the alkyne. Other interactions that can 
also be considered are further M←L π-donation from the orthogonal out-of-plane alkyne π-
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orbitals and the empty metal dyz orbital, as well as a possible M→L δ interaction formed 
between the filled metal dxy orbital and the empty π* orbital of the alkyne. The calculated 
contributions from these four components for the [Au(C2H2)]+ complex show that the M←L σ 
interaction accounts for the largest contribution to the orbital term (ca. 65%). This is followed 
by the M→L π-back donation (ca. 27%), then the out of plane M←L π interaction (ca. 7%) 
and the M→L δ interaction (ca. 1%). Additionally, an electrostatic contribution makes up 
approximately half of the total bond energy.[29] What can be seen here is that apart from 
electrostatic interactions, the main contribution to the bond energy comes from donor 
interactions between the alkyne and the gold, although back donation from the gold still 
accounts for a non-negligible amount.  
Experimentally, this can also be corroborated. The DCD model predicts that coordination of 
an alkyne to the gold center would increase the length of the carbon-carbon bond, due to 
net-donation from the alkyne to the metal and additional population of the antibonding π* 
orbital, as well as cause bending of the alkyne geometry from linearity. Fürstner and 
coworkers could synthesize and crystallize cyclododecyne gold chloride 4 and compared its 
structure to that of the free cyclododecyne (Figure 5). A clear elongation of the triple bond on 
coordination to gold could be seen between 1.196(4) Å in 3 to 1.224(5) Å in 4. Additionally, 
the C3–C2–C1–C12 angle was reduced from 175.9(9)° in 3 to 165(1)° in 4.[30] 
 
Figure 5. Solid state structures of A) cyclododecyne 3 and B) η2-cyclododecyne-gold(I) chloride 4. Selected bond 
lengths and angles (a) C1–C2 = 1.196(4) Å; Φ (C3–C2–C1–C12) = 175.9 °; (b) C1–C2 = 1.224(5) Å; Φ (C3–C2–
C1–C12) = 165(1)°. Adapted from: S. Flügge, A. Anoop, R. Goddard, W. Thiel, A. Fürstner, Chem. Eur. J. 2009, 
15, 8558.[30] 
A) B) 
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Overall, the effect of coordination of the π-system to the gold is to reduce its electron density 
and increase its electrophilicity towards nucleophilic attack. Interestingly, calculations have 
shown that between gold-acetylene and gold-ethylene, ethylene is the slightly better σ-donor. 
It is therefore unlikely that in polyunsaturated ene-yne substrates, the gold center would favor 
coordination of either one, and may even favor the carbon-carbon double bond. This 
contrasts with experimental evidence in ene-yne reactivity towards gold, where the olefin 
acts as a nucleophile towards the gold-coordinated alkyne. The apparent "alkynophilicity" of 
gold is therefore thought to be kinetic in origin, with a pronounced preference for nucleophilic 
attack at the coordinated triple bond.[14]  
The process of nucleophilic attack towards a metal-coordinated π-system occurs via π-
slippage, a process of electronic redistribution from a η2 towards a η1 structure. This 
facilitates charge transfer from the nucleophile to the ligand and consequently onto the metal 
center.[14] If the alkyne has two different substituents, depending on their electronic or steric 
distribution or on the choice of ancillary gold ligand different regiomers can be formed. A 
variety of O, C, N or S centered nucleophiles can be successfully utilized together with 
alkynes, allenes or alkenes in this elementary step.[31,32] The nucleophile attacks the 
coordinated π-system in an outer sphere mechanism and gives an anti-oriented gold 
carbenoid intermediate.[33–35] This can either simply undergo protodemetallation to give the 
desired product and regenerate the active gold catalyst, or through further inter- or intra 
molecular trapping reactions undergo a diverse number of cascades and 
rearrangements.[7,14,31,33–35] In effect, this can quickly lead to a large increase in molecular 
complexity and is a defining advantage of gold catalysis. Moreover, in many cases the 
outcome of the reaction can be controlled through careful choice of ancillary ligand.[36] 
One such example is the cycloisomerisation of allene-diene 5a, which can selectively react to 
give the formal [4+3] or [4+2] cyclisation products 7a or 8a, depending on the choice of 
ancillary ligand at the gold centre (Scheme 2). The Toste group demonstrated that when 
using the bulky biaryl phosphine 9 the product of the reaction was predominantly the [4+3] 
product 8a, whereas when using the electron deficient phosphite 10, the reaction favoured 
the formal [4+2] product 7a.[37] The Mascareñas group described a similar effect for a related 
allene-diene substrate, comprising a sulfonamide tether. When using the ligand 10, the [4+2] 
product was predominantly formed, and a reversal of the selectivity was observed when 
using an N-heterocyclic carbene (NHC) as a ligand.[38]  
DFT studies by both groups found that both products were formed via a concerted [4+3] 
cycloaddition to give the intermediate 6a. Whereas electron withdrawing ligands such as 
phosphites favored a 1,2-carbon shift to give [4+2] product 8a, sterically bulky ligands 
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favored a 1,2-hydride migration to give [4+3] product 7a. The selectivity for the [4+2] product 
8a when using phosphite ligands was found to be due to a reduction in the ability of the gold 
center to backbond towards the carbenoid carbon in 6a when ligated with an electron 
deficient ligand. This raised the energy of the 1,2-hydride shift, favoring the 1,2-carbon shift 
to take place instead.[37–39] Additionally, the 1,2-carbon shift pathway was found to be strongly 
dependent on the nature of the substituents at the terminus of the allene, favoring a higher 
order of substitution.[38]  
 
Scheme 2. Regiodivergent pathways in gold(I)-catalyzed cycloisomerization of allene-diene 5a. Reagents and 
conditions (a) 9·AuCl (5 mol%), AgSbF6 (5 mol%), CH2Cl2, rt, 24h; (b) 10·AuCl (5 mol%), AgSbF6 (5 mol%), 
CH2Cl2, rt, 30 min. 
Careful choice of ligand can also influence the diastereoselectivity and enantioselectivity of a 
given gold catalysed process. The following section will discuss the area of asymmetric gold 
catalysis in more detail. 
1.2 Asymmetric gold catalysis 
While a rapid acceleration of research activity occurred at the beginning of the 21st century in 
gold catalysis, the field of enantioselective gold catalysis progressed at a slower pace. A 
much larger amount of asymmetric gold(I) cyclizations vs gold(III) or platinum(II) have been 
reported,[40–42] however gold(I) complexes present a number of challenges. This is in part due 
to the linear geometry of gold(I) species, whereby any chiral information on the ligand is 
forced to lie at the opposite side of the gold to the substrate This is further exacerbated by 
the outer sphere anti mode of nucleophilic attack to the bound π-system. The mono-
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coordinate geometry additionally permits a large degree of freedom in the ancillary ligand, 
with free rotation around the single bonds permittable(Figure 6).[40]  
Although the first example of gold catalysis by Ito et al in 1986 also involved chiral ligands,[12] 
the first communication on enantioselective gold catalysis through coordination of a π-system 
was reported much later by the group of Echavarren in 2005.[43] A number of approaches 
have led to significant advances in this field, achieving excellent levels of selectivity, and a 
selected number will be presented in this section.[40,42,44–46] 
 
Figure 6. Linear coordination mode and outer sphere mode of nucleophilic attack in gold(I) catalysis. 
1.2.1 Chiral bis(phosphine) complexes 
One highly successful approach towards asymmetric gold catalysis is the use of chiral 
bis(phosphine) complexes, which have been applied in many areas of asymmetric catalysis 
as C2 symmetric, chelating ligands.[47] In contrast, bis(phosphine) complexes form linear, 
binuclear species on coordination to gold. Generally speaking, the most widely used 
catalysts from this ligand class are shown in Figure 7, derived from the BINAP, MeO-BIPHEP 
and SEGPHOS scaffolds.[40,42,44–46] 
 
Figure 7. Chiral bis(phosphines)-gold(I) complexes widely applicable in asymmetric catalysis. 
The BINAP-derived precatalyst 11a was used by the Toste group in the highly 
enantioselective hydroamination reaction of allenes 14a to give enantioenriched pyrrolidine 
derivatives such as 15a (Scheme 3).[48] A strong dependence on the counterion and 
equivalents of the added silver salt was observed, leading the authors to propose that the 
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mono-cationic bis(gold) phosphine complex 11a could be responsible for the high 
enantioselectivity. Ultimately, a screening of counterions showed that the weakly 
coordinating para-nitrobenzoate gave the best results, with a sufficient amount of the 
catalytically active and highly enantioinducing monocationic species 11a  existing in the 
reaction mixture to give high yields and ee’s. It is likely that the additional gold center, though 
not catalytically active, contributes through sterics and potential aurophilic interactions to the 
chiral environment. A brominative variant of the same reaction was also later described, 
using the brominating agent 16 (Scheme 3). The authors commented that the lactam 16 
achieved the perfect balance in being sufficiently reactive to give the halo-deauration product 
over proto-deauration, and not reactive enough to compete in a racemic background 
reaction.[49] 
 
Scheme 3. Hydroamination of allene 14a catalyzed by 11a. Reagents and conditions: (a) 11a (3 mol%), 1,2-
Cl2C2H4, rt; (b) 11a (5 mol%), 16 (2.0 equiv.), MeNO2, rt, 12 h. 
Impressively, the Toste group applied the MeO-BIPHEP derived catalyst 9 towards the three-
fold cyclisation of polyene 17 to give tetracyclic product 18. The latter could be achieved in 
good yield, excellent enantioselectivity and perfect diastereoselectivity, in line with a 
proposed Stork-Eschemoser-type transition state (Scheme 4).[50] Aside from arenes, amines, 
phenols and carboxylic acids were used with comparable levels of selectivity. 
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Scheme 4. Enantioselective gold(I)-catalyzed polycyclisation using the BIPHEP ligand scaffold. Reagents and 
conditions: (a) 12 (3 mol%), AgSbF6 (3 mol%), m-xylene, rt. 
The Toste group additionally described the highly selective intermolecular cyclopropanation 
reaction between styrenes and the propargylic pivolate 19, catalyzed by SEGPHOS 
derivative 13 (Scheme 5).[50–52] The reaction proceeds first via the intramolecular 
rearrangement of 19 to give gold carbenoid species 22, which cyclopropanated styrenes 20 
in excellent diastereoselectivity and enantioselectivity. This is still a rare example of a highly 
enantioselective intermolecular gold catalyzed reaction. 
 
Scheme 5. Gold(I)-catalyzed intermolecular cyclopropanation of styrenes 20. Reagents and conditions: (a) 13 
(2.5 mol%), AgSbF6( 5 mol%), MeNO2, rt, 20–40 min. 
1.2.2 Asymmetric counterion-directed catalysis (ACDC) 
Having observed a strong counterion dependence in the gold(I) catalyzed intramolecular 
hydroamination of allenes,[48,49] the Toste group initiated efforts towards moving the source of 
chirality towards an outersphere counterion and studied if this could widen the scope of the 
transformation to other N- or O-centered nucleophiles. Utilizing the BINOL-derived 
phosphonate silver salt 23, the hydroalkoxylation of allene 24 bearing a hydroxyl functionality 
was investigated.[53] In this case the bis(phosphine) gold complexes derived from SEGPHOS 
and BINAP had given almost racemic mixtures. Using the achiral bis(phosphine) 25 together 
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with chiral silver salt 23 in an apolar solvent to maximize the ion pair led to the 
tetrahydrofuran product 26 in outstanding selectivity (Scheme 6A).  
 
Scheme 6. Asymmetric counteranion-directed catalysis in the cycloisomerization of allenes. Reagents and 
conditions: (a) 25·(AuCl)2 (2.5 mol%), 23 (5 mol%), C6H6, rt, 1 h; (b) (S)-BINAP(AuCl)2 (2.5 mol%), 23 (5 mol%), 
C6H6, rt, 24 h. 
This approach could also be extended to sulphonamides. For the use of carboxylates, a 
chiral phosphine/chiral silver salt pair was necessary to achieve high enantioselectivities 
(Scheme 6B). Here a strong matched/mismatched effect between the two was seen, with the 
combination of (S)-BINAP(AuCl)2 and (R)-23 giving the best results. The group also 
described a brominative variant of this reaction, accessing brominated tetrahydrofurans and 
lactones in high ee’s,[49] as well as an extension towards other nucleophiles, such as 
hydrazines and O- and N-tethered hydroxylamines.[54] In this way, a variety of synthetically 
useful heterocycles commonly found in biologically active compounds could be accessed 
using this strategy. 
1.2.3 Chiral carbene complexes 
Chiral carbenes are strong electron donor ligands and present an advantage when an 
electronic rich gold(I) is beneficial for the outcome of a given transformation. To this end, a 
variety of chiral carbene-gold complexes have been reported in highly asymmetric, 
regiodivergent transformations.[40–42,44,45] One example is the rearrangement of propargylic 
alkynes 29, which when using carbene ligands selectively leads to the allene 30 over the 
gold-carbene intermediate 22. The Toste group exploited this reactivity in an intramolecular 
rearrangement/ hydroalkoxylation reaction using the BINOL derived bis(acylic 
diamino)carbene 31, which proceeded via a dynamic resolution of a chiral allene 
intermediate 30.[55]  
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Scheme 7. Enantioselective kinetic dynamic resolution transformation of propargylic ethers 29 using the 
bis(carbene) 31. Reagents and conditions: (a) 31 (5 mol%), AgOTf (10 mol%), CDCl3, rt or 0 °C, 4 h. 
It was found that the electron rich carbene ligand on the gold accelerated a kinetic dynamic 
resolution of the intermediate chiral allene, which upon intramolecular hydroalkoxylation and 
protodeauration yielded the product 32 in excellent yield and enantioselectivity. Interestingly, 
when using benzylic ethers, the vinyl-gold species underwent an intramolecular benzylation, 
instead of protodeauration. In these cases, the enantioselectivity was even higher, ranging 
from 95 to >99% ee.  
In another example, the groups of Mascareñas, López, Fernández and Lassaletta reported a 
highly selective intermolecular [4+2] cyclisation of N-alleneamides with dienes, leading to 
cyclohexenes such as 33.[56] The reaction proceeded even at low temperatures and afforded 
the desired products in very good yields and excellent enantioselectivities. Furthermore, the 
[2+2] addition product could not be observed.[57] 
 
Scheme 8. Gold catalyzed [4+2] addition of allenamides 34 and dienes 35 using chiral carbene gold complex 36. 
Reagents and conditions: (a) 36 (5 mol%), AgNTf2 (5 mol%), CH2Cl2, –78 °C, 3 h. 
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1.2.4 Chiral phosphoramidite complexes 
Another powerful tool in asymmetric gold catalysis, and indeed much farther afield[58] is the 
emergence of monodentate phosphoramidites. In addition to their modular synthesis, these 
ligands are highly suitable for the restricted one-point binding of gold(I) complexes and, in 
contrast to bidentate phosphines, do not require the presence of two gold centers per 
catalyst. Additionally, their electron deficient nature makes them apt for transformations 
where an electron-poor gold(I) centre can influence the rate or selectivity of a given reaction.  
The groups of Mascareñas, López and Ujaque exploited the ligand effect in the gold(I) 
catalysed cyclisation of sulfonamide tethered allene-diene 5, which selectively forms the 
formal [4+2] cycloaddition product 7 when using electron deficient ancillary ligands at the 
gold centre.[37,38] In the presence of the bulky anthracene-substituted BINOL derived 
phosphoramidite ligand 41, the reaction of 5 to 7 proceeded with near perfect selectivity and 
excellent enantioselectivity (Scheme 9).[38,59] The same group also found that allene-dienes 
which were only mono-substituted at the allene terminus were more prone to undergo a 1,2-
hydride shift and give the [4+3] product 8. Using the same catalyst, excellent levels of 
selectivity could be obtained (Scheme 8).[60] 
 
Scheme 9. Regiodivergent substrate controlled pathways in allene-diene cyclizations. Reagents and conditions: 
(a) 41 (2–10 mol%), AgSbF6 (2–10 mol%), CH2Cl2, –15 °C, 1–3 h; (b) 41 (5 mol%), AgSbF6 (5 mol%), CH2Cl2, –
15 °C to rt. 
Six years ago, the group of Fürstner provided an outstanding mono-dentate catalytic system 
for a variety of gold(I)-catalyzed additions to allenes and alkynes, based on the TADDOL 
derived phosphoramidites 39 (Scheme 10).[52,61] The group showed that modification of the 
backbone of the TADDOL towards the conformationally less rigid methoxy substituents gave 
improved enantioselectivities. The authors attributed this to the higher conformational 
freedom of the modified system, which enabled a tighter chiral pocket to form around the 
gold center, stabilized by secondary interactions. Impressively, catalysts of this type proved 
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not only to be highly selective in the gold catalyzed [4+2] cyclizations of allene-dienes 5b as 
well as the [2+2] cyclizations of allene-enes 42, which rivalled those previously reported, but 
also the cyclopropanation reaction of ene-ynes 44 and 46 with N and O tethers, respectively, 
as well as the hydroarylation, hydroamination and hydroalkoxylation of allenes 48.[41] 
 
Scheme 10. Selected examples of gold(I)-catalyzed reactions using TADDOL-derived gold complexes 50. 
Reagents and conditions: (a) (R,R,R,R) 50a (5.5 mol%), AgBF4 (5 mol%), CH2Cl2, 0 °C; (b) (S,S,S,S) 50b (5.5 
mol%), AgBF4 (5 mol%), toluene, 0 °C; (c) (R,R,R,R) 50c (5.5 mol%), AgBF4 (5 mol%), 1,2-C2H4Cl2, –30 °C. 
In summary, a variety of different approaches can be employed for the development of new, 
highly enantioselective processes using gold(I) catalysis, relying on an array of 
bis(phosphine), carbene or phosphoramidite gold complexes, depending on the nature of the 
reaction. The linear nature of gold(I) complexes presents a challenge, however, which 
necessitates a large distance between the substrate and ligand, meaning that usually in 
order to effectively transfer the chiral information, a steric "wall" must be designed to enclose 
the gold center. This can either be achieved using bulky substituents, such as in TADDOL 
and BINOL derived phosphoramidites, or in the use of a second gold center and/ or bulky 
chiral counterion. The electronic aspect of the ligand also allows control over the reaction 
outcome in some cases. Nevertheless, the development of new ligands can help to 
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overcome as of yet unsolved challenges in this field and expand the possibilities presented 
by gold catalysis in the construction of complex molecular geometries through carbon-carbon 
bond formation. The next section will discuss the development of a new family of ligands 
bearing a cationic charge proximal to the phosphorus center, which present unique π-
accepting properties, and their current applications in π-acid catalysis.  
1.3 Cationic phosphines 
The vast majority of ligands are either neutral or anionic, which naturally stems from a higher 
ability of these systems to coordinate an electropositive metal center and stabilize a metal 
complex. Cationically charged ligands however, have also been used in a variety of 
applications, including as ligands for the detection of reactive intermediates by ESI-MS,[62] as 
easily recyclable water or ionic-liquid-soluble phase transfer catalysts,[63] or as ion pairs in 
asymmetric catalysis (Figure 8).[64] In all of these ligands, the charge is located far from the 
phosphorus center; and although the physicochemical properties are affected by the 
introduction of a cationic charge, the electronic properties do not significantly change. In 
cases when the cationic charge is installed adjacent to the phosphorus, the σ-donor ability of 
the phosphorus center decreases with a concurrent increase in its π-acceptor properties due 
to the strong electron-withdrawing effect of the positively charged substituent. 
 
Figure 8. Examples of cationic phosphines where the charge is located away from the phosphorus center. 
Such phosphorus-based ligands display comparable donor abilities to strong-π-acceptor 
ligands such as polyhalogenated phosphines, trifluorophosphine or 
tris(trifluoromethyl)phosphine. However, in contrast to these last two, which are toxic and 
highly flammable gases, α-cationic phosphines with a relatively inert phosphorus-carbon 
bond can be readily handled under ambient conditions. Strong π-acceptor ligands greatly 
deplete electron density from metals they coordinate. Therefore, if the rate-determining step 
of a catalytic cycle is influenced by a more electrophilic metal center, a dramatic 
enhancement of catalytic activity can be expected. The next section will discuss the 
synthesis of this class of ligands, the evaluation of their donor ability as well as their 
implications for catalysis.  
1. Introduction 
17 
1.3.1 Synthesis of monocationic phosphines and phosphonites 
Although α-cationic phosphines had been mentioned in the literature in reports by Zoller in 
1988[65] and Komarov in 1995,[66] the first fully characterized α-cationic phosphine 51a, was 
described by Kuhn in 1999.[67] Kuhn reported the direct condensation of imidazole-2-ylidenes 
with chlorophosphines, which had the advantage that both starting materials are readily-
available. This method has since been applied using other imidazole-2-ylidenes,[68] 
cyclic(alkyl)(amino)carbenes (CAAC’s),[69,70] dihydroimidazol-2-ylidenes[71] and has also been 
extended to the synthesis of cationic phosphonites (Scheme 11).[72] The carbene can even, 
in several cases, be generated in situ, via the base mediated deprotonation of suitable 
precursors.[70,73]  
 
Scheme 11. Examples of cationic phosphines synthesis through condensation with free carbenes. Reagents and 
conditions: (a) NHC (1.0 equiv), Et2O, 30 min-1h; (b) CAAC (1.0 equiv.), THF, rt; (c) NHC (1.0 equiv.), Et2O, –78 
°C, 15 min; (d) NHC (1 equiv.), toluene, rt, 1 h, then [Et3Si][B(C6F5)4] (1.0 equiv.), rt, 30 min. 
The outcome of this method, however strongly depends on the nature of the carbene used. 
In the formation of 2-imidazolium phosphine adducts such as 51b, the addition of an 
additional equivalent of base facilitates a rearrangement, forming the 4-phosphino-imidazol-
2-ylidene 55 (Scheme 12).[68] The Ruiz group has capitalized on this strategy to selectively 
synthesis 4-[74] and 4,5-[75] phosphino substituted imidazolium salts. In addition, the Weigand 
group has reported related rearrangements when using 4,5-dichloroimidazol-2-ylidenes,[76] 
and postulated the same rearrangement in the presence of additional equivalents of 
imidazole-2-ylidenes.[77] 
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Scheme 12. Base mediated rearrangement of α-cationic phosphine 51b to give the 4-phosphinoimidazol-2-
ylidene 55. Reagents and conditions (a) 56a (1.0 equiv.), Et2O, rt, 1 h; KHMDS (1.0 equiv.), THF, -78 °C, 30 min, 
then rt, 30 min. 
The use of "masked" carbenes also selectively leads to α-cationic phosphines (Scheme 13). 
Thus, decarboxylation of 59 smoothly occurs at room temperature in the presence of 
chlorophosphines to give the imidazolium-derived cationic phosphines 51c-e, as reported by 
the group of Andrieu.[78] Weigand and coworkers also developed a method using the 
carbene-trimethylsilyl triflate adduct 60. The product 61a could then be further functionalized 
with nitrile and azide substituents.[79] Alternatively, reactive bis(carbene) silver complexes can 
be employed as carbene transfer reagents. This was demonstrated by Leitner and coworkers 
for the synthesis of a cationic phosphonite,[80] and also by Stephan and coworkers via the 
direct transformation of the silver chloride complex 63.[70]  
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Scheme 13. Approaches towards monocationic phosphines or phosphonites using carbene carboxylates (59), 
silanes (60) or silver complexes (62a). Reagents and conditions: (a) 59 (1.0 equiv.), CH2Cl2, rt, 4h, then acetone, 
KPF6, rt, 48 h; (b) PCl3 (excess), C6H5F, 50 °C, 10 h, ultrasonic bath; (c) TMSX (2.0 equiv), MeCN, 48 h; (d) 62a 
(0.5 equiv.), CH2Cl2, rt, 2 h. 
Another approach stems from the selective N-alkylation of the corresponding 2-(imidazoyl) 
phosphines using strong alkylating reagents.[66,81] The group of Chauvin has used this 
method in the synthesis of phosphonites such as 50c and 50d (Scheme 14).[72]  
 
Scheme 14. N-Alkylation of 2-(imidazoyl)phosphines or -phosphites. Reagents and conditions: (a) MeOTf (1.0 
equiv.), toluene, rt, 2 h. 
While these various methods allow the synthesis of cationic phosphines or phosphonites in 
good yields, an alternative approach, described by the Alcarazo group, greatly expanded 
upon the scope of different cationic phosphines that had not been previously reported. 
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Starting from readily available secondary phosphines as well as Vilsmeier-type precursors 
and utilizing the so-called reverse "onio" strategy, the group first performed the synthesis of 
cyclopropenium-derived phosphines 61 by simply heating the two precursors together in 
THF. The procedure was also amenable to the use of more electron-withdrawing phosphines 
such as bis-(3,5-bis(trifluoromethyl)phenyl)phosphine by deprotonation of the phosphine with 
nbutyllithium followed by condensation.[82] The same strategy has also been extended 
towards dihydroimidazolium-[83] and formamidinium-derived[84] salts (Scheme 15), in addition 
to cationic arsines.[85] 
 
Scheme 15. Synthesis of cationic phosphines using reverse "onio" strategy. Reagents and conditions: (a) 
PH(R1)2 (3 equiv.), THF, 60 °C, 24 h, then sat. NaBF4; (b) PH(R1)2 (1.0 equiv), nBuLi (1.0 equiv.), THF, –78 °C, 
then 65a (1.0 equiv.), 60 °C, 48 h, then sat. NaBF4; (c) PH(R1)2 (3.0 equiv.), THF, 65 °C, 72 h. aAccording to 
method (b). 
The group additionally described the incorporation of pyridinium substituents using the same 
strategy, either applying  various N-methylated or N-arylated pyridinium chloride salts 
(Scheme 16).[86] Bulky N-aryl substituents, which were not amenable to simple direct N-
arylation protocols, could be synthesized using the Zincke reaction. Upon further elaboration, 
the pyridinium salts 65 were then condensed with various secondary phosphines at high 
temperatures in a microwave reactor.[87] 
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Scheme 16. Synthesis of pyridinium phosphines 71. Reagents and conditions: 70 (1.0 equiv.), PH(R1)2 (2.0 
equiv.), THF, 65 °C, 1–3 days; (b) 73 (1.0 equiv.), PH(R1)2 (3.0 equiv.), THF, 120–140 °C, μ-wave irradiation 12 h, 
then MeCN, NaSb6; (c) PH(R1)2 (1.0 equiv.), KH (8 equiv.), THF, –78 °C, 1 h, then 73 (1.0 equiv), –78 °C to rt, 16 
h, then MeCN, NaSbF6. aAccording to method (c). 
Despite possessing a cationic charge, monocationic phosphines display a rich coordination 
chemistry, with complexes to Au, Ag, Cu, Pt, Ni, Ir, Pd and Rh having been described to 
date.[88] While the cationic charge significantly depletes electron density from the phosphorus 
center, the lone pair remains active, as evidenced by the pyramidal structure of these ligands 
in the solid state. However, unlike many other strong π-acceptor ligands, the presence of a 
relatively inert phosphorus-carbon bond allows many monocationic phosphines to be 
handled under air, or even be used in biphasic aqueous media.  
1.3.2 Synthesis of polycationic phosphines and phosphonites 
The synthesis of di and tricationic phosphines is amenable to many of the same methods 
outlined in the previous section. Dicationic imidazolium derived phosphines have been 
described by the groups of Andrieu[89] and Weigand[90] by reaction of two equivalents of either 
imidazolium carboxylate 59 or trimethylsilylimidazolium salt 60 with different 
dichlorophosphines. Additionally, double N-alkyation of bis(2-imidazoyl)phosphines 74[91] can 
yield the corresponding dicationic salt 75a.  
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Scheme 17. Different approaches towards dicationic phosphines. Reagents and conditions: (a) 59 (2.0 equiv.), 
CH2Cl2, rt, 30 min, then KPF6, EtOH, rt, 24 h; (b) 60 (2.0 equiv.), PhF, 50 °C, ultrasonic bath, 24 h; (c) MeOTf (2.0 
equiv.), CH2Cl2, –78 °C to rt, 2h. 
Our group recently reported the direct reaction of bis(amino)cyclopropylidene 76, prepared 
by lithium-halogen exchange of 65a, with dichlorophosphines to give the dicationic 
derivatives 77. Sterically bulky substituents such as adamantyl and mesityl were amenable to 
this protocol (Scheme 18).[92] Recently the Chauvin group also described a similar method to 
synthesize dicationic phosphines.[93] Additionally, the in situ deprotonation of bis(imidazolium) 
salt 78 and condensation with dichloroethylphosphite to give dicationic 75b has been 
described by the same group.[58] The direct combination of dichlorophosphines with free 
carbenes, however depends strongly on the nature of the carbene used, as evidenced by 
competitive reductive processes when employing other imidazol-2-ylidenes.[94] 
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Scheme 18. Synthesis of dicationic phosphines. Reagents and conditions: (a) 65a (1.0 equiv.), nBuLi (1.0 equiv.), 
THF, –78 °C, 15 min, then PCl2R1 (0.5 equiv.), THF, –78 °C to rt, 16 h; (b) EtOPCl2 (1.0 equiv.), Et3N (2.0 equiv.), 
CH2Cl2, –78 °C to rt, 2 h. 
The reverse "onio" strategy has also been utilized by the Alcarazo group towards the 
synthesis of dicationic cyclopropenium,[92,95] formanidinium[84] and dihydroimidazolium[84] 
phosphines, again offering a complimentary scope of cationic substituents when compared 
with other methods (Scheme 19). Generally, formation of the first C–P bond proceeds more 
readily than the second one, where the corresponding monocationic phosphine 78 must be 
deprotonated with one equivalent of a base to improve conversion. This method therefore 
additionally allows the attachment of differently substituted cationic frameworks to the same 
phosphorus center, as evidenced in the synthesis of dicationic cyclopropenium salts 77. The 
Alcarazo group recently described the dicationic bis(phosphines) 79b and (rac)-80, which 
were synthesized according to the same strategy, using triethylamine as a base. The 
presence of an axially chiral axis in 75 mimics the BIPHEP family of ligands.  
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Scheme 19. Reverse "onio" strategy towards dicationic phosphines. Reagents and conditions: (a) 65a (2.0–3.0 
equiv.), THF or diglyme, 60–100 °C, 16 h; (b) KHMDS (1.0 equiv.), THF, –40 °C, 2h, then 65a (1.0 equiv.), rt, 16h; 
(c) 68 (2.0 equiv.), Et3N (2.1 equiv), THF, 65 °C, 16 h, then aq. NaBF4; (d) 68 (2.0 equiv.), KHMDS, (2.0 equiv.), 
THF, –78 °C to rt, 16 h, then MeCN, NaSbF6, rt, 16 h; (e) 68 (2.0 equiv), Et3N (2.0 equiv.), THF, 60 °C, 16 h. 
Dicationic phosphines and phosphonites display less rich coordination chemistry, owing to 
the diminished donor properties of the resulting compounds. Indeed, bis(imidazolium) 
derivatives such as 75a or 75b have not been found to coordinate any metal. Nevertheless, 
the complexes of Au(I), Pd(II) and Pt(II) with the cyclopropenium-derived dicationic 
phospines 77 have been described, most likely due to the comparatively less electron-
withdrawing nature of thecyclopropenium substituent.[88] One strategy to broaden the 
coordination chemistry of dicationic phosphines is to introduce a second chelating 
phosphorus centre, such as in the chelating dicationic phosphines 79b and (rac)-80 (cf. 
Scheme 19). Indeed, a wider variety of coordination complexes can be formed using these 
chelates, and includes Mo(0), Rh(I), Pd(II) and Pt(II) centers.[83,96] 
Only a limited number of tricationic phosphines have to date been described, by the groups 
of Alcarazo[97] and Weigand.[90] Treatment of tris(trimethylsilyl)phosphine with three 
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equivalents of chlorocyclopropenium salts 65 led to the smooth formation of trications 82. 
The steric bulk of the N-alkyl substituents played a major role in this reaction, with higher 
yields being observed for the methyl derivative 82b. Weigand and coworkers also described 
the trication 83, which was synthesized by refluxing the trimethylsilyl carbene adduct 60 with 
trichlorophosphine.  
Unsurprisingly, no coordination chemistry for trication 83 has been described. Trication 82b, 
however, was found to coordinate Pt(II) and even Au(I), although this complex was not stable 
at room temperature.[97] 
 
Scheme 20. Synthesis of tricationic phosphines 82 and 83. Reagents and conditions: (a) 60 (3.0 equiv.), PhF, 60 
°C, 16–72 h; (b) 60 (3.0 equiv.), 140 °C, 3h. 
1.3.3 Structure and electronic properties of cationic phosphines and phosphonites 
The strong π-accepting nature of cationic phosphines and phosphonites can be explained 
through an examination of their frontier orbitals. In phosphorus-based ligands, the HOMO is 
predominantly located at the phosphorus lone pair thus participating in their σ donor ability, 
and the LUMO is comprised by the σ* orbitals relating of the three phosphorus substituents, 
which accounts for the π-accepting properties of the ligand. An α-cationic substituent would 
be expected to lower all the molecular orbitals of the corresponding phosphine, therefore 
reducing its overall net electron-donating ability. Secondary orbital interactions between the 
phosphorus lone pair and the low lying π-system of an aromatic cationic substituent should 
also be possible, contributing to a further reduction in the σ-donor ability (Figure 9a). 
Additionally, stabilization of the σ* orbitals of the other phosphorus substituents through 
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constructive overlap with the π-system of the cationic substituent could also lead to a further 
increase in the π-accepting ability (Figure 9b). 
 
Figure 9. Secondary orbital interactions in cationic phosphorus based ligands. 
An experimental quantification of the donor properties of phosphines can be found in the 
measurement of the carbonyl stretching frequencies of the corresponding Ni(L)(CO)3 
complexes, where L is the phosphine under study, in a technique known as the Tolman 
analysis.[98] To avoid the handling of highly toxic nickel tetracarbonyl, calculation of the 
NiL(CO)3 CO stretching frequency can be achieved, offering a viable alternative.[99] In 
addition, synthesis of the corresponding RhClCO(L)2 has gained popularity. In these 
systems, the overall net donor character of the phosphine can be deduced, based on the 
shift in the stretching frequency of the metal bound carbonyl ligands. A stronger donor 
translates to increased π-backbonding to the carbonyl ligand from the metal into the (C–O)π* 
orbital. This decreases the bond strength and translates into a lowered CO stretching 
vibration. In many cases when the measured phosphine displays a large steric demand, 
formation of the trans-[RhClCO(L)2] complex leads to a significant deviation of the ligands 
from an ideal square planar geometry.[86] Because this has an additional impact on the orbital 
overlap in the complex, comparison of the resulting stretching frequencies is not always 
possible.[88]  
A Tolman electronic map, comprising phosphines (orange), phosphites (purple) and cationic 
phosphines (green) or arsines (pink) is shown in Figure 10. Experimentally determined 
values are shown as red points, while calculated ones are shown as blue points. Generally, 
monocationic phosphines or arsines can be seen to occupy the region of the map between 
phosphites and polyhalogenated phosphines such as PCl3 or PF3. Introduction of one or 
more additional charge increases the stretching frequency still, placing polycationic 
phosphines 82b, 77c and 72 at the upper reaches of the map alongside AsF3 and PF3. 
Cationic ligands offer distinct advantages in comparison, however, with polyhalogenated 
phosphines or arsines being highly flammable and toxic gases or liquids. Cationic 
phosphines are in contrast solids that can be easily handled under ambient conditions. While 
dicationic 72 would be expected to possess the strongest π-accepting abilities, its lack of 
coordination ability limits its utility as a ligand. Only slightly less donating, 82b and 77c with 
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cyclopropenium substituents still possess enough net donor ability to form a limited number 
of coordination complexes. 
 
Figure 10 Tolman electronic map for a variety of different phosphorus based ligands. Experimentally determined 
values shown as points in red, calculated in blue. Adopted from: M. Alcarazo, Acc. Chem. Res. 2016, 49, 1797.[88] 
An alternative method of measuring the donor ability of phosphines, which can avoid 
potential problems in the synthesis and measurement of metal carbonyl complexes, is the 
determination of oxidation [EP(ox)] and reduction [EP(red)] potentials by cyclic voltammetry. A 
variety of cationic ligands, as well as commercially available phosphines and phosphites are 
shown in Table 1.[88] Although the oxidation potentials of the phosphines shown in Table 1 
are irreversible, qualitatively they follow the same trends as shown in the Tolman electronic 
map (Figure 10). The monocationic phosphines 66a and 67 lie in the range of trimethyl 
phosphite, while others such as 71a and 69a exceed it. Similarly, the polycationic ligands 
display the largest oxidation potentials. Entries 10 and 12 show imidazoyl-/imidazolium-
derived cationic phosphines 84a and 75a, which were part of a wider study by the Chauvin 
group into the coordination limit of cationic ligands.[72] It was found that, while the 
monocationic 84a would still coordinate some metal centers such as [Rh(cod)Cl]2, the 
dicationic 75a was completely inert towards coordination. They proposed that the 
coordination limit may therefore lie between these two ligands.  
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Table 1. Oxidation potentials, calculated vs ferrocene/ferrocenium, Bu4NPF6 (0.1 M) in CH2Cl2.  
Entry Ligand VOx/ V Entry Ligand Ep(ox)/ V 
1  0.534 7 
 
1.400 
2  0.687 8 
 
1.480 
3 
 
0.836 9 
 
1.541 
4 
 
1.207 10 
 
1.900a 
5 
 
1.287 11 
 
2.062 
6 
 
1.289 12 
 
2.450a 
 
aMeasured in CH3CN, adapted to same scale from ref.[72] using conversion constant listed in ref.[100]. Unless 
otherwise stated, all oxidations were irreversible. 
Although a qualitative picture of the net donor properties can be deduced from the 
aforementioned measurements, the relative contributions that different cationic substituents 
have with regards to the σ-donating and π-accepting properties of the resulting phosphine 
cannot be determined. The Alcarazo group recently calculated the HOMO and LUMO 
energies for a variety of cationic substituents, in an effort to shed light on these aspects, 
shown in Figure 11.[88] As can be seen, introduction of any of the calculated cationic 
substituents significantly lowers both the HOMO and LUMO energy of the resulting 
phosphine, in comparison with triphenylphosphine. However, between the different cationic 
substituents, the position of the HOMO is not significantly affected, lying between –9.05 and 
–9.85 eV for the compounds in the series. It is the LUMO, which is strongly influenced by the 
nature of the cationic substituent, with the cyclopropenium (–4.10 eV), imidazolium (–4.37 
eV), formamidinium (5.00 eV) and pyridinium (6.07 eV) substituents giving respectively 
decreasing LUMO energies, thus resulting in higher π-accepting properties for the 
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corresponding phosphines. In turn, it is therefore likely that the variation in the donor ability 
observed for the differently cationic phosphines may be primarily attributable to changes in 
their π-accepting character. 
 
Figure 11. Calculated HOMO and LUMO energy levels for a variety of cationic phosphines. Figure taken from: 
M. Alcarazo, Acc. Chem. Res. 2016, 49, 1797.[69] 
1.3.4 Applications in catalysis 
Based on their increased polarity and high stability, initial applications of α-cationic 
phosphine-containing complexes were primarily as recyclable phase-transfer catalysts in 
polar or biphasic media. This can be beneficial to save the use of volatile organic solvents 
and use easily reused and greener solvents such as ionic liquids. A cationic catalyst system 
should be highly soluble in such polar media, and ideally would enable easy separation of 
reaction products after simple phase separation or extraction. In this regard, a variety of 
reactions, including Negishi,[73] Suzuki, Heck and Sonogashira cross couplings,[101] 
alkynylation,[102] hydroformylation,[103] hydrogenation,[102] hydrosilylation[104] and ene-yne 
cycloisomerisation[105] have been described and demonstrated the recyclability of cationic 
phosphines as catalysts in such a reaction medium. For example, a recent report by the 
group of Alonso and Ramón studied pyridinio phosphines as deep eutectic solvent (DES) 
compatible ligands for a variety of palladium catalysed cross couplings (Scheme 21).[101] A 
DES medium is formed on mixing different Lewis or Brønsted acids or bases and exhibit a 
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lower melting or phase transition temperature than their individual components. The cationic 
pyridinio phosphines were superior to a variety of conventional phosphine ligands for an 
assortment of Suzuki couplings, such as in the formation of 87, when the reactions were 
conducted in a DES medium. Similarly, the same catalyst worked efficiently for Sonogashira 
and Heck couplings and the catalyst system could be recycled up to five times without loss of 
activity after simple extraction of the products with cyclopentylmethyl ether. 
 
Scheme 21. Pyridinio-phosphines as deep eutectic solvent (DES) compatible ligands in palladium catalyzed Suzuki, 
Sonogashira and Heck couplings. Reagents and conditions (a) PdCl2 (0.1 mol%), 71i (0.3 mol%), K2CO3 (3 equiv.), 94/ 95 1:2, 
100 °C, 2h; (b) PdCl2 (0.1 mol%), 71i (0.3 mol%), iPr2NH (2 equiv.), 96/ 95 1:2, 80 °C, 5h; (c) 91 (1.2 equiv.), PdCl2 (0.2 mol%), 
71i (1 mol%), NaOAc (1.5 equiv.) 94/ 95 1: 2, 100 °C, 3h. 
As previously mentioned, the donor properties of α-cationic phosphines also significantly 
alter the electronic properties metals they coordinate. Cationic ligands, as strongly π-
accepting moieties, would be expected to also be beneficial as ligands in catalysis when: 
either the outcome of the reaction can be influenced by the electronic nature of the catalyst; 
or when the rate determining step of a reaction can be influenced by increasing the 
electrophilicity of the catalyst. In π-acid catalysis, there exist a number of reactions which 
possess either of these qualities. The Alcarazo group has actively investigated the 
application of cationic ligands to a number of such reactions, with an interest in following up 
with applications towards total synthesis.[88,106]  
The strongly π-acidic pyridinio-phosphines 71 have been utilized in a variety of 
mechanistically different gold- and platinum-catalyzed reactions.[86] The formal [2+2] 
cycloaddition in 1,8-ene-yne 97 nicely demonstrated the superior reactivity of the pyridinio-
phosphine gold complex 98g, which afforded the bicyclic product 99 in only a few minutes. 
This was significantly faster than any previously reported system, for which a substantial 
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ligand screen had already been conducted.[107] Additionally, due to stabilizing arene-gold 
interactions arising from the N-aryl substituent, the high catalyst stability enabled the reaction 
to be conducted with only 0.2 mol% catalyst loading (Scheme 22).[87] 
 
Scheme 22. Gold(I)-catalyzed reaction of ene-yne 97. Reagents and conditions: (a) 98g (0.2 mol%), AgSbF6 (0.2 
mol%), CH2Cl2, rt, 16 h. 
Another interesting reaction was highlighted by the monocationic arsine-platinum complex 
100, for the cyclopropanation reaction of 1,6-ene-yne 101 giving the highly strained tricyclic 
product 102 in 75% yield (Scheme 23). The evaluation of reactions of similar ene-ynes with 
terminal alkyne moieties had shown that even on heating with platinum the transformations 
proceeded slowly,[108] and when using gold yields were low with the concomitant occurrence 
of polymerization products. For comparison, under the best conditions previously reported for 
the substrate 101 using gallium trichloride, compound 102 was obtained in 12% isolated 
yield.[109] This result was greatly improved upon when using the cationic arsine 100, where 
the desired product could be obtained in 75% yield. 
 
Scheme 23. Platinum-catalyzed cycloisomerization of ene-yne 101. Reagents and conditions: (a) 100 (2 mol%), 
AgSbF6 (2 mol%), 1,2-C2H4Cl2, rt, 30 min. 
The dicationic bis(phosphine) 79b proved to be an excellent ligand in the Rh(I)-catalyzed 
hydroarylation of aryl-substituted dienes.[83] In this reaction both potential issues of reactivity 
as well as regioselectivity were overcome to give the products 103 in high yields and extend 
the scope of the reaction to the addition of azulenes, benzofurans as well as recorsinol 
derivatives. Importantly, the addition of KB(ArF)4 greatly improved conversion, due to the 
increased solubility of the resulting catalyst system (Scheme 24). 
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Scheme 24. Rhodium-catalyzed hydroarylation of dienes. Reagents and conditions: (a) 79b (5 mol%), 
[RhCl(CO)2]2 (2.5 mol%), KB(ArF)4 (10 mol%), 1,2-C2H4Cl2, 70 °C, 12 h. Regiomers ratios are given in square 
parentheses. 
An on-going topic of interest in the Alcarazo group, which has been studied in detail, is the π-
acid-catalyzed intramolecular hydroarylation reaction of ortho-alkynyl-substituted biphenyls 
such as 104 to give phenanthrenes 105.[110] It was found that polycationic ligands were 
excellent catalysts in this transformation, using both platinum(II)[111] and gold(I)[95] complexes. 
In the case of gold, the synthesis of highly strained phenanthrenes with two substituents in 
internal positions was possible, and proceeded with an exceptionally high rate when 
compared with other commercially available ligands (Figure 12).  
The reaction mechanism, calculated on the DFT-D3 level of theory, indicated the nucleophilic 
attack of the arene towards the gold-complexed alkyne moiety as the rate-determining step 
of the reaction. The kinetic barrier to this step was greatly reduced when using dicationic 77c 
as a ligand (green pathway, Figure 13). 
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Figure 12. Gold-catalyzed intramolecular hydroarylation of o-alkynylbiphenyl 104a. Reagents and conditions: (a) 
gold precatalysts (2 mol%), AgSbF6 (2 mol%), CH2Cl2, rt. Figure adapted from: J. Carreras, G. Gopakumar, L. Gu, 
L. Gu, A. Gimeno, P. Linowski, J. Petuškova, W. Thiel, M. Alcarazo, J. Am. Chem. Soc. 2013, 135, 18815.[76] 
 
Figure 13. Calculated relative free energy profile of the rate-determining step of the gold(I)-catalyzed 
hydroarylation of 5. In red: using triphenylphosphine as a ligand; in green: using dicationic species 77c as a 
ligand. Figure taken from: J. Carreras, G. Gopakumar, L. Gu, L. Gu, A. Gimeno, P. Linowski, J. Petuškova, W. 
Thiel, M. Alcarazo, J. Am. Chem. Soc. 2013, 135, 18815.[76] 
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With this knowledge, intramolecular hydroarylations have been utilized to great effect by the 
group, exhibiting a broad scope for the synthesis of new condensed aromatics and 
heteroaromatics using arene-[95,111] furan-[92] thiophene-[84] and pyrrole-based[105] nucleophiles. 
Since a number of naturally occurring phenanthrenes have been isolated from plants of the 
Orchidaceae family, the Alcarazo group has also attempted the synthesis of those 
compounds using this methodology. To this end, natural products such as 
Bulbophylantrin,[112] Coeloginin,[113] Epimedoicarisoside A[114] and Calanquinone C[115] have 
been synthesized to date (Figure 14).  
 
Figure 14. Examples of naturally occurring phenanthrenes synthesized using cationic ligands. 
In conclusion, α-Cationic ligands have emerged as a rapidly growing class of exceptionally 
strong π-acceptor ligands, owing to their modular synthesis and high stability compared with 
other strongly electron withdrawing ligands. Despite their electron poor nature, many exhibit 
rich coordination chemistry. Numerous applications of these complexes have arisen in 
phase-transfer catalysis for their solubility in ionic liquids or aqueous media; however, until 
relatively recently, the applications of their electronic abilities in catalysis had not been 
explored. The intermolecular hydroarylation reaction of ortho-alkynyl biarenes is greatly 
influenced by this class of ligands and has been investigated, amongst other reactions, by 
the Alcarazo group. Using this methodology, a variety of new, highly twisted phenanthrenes 
have been prepared, as well as a variety of natural products. Key to these accomplishments 
is the lowering of the activation barrier for the nucleophilic attack of the arene to the gold-
activated alkyne moiety, which is the rate-determining step when using strong π-acceptor 
ligands. Despite these advancements, the synthesis of chiral cationic ligands has yet to be 
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developed and investigated. Applications of such ligands in enantioselective hydroarylation 
reactions could have the potential to address challenges in the synthesis of highly strained 
polyaromatic systems through carbon-carbon bond formation. 
1.4 Synthesis, structure and applications of Helicenes 
One such class of polyaromatic compounds are helicenes;[116–124] despite their numerous 
interesting properties and applications relating to their axis of chirality, the number of 
enantioselective methods applicable to their synthesis is limited.[117,120] The following section 
will discuss their general properties, applications and selected methods towards their 
diastero- or enantioselective synthesis. 
1.4.1 General properties of helicenes 
Helicenes consist of a minimum of four ortho-fused benzene or other aromatic rings, which 
due to steric repulsions of the terminal rings form a helically chiral axis. The number of rings 
in a helicene is described by the number n in brackets [n], which indicates the number of 
ortho-fused aromatic rings. When a helicene is comprised solely of benzene rings in the 
backbone, it is denoted a carbohelicene; when the aromatic rings comprising its structure are 
thiophenes, pyrroles, pyridines or furans, the corresponding helicenes are denoted 
[n]thiahelicenes, [n]azahelicenes and [n]oxahelicenes, respectively. The helical axis of a 
helicene can either wind clockwise or anti-clockwise. According to the Cahn-Ingold-Prelog 
rules, a left-handed winding of the helix (anti-clockwise) is denoted as the M enantiomer, 
whereas a right-handed winding of the helix (clockwise) is denoted as the P enantiomer.[125] 
Similarly, the M and P enantiomers mostly give respective negative and positive optical 
rotation values. 
 
Figure 15. Depiction of the two enantiomers of π-[6]carbohelicene, including the standard numbering system for 
helicene carbons. 
One of the striking properties of helicenes is their unusually high optical rotation values 
(Figure 16), which are likely due to the large spatial volume their chiral axis occupies. 
Combined with their extended, easily polarizable, aromatic systems, this has sparked interest 
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in helicenes in a diverse array of fields, including asymmetric catalysis, supramolecular 
chemistry, macromolecular chemistry, nonlinear optics and optoelectronic materials, liquid 
crystals, nanoscience and biological chemistry. [116–124]  
Generally, [6]carbohelicenes and higher [n]carbohelicenes are considered to have a stable 
helical axis of chirality (Figure 16). Thus, while [5]helicene is known to racemize at 22 °C[126] 
with a half-life of 1100 min,[127] for [6]carbohelicene the reported t1/2(rac.) is 187 min at 187.6 
°C.[128,129] The racemization barrier dramatically increases however, on incorporating 
substituents into the internal "bay area" of the helix and 1-methyl-[5]helicene forms stable 
enantiomers.[130,131] 
  
   
     
(M)-(–)-107: 
[4]helicene 
(M)-(–)-108a: 
[5]helicenea 
(M)-(–)-106: 
[6]heliceneb 
(M)-(–)-109: 
[7]helicenec 
(M)-(–)-110: 
[8]helicened 
 
[𝛼]578
26  = –1670° 
(iso-octane) 
[𝛼]589
22  = –3640° 
(c = 0.098, CHCl3) 
[𝛼]579
25  = –5900° 
(c = 0.06, 
CHCl3) 
[𝛼]579
25  = –7170° 
 Ea* = 23.5 Ea* = 35.6 Ea* = 41.1 Ea* = 41.6 
                   Δ(Ea*) = 12.1 ← ← ←  Δ(Ea*) = 5.5 ← ← ← Δ(Ea*) = 0.5 
Figure 16. Optical rotations and racemization energies (Ea*/kcal mol–1)[117] of carbohelicenes.aFrom ref.[126] bFrom 
ref.[132] cFrom ref.[129] dFrom ref.[133] 
When one or more five-membered rings make up the helicene, a higher number of rings is 
required to give a stable chiral axis. This is because of the smaller in-plane-turn of a five- vs. 
a six-membered ring. For example, the heterohelicenes 5,8-[6]dithiahelicene and 3,6,9-
[6]trithiahelicene have significantly lower barriers to racemization than [6]carbohelicene 
(Figure  17) and have been reported to not be configurationally stable at room 
temperature.[134] [6]Carbohelicene racemizes via a symmetrical non-planar transition state, 
whereby the helix simultaneously widens to minimize the peripheral overlap (a process 
accommodated by all the aromatic rings of the molecule) and the last aromatic rings of the 
helix invert their respective positions.[135]  
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Figure 17. Racemization barriers (in kcal•mol–1) for helicenes 108a,[126] 108b,[130] 106 (including transition 
state),[135] 109, 110,[128] 111 and 112.[134]  
The helix of helicenes is, in addition, fairly flexible and can be extended and squashed with a 
relatively low energy barrier. A curious property of helicenes is that, unexpectantly, very few 
show a C2 symmetry in the solid state. Frequently, X-ray crystallographic analysis shows that 
the different aromatic rings of the helix accommodate the torsional strain imposed by the 
helical geometry to a different extent, and that the structural features relating to the helical 
geometry can change depending on the crystallization conditions.[120] The group of Sýkora 
recently investigated this phenomenon in greater detail, by studying hexahelicene and some 
of its derivatives in solution and in the solid state.[136] These studies were corroborated by 
theoretical calculations and showed that the energy penalty to widen or narrow the pitch 
(defined as the height of one complete helical turn) of hexahelicene from the minimum 
energy value of 4.2 Å was surprisingly low and to deviate by 0.4 Å in either direction only 
required approximately 0.6 kcal•mol–1 (Figure 18). The pitch of helicenes can therefore be 
expected to be reasonably fluctional in solution and to deviate in the solid state due to 
intermolecular packing forces. 
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Figure 18. Calculated energy dependence Erel/kcal•mol–1 vs. C2–C15 distance (Å) of hexahelicene. Figure taken 
from M. Dračinsky, J. Storch, V. Cirkva, I. Cisařova, J. Sýkora, Chem. Phys. Phys. Chem. 2017, 19, 2900.[105] 
Another interesting feature of helicenes is the π-interactions of their polyaromatic system and 
the resulting absorbance and emission spectra. The helical twist still enables electronic 
delocalization throughout their structure, although the extent of π-conjugation is not as good 
as when compared to other planar polyaromatic systems. This is due to a slight loss of 
aromatic character because of the helical axis.[137] Nevertheless the HOMO-LUMO gap of 
isomeric [n]helicenes and phenacenes (n ≥ 6) has been calculated to be smaller for the 
helicenes, due to π-π overlap across the helical pitches. This was calculated to steadily 
decrease, on increasing n.[138] Incorporation of thiophene and furan sub-units has also been 
shown to decrease the HOMO-LUMO gap, so long as the thiophenes[139] alternate with 
benzene rings to maintain effective π-conjugation. Other methods include annulating 
additional rings or helices onto the structure, therefore increasing the area of electron 
delocalization,[140,141] or incorporating push-pull elements by introduction of electron 
donor/acceptor substituents.[142] Finally, incorporation of an anti-aromatic subunit to the 
helicene also has a dramatic effect on the position of the frontier orbitals.[143] Some selected 
helicenes and their HOMO-LUMO gaps are shown in Figure 19A.  
Helicenes are also fluorescent compounds, although the quantum yield (ΦF) is usually 
relatively low due to non-emissive quenching events decreasing the efficiency of 
fluorescence. For example, for [5]carbohelicene 87a ΦF = 0.04.[144]. This can however be 
increased by incorporating long alkyl chains. Additionally, the wavelength of emission can be 
altered by modulation of the helicene substituents.[144,145] Some examples of helicenes with 
high fluorescence quantum yields are shown in Figure 19B. 
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Figure 19. A) HOMO-LUMO gaps for the helicenes 108a,[142] 109,[146] 113,[139] 114,[141] 115,[140] 116,[142] 117.[143] 
B) examples of helicene derivatives with high fluorescence quantum yields 118[145] and 119.[147] 
1.4.2 Applications of helicenes 
Helicenes exhibit a unique combination of exceptionally strong chiral transfer and a large 
aromatic π-system, which bestows them with interesting optical and electronic properties as 
well as the ability to readily form π-complexes and influence the formation of higher order 
structures. Some selected applications of helicenes will be described in this section to 
highlight the areas of research where they have attracted interest, maintaining an emphasis 
on recent examples as much as possible. 
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One application of helicenes is in asymmetric catalysis.[116,119,148,149] A recent series of 
examples of phosphahelicene-based catalysts was published by the group of Marinetti. 
These compounds were highly selective organocatalysts in the [3+2] cyclization of allenes 
and electron-poor olefins (Scheme 25A)[150] and also as ligands in enantioselective gold(I) 
catalysis (Scheme 25B).[151,152]  
 
Scheme 25. Use of phosphahelicenes 123 as organocatalysts (A) and in gold catalysis (B). Reagents and 
conditions: (a) (P)-123a (10 mol%), toluene, 80 °C, 18–22 h; (b) (SP, P)-123b·AuCl (4 mol%), AgBF4 (4 mol%), 
toluene, rt, 16 h. 
For example, (SP, P)-123a·AuCl efficiently catalyzed the ene-yne cyclisation of 124 into the 
products 125 and 126 with very good ee’s. The reaction was found to be substrate 
dependent, and furnished the product 125 from terminal alkenes (R5 = H) and 126 when R5 = 
Ph.[153] 
The ability of helicenes to transfer chirality to other systems has additionally been explored in 
the field of chiral recognition, where helicenes have been utilized in the sensing of single 
chiral molecules.[116,119,148,149] A tri-helicene organic cage was recently reported by Qiu and 
co-workers (Figure 20).[154] The cavity inside the cage could distinguish between enantiomers 
of racemic mixtures of chiral alcohols and amines, preferentially incorporating one 
enantiomer as a guest molecule that could then be later extracted. The enantiomeric 
excesses of the resulting extracts were impressive in comparison to the lower ee's obtained 
for other chiral cages.[155] 
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Figure 20. Host-guest complexes formed between 127 and racemic mixtures of chiral alcohols and amines. 
Crystal structure of (P,P,P)-127 (top) and representation of triple helix geometry (bottom) are shown as well.[154]  
A variety of studies have also been conducted into the aggregative properties of helicenes, 
including as oligomers, covalently bonded materials and monomers that form higher 
structures.[116,119,121] The group of Katz were important contributors to this field. In addition to 
other molecules, they synthesized the helicenebisquinone 128a[156–158] and found it to 
undergo self-assembly into large fibrous macrostructures (Figure 21).  
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Figure 21. Self-aggregation of 128a into fibres: (A) Optical micrograph; (B) representation of aggregation of 
fibres; (C) and (D) electron transmission microscopy of aggregates. Figure adapted from: C. Nuckolls, T. J. Katz, 
L. Castellanos, J. Am. Chem. Soc. 1996, 118, 3767–3768[157] and A. J. Lovinger, C. Nuckolls, T. J. Katz J. Am. 
Chem. Soc. 1998, 120, 264–268.[159] 
This phenomenon, which could be detected using an optical microscope, was only observed 
by the authors for the enantiopure material (Figure 21A).[157] Interestingly, the optical 
rotations and circular dichroisms were greatly enhanced for the aggregate material, 
compared with dilute solutions of 128a. Further analysis of a macroscopic liquid crystalline 
phase of 128a by X-ray diffraction, electron transmission microscopy and polarized light 
microscopy showed that the helicenes self-assembled end-to-end into helical fibres that 
aggregated into bundles (Figure 21B, 21C and 21D).[159] Langmuir-Blodgett films of 128a also 
formed the same columnar aggregates, which again displayed significantly enhanced circular 
dichroism and optical rotations. The circular dichroism spectra could be measured for a 
single mono-layer of 128a, which at that time was unprecedented. This is testament to the 
inherently large dichroisms of the helicene 128a and the following amplification of its 
chiroptical properties through aggregation.[160] Furthermore, the aggregates of the Langmuir-
Blodgett film displayed a strong second order non-linear optical response, which was a direct 
consequence of the supramolecular chirality of the system.[161] 
Another emerging field augmented by helicenes is so-called "chiranoscience", which studies 
chirality of systems on the nanoscale.[116] An investigation of the absorption of 
(A) (B) 
(C) (D) 
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[7]carbohelicene onto a copper (110) surface by scanning tunneling microscopy (STM) 
showed that the racemic material self-organized into homochiral domains (denoted λ and ρ), 
where even a small excess of one enantiomer led to a non-linear expression of chirality on 
the surface (Figure 22).[162] The domains themselves were composed of both (M) and (P) 
enantiomers of the helicene alternating in a zig-zag geometry, but the lattice formed and the 
vectors of the respective domains were mirror images of each other, tilted by an angle of 
±10.9 ° with respect to the Cu(110) surface direction. This seminary work opened the 
possibility of building chiral surfaces that may lead to the development of future asymmetric 
heterogeneous processes. 
 
Figure 22. Absorption of [7]carbohelicene onto copper (110) surface and organization into homochiral domains: 
(left) STM image of λ (red) and ρ (yellow) domains; (middle) structure of domains, composed of zig-zag 
alternation of enantiomers and representation of vector of lattice; (right) composition of domains at carrying ee 
values. Figure taken from R. Fasel, M. Parschau, K. H. Ernst, Nature 2006, 439, 449.[162] 
The tunable polyaromatic system of helicenes has attracted interest towards their possible 
applications in opto-electronic devices. Optical devices which directly emit circularly polarized 
light have been proposed to be more favorable in terms of simplicity, compactness, energy 
efficiency and cost. Fuchter and co-workers recently explored this concept, by doping a light 
emitting polymer (LEP) with either the enantiopure 1-aza[6]helicene or [7]carbohelicene and 
investigating the influence on the overall structure and the emissive properties (Figure 
23).[163] Prototypical devices doped with the enantiopure helicenes exhibited a strong 
brightness and emitted strongly circularly polarized light, indicating the helicene had a 
significant influence on the higher order structure of the material. The properties were 
comparable to other approaches using chiral light emitting polymers,[164] however the 
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advantages of this method are that the helicenes could be potentially doped into a variety of 
established PLED and OLED materials across the full visual spectrum and don't require 
bespoke chiral polymer synthesis. Other optical-electronic applications of helicenes include 
organic field-effect transistors,[165] organic semi-conductors,[166] dye sensitized solar 
cells,[145,167] organic spin filters[168] chiroptical switches,[169] as well as biological imaging 
agents.[170] 
 
Figure 23. A) Helicenes doped into the circularly polarized light emitting device; B) light emitting polymer used in 
the study; C) schematic of circularly polarized light emitting device using (M)-helicenes. Figure taken from Y. 
Yang, R. C. da Costa, D. M. Smilgies, A. J. Campbell, M. J. Fuchter, Adv. Mater. 2013, 25, 2624.[163] 
All of the applications of helicenes mentioned in this section are a consequence of their 
unique chiroptical properties and the extent to which this has an influence on other systems - 
be that in catalysis, in molecular recognition or chiral sensors. In many cases, helicenes 
display fascinating self-organization and amplification of their chiroptical properties on 
formation of higher order structures. Initiated by more fundamental studies, this is leading to 
an ever increasing number of applications, where helicenes could already be incorporated 
into a variety of efficient optical devices. Since their inherent chirality is at the forefront of 
their unique properties, it is interesting to note that all of the applications described in this 
section relied on the racemic synthesis of the helicene followed by its preparative chiral 
separation[154,162,163] or diastereoselective methods.[150,157] In almost no cases was the 
helicene prepared enantioselectively. This highlights both the still limited number of ways in 
which helicenes can be accessed in their enantiopure forms as well as the need for ongoing 
A) B) 
C) 
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work on their enantioselective syntheses. The following sections will discuss the most 
prominent methods for the achiral, diastereoselective and finally enantioselective 
preparations of carbohelicenes up the writing of this thesis. 
1.4.3 Synthesis of helicenes 
1.4.3.1 Transition metal free synthesis 
The synthesis of [6]carbohelicene was first described by Newman in 1955[171] and 1956,[132] 
utilizing a 10-step Friedel-Crafts/dehydration sequence. Resolution could also be achieved 
by repeated crystallization with 2-(2,4,5,7-tetranitro-9-fluorenylideneaminooxy)propionic acid 
(TAPA). Although low yielding, this was highly innovative for its time and confirmed the 
helical chirality of [6]carbohelicene (Scheme 26). 
 
Scheme 26. First optical resolution of hexahelicene 106. 
The first major breakthrough in helicene synthesis however, was the photochemical strategy 
reported by Schölz[172] and Martin[173] in 1967. The synthesis of [7]carbohelicene [(rac)-109] is 
shown in Scheme 27.[142] Starting from 3-phenanthrylacetyl chloride (128) and phenanthrene 
(129), hydrocarbon (rac)-109 could be prepared in four steps with a 12.5% yield for the 
photocyclization step. This enabled the preparation of functionalized [5]carbohelicenes,[174] 
[6]-, [8]-, [9]-,[175] [10]-, [11]-, [12]-, [13]-[176] [14]-[177] and more recently [16]carbohelicenes,[178] 
as well as other heterohelicenes.[120] Later optimizations of Martin[176,179] and Katz,[180,181,182] 
led to improved yields and regioselectivities.[183] Thus, [7]carbohelicene [(rac)-109] was 
prepared over four steps in 29% overall yield with a 75% yield for the photocyclization 
step.[181]  
This method still stands out today as a way to quickly access small quantities of 
functionalized helicenes,[182] since the synthetic precursors are easily prepared by Wittig 
olefination or Heck coupling and the reaction shows a good functional group tolerance. 
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Drawbacks of helicene photochemical synthesis are that extremely high dilutions are 
necessary to avoid dimerization reactions, which limits the amount of helicene that can be 
obtained on a preparative scale. Additionally, highly pure solvents are required for the 
cyclization. Notably, no general enantioselective process for this type of reaction currently 
exists.[117] 
 
Scheme 27. Photochemical synthesis of [7]carbohelicene. Reagents and conditions: (a) 128, 129, AlCl3, 
C6H5NO2, 20 °C; (b) LiAlH4, workup; then HCO2H, heating (c) hv (Hg middle pressure lamp), I2, C6H6, 20 °C, 8 h, 
12.5% yield. 
Another breakthrough came in 1990 when Katz and coworkers described the synthesis of 
helicenes via a Diels-Alder reaction involving divinyl arenes 112 with an excess of p-
benzoquinone (Scheme 28).[156,184] The rates and yields of the reaction could be improved by 
adding electron-donating substituents to the diene molecule, especially at the vinyl moiety. 
Although the yields are in many cases diminished, this approach enabled rapid access to 
gram quantities of helicenes and accelerated further study of these compounds. 
 
Scheme 28. Access to helicenebisquinones 128 through Diels-Alder strategy; selected examples. Reagents and 
conditions: (a) CCl3CO2H or basic Al2Os (cat.), toluene, reflux. 
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Importantly, the enantiomers of the racemic helicenes could be resolved by reduction to the 
bishydroquinone, ester formation with (–)-camphoryl chloride and diastereomeric resolution 
by crystallisation. The resolved enantiomers could then be reoxidised to the bisquinones 
without erosion of the enantiopurity.[157] A diastereoselective variant of this Diels-Alder 
approach was reported by the group of Urbano and Carreño. The chiral information stems 
from a chiral sulfoxide auxiliary of quinone (S)-134 that was pyrolytically cleaved under the 
reaction conditions, giving helicenes such as (M)-135 in up to 88% ee (Scheme 29A).[185] 
Considerably high pressures (4–12 kbar) were required for this reaction and compound (M)-
135a was furnished in low yields. The reactivity of the diene could be improved by using 
alicyclic variants such as 136, which furnished dihydrohelicenes 137 with good to excellent 
ee's (Scheme 29B).[186] This approach was also extended towards partially saturated [4]-[187] 
and [7]carbohelicenes.[188] 
 
Scheme 29. Selected examples of diastereoselective Diels-Alder reactions to give carbohelicenes 135 and 
dihydrohelicenes 137. Reagents and conditions: (a) 134 (6.0 equiv.) CH2Cl2, 4kbar, 4 d; (b) 134 (2.0 equiv.) 
CH2Cl2, –40 to –60°C, 6–17 d; (c) DDQ, C6H6, reflux, 4 d. 
1.4.3.2 Transition metal-mediated synthesis 
A much larger number of transition metal-catalyzed synthetic transformations have been 
described for the synthesis of helicenes. Among them, Pd-catalyzed intramolecular C–H 
bond arylations have been used, however, in racemic versions.[189] Stará, Starý and 
coworkers pioneered a wide-ranging and largely successful approach, based on the [2+2+2] 
cycloisomerization of triynes using Co(I) or Ni(0). Early reports, using Co(I) catalysis enabled 
the synthesis of a variety of partially saturated [5]-, [6]- and [7]- oxa-, aza- and 
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carbohelicenes in mostly good yields.[190,191] Later a variety of O-, N-, S-, and P- 
functionalized helicenes were described. Partially saturated helicenes such as 140 in 
Scheme 30 could be aromatized to the helicenes such as 141 using triphenylcarbenium 
tetrafluoroborate in excellent yields.[192] This work was then extended to use Ni(0), which was 
generally more reactive, to the direct access of [6]- and [7]carbohelicenes from cis, cis-diene-
triynes at room temperature.[193] Generally, this method is widely applicable and amongst the 
types of helicenes accessible are [11]carbohelicene,[194] a [19]oxahelicene,[195] at this moment 
the largest known helicene that has been synthesized, as well as pyridio-[196] and pyridazino-
[197] [5]-, [6]- and [7]helicenes from the corresponding cyanodiynes and ynedinitriles. 
 
Scheme 30. Examples of carbohelicenes accessed through 2+2+2 cyclotrimerization. (a) CpCo(CO)2 (20 mol%), 
PPh3 (40 mol%), decane, halogen lamp, 140 °C, 2.5 h; (b) Ph3BF4 (3.4 equiv.), 1,2-DCE, 80 °C, 2 h. 
Recently published reports have described the highly diastereoselective synthesis of 
carbohelicenes 144.[198] Thus, enzymatically resolved propargylic alcohols, when 
incorporated into triyne substrates 142 and subjected to the cobalt catalyzed [2+2+2] 
cycloisomerization, enabled a highly efficient transfer of chirality to the helical backbone 143 
(Scheme 31).  
 
Scheme 31. Diastereoselective 2+2+2 cycloisomerization to access enantiopure [5]-, [6]- and [7]helicenes.[198] 
Reagents and conditions: (a) CpCo(CO)(fum) (50 mol%), 1-butyl-2,3-dimethylimidazolium tetrafluoroborate in 
THF, microwave irradiation, 150–180 °C, 10–20 min; (b) p-TSA or HCl, MeCN. 
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The authors showed that the high reaction temperatures enabled enantioinversion of the 
helical axis, which then arranged itself to give the most stable diastereomer in all cases, 
driven by the central chirality of the OMOM ether. An elimination procedure then yielded the 
helicenes 144, which included [6]- and [7]- aza- and carbohelicenes with a variety of 
substituents. Although highly diastereoselective, this procedure still has the drawback that a 
chiral center must be introduced and later removed to access the enantiopure helicenes. 
This is still an inherently wasteful method when compared to directly enantioselective 
reactions. 
Numerous efforts have so far been described in the enantioselective [2+2+2] 
cycloisomerization of triynes such as 145 to give enantioenriched helicenes using nickel 
catalysts, as they are generally more reactive and do not require such high 
temperatures,[191,199,200] although in these cases the number of substrates described has so 
far been limited.  
 
Scheme 32. Enantioselective [2+2+2] cycloisomerization to give carbohelicene 146 using oxahelicene-NHC-
based ligand 147. Reagents and conditions: (a) Ni(acac)2 (20 mol%), 147 (44 mol%), EtMgCl (0.9 equiv.), THF, rt, 
2 h. 
One recent example details the synthesis and catalytic behavior of oxahelicenes-substituted 
imidazolium salts of the type 147 (Scheme 32).[201] These helicene-based ligands were, in 
turn, themselves synthesized according to a diastereoselective [2+2+2] cyclisation. Although 
the application of 147 to the cyclisation of 145 reached a promising ee of 86%, it is strange 
that the evaluation of no further substrates was described. Additionally, an analogous 
method using Rh(I)-BINAP complexes has been recently described by the group of Tanaka 
in the enantioselective synthesis of dibenzo[7]helicenes, although the selectivity of the 
transformation was lower and a limited scope was reported.[202] 
Other transition metal-based strategies that have been applied to helicene synthesis include 
the Pd(0) catalyzed [2+2+2] cycloisomerization of arynes and electron-deficient alkynes, of 
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which an enantioselective variant has been reported.[203] A variety of chiral ligands were 
screened; although a high ee for one substrate was described, very low conversion and poor 
selectivity towards the desired product remain significant challenges for this transformation. 
An approach using ring closing alkene metathesis (RCM) has also been investigated by the 
group of Collins, where the synthesis of a variety of functionalized racemic [5]- and [6]- and 
[7]carbohelicenes could be performed in good yields.[204] An enantioselective variant using 
chiral carbene-derived catalysts aimed to furnish [7]helicene from the racemic precursor 148 
via a kinetic resolution.[205] After multiple rounds of optimization, the targeted [7]helicene [(M)-
109] could be accessed in an 80% ee and 38% conversion, with a significant solvent effect 
seen for hexafluorobenzene and the addition of vinylcyclohexane as an additive. 
Nevertheless, an inherent drawback of this reaction is that the starting material is already 
chiral and therefore the reaction proceeds via a kinetic resolution. Moreover, no comment in 
the paper is given on the ease in which starting material can be separated from the product. 
Some examples of [4]carbohelicenes have also recently been described using the emerging 
olefin-carbonyl metathesis reaction.[206]  
 
Scheme 33. Synthesis of [7]helicene using RCM. Reagents and conditions: (a) 149 (4 mol%), vinylcyclohexane 
(10 equiv.), C6F6, rt, 2 h. 
Another effective strategy derives from the π-acid-catalyzed cycloisomerization of aryl 
alkynes.[110,207] Some asymmetric variants of this reaction have also been attempted by 
Tanaka and coworkers, in the synthesis of [6]- (151) and S-shaped double [6]carbohelicenes 
154.[202] This reaction proceeds through a tandem gold-catalyzed 
hydroarylation/carbocyclization of diyneones 150 (Scheme 34A) or tetraynediones 153 
(Scheme 34B) and yields the corresponding [6]carbohelicenes 151 after methylation in 
moderate to good yields, with ee's between 37 and 74%. An extension towards the synthesis 
of S-shaped double [6]carbohelicenes 154 via the twice-repeated tandem gold-catalyzed 
hydroarylation/carbocyclization of tetraynediones 153 was also described, although ee's did 
not increase and very high catalyst loadings of gold and silver (60 mol% and 90 mol%, 
respectively) were required, when compared with the isolated yield of 151 for 29–34% 
(Scheme 34B).  
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Additionally, the group has demonstrated the enantioselective synthesis of mono and double 
S-shaped aza[6]helicenes,[208] as well as a [10]azahelicene[209] from the corresponding 
substrates. In these cases, the ee's were very good for the double azahelicene and 
[10]helicene (up to >99%), although catalyst loadings were still high and yields remained low. 
 
Scheme 34. Enantioselective gold(I)-catalyzed intramolecular hydroarylation of diynones 150 (A) and ii). tetrayne-
diones 153 (B). Reagents and conditions: (a) i). AuCl·SMe2 (20 mol%), AgNTf2 (30 mol%), 152 (12 mol%), 
CH2Cl2, rt, 16 h. ii). TMS-diazomethane, MeOH/toluene, 0 °C to rt, 16 h; (b) i). AuCl·SMe2 (60 mol%), AgNTf2 (90 
mol%), (R)-BINAP (36 mol%), CH2Cl2, rt, 16 h. ii). TMS-diazomethane, MeOH/toluene, 0 °C to rt, 16 h (154a) or 
MeI, K2CO3 (154b).  
In summary, although the applications of helicenes are closely related to their intrinsic 
chirality, there is still a deficiency in effective asymmetric methods to access them. The 
reactions that have been reported, up to the date of writing this thesis, mostly do not display 
a broad scope, with variant ee’s depending on substitution of the substrate or very few 
substrates reported. Additionally, in many cases high catalyst loadings are required, 
sometimes higher than the yield of the products, which are also in many cases also low. This 
is especially true for carbohelicenes, for which there is currently no general method that 
furnishes carbohelicenes with high yields and ee. This highlights the fundamental difficulty in 
transferring chirality efficiently to form a helically chiral axis. Considering the previous work of 
the Alcarazo group in the hydroarylation of alkynes catalyzed by strong π-accepting π-acid 
catalysts,[88] it was envisaged that the synthesis of [6]carbohelicenes through an 
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enantioselective gold(I)-catalyzed hydroarylation reaction could provide an exciting new entry 
to this field. 
1.5 Naturally occurring bisphenanthrenes 
The work conducted by the Alcarazo group into π-acid catalyzed hydroarylation reactions 
has resulted in the synthesis of a number of natural products comprising a phenanthrene 
core.[88,106] In nature, a variety of phenanthrenes have been isolated from the Orchidaceae 
family. Many of these plants have been used in traditional folk medicine and phenanthrenes 
have therefore been studied for their antimicrobial, spasmolytic, anti-inflammatory, 
antiplatelet aggregative, anti-allergic and phytotoxic activity.[210] Phenanthrenes are classified 
as secondary metabolites and are widely thought to be synthesized by plants through the 
oxidative cyclisation of stilbene precursors. Their structure is often highly oxygenated and a 
variety of dihydroderivatives also exist, which are thought to occur through bibenzyl 
precursors.[211] As many of the monomers of dimeric phenanthrenes are also isolated from 
the same plant, it is probable that these occur through dimerization pathways. 
Naturally occurring phenanthrenes can be subdivided into three groups: 
monophenanthrenes, diphenanthrenes and triphenanthrenes. By far, the most 
phenanthrenes occur in monomeric form; however, diphenathrenes still comprise 
approximately 40 different naturally occurring species.[210] A series of bisphenanthrenes, the 
Blestriarenes family 155 (Figure 24), were isolated from Bletilla striata, the plant used in 
Chinese folk medicine to treat pulmonary disorders. They were found to exhibit antibacterial 
efficacy against a variety of microorganisms, with Blestriarene B (155b) showing the highest 
activity.[212]  
 
Figure 24. Structures of Blestriarenes A, B and C. 
Blestriarene C (155c) was recently the target of a diastereoselective total synthesis by the 
group of Miyano and was obtained via an oxidative coupling of the two phenanthrene 
subunits, followed by diastereomeric resolution.[213] The authors reported that on isolation of 
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the enantiopure natural product, rapid racemization was observed, the rate of which was 
strongly dependant on whether or not the sample was exposed to light and oxygen. A follow 
up study concluded that the highly oxygenated phenanthrenes were susceptible to oxidation 
by atmospheric oxygen and could racemize through a cationic radical species (Scheme 
35).[214] The propensity of photoracemization depended strongly on the substituents, and the 
authors could correlate the oxidation potentials of a number of biphenanthrene derivatives 
with their rates of racemization. 
 
Scheme 35. Proposed racemization pathway of Blestriarene C (155c). 
While many biphenanthrenes possess free hydroxyl groups in the 2,2' positions and 
therefore could also potentially participate in such photoracemizations with similar pathways; 
in a selected group of naturally occurring biphenanthrenes these 2,2' positions are protected 
with methyl ether groups (Figure 25).  
Due to hindered rotation about the carbon-carbon between the two phenanthrene units, 
these natural products should be chiral. Indeed, the natural biphenanthrenes Monbarbatain A 
(156a) and Monbarbatain B (156b), isolated from Monomeria babarta Lindl of the 
Orchidaceae family, were both optically active and showed significant cytotoxic activity 
against liver carcinoma HepG-2 and promyelocytic leukaemia HL-60 cell lines.[215] The bulb 
of Monomeria babarta Lindl is used in traditional Chinese folk medicine to treat cough, 
pulmonary tuberculosis and trauma. The tetrahydro biphenanthrene 157 was isolated from 
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Deondrobium plicatile, another plant used in traditional folk medicine as a tonic and to treat 
fever; its structure was established as 2,2'-dimethoxy-9,9',10,10'-tetrahydro-[1,1'-
biphenanthrene]-4,4',7,7'-tetraol.[216] Finally, the prenylated biphenanthrene 158 was isolated 
from the orchid Prosthechea michuacana, traditionally used plant in folk medicine in Mexico 
as a kidney anti-inflammatory, diuretic, in wound healing and in the treatment of diabetes. 
This compound exhibited anti-oxidant activity as a scavenger of the DPPH radical.[217] 
 
Figure 25. Naturally occurring biphenanthrenes Monbarbatain A (156a), Monbarbatain B (156b), 157 and 158. 
To the best of our knowledge, no synthesis of this class of natural products has been 
previously attempted. The structure of Monbarbatain A, with an axis of chirality formed from 
the two fused phenanthrene moieties, could make an interesting target for total synthesis 
using a gold(I)-catalyzed hydroarylation as the key step. Moreover, an approach to access 
larger amounts of this compound could allow the possibility of further evaluating its biological 
activity.  
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2 Previous research of our group in the synthesis of 
[6]helicenes 
2.1 Introduction 
The Alcarazo group had previously studied the Au(I) or Pt(II) catalysed intramolecular 
hydroarylation of alkynes in the synthesis of condensed polyaromatic compounds,[88,106] 
demonstrating a significant enhancement of the reaction rate when α-cationic phosphines 
were used as ancillary ligands. This approach enabled the synthesis of a variety of highly 
twisted phenanthrenes. It was envisaged that the related prochiral diyne 159 could act as a 
suitable substrate for a Au(I) catalysed, intramolecular double hydroarylation sequence, 
which would then afford [6]carbohelicenes 160 (Scheme 36). Because the precursor 159 is 
prochiral, an axis of helical chirality would be formed in this reaction.  
 
Scheme 36. Proposed approach to access [6]helicenes through asymmetric gold catalysis using cationic 
phosphonites.  
Previous work in enantioselective gold catalysis had highlighted the utility of monodentate 
TADDOL derived phosphoramidites, which as ligands in gold catalysis had provided high 
enantioselectivities in a variety of mechanistically different processes.[58,61,218] A novel family 
of chiral cationic phosphonites was therefore proposed (Scheme 36), combining a chiral 
TADDOL framework and a cationic substituent. Due to the electron-withdrawing nature of 
both the oxo- and cationic substituents, it was envisaged that this class of ligands would 
have strong π-acceptor properties and that the corresponding gold complexes would 
efficiently promote a gold(I) catalysed hydroarylation sequence to afford [6]carbohelicenes. 
Moreover, the modular synthesis of TADDOL derivatives would allow the preparation of a 
variety of ligands to be screened in this reaction. The following section will discuss the 
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Alcarazo group’s previous work in the synthesis of cationic phosphonites and the 
applications of their gold(I) complexes in the enantioselective synthesis of 
[6]carbohelicenes.[219,220] 
2.2 Synthesis of cationic phosphonites 
The cationic phosphonite motif in the targeted ligand family had been previously described in 
two literature reports. The first, by the group of Chauvin,[72] offered two different approaches: 
by condensation of N-phenyl-1H-imidazole and chlorodiethylphosphite followed by selective 
N-methylation (Scheme 37A), or through direct condensation of the N-heterocyclic carbenes 
56 and chlorodiethylphosphite at low temperatures (Scheme 37B). Another report by the 
group of Leitner described the metathesis of bis(carbene)silver complexes with the BINOL 
derived chlorophosphite 159a (Scheme 37C).[80] 
 
Scheme 37. Literature reported methods (A)–(C) to synthesize cationic phosphonites 53 and 160a. Reagents and 
conditions: (a) 1-phenylimidazole (1.0 equiv.), nBuLi (1.0 equiv.), Et2O, –78 °C to rt, 4 h, then (EtO)2PCl (1.0 
equiv.), –78 °C to rt, 2 h; (b) MeOTf, toluene, rt, 2h; (c) 56 (1.0 equiv.), Et2O, –78 °C, 15 min; (d) THF, rt, 2 h; the 
yield is not reported. 
From these options, the most preferable approach would be to allow free carbenes to directly 
react with chlorophosphites, (Scheme 35B) which would permit the incorporation of bulky 
and readily available N-heterocyclic carbenes (NHCs). Following the aforementioned 
strategy, the cationic phosphonites 169a–k were synthesized using TADDOL derivatives with 
different aryl substituents and acyclic or cyclic backbones, as well as the NHC 56b and the 
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cyclic(alkyl)(amino)carbene (CAAC) 56c (Scheme 38). This was achieved by addition of the 
carbenes to the corresponding chlorophosphites at –78 °C and allowing the reaction mixture 
to warm up to room temperature overnight, before exchanging the counter ion to 
hexafluoroantimonate and purification by column chromatography.  
 
Scheme 38. Synthesis of cationic phosphonites 169a–i,k from chiral TADDOL derivatives. Reagents and 
conditions: (a) 170 (1.0 equiv.), molecular sieves 4 Å, Et3N (3 equiv.), PCl3 (1.05 equiv.), toluene, 60 °C, 1 h; (b) 
170 (1.0 equiv.), molecular sieves 4 Å, pyridine (3 equiv.), PCl3 (1.1 equiv.), toluene, 60 °C, 1 h; (c) (i) 56 (1.0 
equiv.), Et2O, –78 ° to rt, 16 h; (ii) NaSbF6 (3.0 equiv), MeCN, rt, 2 h; (d) 56 or (0.7 to 0.9 equiv.), NaSbF6 (3.0 
equiv.) Et2O, –78 °C to rt, 16 h. aPrepared using conditions (a), then (c). bPrepared using conditions (b), then (d). 
Certain optimizations led to improved yields in this protocol.[219] Firstly, it was found that 
triethylamine hydrochloride, formed upon preparation of the chlorophosphites, was difficult to 
remove and subsequently protonated the free carbenes 56 in the next step. This could be 
avoided by using pyridine instead, as pyridinium chloride could be easily separated. 
Secondly, it was found that the ion exchange to hexafluoroantimonate could be performed in 
situ, reducing the number of synthetic steps in the sequence. Finally, greater yields could be 
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obtained by purifying the crude reaction mixture by column chromatography at reduced 
temperatures. 
The ligands were then coordinated to gold using the gold precursor (dimethyl sulfide)gold(I) 
chloride, affording the gold complexes 172a–e and 172i in good to excellent yields (Scheme 
39).  
 
Scheme 39. Synthesis of gold(I) complexes 146 from cationic phosphonites 145. Reagents and conditions: (a) 
145 (1.0 equiv.), (Me2S)AuCl (1.0 equiv), CH2Cl2, –20 °C to rt, 1 h. a(Me2S)AuCl (1.2 equiv.), CH2Cl2, rt, overnight. 
Conversely, reactions with the ligands 169f–169h and 169k led to complete decomposition. 
The well-defined species 173 and 174a, relating to the decomposition of 169k, as well as 
175a and 174a, resulting from the decomposition of 169g could be isolated and 
characterized (Scheme 40). The proposed mechanism followed previous work published by 
Seebach and coworkers on the decomposition of electron-rich TADDOLs in acidic media.[221] 
In the case of 169k and 169g, it was proposed that the gold(I) complex should indeed form, 
but would be unstable due to the possibility of forming transient diarylsubstituted 
carbocations, which would then decompose through a Friedel-Crafts-type alkylation–
elimination–1,2-aryl shift cascade leading to the compounds shown in Scheme 40. This 
process was proposed to be triggered by the highly electron deficient nature of the gold-
coordinated phosphonite with a CAAC substituent, making this fragment an excellent leaving 
group. Additionally the higher conformational freedom of the TADDOL subunit with an acyclic 
backbone, would likely enable the gold complex to adopt conformations prone towards 
elimination processes more easily.[219] 
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Scheme 40. Decomposition of 169k and 169g into phosphonous acids 173, 175a and naphthalene 174a upon 
attempted coordination to gold(I). Reagents and conditions: (a) 169k,g (1.0 equiv.), (Me2S)AuCl (1.0 equiv), 
CH2Cl2, –20 °C to rt, 1 h. 
2.3 Preparation of helicene precursors 
The substrate 159 with a 1,2,7,8-tetrasubstituted naphthalene core was synthesized through 
a six-step sequence from 2,7-dimethylnaphthalene (179), which in turn was prepared in two 
simple steps (Scheme 41). A regioselective bromination at the positions 1 and 8 allowed the 
subsequent introduction of aryl substituents through Suzuki-Miyaura coupling. Attachment of 
2-naphthyl substituents led to syn- and anti-conformers due to hindered rotation of the two 
aryl substituents, which were visible in the 1H NMR spectrum even upon heating to 50 °C. 
Radical bromination, hydrolysis, oxidation and Seyferth-Gilbert homologation then gave 
access to the terminal diynes 186, which could be further functionalized by alkylation or 
Sonogashira-Hagihara coupling. Although limited by the necessity of introducing aryl 
substituents close to the beginning of the synthetic sequence, which restricted installations of 
some functional groups in these positions, the robust chemistry involved, mostly high yields 
and the straightforward purification of many of the steps allowed the synthesis to be 
conducted on a multigram scale. A summary of the synthesized derivatives of 159 is shown 
inTable 2.[219]  
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Scheme 41. Synthesis of terminal diynes 186a–d starting from compounds 176 and 177. Reagents and 
conditions: (a) 176 (1.1 equiv.), Mg (1.5 equiv.), Et2O, 35 °C, 3.5 h, then 177 (1.0 equiv.), 15 °C, 1 h; (b) AcOH 
(glacial), HBr (40% aq.), 100 °C 1h; (c) NBS (2.0 equiv.), DMF, rt, 12 days; (d) RB(OH)2 (4.0 equiv), Cs2CO3 (3.0 
equiv.), Pd2(dba)3 (4 mol%), SPhos (8 mol%), 1,4-dioxane/toluene, 100 °C, 2-16 h;(e) Bz2O2 (5 mol%), NBS (2.0 
equiv.), benzene, reflux, 5 h, (f) CaCO3 (5.5 equiv.), 1,4-dioxane/H2O, reflux, 48 h; (g) PCC (3.0 equiv.) CH2Cl2, 
reflux, 1 h,; (h) 185 (3.0 equiv.), K2CO3 (5.0 equiv.), MeOH, rt, 20 h. 
Table 2. Synthesis of substrates 159 according to Sonogashira-Hagihara coupling.  
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Table 3 (continued). 
Entry R1 R2 159 Yield (%) 
1 H Me 159aa 80a 
2 H p-Tolyl 159ab 80b 
3 H Ph 159ac 55b 
4 H 4-Cl-C6H4- 159ae 65b 
5 H 3,5-Me2-C6H3- 159ad 86b 
6 MeO p-Tolyl 159bb 97b 
7 MeO (S)-(1-phenylethoxy)-C6H4- 159bf 75b 
8 Ph p-Tolyl 159cb 73b 
9 Cl p-Tolyl 159ob 66b 
10 MeO Me 159ba 62a 
11 MeO 4-Cl-C6H4- 159be 63b 
12 MeO 4-TMS-C6H4- 159bg 61b 
13 MeO 4-TIPSOCH2-C6H4- 159bh 92b 
Reagents and conditions: (a) LiHMDS (3.5 equiv.), MeI (5.0 equiv.), THF, –20 °C to rt, 2.5–3 h; (b) R2I (4.0 
equiv.), Pd(PPh3)4 (5.5 mol%), CuI (9 mol%), NHiPr2/THF, rt, 3 h. aPrepared according to conditions (a). 
bPrepared according to conditions (b). 
2.4 Enantioselective synthesis of helicenes 
With the helicene precursors 159 in hand, attention turned towards their transformation into 
[6]carbohelicenes 160. Following promising initial results of screening with achiral 
catalysts,[219] the asymmetric gold(I)-catalyzed intramolecular hydroarylation was studied 
using the family of cationic phosphonite gold(I) complexes 172. In initial tests with the methyl-
substituted diyne 159aa, consistently low ee's were obtained; however, switching to the aryl-
substituted substrate 159ab dramatically improved the enantioselectivity. A rigorous 
screening of ligands, solvents and temperatures was conducted aiming to achieve: high 
conversion of both 159ab and the intermediate 187; high regioselectivity towards the desired 
helicene 160ab over the undesired 6-endo-dig/ 5-exo-dig product 188ab; and high 
enantiomeric excess of 188ab.[219] Gratifyingly, the precatalyst 172i, with an acyclic backbone 
and para-trifluoromethyl groups furnished the helicene 160ab with excellent yield, regio- and 
enantioselectivity. A comparative study using phosphoramidites with the same TADDOL-
substructure displayed poorer conversion and selectivities, demonstrating that the 
imidazolium moiety was not only key to the high activity of the catalysts, but also the regio- 
and enantiocontrol.[219] Under the optimized conditions, the scope of the reaction was 
evaluated for the substrates 159 (Table 3). An aromatic substituent proved to be important to 
maintain high ee's, with 63% and 30% ee being obtained for methylated diynes 159aa and 
159ba, respectively (entries 1 and 10). The phenyl- and 3,5-(dimethyl)phenylsubstituted 
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compounds 159ac and 159ad gave regio- and enantioselectivities similar to 159ab, although 
appreciable amounts of the intermediates 187ac and 187ad were detected due the poor 
solubility of both substrates in fluorobenzene (entries 3 and 4). 
Table 3. Scope of the asymmetric gold-catalyzed synthesis of [6]carbohelicenes 160.  
 
Entry 159 R1 R2 Yield (%)a 
160: 188: 
187 
ee (%) 
1 159aa Me H 82 99: 1: 0 +63 
2 159ab p-Tolyl H 88 97: 3: 0 +91 
3 159ac Ph H 77 82: 4: 14 +92 
4 159ad 3,5-Me2-C6H3- H 99 57: 4: 38b +89 
5 159bb p-Tolyl MeO 99 88: 12: 0 +78 
6 159cb p-Tolyl Ph 84 97: 3: 0 +82 
7 159ba Me MeO n. d. 98: 2: 0 +30 
8 159be 4-Cl-C6H4- MeO 92 87: 13: 0 +95 
9 159bg 4-TMS-C6H4- MeO 64 73: 27: 0 +94 
10 159bh 4-TIPSOCH2-C6H4- MeO 94 80: 20: 0 +82 
Reagents and conditions: (a) 172i (10 mol%), AgSbF6 (10 mol%), C6H5F, –20 °C, 96 h. Unless otherwise stated, 
all reactions reached >95% conversion of 159. aCombined yields of inseparable isomers 160, 188 and 187. b6% 
of 159ad remained in the reaction mixture. 
Introducing a phenyl substituent to the helicene periphery in 159cb resulted in the same level 
of regioselectivity but lower enantioselectivity (entry 6), whereas methoxy groups in the same 
positions (entry 5) resulted in lower both regio- and enantioselectivity. Maintaining methoxy 
groups in these positions and varying the substituent on alkyne moieties (entries 8–10), 
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resulted in consistently low regioselectivities, although excellent enantioselectivities were 
observed for the 4-chlorophenyl- and 4-(trimethylsilyl)phenylsubstituted derivatives 160be 
and 160bg.[220] In summary, of the substrates 159 tested in this screening, it could be seen 
that maintaining high conversion, selectivity and enantioselectivity remained challenging, as 
even small changes in the substrate structures could either affect solubility and reduce 
conversion, or have large impacts on the regio- or enantioselectivity of the reaction.  
Finally, to investigate whether the first or second cyclisation of the process was 
enantiodetermining, the diastereomeric intermediate 187bf was prepared, bearing chiral (S)-
1-phenylethoxy substituents. On measuring variable temperature 1H NMR, two coalescence 
phenomena could be seen (Figure 26).  
 
Figure 26. Coalescence phenomena of diastereomeric tetrahelicene intermediate 53bf. 
The first (313 K, blue arrows, interconversion of Ha with Hd and Hb with Hc), relating to 
rotation of the arene located in the bay of the tetrahelicene core does not lead to 
racemization; while the second (338 K, red arrow) relating to the complete inversion of the 
tetrahelicene skeleton, leads to racemization. The 1H NMR spectrum of the methoxy region 
in 187bf relating to MeO(I), MeO(II), MeO(I’) and MeO(II’) is shown in Figure 26. At their 
respective coalescence temperatures, the activation barriers ΔGǂ were calculated to be 59.4 
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and 74.5 kJ mol-1 for the ring rotation and skeleton inversion, respectively. These were in 
agreement for previously reported literature values for related tetrahelicenes.[222] From the 
Eyring plot of the rates of exchange for skeletal inversion at varying temperatures, the 
thermodynamic parameters could be estimated. The enthalpy of activation was found to be 
relatively low (ΔHǂ = 33.5 kJ mol-1) and the entropic contribution was negative (ΔSǂ = -0.13 
kJ mol-1), indicating a highly ordered transition state. Because of this it was proposed that the 
racemization process of tetrahelicene 187bf occurs via a transition state where the 
tetrahelicene core and the phenyl substituent are perpendicular, i.e. where the skeletal 
inversion and the ring rotation occur simultaneously (shown as a red arrow in Figure 26). 
Finally, the half-life of diastereomeric interconversion was determined to be approximately 5 
seconds at -20 °C, indicating that the intermediate of the reaction racemises much too 
quickly for the first cyclisation to be enantiodetermining. From these results it was concluded 
that the reaction proceeds via a dynamic kinetic resolution of the enantiomers of 
intermediates 187bf.[219] 
2.5 Summary 
In summary, an enantioselective sythesis of [6]carbohelicenes 160 from diyne precursors 
159 was developed, utilising a novel family of TADDOL-derived phosphonite ligands with an 
α-imidazolium substituent. These ligands benefit from a modular synthesis and can be 
accessed in high yields. The helicene precursors 159 were accessed in a 9-step procedure 
that is both robust and scalable, however suffers from the number of synthetic steps involved 
and a limited functional group tolerance and modularity in the arene substituents directly 
attached at the 1-and 8-positions of the naphthalene core. After a thorough screen of 
conditions and gold-complexes, the cationic phosphonite gold-complex 172i, with an acyclic 
backbone and para-trifluoromethyl groups at the TADDOL moiety was found to furnish the 
helicene 160ab from 159ab in excellent yield, regio- and enantioselectivity. Furthermore, 
control studies with structurally related phosphoramidite ligands found the cationic 
substituent to be crucial to these results. A preliminary screen of other helicene precursors 
however, showed that maintaining high conversion, regio- and enantioselectivity was a 
challenge in this transformation. Finally, an NMR study concluded that the reaction proceeds 
via a kinetic dynamic resolution of the tetrahelicene intermediates 187, which under the 
reaction conditions rapidly racemise. 
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3 Project aims 
In light of the group’s previous work in the synthesis of cationic phosphonite gold complexes 
and their applications towards enantioselective hydroarylation reactions, an expanded 
investigation will be conducted (Chart 1). The content of this thesis will target the following 
areas: 
i. In order to evaluate the scope of the enantioselective transformation of 159 into 160, 
a wider variety of precursors 159 will be synthesised. Firstly, a greater variety of 
alkyne substituents will be incorporated using the established synthesis of 159. 
Secondly, alternate synthetic routes towards 159 will be considered, aiming to reduce 
the number of synthetic steps and allow the easy introduction of different aromatic 
and heteroaromatic substituents at the 1- and 8-positions of the naphthalene core. 
ii. To probe the wider influence of structural changes to the cationic phosphonite ligand 
family, in addition to further modulating the TADDOL back-bone structure, a number 
of additional cationic groups will be incorporated and studied. Furthermore, the 
synthesis of cationic phosphonites with a BINOL scaffold will be attempted. 
iii. The gold complexes of the new cationic phosphonite ligands will be evaluated as 
precatalysts in the enantioselective synthesis of helicenes 160, aiming to widen the 
scope of the transformation and afford consistently high conversion, regioselectivity 
and enantioselectivities. In addition, the absolute configuration of the helicenes 
formed using this methodology will be assigned. 
iv. The new and existing cationic phosphonite gold(I) precatalysts will be evaluated in 
the enantioselective synthesis of the naturally occuring bisphenanthrene 
Monbarbatain A (156a). In order to achieve this, a retrosynthetic analysis will be 
conducted, focusing on a key asymmetric gold(I) catalysed intramolecular double 
hydroarylation reaction as the key step. 
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Chart 1. Proposed composition of chiral cationic phosphonites and the applications of their gold(I) complexes 
towards enantioselective hydroarylation reactions. 
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4 Synthesis of new [6]helicene precursors 
4.1 Synthesis of new [6]helicene precursors using existing 
methodology 
From a preliminary screening of different substrates 159 (see above), it was apparent that 
obtaining consistently high yields, regio- and enantioselectivities was a challenge in the 
synthesis of helicenes 160. Considering the high potential of this system, the evaluation of a 
greater variety of substrates would be interesting to extend the scope of this transformation. 
Firstly, it was clear that aryl substituents at the alkyne were necessary for good ee's under 
the optimised conditions. Secondly, the regioselectivity was also not significantly affected on 
changing the substituents in this position. Fortunately, the existing substrate synthesis 
permitted diverse functionalization of the building block 186 with different arene substituents 
via Sonogashira-Hagihara coupling (Table 4). 
Table 4. Synthesis of new substrates 159 via Sonigashira Hagihara coupling, bromination and silylation. 
 
Entry 159 R Yield (%) 
1 159af 4-F-C6H4- 76a 
2 159ag 4-MeO-C6H4- 85a 
3 159ah 4-BnO-C6H4- 73a 
4 159ai 4-TMS-C6H4- 53a 
5 159aj 4-iPr-C6H4- 37a 
6 159ak 3,4-(Me)2-C6H3- 64a 
7 159al 4-TIPSOCH2-C6H4- 45a 
8 159am 4-MeOCH2-C6H4- 75a 
9 159an Br 88b 
10 159ao TMS 54c 
11 159ap TIPS 39c 
Reagents and conditions: (a) 186a (1.0 equiv.), Ar-I (4 equiv.), Pd(PPh3)4 (5.5 mol%), CuI (9 mol%), iPr2NH/THF, 
rt, 3–5 h; (b) 186a (1 equiv.), AgNO3 (13 mol%, NBS (2.4 equiv.), acetone, rt, 30 min; (c) 186a (1.0 equiv.), nBuLi 
(2.2 equiv.), –78 °C, 1 h, then TMSCl or TIPSCl (2.2 equiv.), –78 °C, 30 min, then rt, 3 h. a According to conditions 
(a). b According to conditions (b). c According to conditions (c). 
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A variety of electron-donating and electron-neutral substituents, such as protected phenols 
(entries 2 and 3), silanes (entry 4), alkanes (entries 5 and 6) and protected benzylic alcohols 
(entries 7 and 8), were installed (Table 6). For comparison, substrate 159af with a para-
fluorophenyl substituent was also synthesized (entry 1). The terminal alkyne 186a was 
additionally functionalized as the dibromide 159an as well as the trimethylsilyl and 
triisopropylsilyl derivatives 159ao and 159ap (entries 9–11). 
Furthermore, motivated by the prospect of synthesizing dibenzohelicenes, the substrate 
159db, bearing two 2-naphthyl substituents, was prepared from the precursor 181d following 
the sequence outlined in Scheme 42. Because of the instability of dialdehyde 184d toward 
purification by column chromatography, the terminal diyne 186d was prepared according to a 
four-step procedure. As discussed above, compound 181d had demonstrated syn-anti 
conformerism in the 1H NMR spectra. These conformers did not coalesce on heating up to 
60 °C, and their ratio remained the same until the final step of the sequence, with the final p-
tolyl-substituted diyne 159db having a syn/anti ratio of 45: 55.  
 
Scheme 42. Synthetic sequence to access alkyne 159db. Reagent and conditions: (a) Bz2O2 (6.7 mol%), NBS 
(2.2 equiv.), benzene, reflux, 7 h, (b) CaCO3 (5.5 equiv.), 1,4-dioxane/H2O, reflux, 48 h; (c) PCC (3.0 equiv.) 
CH2Cl2, reflux, 1 h; (d) 185 (3.0 equiv.), K2CO3 (4.0 equiv.), MeOH, rt, 20 h; (e) Ar-I (4 equiv.), Pd(PPh3)4 (5.6 
mol%), CuI (9.0 mol%), iPr2NH/THF, rt, 4 h.  
Although the naphthalene substituent in 159db has two reactive centers for possible 
nucleophilic attack, the position 1 is generally accepted to be the most nucleophilic (Figure 
27). An initial 6-endo-dig cyclization from this position would result in tetrahelicene 
intermediate 180db. This would likely have greater conformational freedom than the 
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substrate 167db and be able to racemize according to skeletal inversion/rotation of the 
second 2-naphthyl substituent. If the kinetic dynamic resolution would still take place, then 
the product of the reaction would be enantioenriched (Figure 27). However, this would 
strongly depend on the regioselectivity of the reaction. 
 
Figure 27. Postulated racemization process of intermediate 180db, formed after the first gold(I)-catalyzed 
intramolecular hydroarylation in substrate 167db. 
4.2 Development of a new synthesis of [6]helicene precursors 
The existing synthesis of the helicenes substrates 159 involved nine synthetic steps, 
functional group interconversions and had a relatively limited scope. Moreover, the variation 
of the aryl substituents at the 1- and 8-positions of the naphthalene core was difficult, namely 
due to the necessary installation of these groups early on in the sequence. Despite of this, 
modulation of the substituents at the periphery of the helicene most probably has a larger 
impact on their electronic structure and thus on the possible applications of this interesting 
class of compounds. Therefore, a modified procedure was envisaged according to the 
retrosynthetic analysis shown in Scheme 43. This is based on previously reported strategies 
for the synthesis of ortho alkynyl biphenyls reported by Gevorgyan[223] and Lautens.[224] 
Starting from the commercially available 2,7-dihydroxynaphthalene and following a literature 
reported regioselective bromination at the 1 and 8 positions of the naphthalene with 
subsequent triflation of the free hydroxyl groups, a precursor 189 amenable to a 
chemoselective Sonogashira-Hagihara ethynylation followed by Suzuki-Miyaura coupling 
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would be obtained. This approach would be ideally placed to easily modulate the aromatic 
groups at the 1 and 8 positions of the naphthalene core, enabling the access to a larger 
scope of diyne substrates. Efforts would be made to incorporate heteroaromatics using this 
methodology and add heterohelicenes to the list of substrates amenable to this 
enantioselective hydroarylation. 
 
Scheme 43. Disconnection approach to access substrates 159 from 2,7-dihydroxynaphthalene. 
The proposed synthesis was started by the selective bromination at the 1- and 8- positions of 
commercially available 2,7-dihydroxynaphthalene with N-bromosuccinamide (NBS). This had 
been described in the literature using two sets of conditions, firstly by Whiting, using 
substoichiometric pyridine in chloroform[225] and later by Pérez, carrying out the reaction in 
acetonitrile at 10 °C.[226] Several variations of the conditions described were tried, including 
changing the order of reagents, method of addition and working with or without the exclusion 
of air and moisture. The best conditions in this study were found to be by adding NBS as a 
solid to a solution of 2,7-dihydroxynaphthalene at 10 °C under argon. This method afforded 
an approximately 70% pure product 190 as a mixture with other isomers. Dibromide 190 was 
reported to be unstable for purification by column chromatography but could be conveniently 
converted into stable bis-triflate 9. The latter was obtained in a yield of 26% over two steps. 
In spite of a poor yield, low starting material costs and short preparation times mean that 
larger amounts of this intermediate could be accessed relatively quickly and used in the 
following steps.  
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Scheme 44. Two-step sequence to prepare bis-triflate 189. Reagents and conditions: (a) 2,7-
dihydroxynaphthalene (1.0 equiv.), NBS (2.0 equiv.), MeCN, 10 °C, 2 h; (b) crude 190 (1.0 equiv.), Tf2O (2.3 
equiv.), pyridine (3.0 equiv.), CH2Cl2, 0 °C, 30 min.  
The Sonogashira-Hagihara coupling proceeded chemoselectively to give the bis-alkynes 
188a–c in moderate to good yields, with conservation of the two bromine substituents 
(Scheme 45). However, upon preparation of TMS-substituted diyne 188a, stirring of reaction 
mixture for longer than 1 h periods lead to the formation of additional side products, 
observable by GC-MS. Curiously, the selective mono-Sonogashira coupling of 189 to give 
TMS-substituted alkynylnaphthalene 191 could be carried out when using the less active 
palladium species PdCl2(PPh3)2. 
 
Scheme 45. Sonogashira-Hagihara coupling to give alkynes 188a–c and 191. Reagents and conditions: (a) 189 
(1.0 equiv.), arylacetylene (8–10 equiv.), Pd2Cl2(dppf) (5 mol%), CuI (10 mol%), Et3N/DMF, rt, 1–4 h; (b) 189 (1.0 
equiv.), TMS-acetylene (2.0 equiv.), PdCl2(PPh3)2 (5 mol%), CuI (10 mol%), Et3N/DMF, rt, 16 h. 
Single crystals of 188b were grown by slowly cooling a hot ethyl acetate solution. The solid 
state structure is shown in Figure 28. The two bromine atoms, forced into close proximity due 
to their position on the naphthalene ring, display a large steric repulsion, bending the whole 
naphthalene core out of the plane and resulting in a torsional angle of 30.0° between the two 
bromine atoms. 
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Figure 28. Structure of diyne 188b in the solid state. Solvent molecules and counterions are omitted for clarity. 
Thermal ellipsoids set at 50% probability, the numbering does not correspond to the IUPAC rules. Selected bond 
lengths (Å) and angles (°): C1–Br1 = 1.897(1), C2–Br2 = 1.889(1), Br1–C1–C2–Br2 = –29.96(7). 
Finally, the Suzuki-Miyaura coupling of the precursors 188 was evaluated for a variety of 
aromatics and heteroaromatics (Table 5).  
Table 5. Suzuki-Miyaura coupling with compounds 188b and 188c.  
 
Entry 159 R1 R2 Yield (%) 
1 159eb p-Tolyl 2-thienyl 51 
2 159fb p-Tolyl 2-furanyl 88 
3 159gb p-Tolyl 3-thienyl 57 
4 159hb p-Tolyl 3-furanyl 45 
5 159ib p-Tolyl 4-TMS-C6H4- 37 
6 159jb p-Tolyl 4-BnO-C6H4- 46 
7 159kb p-Tolyl 4-MeOCH2-C6H4- 54 
8 159lb p-Tolyl 4-Ph-C6H4- 24 
9 159mb p-Tolyl 3,5-(MeO)2-C6H3- 63 
10 159nb p-Tolyl 3,5-Me2-C6H3- 34 
11 159ag 4-MeO-C6H4- C6H5 53 
12 159pg 4-MeO-C6H4- p-Tolyl 50 
13 159ig 4-MeO-C6H4- 4-TMS-C6H4- 25 
14 159qg 4-MeO-C6H4- 4-F-C6H4- 34 
15 159ng 4-MeO-C6H4- 3,5-Me2-C6H3- 39 
Reagents and conditions: (a) 188 (1.0 equiv.), ArB(OH)2 (3.0–4.3 equiv.), Cs2CO3 (3.0 equiv.), Pd2(dba)3 (4 
mol%), Sphos (8 mol%), THF/H2O, 60 °C, 1–16 h. 
This was carried out according to a modified procedure reported by Buchwald for the 
coupling of bulky participants,[227] although using a ten to one  mixture of tetrahydrofuran and 
C1 C2 
Br1 Br2 
188b 
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water as solvent was found to improve conversion. A variety of aromatic and heteroaromatic 
groups could be incorporated, including thiophenes and furans. For these both, the 2- and 3-
substituted thienyl- and furanylboronic acids were employed. In addition, para-functionalized 
aromatics, including 4-trimethylsilyl-, 4-benzyloxy-, 4-methoxymethyl-, 4-phenyl-, 4-methyl- 
and 4-fluorophenyl, as well as the meta-substituted 3,5-dimethoxy- and 3-5-dimethylphenyl, 
could also be installed. Single crystals suitable for X-ray diffraction, could be grown for the 
products 159eb, 159fb, 159gb and 159ib, confirming their structural identity (Figure 29). 
 
Figure 29. Solid state structures of compounds 159eb (A), 159fb (B), 159gb (C) and 159ib (D). Solvent 
molecules and counterions are omitted for clarity. Thermal ellipsoids set at 50% probability. 
Unfortunately, the Suzuki-Miyaura couplings were not completely selective. Despite full 
conversion being reached in almost all cases, the yields of the transformations remained 
mostly poor or moderate. No single major side product could be identified in the crude 
reaction mixtures, although one clue as to the types of additional products formed could be 
elucidated from the structure of deep red dinaphthopentalene 192, which crystallized from 
the crude reaction mixture upon preparation of 159kb (Figure 30). As they possess only 8 π-
electrons, pentalenes are formally anti-aromatic. Typically, pentalenes exhibit a relatively 
small HOMO-LUMO gap, due to the propensity to accept or donate electrons to relieve their 
anti-aromaticity.[138] While helicenes containing a pentalene subunit, to the best of our 
knowledge, have not been reported, the incorporation of anti-aromatic subunits into 
polyaromatic structures such as helicenes has been previously shown to significantly alter 
their electronic properties.[143,228]  
(A) (B) 
(C) (D) 
159eb 159fb 
159gb 159ib 
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Figure 30. Solid state structure of 192. Solvent molecules and counter ions are omitted for clarity. Thermal 
ellipsoids set at 50% probability. 
The group of Don Tilley has reported the synthesis of dibenzopentalenes via the palladium-
catalyzed homocoupling of ortho-alkynylaryl bromides under reductive conditions at high 
temperatures, with yields as high as 88%.[229]  
 
Scheme 46. Reductive homodimerization to give dibenzopentalenes. Reagents and conditions: (a) hydroquinone 
(2.0 equiv), Cs2CO3 (2.0 equiv), CsF (2.2 equiv.), Pd2(dba)3 (1.5 mol%), P(tBu)3 (6 mol%), 1,4-dioxane, 135 
°C.[229]  
Presumably, the product 192 is formed through the mechanism shown below, which is based 
on the findings of the group of Don Tilley (Scheme 47). Firstly, a Suzuki coupling would take 
place, giving monobrominated intermediate 195. After oxidative addition to the second 
carbon-bromine bond, instead of proceeding through a second transmetalation, the Pd(II) 
species 196 would undergo a migratory insertion with a second equivalent of the 
intermediate 195. The vinyl palladium(II) species 197 would then participate in a second 
migratory insertion, completing the first cyclopentadiene ring and giving intermediate 198. 
Finally, after oxidative addition to the closely proximal carbon-bromine bond in 198, reductive 
elimination from the resulting palladium (IV) species 199 would afford the 
dinaphthopentalene product 192and a palladium(II) species. The low yields of this product 
192 
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192 may result from the lack of reductant in the reaction mixture, as the palladium(II) should 
be reduced back to palladium(0) to continue the catalytic cycle. 
 
Scheme 47. Proposed mechanism for the formation of compound 192. 
The solid-state structure of the product 192 suggests that the molecule may not yet be chiral, 
as the aromatic substituents in the two bay areas lie parallel to one another. Moreover, it can 
be considered as a potential substrate for a gold-catalyzed intramolecular hydroarylation, 
which would give the S-shaped fused double [5]helicene 200 (Scheme 48). The synthesis of 
fused helicenes and higher order polyaromatic structures has attracted a great deal of 
attention recently;[140,230,231] however to the best of our knowledge, only one example of an 
attempted enantioselective synthesis of a fused dihelicene[232] as well as one example of a 
fused diheterohelicene[208] have been reported up to now. If the compound 192 could be 
synthesized in better yield, it may offer an exciting entry to this emerging field of research. 
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Scheme 48. Possible transformation of 192 in gold(I)-catalyzed hydroarylation reactions. 
4.3 Summary 
In summary, a variety of new helicene precursors 159 were synthesised. Because the 
existing synthesis for helicene precursors 159 enabled modulation of the alkyne substituent; 
a broad range of aromatic substituents were installed using this methodology, incorporating 
functional groups amenable to further transformations such as ethers, protected phenols, 
silanes and halogens. The alkyne was additonally brominated and silylated in the interest of 
further study. 
In addition, a new synthetic route to diynes 159 was developed, which significantly lowered 
the number of synthetic steps required and allowed the introduction of a diverse range of 
aromatic and heteroaromatic groups directly onto the naphthalene core, which was a 
challenge when using the existing precursor synthesis. The new synthesis of 159 proceeded 
through a regioselective bromination of 2,7-dihydroxynaphthalene, followed by triflation, 
chemoselective Sonogashira-Hagihara coupling and finally Suzuki-Miyaura coupling. The 
final Suzuki-Miyaura coupling however, gave trace amounts of side products, one of which 
could be identified as the dinaphtho pentalene 192. This is likely formed via a palladium 
catalysed, reductive dimerisation reaction, which if it could be optimsied further may provide 
an entry towards fused dihelicenes with an anti-aromatic core. 
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5 Synthesis and structure of cationic phosphonites 
5.1 Synthesis of cationic phosphonites from TADDOL derivatives 
Following an interest in further diversifying additional aspects of the cationic phosphonite 
ligand structure, wider modulation of the cationic substituents of the aromatic groups of the 
TADDOL subunit, as well as the cyclic or acyclic nature of the TADDOL backbone was 
targeted. Accordingly, the phenyl-substituted TADDOL (S,S)-170l,[233] its acyclic analogue 
(R,R)-170q[52] as well as the cyclohexyl-acetal derivative (R,R)-170t[234] were synthesised to 
systemically evaluate the effect of the backbone on the ligand structure (Scheme 49).  
 
Scheme 49. Targeted TADDOL derivatives bearing different cyclic or acylic substituents at the backbone. 
Reagents and conditions: (a) PhMgBr (5 equiv.), THF, reflux, 2 h.  
Furthermore, the electron-deficient TADDOL derivative (R,R)-170s, decorated with 3,5-
bis(trifluoromethyl)phenyl substituents, was synthesized in 72% yield according to a modified 
literature procedure[186–188] by adding a solution of freshly prepared 3,5-bis(trifluoromethyl)-
phenylmagnesiumbromide to a solution of 201b in tetrahydrofuran and refluxing for 2 hours 
(Scheme 50). 
 
Scheme 50. Synthesis of TADDOL derivative 170s. Reagents and conditions: (a) 3,5-bis(trifluoromethyl)-
bromobenzene (5.0 equiv.), Mg (5.0 equiv.), I2 (cat.), THF, 70 °C, 2 h, then 201b (1.0 equiv.), 70 °C, 2 h.  
A variety of new cationic groups were proposed, comprising a variety of electronic and steric 
environments (Scheme 51). Accordingly, the carbodiphosphorane (202),[235,236] and the N-
 5. Synthesis and structure of cationic phosphonites  
78 
heterocyclic carbenes IPr (56a), IMes (56b),[237] MeIiPr (56d),[238] ClIMes (56e)[239] and MeIMes 
(56f)[240] were prepared in gram scale following established literature procedures.   
 
Scheme 51. Carbenes 56 and carbodiphosphorane 202 targeted for the synthesis of cationic phosphonites. 
Attention then turned towards the synthesis of the cationic phosphonite ligands themselves. 
The new ligands were all prepared by condensation of the chlorophosphites with the 
carbenes or carbodiphosphorane, followed by ion exchange to hexafluoroantimonate, in 
analogy to the synthesis of phosphonites 169a-i, k described in the second chapter of this 
thesis. Chlorophosphites 171l and 171m were prepared according a procedure originally 
reported by Fürstner;[52] by heating suspensions of the TADDOL derivative, trichlophosphine, 
triethylamine and molecular sieves 4 Å in toluene, followed by filtration to remove the 
triethylammonium chloride by-product and concentration in vacuo. However, as discussed 
above, it was found that the carbenes 56 used in the condensation were susceptible to 
protonation by residual amounts of triethylammonium chloride, which is known to be partially 
soluble in many organic solvents and thus difficult to completely remove from the crude 
chlorophosphites 171. Nevertheless, the carbodiphosphorane-derived cationic phosphines 
169l and 169m could be prepared in this fashion (Scheme 52). The formation of the new 
species was clear in the 31P NMR, showing a characteristic doublet at 20.4–20.6 ppm and a 
triplet at 175.1–179.5 ppm, with coupling constants of 91.8 (169l) and 100.9 (169m) Hz. 
Phosphonite 169l could be easily purified by simply recrystallizing the crude mixture from 
dichloromethane and pentane after ion exchange. In the case of 169m, formation of the 
ligand was slow, and full conversion of the chlorophosphite was only reached on addition of 
two equivalents of carbodiphosphorane 201 and heating to 60 °C. To our satisfaction, after 
ion exchange to the hexafluoroantimonate anion, 169m could be purified by column 
chromatography and isolated in a 32% yield.  
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Scheme 52. Synthesis of cationic phosphonites 169l and 169m. Reagents and conditions: (a) 170l (1.0 equiv.), 
PCl3 (1.1 equiv.), NEt3 (2.2 equiv.), THF, –78 °C, 1h, then rt, 1h; (b) 202 (1.0 equiv.), THF, rt, 16 h; (c) NaSbF6 
(excess), MeCN, rt, 16 h; (d) 170g (1.0 equiv.), PCl3 (1.2 equiv.), NEt3 (3.0 equiv.), toluene, 0 °C, then 60 °C, 1 h; 
202 (0.9 equiv.), THF, rt, 24 h, 202 (0.9 equiv.), 60 °C, 4 h. 
The ligands 169n–t could be prepared in moderate to very good yields (Scheme 53), 
following the previously discussed optimisations outlined in the second chapter of this thesis. 
The formation of the ligand 169p with larger IPr carbene moiety and bearing the bulky 
biphenyl substituents at the TADDOL backbone proved to proceed slower and gave poor 
conversion; however, adding the carbene to the chlorophosphite at –40 °C, followed by 
stirring the mixture for a further 24 h after allowing to warm up to room temperature enabled 
169p to be isolated in a yield of 40% after column chromatography. Similarly, due to the 
electron poor nature of the dichlorocarbene 56e, longer reaction times were necessary to 
achieve full conversion of the chlorophosphite in the synthesis of the ligands 169u and 169t. 
Interestingly, no conversion was detected when conducting this reaction in the absence of 
sodium hexafluoroantimonate. This might indicate pre-activation of the chlorophosphite by 
sodium cationic in the reaction mixture, facilitating nucelophilic attack by the carbene. In all 
cases a characteristic shift at between 138.1 and 153.0 ppm in the 31P NMR indicated 
formation of the ligand. 
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Scheme 53. Synthesis of cationic phosphonites 169n–u, 202a and 202b according to optimized protocol. 
Reagents and conditions: (a) diol 170 (1.0 equiv.), PCl3 (1.0–2.0 equiv.), pyridine (3.0-3.2 equiv.), toluene, 60 °C, 
1 h; (b) carbenes 56 (1.0 equiv.), NaSbF6, Et2O, –78 °C to rt, 16 h. Yields over two steps. aCarbene added at –40 
°C and after allowing warming to rt stirred for another 24 h. bAfter warming to room temperature, stirred for a 
further 48 h at ambient temperature.  cAfter warming to room temperature, stirred for a further 24 h at this 
temperature. 
Single crystals suitable for X-ray structure determination of compounds 169q and 169r 
(Figure 31) were grown by slow diffusion of pentane into dichloromethane solutions. In 169q, 
disorder about the phosphorus center can be seen, indicating that two conformational 
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isomers exist in the solid state. Because of the C2 symmetry of the structure however, the 
symmetry of the structure is independent with respect to this orientation. The P1a–C1 
[1.864(4) Å] and P1b–C1 [1.976(5) Å] bond lengths are slightly longer than in previously 
published cationic phosphines with imidazolium substituents (1.813–1.840 Å).[67,78,79] A 
slightly decreased P1–C1 bond length [1.837(5) Å] in 169r are in better agreement with the 
latter values. In both ligands, the phosphorus retains a pyramidal geometry (sum of angles 
for 169q = 298.1°; for 169r = 291.9°), although the steric shielding of the 
bis(mesityl)imidazolium substituent in 169q is higher and the phosphorus atom in 169r is less 
shielded from the side of the cationic substituent.  
 
Figure 31. Molecular structures of compounds 169q (A) and 169r (B). Counterions and solvent molecules are 
omitted for clarity. Thermal ellipsoids at 50% probability. Peripheral arene rings displayed as capped sticks for 
clarity. Selected bond distances (Å): (A) P1a–C1 = 1.864(4), P1b–C1 = 1.976(5), P1a–O1 = 1.595(3), P1b–O1 = 
1.500(4), P1a–O2 = 1.582(3), P1b–O2 = 1.447(5), N1–C1 = 1.332(5), N2–C1 = 1.340(5); (B) P1–C1 = 1.837(5), 
P1–O1 = 1.633(3), P1–O2 = 1.634(3), N1–C1 = 1.367(6), N2–C1 = 1.358(6); sum of angles around phosphorus 
(°): (A) P1a = 298.1, P1b = 309.6; (B) P1 = 291.9. 
Interestingly the products of the reactions between the IMes 56b and chlorophosphites 171t, 
with a 1,1'-cyclohexyl linked backbone and 171s, with bulky 3,5-bis(trifluoromethyl)phenyl 
substituents, exhibited quite different 1H NMR spectra when compared with the series of 
other synthesized ligands. In both cases, characteristic 31P NMR shifts in the same range 
were seen (203a = 145.9; 203b = 143.1 ppm); however, whereas the two protons of the 
imidazolium backbone for the other IMes derivatives gave a single singlet at 7.78 ppm (2H) 
(169n) and 7.73 ppm (2H) (169q) in the 1H NMR, in the ligand 203a two singlets at 8.85 ppm 
and 8.83 ppm, each integrating to one proton, were observable. HSQC measurements could 
also correlate both of these signals with two signals in the 13C NMR at quite different 
chemical shifts (141.7 ppm and 130.5 ppm). The former shift lays in the range normally 
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associated with the carbon adjacent to phosphorus in the other IMes derivatives (169n: 
145.3 ppm, d, JC-P = 64.2 Hz; 169q: 145.4 ppm, JC-P = 66.4 Hz). Definitive proof of the 
structure of 203a could be confirmed by the analysis of single crystals by X-ray 
crystallography (Figure 32); the appropriate single crystals were grown by pentane diffusion 
into a dichloromethane solution.  
   
Figure 32. Molecular structure of compound 152a. Counterions and solvent molecules omitted for clarity. Thermal 
ellipsoids at 50% probability. Peripheral arene rings displayed as capped sticks for clarity. Selected bond lengths 
(Å): P1–C2 =1.807(8), P1–O1 = 1.641(5), P1–O2 = 1.631(5), C2–C3 = 1.35X(1), N1–C1 = 1.394(1); Sum of 
angles around phosphorus = 286.7°. 
As can be seen, the connectivity of the imidazolium fragment to the phosphorus occurs not 
through the C1 carbon, but rather the C2 carbon (Figure 32). This would explain the 
observed discrepancies in the NMR spectra, as both methyne carbons of the imidazolium 
ring would be expected to lie in different environments and give different chemical shifts. 
When comparing the solid state structures of 169q, 169r and 203a, a shortening of the P1–
C2 bond length in 203a is discernible [1.807(8) Å]; this may be because of the specific 
features of electronic density of the abnormally bound cationic substituent. The first abnormal 
carbene was synthesized by Bertrand.[241] Calculations on its structure described this class of 
carbenes to be stronger σ-donors compared to their NHC analogues, with the free lone pair 
comprised of a higher s-character. This stronger σ-donor ability should increase the strength 
of the resulting carbon phosphorus bond and would result in a shortening of P–C bond length 
in 203a.  
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Considering previous reports by Bertrand[68] and Weigand[76,77] into the base mediated 
interconversions of NHC’s, it is possible that the abnormal phosphonites 203a and 203b are 
formed via mechanisms related to those proposed by Bertrand and Weigand, with the IMes 
carbene 56b acting as external base (Scheme 54). Firstly the adduct 169 would form via the 
condensation between 56b and chlorophosphites 171s or 171t. In the absence of any other 
external base other than an excess of carbene 56b, the IMes would transiently deprotonate 
the backbone of the adduct 169 to give the mesoionic carbene 204 and the imidazolium salt 
56b·HX (X = Cl– or SbF6–). The mesoionic carbene 204 would then react with another 
equivalent of 169, giving IMes 56b and the bis-adduct 205. Finally, reaction with one more 
equivalent of the IMes 56b or adduct 169 would regenerate the adduct 203, as well as 56b or 
169, continuing the cycle. 
 
Scheme 54. Proposed mechanism for the formation of cationic phosphonites 203a and 203b. 
It is likely that these species exist in equilibrium with each other, as has also been proposed 
by Weigand.[76,77] The higher σ-donor character of the mesoionic carbene substructure would 
confer a higher stability to the abnormal carbene adduct 204. Presumably, the backwards 
reaction, i.e. displacement of the abnormal carbene adduct 204 from the bis-adduct 205 by 
the carbene 56b, would be less favorable, thus driving the reaction forward. 
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The only difference between the TADDOL precursors (S,S)-170l, (R,R)-170q and (R,R)-170t 
is the backbone linker. The cyclohexyl acetal linker in (R,R)-170t should confer a higher 
conformational rigidity to the corresponding chlorophosphite 171t, which would likely then 
result in a higher steric clash between the TADDOL and IMes subunits, potentially driving the 
formation of the 4-adduct instead. Similarly, the 3,5-bis(trifluoromethyl)phenyl substituents in 
the TADDOL (R,R)-170s should also be quite sterically demanding. Furthermore, it is 
interesting that in both cases, the abnormal adducts were almost exclusively formed and 
could be readily purified. Nevertheless, it is still not clear why in other cases, when using 
sterically demanding systems such as those used in the synthesis of the ligands 169p and 
169e, the normally expected C-2 adducts were exclusively formed instead. 
5.2 Synthesis of BINOL-derived phosphonites 
2,2'-Diphenylsubstituted diol 207, prepared according to a procedure by Jørgensen,[242] was 
considered as a suitable precursor to evaluate the synthesis of BINOL-derived cationic 
phosphonites. When 207 was reacted with carbene 56b under the standard conditions, it 
was evident in the 1H NMR data that two structurally related species, both containing 
imidazolium and BINOL fragments, were formed in almost equal amounts (Scheme 55). After 
careful purification and analysis, the structures of C-2 adduct 208a and C-4 adduct 208b 
could be elucidated. In analogy to the ligands 203a and 203b, this was achieved by 
assignment on the basis of {C–H} interactions in the imidazolium ring through 2D NMR 
experiments and comparison of the chemical shifts.  
 
Scheme 55. Synthesis of compounds 208a and 208b. Reagents and conditions: (a) 207 (1.0 equiv.), PCl3 (1.5 
equiv.), pyridine (3.0 equiv.), toluene, 60 °C, 1 h; (b) 56b (1.0 equiv.), NaSbF6 (3 equiv.), Et2O, –78 °C to rt, 16 h.  
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Additionally, single crystals of 208a suitable for X-ray diffraction could be grown by layering 
toluene over a solution in dichloromethane, unambiguously confirming its structure (Figure 
33). Again, the C1–P1 bond length of 1.890(2) Å is longer than would be normally expected 
for cationic phosphines with an imidazolium substituent.[67,78,79] The phosphorus also retains a 
pyramidal geometry (sum of angles = 304.2°).  
 
Figure 33. Molecular structure of compound 208a. Counterions and solvent molecules are omitted for clarity. 
Peripheral arene rings displayed as capped sticks for clarity. Thermal ellipsoids at 50% probability. Selected bond 
lengths (Å): P1–C1 = 1.890(2), P1–O1 = 1.621(1), P1–O2 = 1.631(1), N1–C1 = 1.358(2), N2–C1 = 1.354(2); 
degree of pyramidalization (°) = 304.2. 
In analogy to ligands 203a and 203b, these two products should be formed accordingly to 
the mechanism proposed in Scheme 54. However, in contrast to ligands 203a and 203b, 
where the C-4 adducts were almost exclusively formed and could be easily purified, a 1:1 
mixture of both C-2 (208a) and C-4 (208b) products was obtained, which severely 
complicated their isolation. In order to avoid this problem, the reactivity of the carbene 
participant was blocked by using its 4,5-dimethyl derivative MeIMes (56f).[240] Accordingly, this 
carbene was subjected to the optimised conditions with chlorophosphite 160b. In this case, 
no rearrangements were observed and the corresponding BINOL-derived cationic 
phosphonite 208c could be prepared in a dramatically improved yield of 73% (Scheme 56).  
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Scheme 56. Synthesis of ligand 208c. Reagents and conditions: (a) diol 207 (1.0 equiv.), PCl3 (1.1 equiv.), 
pyridine (3.2 equiv.), toluene, 60 °C, 1 h; (b) 56f (0.95 equiv.), NaSbF6 (3 equiv.), Et2O, –78 °C to rt, 16 h.  
Single crystals of 208c suitable for X-ray diffraction could be grown by layering a 
dichloromethane solution with toluene. A comparison of bond lengths shows a very strong 
similarity to 208a (Figure 30 and Figure 29), albeit with the exception of the P1–C1 bond 
length, which is notably shorter for the latter [1.890(2) Å in 208c vs. 1.849(6) Å in 208a]. 
 
Figure 34. Molecular structure of 208c. Counterions and solvent molecules are omitted for clarity. Thermal 
ellipsoids  at 50% probability. Peripheral arene rings displayed as capped sticks for clarity. Selected bond lengths 
(Å): P1–C1 =1.849(6), P1–O1 = 1.620(4), P1–O2 = 1.638(4), N1–C1 = 1.365(7), N2–C1 = 1.364(7); degree of 
pyramidalization (°) = 303.0. 
With a series of structurally varied cationic phosphonites in hand, the donor properties and 
coordination chemistry were investigated. 
5.3 Electronic properties 
The Chauvin group had previously described the calculated IR stretching frequencies for a 
series of cationic phosphines and phosphonites bearing imidazolium substituents.[72] Based 
on these reports, cationic phosphonites with imidazolium substituents would be expected to 
be extremely good π-acceptors and weak σ-donors, lying approximately between dicationic 
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77c and tricationic 82a, due to the cumulative electron withdrawing effect of the imidazolium 
and two neighboring oxygen atoms. Unfortunately, attempts to coordinate 169n to 
[RhCl(cod)]2 and [IrCl(cod)2]2 were unsuccessful. The donor capacity of the chiral cationic 
phosphonites 169l, 169o–q and 169b was therefore probed by measuring their oxidation 
potentials using cyclic voltammetry. The results are summarized together with other 
illustrative examples in Table 6.  
The imidazolium substituted 169o, 169p and 169q all undergo irreversible oxidations in the 
range of 1.76–1.88 V, which is located close to the oxidation potential of the monocationic 
imidazoyl/imidazolium phosphine 84a and in between potentials of dicationic and tricationic 
phosphines 77c and 82a. The ligand 203a exhibits a slightly higher irreversible oxidation 
potential of 1.93 V, which is likely a consequence of the electron-withdrawing 3,5-
bis(trifluoromethyl)phenyl substituents at the TADDOL backbone. This appears to off-set the 
expected higher σ-donor capacity of the abnormally bound imidazolium fragment. 
Conversely, the carbodiphosphorane-derived ligand 169l displays a significantly lower 
irreversible oxidation potential of 0.94 V, which is in line with the ylidic nature of the carbon 
atom adjacent to the phosphorus. 
Despite exhibiting high oxidation potentials, the solid state structures of the cationic 
phosphonites all showed a phosphorus center that was pyramidal, implying the existence of 
an active lone pair. Phosphorus-based ligands which exhibited similarly high oxidation 
potentials, such as tricationic phosphine 82a, did not readily coordinate gold(I).[243] It is 
possible that coulombic repulsion between the cationic ligands and the cationic gold atoms 
could have an additional influence. Being only monocationic, it was therefore more probable 
that this cationic phosphonite ligand family would readily coordinate metal centers. 
Additionally, previously observed arene-gold(I) interactions for TADDOL-based phoramidites 
would likely also favour coordination.[61] 
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Table 6. Oxidation and reduction potentials measured using cyclic voltammetry.  
Entry Ligand VOx/ V Entry Ligand VOx/ V 
1 
 
0.94 6 
 
1.40 
2 
 
1.76 7 
 
1.54 
3 
 
1.78 8 
 
2.06 
4 
 
1.88 9a 
 
1.900 
5 
 
1.93 10a 
 
2.45 
All voltammograms were measured using a NBu4PF6 electrolyte solution (0.1 M in CH2Cl2) in the solvents 
indicated. Oxidation potentials were referenced to the ferrocene/ferrocenium oxidation potential. Unless otherwise 
stated, all oxidations were irreversible. aMeasured in MeCN, adapted to the same scale from ref [72] using 
conversion tables listed in ref.[100] 
5.4 Coordination chemistry 
Fortunately, the gold(I) complexes of both TADDOL derived ligands 169l–o, 169q, 169s-u, 
203a,b and the BINOL-derived 164c could be prepared in good to excellent yields by adding 
(dimethyl sulfide)gold(I) chloride to dichloromethane solutions of the ligands at –20 °C 
(Scheme 57). Formation of the desired gold(I) complexes was confirmed by 31P NMR, 
indicated by shifts to 132.5 ppm (t, J = 38.2 Hz) and 129.1 ppm (t, J = 35.5 Hz) for 
carbodiphosphorane derived complexes 172l,m and 106.8–112.8 ppm for imidazolium-
derived complexes 172l-o,q,s-u, 209a,b, and 210a. 
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Scheme 57. Synthesis of gold complexes 172l–o, 172q, 172s-u,  209a,b and 210a. Reagents and conditions: (a) 
ligand (1.0 equiv.), AuCl·SMe2 (1.0 equiv.), CH2Cl2, –20 °C to rt, 30 min to 1h. aReaction performed in MeCN. 
Single crystals of gold(I) complexes 172q, 209a, 172s and 172t for X-ray structure 
determinations (Figure 35) were grown by layering pentane over dichloromethane solutions. 
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A comparison of selected bond lengths, including those in precatalyst 172i,[219] is given in 
Table 7. 
 
Figure 35. Molecular structures of gold(I) complexes 172q, 209a, 172s and 172t. Solvent molecules and counter 
ions are omitted for clarity. Thermal ellipsoids set at 50% probability. Points A1-A3 depict closest arene gold 
contacts. Peripheral aromatic rings depicted as wire frames for clarity. The numbering does not correspond to the 
IUPAC rules. 
The solid state structure of all the gold(I) complexes shows the gold atom embedded in a 
deep chiral pocket, enclosed by two arene rings from the TADDOL backbone and one from 
the mesityl fragment of the imidazolium with a pseudo C3 symmetry. This arrangement bears 
a structural similarity to the TADDOL-derived phosphoramidite gold complexes developed by 
the group of Fürstner, which performed exceptionally well in enantioselective gold(I) 
catalyzed transformations.[52] It can also be seen that for the gold complexes 172s and 172t, 
O1 
O2 
P1 
A1 
A2 A3 
Au1 
Cl1 
N2 
N1 
C1 
172q 
(A) (B) 
209a 
O1 
O2 
P1 
A1 
A2 
Au1 
Cl1 
N2 
C2 
C1 
A3 
(C) 
O1 O2 
P1 
A1 
A2 A3 
Au1 
Cl1 
N2 
N1 
C1 
172s 
(D) 
172t 
O1 O2 
P1 
A1 
A2 
Au1 
Cl1 
N2 
N1 
C1 
A3 
5. Synthesis and structure of cationic phosphonites 
91 
the para-trifluoromethyl groups at the arenes enclose the gold centre further. η2-Arene–gold 
interactions can also be observed between the two rings on the TADDOL backbone and the 
gold center for the ligands 172q, 172s and 172t, as visualized by the points A1 and A2 in 
Figure 35 and Table 7, entries 8-10 (sum of van der Waals radii = 3.36 Å). Although the 
mesityl substituents clearly act to shield the gold centre, no short contacts with gold(I) centre 
could be observed in any cases. In addition, comparing all new gold(I) complexes with 172i, 
only a few changes in the structural properties are immediately apparent. The P1–C1 bond is 
slightly shortened in 172s and 209a, compared with the other gold(I) complexes (entry 3). 
This may reflect the specific electronic strucutre of these cationic substituents, which are 
likely less electron withdrawing.  
Table 7. Solid state structures and selected bond lengths of gold complexes 172q, 209a, 172s and 172t.  
Entry Selected parameters 172q 209a 172s 172t 172i[219] 
1 Au1–Cl1 (Å) 2.278(1) 2.273(2) 2.272(2) 2.268(2) 2.255(3) 
2 Au1–P1 (Å) 2.200(1) 2.201(4) 2.193(1) 2.191(2) 2.185(2) 
3 P1–C1 (Å) 1.829(4) 1.805(1) 1.815(6) 1.827(7) 1.829(6) 
4 P1–O1 (Å) 1.588(3) 1.578(9) 1.585(4) 1.588(5) 1.581(4) 
5 P1–O2 (Å) 1.5890(3) 1.584(9) 1.595(4) 1.593(5) 1.584(6) 
6 N1–C1 (Å) 1.343(6) 1.335(2) 1.349(7) 1.344(1) 1.351(7) 
7 N2–C1 (Å) 1.350(6) 1.404(2) 1.368(7) 1.358(9) 1.351(7) 
8 Au1–A1 (Å) 3.259 3.431 3.282 3.282 3.368 
9 Au1–A2 (Å) 3.325 3.403 3.326 3.289 3.438 
10 Au1–A3 (Å) 3.394 3.579 3.460 3.464 3.351 
11 Au1–P1–C1–N2 (°) 47.85 54.05 55.2(5) 52.7(7) 54.0(6) 
 
Under otherwise identical conditions, ligands 169p and 169r did not afford the gold(I) 
complexes smoothly. While the ligands themselves were quite stable, complete 
decomposition on addition to the gold(I) precursor could be seen. In 31P NMR spectrum of a 
mixture of products formed from the ligand 169r, a broad signal could be seen at 89.3 ppm, 
essentially, in the same range as for the previously reported phosphonous acid gold(I) 
chlorides 173 and 175a (cf. Scheme 40).[219] In the case of 169p, the two well defined 
species, namely phosphonous acid 175b and polysubstituted naphthalene 174b, could be 
isolated and characterized. By simply washing the crude reaction mixture with acetonitrile the 
naphthalene fragment 174b could be cleanly isolated. The phosphonous acid fragment 175b 
was then purified by crystallization from dichloromethane/ toluene and displays a 
characteristic 31P NMR shift of 83.3 ppm. It is likely that the steric environment of the 
intermittently formed gold complex 169p is too demanding to form a stable structure. 
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Scheme 58.  Decomposition of ligand 169p on treatment with (dimethyl sulfide)gold(I) chloride, giving 175b and 
174b. Reagent and conditions: (a) 169p (1.0 equiv.), AuCl·SMe2 (1.0 equiv.), CH2Cl2, –20 °C to rt, 30 min. 
5.5 Synthesis of 1,2,4- and 1,2,3-triazolium-derived phosphonites and 
their corresponding gold(I) complexes 
The work outlined in this section was carried out in collaboration with two Masters students: 
Maximillian Marx MSc.[244] and Thierry Hartung MSc.[245] 
In addition to the TADDOL-derived phosphonites previously described in this section, 1,2,4- 
and 1,2,3- triazolium substituted phosphonites were targeted (Figure 36).  
 
Figure 36. Targeted 1,24- and 1,2,3-triazol-5-ylidenes to be used in the synthesis of chiral cationic phosphonites. 
In the first instance, incorporation of additional nitrogen to the cationic substituent would most 
likely lower the energy of the π-system and make such substituents even more electron 
withdrawing than imidazolium substituents. Secondly, these carbenes were reported to be 
stable at room temperature and would therefore be compatible with the existing cationic 
phosphonite synthesis.[246,247] With this in mind, the 1,2,4- and 1,2,3-triazol-5-ylidenes 56g-j 
were synthesised. The 3-isopropyl and 3-mesityl 1,2,3-triazol-5-ylidenes were prepared 
according to modified literature procedures,[246] while the 3-methyl- (56i) and 3-phenyl-1,2,4-
triazol-5-ylidene (56j) were prepared according to an optimized sequence proceeding via 
1,3,4-oxadiazolium salts.[244,245] 
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These precursors were then condensed with chlorophosphite 171i under the standard 
conditions to give the ligands 169x–aa (Scheme 59).  
 
Scheme 59. Synthesis of cationic phosphonite gold(I) chloride complexes 172v-y. Reagents and conditions: (a) 
diol (1.1 equiv.), PCl3 (1.2 equiv.), pyridine (3.2 equiv.), toluene, 60 °C, 1 h; (b) 171i (1.0 equiv.), NaSbF6 (2.1 
equiv.), Et2O, –78 °C to rt, 22–24 h; (c) ligand 169 (1.0 equiv.), AuCl·SMe2 (1.0 equiv.), CH2Cl2, –20 °C to rt, 1 h.  
While the ligands 169x and 169y derived from 1,2,4-triazol-5-ylidenes 140g,h were quite 
unstable towards purification by column chromatography even at reduced temperatures, their 
gold(I) complexes were more resistant and could be chromatographed at –10 °C giving pure 
172x and 172y, both in 17% yields over three steps. The phosphonite gold(I) complexes 
172z and 172aa derived from 1,2,3-triazol-5-ylidenes 56i,j were similarly obtained in yields of 
26 and 20%, respectively, over two steps, as the crude ligands 169z and 169aa were still 
contaminated with inseparable impurities after attempted purification. 
As the ligand 169a prepared from the para-tert-butylphenyl-substituted TADDOL 169a 
(Scheme 38) had shown promising enantioselectivities in the previous ligand screening for 
the gold(I)-catalyzed twofold hydroarylation reaction,[219] this TADDOL framework might be 
another potentially promising ligand scaffold for the asymmetric helicene-forming synthesis. 
The 1,2,4-triazolium-based phosphonite 169ab proved to be more stable than its analogue 
172y, and was isolated in 44% yield before forming the gold(I) complex 172ab in 85% yield 
(Scheme 60). However, when the same conditions were applied using the 4-methyl-1,2,4-
triazol-5-ylidene (56g), in addition to the desired ligand 169ac, which was detected by NMR 
but could not be isolated, the bisphosphonite 211 was formed. This presumably resulted from 
the in situ deprotonation of the methyl backbone in 169ac, followed by reaction with the 
second molecule of chlorophosphite 171a. Interestingly, this shows some resemblance to 
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intermediate 205 proposed for the formation of 3-imidazolioadducts 203a and 203b (Scheme 
54) 
 
Scheme 60.  Synthesis of gold(I) phosphonite complex 172ab and bis-phosphonite 211. Reagents and 
conditions: (a) 170a (1.1 equiv.), PCl3 (1.2 equiv.), pyridine (3.2 equiv.), toluene, 60 °C, 1 h; (b) carbene 56g or 
56h (1.0 equiv.), NaSbF6 (2.1 equiv.), Et2O, –78 °C to rt, 22–24 h; (c) ligand 169ab (1.0 equiv.), AuCl·SMe2 (1.0 
equiv.), CH2Cl2, –20 °C to rt, 1h. 
5.5.1 Donor properties 
The donor ability of the new ligand 169ab was also evaluated by cyclic voltammetry (Table 
8).  
Table 8. Cyclic voltammetry of triazolium-derived 169ab and 169q.  
Entry L EOx/ V ERed/ V 
1 169q 1.88 -2.10 
2 169ab - -1.71, -2.02 (reversible) 
Voltammograms conducted in MeCN with Bu4PF6 (0.2 M), referenced to ferrocene/ferrocinium. 
Although no oxidation was seen for 169ab, an irreversible reduction at -1.71, followed by a 
reversible reduction at 2.02 V was observed. Comparison to the cationic phosphonite 169q 
showed that the first reduction potential was 0.39 V lower, indicating that the π-system in the 
triazolium moiety has a lower LUMO energy than the imidazolium structure and that the 
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resulting cationic phosphonites may be even less electron rich. The second reversible 
reduction lies in the same range as a reversible reduction found for the Enders carbene,[248] 
therefore it is likely that upon a one electron reduction of 169ab, the corresponding radical 
species collapses to give the free triazol-5-ylidene carbene 56h, which can be further 
reversibly reduced. 
5.6 Summary 
A number of new chiral cationic phosphonites with different steric and electronic 
environments have been synthesized, including a variety of TADDOL derivatives and the first 
described BINOL derivative. In addition, the cationic substituent was modulated to include a 
diverse array of imidazolium, 1,2,4-triazolium, 1,2,3-triazolium and carbodiphosphonium 
substituents (Chart 2).  
 
Chart 2. Chiral cationic phosphonites: Summary. 
The reactions of the two TADDOL precursors (R,R)-169s and (R,R)-169t led almost 
exclusively to the abnormally bound phosphonites 203a and 203b, which likely form via a 
mechanism related to a base-mediated rearrangement reported by Bertrand and 
coworkers.[68] Reactions between the BINOL precursor 207 and IMes 56b resulted in 
formation of a complex mixture consisting of both the normal and abnormal adducts 208a 
and 208b, which could be circumvented by using the carbene 56e with blocked reactivity at 
the backbone, thus allowing the synthesis of BINOL-derived phosphonite 208c in very good 
yield.The donor properties were investigated using cyclic voltammetry and the imidazolium 
derived phosphonites displayed irreversible oxidation potentials in the range of 1.76–1.93 V, 
indicating this class of ligands to be excellent π-acceptors and poor σ-donors. The 
carbodiphosphorane-derived 169l conversely conversely exhibited a decreased oxidation 
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potential. Finally, the gold(I) complexes 172m–o,q,s-u,x-ab, 208a,b and 209a could be 
synthesized, indicating hese compounds to be excellent ligands for gold. Interestingly, the 
gold(I) complexes of 169p and 169q could not be formed, with concommitant decomposition 
occuring instead. The isolated gold(I) phosphonous acid species 175b and naphthalene 
174a indicate that decomposition likely occurs via a previously described Friedel-Crafts-type 
alkylation–elimination–1,2-aryl shift cascade. 
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6 Enantioselective synthesis of [6]carbohelicenes 
6.1 Enantioselective synthesis of [6]carbohelicenes using precatalyst 
172i 
Aiming to expand the scope of the gold(I) catalysed enantioselective hydroarylation of 
precursors 159 into [6]helicenes 160, the substrates 159ae-am, with variable substituents at 
the alkyne, were evaluated using the chiral precatalyst 172i under the optimized reaction 
conditions. The conversion of the starting material (159) and the intermediate (187) after one 
6-endo-dig cyclisation were measured, in addition to the regioselectivity of the desired 
helicene (160) over the 6-endo-dig/ 5-exo-dig product (188) and the enantioselectivity of the 
desired helicene (160). A summary of the results is given in Table 9. For details of the 
racemic reactions, which were required to measure the enantiomeric excess, see the 
experimental section of this thesis. 
Under the optimized conditions, almost all of the reactions reached full conversion. For 
reactions of the substrates 159af, 159ah and 159ae with 4-fluorophenyl, 4-benzyloxy and 4-
chlorophenyl substituents, respectively, the reaction mixture contained residual starting 
material (entries 1, 3 and 7). All of these substrates were generally less soluble, and this was 
most likely the determining factor in their lower conversion. Because conversion was so low 
for substrates 159ah and 159ae, the reactions were also conducted in dichloromethane, 
where full conversion for 159ah and an improved conversion for 159ae were obtained 
(entries 4 and 8). 
Especially high regioselectivities over the undesired isomer 188 were obtained using 
substrates with substituents that favorably polarized the alkyne, such as 4-methoxyphenyl 
(entry 2), 4-benzyloxyphenyl (entries 3 and 4) and 3,4-dimethylphenyl (entry 9). Similarly, 4-
chlorophenyl-substituted substrate 159ae displayed a very good selectivity, although chlorine 
is generally considered to be a weakly electron-withdrawing group, taking into account its 
Hammet parameter.[249] In the case of 159af, with 4-fluorophenyl substituents, the disclosed 
selectivity was slightly lower (entry 1). When steric bulk in the para position was increased, 
again generally lower selectivities were detected. This was seen for the substrates 159ai, 
159al and 159aj containing 4-(trimethylsilyl)phenyl (entry 5), 4-
(triisopropylsilyloxymethyl)phenyl (entry 10) and 4-isopropylphenyl (entry 6) substituents. In 
these cases, separation of the desired helicene 160 could only be achieved by preparative 
HPLC separation.  
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Fortunately, the enantioselectivities remained high across the tested series, for the most part 
lying in the range of 86–92% ee, and showing tolerance for the range of functional groups 
within the scope of this transformation. Exceptions to this were substrates 159ak and 159ag, 
bearing 3,4-dimethylphenyl and 4-methoxyphenyl substituents, which displayed ee's of 77 
and 81%, respectively. Conversely, substrate 159ah gave an astonishing 99% ee, even 
considering that the reaction was conducted in dichloromethane and not in fluorobenzene, 
which generally resulted in lower enantioselectivites for this reaction. Similarly, cyclization of 
4-chlorophenyl-substituted diyne 159ae resulted in an excellent 92% ee.  
Table 9. Enantioselective synthesis of helicenes.  
 
Entry 159 R Yield (%)a 160:188:187 (%)b ee (%)c 
1 159af 4-F-C6H4- 90 92: 7: 1f +90 
2 159ag 4-MeO-C6H4- 90 96: 4: 0 +81 
3 159ah 4-BnO-C6H4- 98 62: 2: 10g -e 
4e 159ah 4-BnO-C6H4- 98 95: 5: 0 +99 
5 159ai 4-TMS-C6H4- 76 84: 13: 3 +87 
6 159aj 4-iPr-C6H4- 99 92: 8: 0 +88 
7 159ae 4-Cl-C6H4- 98 81: 3: 16h +97 
8e 159ae 4-Cl-C6H4- 97 72: 6: 22i +92 
9 159ak 3,4-(Me)2-C6H3- >99 95: 5: 0 +77 
10 159al 4-TIPSOCH2-C6H4- 98 88: 12: 0 +86 
11 159am 4-MeOCH2-C6H4- traces - - 
Reagents and conditions: (a) 159 (1 equiv.), 172i (10 mol%), AgSbF6 (10 mol%), C6H5F, –20 °C, 72 h. aYields 
determined of mixtures of inseparable isomers. bSelectivity determined by NMR and/ or HPLC. cEnantiomeric 
excess determined by HPLC. dReaction conducted in dichloromethane. eEnantiomeric excess could not be 
determined due to poor separation in HPLC. f8% residual 159af. g36% residual 159ah. h69% residual 159ae. i15% 
residual 167ae. 
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On submission of the 2-naphthyl-substituted compound 159db to the reaction conditions, 
one major product, approximately 68% of the crude reaction mixtrure, could be identified in 
the 1H NMR. Upon preparative HPLC, the structure could be identified as the 
dibenzohelicene 160db (Scheme 61), with an enantiomeric excess of 46%. Although this is 
rather low in comparison to the other helicenes, it is proof of dynamic interconversion of the 
enantiomers (P)-187db(I) and (M)-187db(II) of the tetrahelicene intermediate (cf. Figure 27). 
 
Scheme 61. Enantioselective gold(I) catalysed hydroarylation on 159db. Reagents and conditions (a) 159db (1 
equiv.), 172i (10 mol%), AgSbF6 (10 mol%), C6H5F, –20 °C, 72 h. 
The enantioselective gold(I) catalysed hydroarylation reaction was next evaluated for bromo-
substituted substrate 159an, under the optimised conditions using precatalyst 172i (Scheme 
62). Full conversion of starting material was reached using the gold(I) catalyst 172i, also 
giving what appeared to be one major product in the crude NMR, with some additional small 
impurities. Although the product was C2 symmetric, its identity could not be confirmed soley 
using NMR techniques.  
 
Scheme 62. Gold(I) catalysed intramolecular double hydroarylation of 159an.Reagents and conditions (a) 172i 
(10 mol%), AgSb6 (10 mol%), C6H5F, -20°C. 96h. aNMR yield determined using 1,4-dioxane as internal standard.  
Attempts to separate the crude reaction mixture by preparative HPLC only decreased the 
purity and upon comparison with the original crude 1H spectrum appeared to show formation 
of new signals, suggesting decomposition of the sample under the HPLC conditions. (For 
further details see experimental section) Because all the other samples had been stable to 
the HPLC conditions, it was likely that a different isomer formed under the reaction 
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conditions. Gratifyingly, after crystallisation, the unambiguous identitiy of the product could 
be as the 5-exo-dig/ 5-exo-dig product 212an. Because dibromide 212an contains two five-
membered rings, the helix does not form a 360° turn and the peripheral rings do not overlap. 
It is therefore likely that this product is not configurationally stable at room temperature. The 
Lewis acid catalysed cyclisation of haloalkynes has been previously studied by Fürstner and 
coworkers.[110] It was found that for certain Lewis acids, such as Au(I)Cl a 1,2- migration of 
the halogen could occur. This was not observed for harder Lewis acids, such as In(III)Cl3.[250] 
The authors proposed that back-bonding from a Au(I) centre could favour formation of a Au(I) 
vinylidene intermediate 213, in which the halogen has migrated to the other side of the 
alkyne, leading to the 9-bromo product 214 (Scheme 63).[251] Presumably, a highly electron-
withdrawing ligand at the gold center, such as 169i, would diminish the gold's backbonding 
capability, disfavoring the formation of a gold(I) vinylidene species. Netherless, it is not 
immediately clear why a 5-exo-dig cyclisation would then be favoured when using precatalyst 
172i, as in previous studies a 6-endo-dig cyclisation has been favoured for 
bromoalkynes.[110,250] Perhaps the large steric bulk of the bromo substituent and the ligated 
gold(I) catalyst cause a steric clash, which favours the isomer 212. 
 
Scheme 63. Divergant, Lewis acid catalysed cycloisomerisations of haloalkynes using In(III) chloride (a) and 
Au(I)Cl (b), as reported by the Fürstner and corworkers.[110] Reagents and conditions (a) In(III)Cl3 (1.0 equiv.), 
toluene, 80 °C, 16 h; (b) Au(I)Cl (20 mol%), toluene, 80 °C, 20 h. 
In summary, the enantioselective gold(I)-catalyzed hydroarylation to give [6]carbohelicenes 
described herein demonstrates the highest enantioselectivities in the catalytic synthesis of 
[6]carbohelicenes obtained to date. The scope outlined in this section extends this 
transformation to include a variety of functional groups amenable to further conversions, 
including protected alcohols, silanes and halogens. Certain aspects of this transformation 
however, could still be optimized to further increase the applicability of this method. Firstly, 
although conversion of the starting material 159 and intermediate 187 formed in the reaction, 
as well as the ratio between the desired helicene product 160 and other isomers relating to 
the 6-endo-dig/5-exo-dig cyclization was mostly very good, in certain cases these undesired 
side-products could still be detected in the reaction mixture. In this instance, to isolate the 
helicene a semi-preparative HPLC separation was necessary, which afforded the pure 
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helicenes in low yields. Moreover, several substrates still displayed poor conversions when 
using the catalyst system 172i. Secondly, the high enantioselectivities obtained were limited 
to aryl-substituted alkynes, with a significant drop seen for the alkyl-substituted substrates 
159aa and 159ba (63 and 30% ee, respectively, cf. Table 3). With this in mind, it was 
decided to try to further optimise this reaction, by evaluating the new chiral cationic 
phosphonites described in chapter 5 of this thesis in a series of model studies.  
6.2 Model catalytic studies using new cationic phosphonite gold(I) 
complexes 
The new series of phosphonites (Figure 37) was evaluated in a series of model reactions 
with the substrates 159ab, 159aa and 159ae. 
 
Figure 37. New cationic phosphonite gold(I) complexes evaluated in model studies. 
Diyne 159ab, being the most studied in this transformation, was a natural choice to evaluate 
the profile of the new generation of catalysts. However, as the substrates 159aa and 159ae 
had demonstrated respectively poorer ee's and conversion using the previous system, they 
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were also chosen to find out how these aspects may also be improved. The results obtained 
with the new generation of catalysts in the cyclisation of 159ab are shown in Table 10.  
Table 10. Results of screening for the enantioselective gold(I)-catalyzed cyclization of substrate 159ab.  
 
Entry [Au] T (°C) Yield (%)a 160ab: 188ab:187ab (%)b ee (%)c 
1d 172i -20 88 97: 3: 0 +91 
2d 172l 0 43 Only 212abh - 
3d 172o -20 98g 45:50:5h -60 
4d 209a -20 - -g - 
5 172s -20 85 87: 13: 0 +82 
6 172t -20 76 96: 4: 0 +84 
7e 172y -20 >95 98: 2: 0 +87 
8e 172x -20 >95 96: 4: 0 +84 
9f 172z -20 >95 98: 2: 0 +82 
10f 172aa -20 >95 98: 2: 0 +85 
Reaction conditions: (a) 159ab (1 equiv. 0.025 mmol), [Au] (10 mol%), AgSbF6 (10 mol%), C6H5F, T, 96 h. aNMR 
yield determined using dioxane (4 equiv.) as internal standard. bConversion and selectivity were determined using 
NMR/HPLC. cEnantiomeric excess was determined using HPLC. dReaction conducted by Dr. E. González-
Fernández.[219,245]  eReaction conducted by M. Marx MSc.[244] fReaction conducted by T. Hartung MSc. g 
Combined yield determined as a mixture of isomers 160ab, 188ab and 187ab. hReaction conducted using 5 mol% 
precatalyst and 5 mol% AgSbF6 in CH2Cl2 for 72h. 
For comparison, entry 1 shows the results obtained in this reaction using the precatalyst 
172i.[219] In all cases, complete conversion of the starting material was observed. 
Interestingly, using the carbodiphosphonium derived precatalyst 159l resulted in the 
exclusive formation of 212ab.[219] It is likely that the larger steric demand on the 
carbodiphosphonium substituent favours formation of the 5-exo-dig product. Additionally, 
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209a, with an abnormally bound imidazolium unit failed to give any conversion in this 
transformation, while the complex 172o, with the smaller imidazolium substituent gave poor 
results. The complexes 172s,t,y-aa allowed a systematic comparison to 172i, with the only 
change being in the cationic group. A decrease in selectivity was observed for 172s, with 
electron donating methyl groups at the backbone of the imidazolium moiety. Conversely, 
attachment of the more electron poor chloro substituents (172t, entry 6) maintained a 
regioselectivity comparable to 172i. Similarly, for the complexes of 1,2,4-triazolium- and 
1,2,3-triazolium-derived phosphonites, a trend in the increasing electron-withdrawing 
capacity of the cationic group and an increase in the regioselectivity towards the formation of 
the desired helicene could be observed, with the best results being obtained for phosphonite 
precatalysts 172y, 172z and 172a (entries 7, 9 and 10). However, the enantioselectivity 
displayed by the new generation of ligands slightly dropped in all cases, with the best ee of 
87% for the new generation of catalyst obtained using 172y (entry 7). 
While consistently giving higher regioselectivities, the propynyl-substituted naphthalene 
167aa had consistently shown lower enantioselectivities compared to the substrates 
decorated with arylethynyl groups, the preparation of hexahelicenes with aliphatic chains 
using this methodology necessitates further optimization of the enantiomeric excess. It was 
decided to start with gold complexes that exhibited the best ee's in the initial screening 
studies conducted with this substrate,[219] but to replace the solvent with fluorobenzene and 
carry out the reaction at –20 °C. In addition, gold complexes of the cationic phosphonites of 
the new generation of precatalysts were also evaluated (Table 11). 
The result obtained using the gold complex of cationic phosphonite 172i under the optimized 
reaction conditions gave a moderate ee of 63% (entry 1).[219] For all the complexes tested, 
the conversion and selectivity towards the desired hexahelicene 160aa remained excellent. 
The complexes 172s and 172t derived from 4,5-dichloro- and 4,5-dimethylsubstituted 
phosphonites gave respectively better and poorer selectivities, fitting with the trend found 
when using the model substrate 159ab discussed above. Unfortunately, these catalysts gave 
significantly poorer enantiomeric excesses, as did the precatalysts 172n and 172q (entries 
2–5). Among the ligands tested, the tert-butylphenyl-substituted catalysts gave the highest 
ee's, with para-tertbutylphenyl substituted 172a and 146ab both giving ee's of –70% (entries 
6 and 8), improving marginally on the previous result. 
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Table 11. Results of screening for the enantioselective gold(I)-catalyzed cyclisation of substrate 159aa.  
 
Entry 172 Yield (%)a 160aa: 188aa:187aa (%)b ee (%)c 
1d 172i 96 98: 2: 0 +63 
2 172s 91 98: 1:1 +21 
3 172t 98 99:1:0 +14 
4 172q 98 98: 2: 0 +22 
5 172n 99 96:2:2 –18 
6 172a 96 98:1:1 –70 
7 172u 94 >99: 1: 0 –66 
8e 172ab 95 >99: 1: 0 –70 
Reaction conditions: (a) 159aa (1 equiv. 0.025 mmol), 172 (10 mol%), AgSbF6 (10 mol%), C6H5F, –20 °C, 96 h. 
aNMR yield determined using dioxane (4 equiv.) as internal standard. bConversion and selectivity determined 
using NMR/HPLC. cEnantioselectivity determined using HPLC. dReaction conducted by Dr. E. González-
Fernández.[219] eReaction conducted by M. Marx MSc.[244] 
Finally, the reactivity of the new catalysts was further evaluated in the cyclisation of substrate 
159ae bearing p-chlorophenyls (Table 12), which had given poor conversion using the 
catalyst 172i (entries 1 and 2). In dichloromethane, full conversion and an excellent 
selectivity of 98:2 could be reached when using 172t; however, the ee was only a moderate 
77% (entry 3). In fluorobenzene, while the ee was increased to 87%, the conversion was only 
67% (entry 4). Interestingly, the same reaction with the triazolium derived catalyst 172y 
displayed a lower conversion, while the selectivity and enantioselectivity were improved 
(entry 5). 
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Table 12. Results of screening for the enantioselective gold(I)-catalyzed cyclisation of substrate 159ae.  
 
Entry 172 Solvent Yield (%)a 160ae: 188ae:187ae (%)b ee (%)c 
1 172i CH2Cl2 98e 81: 3: 16f +97 
2 172i C6H5F 97e 72: 6: 22g +92 
3 172t CH2Cl2 91 98: 2: 0 +77 
4 172t C6H5F 37 85: 4: 11h +87 
5d 172y C6H5F 33 93: 2: 5i +92 
Reaction conditions: (a) 159ae (1 equiv. 0.025 mmol), 172 (10 mol%), AgSbF6 (10 mol%), solvent, –20 °C, 96 h. 
aNMR yield determined using dioxane (4 equiv.) as internal standard. bConversion and selectivity determined 
using NMR/HPLC. cEnantioselectivity determined using HPLC. dReaction conducted by M. Marx MSc.[244] eYield 
determined as a mixture in separable isomers. f 69% residual 159ae observed. g15% residual 159ae observed. 
h37% residual 159ae observed. i50% residual 159ae observed. 
The results of the model studies on substrates 159aa, 159ab and 159ae had shown that the 
new cationic phosphonite complexes were indeed more reactive, although equivocal results 
relating to the selectivities and enantioselectivities were obtained. For instance, a clear 
increase in conversion for both the precatalysts 172t and 172y as well as better selectivities 
in both cases were seen for the substrate 159ae in comparison to 172i. However, full 
conversion could still not be reached in fluorobenzene, which was necessary to give high ee 
values. Moreover, while marginally worse enantioselectivities were detected when using the 
substrate 159ab with 172y and 172aa in comparison to the complex 172i, slightly higher 
selectivities could be obtained. Overall, the second generation catalyst 172y, with a 1,4-
bis(mesityl)-3-phenyl-1,2,4-triazolium substituent, had displayed a promising profile regarding 
conversion, selectivity and enantioselectivity. It seemed that this triazolium substituent could 
have an especially positive effect on the selectivity and of the reaction. An increase in 
selectivity would circumvent problems with purification that occurred in purifying the 
helicenes when formed together with significant amounts of other isomers, which consistently 
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required low-yielding preparative HPLC separations. Motivated by the possibility of 
optimizing this aspect, as well as aiming to further evaluate the effect on the comparable 
reactivity and enantioinduction of the new system, the cationic phosphonite gold(I) complex 
172y was evaluated for a wider variety of substrates, including those newly accessed using 
the optimized substrate synthesis, as well as those that had been made with poorer 
selectivity when using the precatalyst 172i. 
6.3 Substrate scope of new precursors and comparison studies using 
cationic phosphonite gold(I) complex 172y 
The results of the comparison study are shown in Table 13. Firstly, the substrate 159ob, 
which had shown almost no conversion with the precatalyst 172i,[219] enabled another direct 
comparison with the reactivity of the new generation of triazolium derived gold catalysts. 
Impressively, the new precatalyst 172y afforded very good conversion towards helicene 
160ob, with only small amounts of other isomers 159ob, 188ob and 187ob observed (entry 
12).  
The new substrate synthesis of diynes 159 also enabled the easy modulation of the 
substituents at aryl R2 and thus an evaluation on the change in selectivity and 
enantioselectivity in this reaction on variation of these groups. Previously, the effect of 
introducing methoxy groups at the positions 3 and 14 of the helicene had had a negative 
impact on the selectivity. However, when using the triazolium-derived catalyst 172y, a 
dramatic increase in selectivity towards the helicene was observed (entries 6 and 8). 
Similarly, a dramatic increase in selectivity was observed for both para-benzyloxy- and 
3,5,dimethyl-phenylsubstituted 159jb and 159nb when using the catalyst 172y (entries 14 
and 16). The same reactions catalyzed by 172i resulted in much poorer selectivity (entries 13 
and 15).  
Gratifyingly, in most cases of the substrates tested, the enantioselectivities remained high, 
lying between 85 and 88% for the dimethoxy-, dibenzyloxy- and tetramethylsubstituted 
helicenes 160bb, 160jb and 160nb and even exceeding 90% ee for the chlorosubstituted 
helicenes 160ae and 160ob (entries 4 and 12). A moderate drop in enantioselectivity was 
apparent for the phenyl substituted helicene 160cb (entry 9). 
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Table 13. Comparative study between gold(I) complexes 172i and 172y.  
 
Entry 159 R1 R2 172 Yield (%)a 
160: 188: 187 
(%)b 
ee (%)c 
1d 159ab p-Tolyl Ph 172i   88 97:3:0 +91 
2e 159ab p-Tolyl Ph 172y >95 98:2:0 +87 
5d 159bb p-Tolyl 4-MeO-C6H4- 172i >95h 88:12:0 +78 
6 159bb p-Tolyl 4-MeO-C6H4- 172y  83 96:4:0 +86 
7f 159be 4-Cl-C6H4- 4-MeO-C6H4- 172i   92h 87:13:0 +95 
8 159be 4-Cl-C6H4- 4-MeO-C6H4- 172y  93 95:5:0 +85 
9d 159cb p-Tolyl 4-Ph-C6H4- 172i >95 97:3:0 +82 
10 159cb p-Tolyl 4-Ph-C6H4- 172y   99 98:2:0 +75 
11d 159ob p-Tolyl 4-Cl-C6H4- 172i - - - 
12 159ob p-Tolyl 4-Cl-C6H4- 172y   76i 86:7:7j +92 
13g 159jb p-Tolyl 4-BnO-C6H4- 172i   86i 87: 13: 0 +75 
14 159jb p-Tolyl 4-BnO-C6H4- 172y  92 97: 3: 0 +88 
15g 159nb p-Tolyl 3,5-(Me)2-C6H3- 172i   84i 88: 12: 0 +75 
16 159nb p-Tolyl 3,5-(Me)2-C6H3- 172y  90 97: 3: 0 +87 
17 159ib p-Tolyl 4-TMS-C6H4- 172y   87i 89:11:0 +62 
Reagents and conditions: (a) 159 (1 equiv. 0.025 mmol), 172 (10 mol%), AgSbF6 (10 mol%), C6H5F, –20 °C, 96 h. 
aIsolated yields, unless otherwise stated. bSelectivity determined by NMR and HPLC; cee determined by HPLC. 
dReaction conducted by Dr. E. González-Fernández.[219] eReaction conducted by M. Marx MSc.[244] fReaction 
conducted by L. Schaaf MSc.[220] gReaction conducted by T. Hartung MSc.[245] hYield reported as a mixture of 
isomers either/or 168, 182, 181 and/or 167. iYield determined using 1,4-dioxane as internal standard. j 6% 
residual 159ob observed. k73% residual 159eb observed. l92% residual 167fb observed. m47% residual 159gb 
observed. 
Having compared a wider range of substrates with both the triazolium derived 172y and 
imidazolium derived 172i, it was clear that the triazolium derived catalyst exhibited an 
outstanding increase in selectivity compared to the previous system. This obviates the need 
for costly additional separations and opens the possibility of accessing a wider variety of 
enantiomerically enriched carbohelicenes. Additionally, in many cases, the enantioselectivity 
was also higher, indicating the high potential of this new generation of cationic phosphonites. 
Attention then turned to the prospect of extending the synthesis to heterohelicenes. 
Accordingly, the thiophene and furan substituted diynes 159eb-hb were submitted to the 
reaction conditions using 172y as a precatalyst. The results are summarised in Table 14. 
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Interestingly, in no cases were any isomers relating to the 5-exo-dig/ 6-endo-dig product 188 
observed. Unfortunately, in the reactions of 2-thienyl (159eb) and 2-furanyl (159fb) 
substituted conversion remained low, indicating that even the precatalyst 172y was not 
reactive enough to enact a cyclisation for these substrates. Furthermore, the 
enantioselectivities of the products was also much lower than for the [6]carbohelicenes 160. 
For the 3-thienyl substituted diyne (159gb) conversion was high, although still incomplete, 
while for 3-furanyl substituted 159hb the only product detectable in the crude reaction 
mixture was the 3,12-dioxa helicene 160hb, albeit with a low isolated yield of 33%. In both 
cases, the regioselectivity with respect to the nucleophilic attack of the heteroatom to the 
alkyne was excellent, with the exclusive products arising from attack via the 2-position of the 
heteraromatics. On measurement of the enantiomeric excess of the resulting 
heterohelicenes, both 160gb and 160hb were racemic. 
Table 14. Enantioselective gold(I) catalysed hydroarylation of precursors 159eb-hb bearing heteroaromatic 
groups. 
 
Entry 159 X = Y = Yield (%)a Conv. (%)b 160: 187 (%)c ee (%)d 
1 159eb -C- -S- 21 27 81:19 +24 
2 159fb -C- -O- 5 8 >99:0 +24 
3 159gb -S- -C- 16 53 38:62 0 
4 159hb -O- -C- 33 >95 >99:0 0 
Reagents and conditions: (a) 159 (1 equiv.), 172y (10 mol%), AgSbF6 (10 mol%), C6H5F, –20 °C, 96 h. a,bYields 
and conversion determined using 1,4-dioxane as internal standard. cSelectivity determined by NMR and HPLC. 
dee determined by HPLC. 
To the best of our knowledge, helicenes such as 160eb, 160fb and 160hb have until now not 
been described, although 3,12-dithia[6]helicene was originally reported by the group of 
Wynberg in 1973,[252] and a quadruple helicene comprised of two 3,12-dithia[6]helicenes and 
two [5]helicenes was recently reported by the group of Itami.[230,253] In this report, the two 
[5]helicene moieties were found to racemize on heating to 80 °C for two days; however, the 
two dithia[6]helicene moieties remained configurationally stable. The structurally related 5,8-
dithia[6]helicene 111, which was determined not to be configurationally stable at room 
temperature with an experimentally determined barrier to racemization of 23.7 kcal•mol–1 (cf. 
Figure 17), was also described by Wynberg in 1969.[134] Nevertheless, the barrier to 
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racemisation for any of the new heterohelicenes had not been previously described. As a low 
barrier to racemisation was a possible reason for the low ee values obtained, it was decided 
to perform a computational study to investigate this further.  
Accordingly, the ground and transition state geometries for the helicenes 160eb-hb were 
optimized using Gaussian[254] at the B3LYP/6-31+g(d) level of theory, including 
[6]carbohelicene for comparative purposes. For the helicenes 160eb, 160gb and 160hb, well 
defined transition state geometries could be optimized. All attempts to do the same for 
helicene 160fb were unsuccessful, and the reasons for this are not immediately clear. It is, 
however, possible that 160fb could racemize through an alternative pathway, distinctly 
different to the other helicenes. The optimized transition state geometries for 
[6]carbohelicene and heterohelicenes 160eb, 160gb and 160hb are shown in Figure 38. 
 
Figure 38. Optimized transition state geometries and calculated racemization barriers (in kcal•mol–1) for 
[6]carbohelicene 106 and heterohelicenes 160eb, 160gb and 160hb. 
The calculated racemization barrier of [6]carbohelicene 106 is in good agreement with a 
recently published literature value of 38.16 kcal•mol–1.[135] The three calculated 
heterohelicenes showed barriers to racemization in the same range as that of 
[6]carbohelicene, indicating that they would be configurationally stable at room temperature 
and therefore suitable substrates for asymmetric catalysis. Helicene 160eb showed the 
highest barrier in the series, likely due to the large repulsion between the overlapping sulfur 
atoms at the periphery of the helix. Dithiahelicene 160gb shows a significantly higher barrier 
than its isomer, 5,8-dithia[6]helicene, 11 (cf. Figure 17, 23.7 kcal•mol–1). It is likely that 111, 
106: 36.31 160eb: 41.09 
160gb: 37.61 160hb: 35.02 
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with two internally embedded thiophene rings in the helical structure, is more flexible. As a 
result, it should approach the racemization transition state more easily than 160gb, in which 
the thiophene rings are at the periphery of the helix. In light of the calculated racemisation 
barriers for the heterohelicenes, it is possible that another chiral catalyst would be more 
effective in catalysing an enantioselective hydroarylation reaction for the substrates 159eb-
hb. However, considering the poor conversion of all the substrates tested in this study using 
chiral cationic phosphonites, this was not investigated further. 
6.4 Enantioselective hydroarylation of cyanated tetrahelicenes 
A highly selective cyanative chlorination of alkynes recently developed in the Alcarazo group 
by A. García-Barrado,[255] mediated by boron trichloride and the electrophilic cyanating 
reagent 215,[256] has subsequently been expanded to give cyanated phenanthrenes. [257] On 
submission of the helicene substrate 159ag to these conditions, even when using an excess 
of borane, the monocyanated intermediate 216a was selectively formed in excellent yield 
instead of the expected dicyanated helicene (Scheme 64). 
 
Scheme 64. Cyanative cyclisation of 159ag to give 216a using electrophilic cyanating reagent 215. Reagent and 
conditions (a) 159ag (1.0 equiv.), 215 (2.5 equiv.), BCl3 (2.5 equiv.), 2,6-di-tert-butylpyridine (2.0 equiv.), CH2Cl2, 
0 °C, 1 h. Reaction performed by A. García-Barrado.[257] 
Tetrahelicenes such as 216a had been previously proven to easily convert between the two 
helically chiral enantiomers, even when cooled down to –20 °C.[219] A second cyclisation, this 
time mediated by chiral gold catalysts, would give access to cyanated, enantioenriched 
helicenes. Encouraged by this prospect, the tetrahelicene 216a was subjected to a variety of 
conditions using the cationic phosphonite gold complex 172y. The results are shown in Table 
15. Firstly, the reactions were tried in both dichloromethane and fluorobenzene at room 
temperature and 0 °C. In both solvents, the cyclizations were practically completed at room 
temperature, but enantioselectivities remained low (entries 1 and 2). Gratifyingly, no other 
isomers could be detected in the reaction mixtures. A stark increase in enantioselectivity was 
seen, especially in fluorobenzene (entries 3 and 4), when lowering the temperature to 0 °C; 
however, incomplete conversions were observed in both cases. Increasing the temperature 
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to 5 °C in fluorobenzene led to a moderate conversion of 67%, but still very good ee of 89%. 
It is probable that the cyano group in the substrate inhibits reactivity of the catalyst by 
coordinating the cationic gold species, thus limiting conversion. 
Table 15. Screening for the enantioselective intramolecular hydroarylation in [4]helicene 216a. 
 
Entry Solvent T (C) t (h) Conversion (%)a Yield (%)b ee (%)c 
1a CH2Cl2 25 16 >95 61 +39 
2 C6H5F 25 16 93 47 +36 
3 CH2Cl2  0 72 75 58 +82 
4 C6H5F  0 72 39 29 +92 
5 C6H5F  5 72 67 57 +89 
Reagents and conditions: (a) 216a (1.0 equiv.), 172y (10 mol%), AgSbF6 (10 mol%), solvent (0.05 M), T, t. a,bNMR 
yields and conversions determined using hexamethyltricyclotrisiloxane as internal standard. cEnantioselectivities 
determined using HPLC.  
In any case, the conditions of fluorobenzene at 5 °C, which gave the best enantiomeric 
excess at a reasonable conversion, were chosen with an interest in further evaluating other 
substrates in a preliminary screening. From a variety of substrates 159ag–ng tested in the 
cyanative cyclisation, three more tetrahelicenes 216b–d could be selectively synthesized.[257] 
These were subsequently evaluated in the gold-catalyzed hydroarylation (Table 16).  
The chlorinated tetrahelicenes 216c and 216d unfortunately displayed lower conversions in 
comparison to 216a. Additionally, the enantiomeric excess measured for 217c was also very 
low. Cyclization of compound 216b with a 3,5-dimethylphenyl substituent proceeded to give 
excellent conversion to the hexahelicene product 217b. In this case, however, a lower 
enantiomeric excess was observed. Presumably the tetrahelicene 216b exhibits a higher 
inversion barrier than the other tetrahelicenes, because of the meta-substituted arene 
moieties pointing into the tetrahelicene core and the additional internal methyl group. In this 
case, the kinetic dynamic resolution to give the enantioenriched hexahelicene would likely 
proceed more slowly, and this is most likely a contributing factor to the low enantiomeric 
excess obtained. It is still interesting to note, however, that the structurally related substrate 
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159nb was cyclized to give a good ee in the double hydroarylation reaction, as outlined in 
Table 13, entry 16. Perhaps in this case an enantiomerically enriched intermediate is formed 
after the first cyclisation.  
Table 16. Enantioselective gold(I)-catalyzed cyclisation of tetrahelicenes 216a–d to give cyanated 
[6]carbohelicenes 217a–d.  
 
Entry 216a R1 R2 R3 Conversion (%)b Yield (%)c ee (%)d 
1 216a 4-MeO-C6H4- H H 67 57 +89 
2 216b 4-MeO-C6H4- H   Me >95 81e +51 
3 216c 4-MeO-C6H4- Cl H 24 19 +12 
4 216d p-Tolyl Cl H 27f traces - 
Reagents and conditions: (a) 216 (1.0 equiv.), 172y (10 mol%), AgSbF6 (10 mol%), C6H5F (0.05 M), 5 °C, 72 h. 
aPrepared by Alejandro García-Barrado.[257] b,cNMR yields and conversions determined using 
hexamethyltricyclotrisiloxane as internal standard. dEnantioselectivity determined using HPLC. eIsolated yield. 
fDetermined using 1,4-dioxane as internal standard. 
Although the synthesis of cyanated helicenes is an interesting line of study, with the 
possibility of creating asymmetrically substituted push-pull helicenes and the high synthetic 
utility of the cyano substituent towards further derivatization, the likelihood is that the cyano 
group inhibits the reactivity of the gold catalyst too strongly to give any promising results in 
this type of transformation. Nevertheless, there appears to be an exploitable difference in 
reactivity between the substrate 159ag and its intermediate. It would be certainly worthwhile 
to asymmetrically functionalize the helicene using other electrophilic group transfer reagents. 
Interrupted cyclizations to give iodo, bromo, and sulfenyl substituted phenanthrenes have 
already been reported by the group of Larock[151] and would make an ideal starting point for 
this line of research.  
6.5 Solid state structures 
The solid state structures for the helicene 160af, 160ae, 160ob and 160ag are shown in 
Table 17. The structural features of helicenes that are commonly compared are (i) the 
interplanar angle, defined by the angle between the planes set by each of the peripheral 
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rings; (ii) the torsional angles of the inner helix and (iii) the distances between the innermost 
carbons of the inner helix (C1–C9, C2–C8). Many helicenes display unequal torsional angles 
in the solid state, as is the case for helicenes 160af and 160ob. This implies that each of the 
aromatic rings bears the strain of the helical axis differently.  
Table 17. Solid state structures of 160af, 160ae, 160ag and 160ob  
 
 
Selected features 160af 160ae 160ag 160ob 
Space group P1 C2/c C2/c P21/c 
C2–C8 (Inner pitch) (Å) 3.074(1) 3.003(1) 3.090(1) 3.211(2) 
C1–C9 (Å) 4.225(1) 3.978(1) 4.367(1) 4.566(1) 
Interplanar angle (°) 49.15 42.09 53.84 58.04 
Φ(C2–C3–C4–C5) (°) 12.6(2) 19.1 7.9 16.3(2 
Φ(C3–C4–C5–C6) (°) 28.5(2) 23.9 30.5 28.0(2) 
Φ(C4–C5–C6–C7) (°) 24.7(2) 23.9 30.5 28.4(2) 
Φ(C5–C6–C7–C8) (°) 18.9(2) 19.1 7.9 18.2(2) 
Solvent molecules are omitted for clarity. Thermal ellipsoids are set to 50% probability. The numbering does not 
correspond to the IUPAC rules. 
Curiously, helicenes 160ae and 160ag crystallized in a C2-symmetric space group, which is 
less commonly seen for helicenes.[120] As can be seen in Table 17, despite the only 
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difference in their respective structures being the substitution of fluorine for chlorine or 
methoxy groups, helicenes 160af, 160ae and 160ag display quite different interplanar 
angles, torsional angles and C2–C8 bond distances. However, this is likely due to differences 
in crystal packing effects, which can have a large influence on the flexible helix structure.[136]  
The solid state structure of helicene 212an is shown in Figure 39. Here the poorer overlap of 
the peripheral aromatic rings can be seen, and is manifested by the dramatically reduced 
values for the outermost two torsional angles [C2–C3–C4–C5 = 5.0(6)°; C5–C6–C7–C8 = 
10.0(6)°]. The X-ray structure also confirms the geometry of the two exocyclic double bonds, 
with both shown to be (E)-configurated. This geometry is expected to be formed under the 
gold(I) catalysis conditions due to the anti mode of nucleophilic attack. It also indicates that 
no further isomerization occurs under the reaction conditions or upon workup. 
 
 
Figure 39. Solid state structure of 212an. Thermal ellipsoids set at 50% probability. The numbering does not 
correspond to the IUPAC rules. Space group P21/c. Selected bond lengths (Å) Br1–C11 = 1.878(4), Br2–C13 = 
1.877(3), C10–C11 = 1.339(5), C12–C13 = 1.342(5), C2–C8 (inner pitch) = 3.034(5); interplanar angle = 54.20°; 
torsional angles (°) C2–C3–C4–C5 = 5.0(6), C3–C4–C5–C6 = 22.3(6), C4–C5–C6–C7 = 25.2(6), C5–C6–C7–C8 
= 10.0(6). 
Dibenzohelicene 160db crystallizes in a P1 space group, with two symmetry-independent 
molecules of each enantiomer occupying the asymmetric unit cell (Table 18). The annulated 
peripheral benzene rings have an interesting twisted structure, and actually bend in the 
opposite direction to the rings making up the central helicene. This can be seen by 
comparing the interplanar angle of these rings (shown as rings A and H in Table 18) with that 
of the helix (rings B and G), where the planes formed by these rings intersect at opposite 
sides of the structure. This also has the effect of significantly reducing the C4–C11 distance 
in comparison to the other helicenes and may indicate some degree of electronic overlap 
between the π-systems of the two rings.  
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Table 18. Structure of dibenzohelicene 160db in the solid state: selected features for both symmetry independent 
molecules.  
 
 
Selected features 168db(1) 168db(2) 
C5–C10 (Å) 2.954(2) 2.968(2) 
C4–C11 (Å) 3.587(2) 3.537(2) 
Interplanar angle (rings B and G) (°) 21.44 15.79 
Interplanar angle (rings A and H) (°) –9.17 –6.52 
Φ(C11–C10–C9–C8) (°) 19.4(2) 26.7(2) 
Φ (C10–C9–C8–C7) (°) 20.8(2) 20.3(2) 
Φ (C9–C8–C7–C6) (°) 24.1(2) 20.2(2) 
Φ (C8–C7–C6–C5) (°) 24.0(2) 26.0(2) 
(A) One symmetry-independent molecule of 160db. (B) Side on-view of 160db, depicting twisting of the peripheral 
benzene rings of the helix; ancilliary p-tolyl rings set as capped sticks for clarity. Thermal ellipsoids set at 50% 
probability; the numbering does not correspond to the IUPAC rules. 
The solid state structures of the new helicenes 168eb, 168fb, 168gb and 168hb are shown 
in Table 19. Helicene 168eb crystallized in a racemic space group P21/n, with three 
symmetry independent molecules making up the asymmetric unit cell, while helicene 168fb 
crystallized in a space group Pn consisting of two symmetry independent molecules in the 
asymmetric unit cell. A comparison of each of these symmetry-independent molecules of the 
same structure shows the helix to be differently twisted in all cases. Nevertheless, a clear 
steric repulsion between the two sulphur atoms in 168eb can be seen, shown by a large 
increase in the interplanar angle, torsional angles and the inner pitch of the helix compared 
to 168gb, where the helix is much narrower. Differences between the helicenes 168fb and 
168hb are less manifested; presumably as the heteroatom is positioned outside the helix. 
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Table 19. Solid state structures of the heterohelicenes 160eb 160fb, 160gb and 160hb and selected structural 
parameters. 
 
Table 19 (continued) 
160 
Space 
group 
Inner 
pitch (Å) 
Inner pitch 
(outer) (Å) 
Interplanar 
angle (°) 
Φ1 (°) Φ2 (°) Φ3 (°) Φ4 (°) 
160eb(1) P21/n 3.2533(5) 4.900(2) 57.38 6.7(2) 30.0(2) 30.5(2) 7.7(2) 
160eb(2) P21/n 3.3149(5) 4.979(2) 60.89 8.9(2) 33.8(2) 27.5(2) 7.4(2) 
160eb(3) P21/n 3.2466(5) 4.969(2) 58.93 4.8(2) 28.5(2) 32.6(2) 7.5(2) 
160fb Pbca 2.607(1) 3.906(2) 47.90 5.4(2) 25.5(2) 24.0(2) 8.6(2) 
160gb Pbca 2.930(2) 4.199(2) 50.83 5.6(2) 27.9(2) 25.7(2) 11.1(2) 
160hb(1) Pn 3.044(3) 4.569(4) 57.72 6.8(4) 27.4(4) 29.6(4) 6.3(4) 
160hb(2) Pn 2.998(3) 4.441(4) 53.70 11.3(4) 25.7(4) 25.4(4) 11.7(4) 
Solvent molecules and additional symmetry independent molecules omitted for clarity. Thermal ellipsoids set at 
50% probability. The numbering does not correspond to the IUPAC rules. Inner pitch defined as (160eb) S1–S2; 
(160fb) O1–O2; (160gb, 160hb) C2–C8. Inner pitch (outer) defined as (160eb, 160fb) C1–C7;(160gb, 160hb) 
C1–C9. Torsional angles of inner helix (Φ) measured in anticlockwise order. 
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6.6 Optical properties 
Because the synthesized helicenes systemically crystallized in racemic space groups, no 
information about which enantiomer was preferentially formed in the reaction could be 
inferred from their solid state structures. A characteristic chiroptical property of helicenes is 
their circular dichroism spectra, which have the same shape, but are oppositely directed, 
depending on the enantiomer being measured. Circular dichroism is the ability of 
enantioenriched chiral molecules to differently absorb left- or right-handed circularly polarized 
light. Many helicenes exhibit two characteristic transitions; for example, in [6]carbohelicene 
106 one at 246 and another at 324nm can be seen (Figure 40).[258] For the enantiomer (P)-
106, the circular dichroism is positive for the transition at 324 nm and negative for the 
transition at 246 nm. This is equal and opposite for the (M)-enantiomer. By analyzing the 
known circular dichroism spectra (CDS) for both enantiomers of other similar compounds, 
the CDS of enantioenriched helicenes can be used as a tool to determine their absolute 
configuration.[200,258] Accordingly, the CDS of helicenes 160af, 160ag and 160ah, as well as 
160be, 160bi and 160bl[220] were measured and compared to that reported for hexahelicene 
106 (Figure 41). The helicenes 160af, 160ag and 160ah showed a strong agreement to the 
(P)-enantiomer of hexahelicene (P)-106, with positive circular dichroisms for the transitions at 
between 324–366 and negative circular dichroisms at 246–250 nm being observed. The 
helicenes 160be, 160bi and 160bl also showed a strong similarity, with the transitions shifted 
roughly 20 nm to higher wavelengths, in the range of 264 and 344 nm. Based on these 
findings, the absolute configuration of the helicenes formed using the (R,R) precatalyst 
(R,R)-172i was assigned as the (P)-enantiomer. 
 
Figure 40. Experimentally determined circular dichroism spectra of optically resolved [6]carbohelicene: (P) shown 
in blue; (M) shown in red. Figure taken from: Y. Nakai, T. Mori, Y. Inoue, J. Phys. Chem. A, 2012, 116, 7372.[202] 
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Figure 41. Experimentally determined CDS of helicenes synthesized through enantioselective gold(I) catalysis. 
Measured as solutions (100 μM in THF) of (A) compounds 160af, 160ag, and 160ah; (B) compounds 160be, 
160bi and 160bl. Helicenes 160be, 160bi and 160bl were prepared by Lukas Schaaf MSc.[220]  
In addition, some photophysical properties for the helicenes formed using the precatalyst 
172y were measured. In this instance, a comparison of how the substituents directly bound 
to the helicene termini affect photophysical properties such as circular dichroism, UV/Vis and 
fluorescence was possible. Although the helicenes were not formed with perfect 
enantiomeric excesses, a qualitative evaluation of the effect of different substituents can be 
seen from their respective spectra. The overlaid circular dichroism (CD) spectra for helicenes 
160ab, 160bb, 160jb, 160ob and 160nb, which have comparable enantiomeric excesses are 
shown in Figure 42A.  
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Figure 42. (A) Circular dichroism spectra of enantioenriched helicenes 160ab (87% ee) , 160bb (86% ee), 160jb 
(88% ee), 160ob (92% ee) and 160nb (87% ee). Samples measured in THF, 100 μM; (B) UV/Vis and 
fluorescence spectra of helicenes 160ab. 160bb, 160jb, 160ob and 160nb. Fluorescence shown as dashed lines. 
Spectra normalized to the relative maxima of each spectrum. Samples measured in THF. 
In contrast to the previous series of helicenes (Figure 41), the positions of both maxima in 
the CD spectra are more significantly affected by the introduction of different functional 
groups directly on the helicene. Again, the spectra support the assignment of the (P)-
enantiomer to the synthesized helicenes using (R,R)-172y. Additionally, the UV/Vis 
absorbance spectra of the helicenes 168ab, 168bb, 168jb, 168ob and 168nb, as well as 
their fluorescence spectra were measured. An overlay of the normalized spectra is shown in 
Figure 42B. Wavelengths in the absorption band at approximately 340 nm were chosen in all 
cases as excitation wavelengths, and fluorescence was measured between 400 and 600 nm. 
As can be seen, all samples fluoresced in the region of 430–460 nm, with two maxima being 
observed. These resemble recently reported emission spectra for other [6]carbohelicenes.[232]  
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6.7 Summary  
In summary, an expansion of the scope of the enantioselective gold(I) catalysed double 
hydroarylation of diynes 159 into 160 has been accomplished, and some additional variants 
on this reaction investigated. Firstly, a wider scope of the hydroarylation of diynes 159, with 
varying substituents at the alkyne substituents was evaluated using the chiral cationic 
phosphonite precatalyst 172i. Across a range of substrates, high yields, regio- and 
enantioselectivities could be obtained. Nevertheless, in instances where either the 
conversion of starting material 159 and intermediate 187, or regioselectivity over 6-endo-dig/ 
5-exo-dig isomer 188 was not excellent, the desired helicene could only be separated by low 
yielding preparative HPLC separations. 
Using a new selection of cationic phosphonite ligands, with a greater variety of cationic 
substituents, a series of model studies were carried out aiming to optimise the reactivity of 
the catalyst, in addition to achieve higher regio- and enantioselectivities in for a wider 
selection of substitution patterns. The 1,2,4-triazolium-based precatalyst 172y displayed a 
promising profile, and upon further evaluation across a range differently substituted 
precursors was shown to be highly reactive and consistently afforded helicenes 160 in 
excellent regioselectivities and enantioselectivites. Specifically, in challenging substrates 
where the precatalyst 172i afforded poor regioselectivities, 172y consistently resulted in 
dramatic improvements. Across a wide range of precursors 159, it is feasible to obtain 
[6]carbohelicenes 160 in high purity and enantiomeric excess (Chart 3). Although the 
[6]carbohelicenes consistently crystallised in racemic space groups, the absolute 
configuration could be assigned upon comparison of the CD spectra with ltierature reported 
values of [6]helicene. Therefore, when using the precatalyst (R,R)-172y, the (P)-
[6]carbohelicenes 160 are formed. 
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Chart 3. Gold complexes of first generation of chiral cationic phosphonites in twofold intramolecular 
hydroarylations towards [6]helicenes. 
7 Towards the enantioselective total synthesis of 
Monbarbatain A 
7.1 Retrosynthetic analysis 
Because Monbarbatain A contains two symmetrically joined phenanthrene subunits, it was 
envisaged that a twofold gold-catalyzed hydroarylation reaction of diyne 219 could affect the 
key cyclization and introduce an axially chiral axis in the resulting product 218, as shown in 
the retrosynthetic analysis outlined in Scheme 65. In addition, the natural product bears a 
series of free hydroxyl groups, which would most likely have to be protected during the gold 
catalysis step, so as not to allow a proton-catalyzed background reaction to take place due to 
coordination of the active gold species to any unprotected oxygen. A suitable protecting 
group, orthogonal to the two methoxy substituents, would therefore have to be chosen. 
 7. Towards the enantioselective total synthesis of Monbarbatain A  
122 
 
Scheme 65. Retrosynthetic analysis of Monbarbatain A. 
It was envisaged that to access the terminal diyne substrate 219, a double cross-coupling of 
the biaryl diiodide 220 and arylbromide 221 would be suitable. Aryl bromide 221 would be 
easily accessible from the commercially available 2-bromo,5-hydroxybenzaldehyde; and 
biaryl iodide 220 through a closely related iodination[259]/cross coupling[260] protocol (Scheme 
66).  
 
Scheme 66. General strategy to access biaryl 220. 
When choosing a suitable protecting group, previously obtained but unpublished results in 
the Alcarazo group indicated silyl groups to be particularly labile when using the cationic gold 
catalysts, and that significant decomposition of substrates bearing silyl ethers would occur 
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unless the reactions were conducted at low temperatures. Otherwise, methoxymethylethers 
were thought to potentially cause issues relating to the catalytic activity, as the substrate 
159am, bearing aliphatic ethers tested in this thesis gave low conversion, presumably 
through coordination of the oxygen to the highly electron deficient gold center in the catalyst 
(for the racemic reaction of 159kb, also with aliphatic chains, see experimental section). 
Two protecting group strategies that were hypothesized to tolerate the catalytic conditions, 
as well as to be selectively removed in the presence of the methyl ethers, were found. The 
robust benzyl protecting group had already shown high stability in other gold-catalyzed 
reactions conducted in the group, and it can be removed under mild hydrogenation 
conditions. Although the central double bond of phenanthrenes is known to be relatively 
reactive towards hydrogenation,[95] a variety of phenanthrenes have successfully been 
synthesized using this strategy, including in the synthesis of the natural product confusarin 
with two benzyl ethers on one phenanthrene skeleton,[261] and an analogue of Combretastatin 
A-4[110] (Scheme 67). On the other hand, partial reduction of the phenanthrene moieties in 
Monbarbatain A could lead to the other natural products Monbarbatain B (156b) and 157 
(Figure 25). 
 
Scheme 67. Deprotection of benzylated phenanthrenes 225[261] and 227.[110] Reagents and conditions: (a) H2 (20 
atm), 45 wt-% Pd/C, EtOAc; (b) H2 (1 atm), 10 wt-% Pd/C (0.1 equiv.), EtOAc.  
Another possible orthogonal protecting group would be the isopropyl ether, which would 
likely sterically shield the oxygen from the large gold catalyst and not inhibit its reactivity or 
be deprotected. Amongst others, the natural product reports on Dictyodendrin B[262], 
Dengibsin[263] as well as Fraxetin[264] had also established that the isopropyl group could be 
selectively removed using boron trichloride at 0 °C in excellent yields, even in the presence 
of a two-to-one ratio of isopropyl to methoxy groups. 
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Scheme 68. Deprotection of isopropyl ethers in the synthesis of Dengibsin[263] and Fraxetin.[264] Reagents and 
conditions: (a) BCl3 (4.0 equiv.), CH2Cl2, 0 °C to rt, 2 h; (b) BCl3 (3.0 equiv.), CH2Cl2, 18 °C, 3 h. 
While both protecting group strategies were deemed to viable, it was still unclear how each 
one would affect the outcome of the gold(I)-catalyzed hydroarylation. Because of this, both 
strategies were evaluated. 
7.2 Isopropyl group strategy 
The work described in this section was performed by A. Brennecke as a part of her bachelor 
thesis.[265] 
Starting from commercially available 4-bromo-3-methoxyphenol, the free hydroxyl was 
protected as the isopropyl ether under basic conditions in excellent yield. This was followed 
by a Yamamoto homocoupling,[260] giving biaryl 222a, which underwent iodination[259] using in 
situ generated HICl2 giving 220a in excellent yield (Scheme 69). No iodination in the position 
between the isopropyl and methyl ethers was observed. 
 
Scheme 69. Synthesis of biaryl 222a. Reagents and conditions: (a) 232 (1.0 equiv.), K2CO3 (3.8 equiv.), iPrBr 
(1.9 equiv.), 100 °C, 16 h; (b) 223a (1.0 equiv.), PPh3 (0.75 equiv.), NiCl2 (5 mol%), BiPy (5 mol%), Zn (1.5 
equiv.), DMAc, 90 °C, 16 h; (c) 222a (1.0 equiv.), I2 (1.90 equiv.), HCl (0.9 equiv, 37% aqueous), H2O2 (1.8 
equiv.), MeCN, rt, 16 h. 
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The aromatic building block 221a was prepared from the commercially available 2-bromo-5-
hydroxybenzaldehyde (233), firstly by forming the acetal with ethylene glycol under acidic 
catalysis to give phenol 234. It appeared that some of the starting material polymerized 
during this reaction, leading to a moderate yield of 50%. After this, the hydroxyl group was 
protected as the isopropyl ether following standard conditions in excellent yield (Scheme 70). 
 
Scheme 70. Preparation of building block 221a starting from benzaldehyde 233 by acetal protection followed by 
isopropyl ether formation. Reagents and conditions: (a) 233 (1.0 equiv.), p-TSA•H2O (5 mol%), ethylene glycol 
(1.3 equiv.), toluene, reflux 24h; (b) 234 (1.0 equiv.), K2CO3 (3.5 equiv.), iPrBr (1.43 equiv.), 100 °C, 16 h. 
With both building blocks in hand, the aromatic bromide 221a was converted into the 
organozinc derivative 235a via lithiation followed by transmetalation with zinc chloride. This 
was followed by Negishi coupling with diiodide 220a using modified conditions by 
Buchwald,[266] namely using Pd2(dba)3 and SPhos. After work up, the reaction mixture was 
directly mixed with tetrahydrofuran and 1M hydrochloric acid to deprotect the formyl groups in 
situ yielding dialdehyde 236a in 51% yield after three-step synthesis (Scheme 71). 
 
Scheme 71. Synthesis of dialdehyde 236a by Negishi coupling, followed by deprotection of the acetal under 
acidic conditions. Reagents and conditions: (a) 221a (1.0 equiv.), nBuLi (1.0 equiv.), THF, –78 °C, 2 h, then ZnCl2 
(2.5 equiv.), –78 °C to rt, 1.5 h, directly used in next step; (b) 235a (3.0 equiv.), 220a (1.0 equiv.), Pd2(dba)3 (3 
mol%), SPhos (6 mol%), THF, 70 °C, 18 h; (c) THF, HCl (1M), 60 °C, 2 h. 
The dialdehyde 236a was then subjected to the Seyferth-Gilbert homologation following the 
Bestmann-Ohira modification, which proceeded in a good yield (Scheme 72). It was found for 
this reaction that using a mixture of acetonitrile and methanol better solubilized the substrate 
and led to overall improved conversion. 
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Scheme 72. Seyferth-Gilbert homologation using the Bestmann-Ohira modification to give 219a. Reagents and 
conditions: (a) 236a (1.0 equiv.), 185 (3.1 equiv.), K2CO3 (6.3 equiv.), MeOH/ MeCN, rt, 16 h. 
This set the stage for the key gold(I)-catalyzed cyclization to give biphenanthrene 218a and 
form the chiral center in Monbarbatain A. As was the case for the [6]carbohelicene synthesis, 
it was likely that as well as the desired biphenanthrene 218a, additional products possibly 
identifiable in the reaction mixture would be the monocyclized intermediate 237a, as well as 
the 6-endo-dig/5-exo-dig product 238a (Scheme 73).  
The non-chiral gold(I) catalyst 98f, developed by Dr. H. Tinnermann,[87] was tried as 98f had 
shown promising results in previous hydroarylation chemistry. On stirring diyne 219a, 
precatalyst 98f and silver hexafluoroantimonate in dichloromethane, a mixture of products 
was formed, which could be identified as 218a, 219a and 237a (12: 39: 49) according to the 
crude NMR spectrum. A mixture of compounds 218a and 237a was isolated after purification 
by column chromatography and submitted to the same reaction conditions again, using 10 
mol% catalyst loading for a second run. After work up and repeated purification by column 
chromatography, the desired product 218a was obtained, however, as inseparable mixture in 
a ratio of 78:22 with a new compound 238a. The latter was tentatively assigned as the 
product of 6-endo-dig/5-exo-dig cyclization. Both regioisomers could later be purified by 
semi-preparative HPLC, allowing the product 218a to be completely characterized. 
Unfortunately, the 6-endo/5-exo-dig product 238a proved to be unstable in solution and could 
only be recognized by its 1H NMR spectrum.  
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Scheme 73. Gold(I)-catalyzed hydroarylation of diyne 219a to give the products 218a, 237a and 238a. Reagents 
and conditions: (a) 219a (1.0 equiv.), 98f (5 mol%), AgSbF6 (5 mol%), CH2Cl2, rt, 48 h; then 98f (10 mol%), 
AgSbF6 (10 mol%), CH2Cl2, rt, 18 h; 46% yield of 218a/238a mixure in ratio of 78:22. 
The product 218a, as well as 238a displayed characteristic low-field doublets at 9.72, and 
9.61 and 7.85 ppm, indicative of the phenanthrene ring having formed. 2D NMR assigned 
these low-field shifts to the inner C–H of the phenanthrene bay area, which likely becomes 
deshielded due to an interaction with the proximal isopropyl ether oxygen.It is also easy to 
see a possible steric clash for the isopropyl group at the oxygen pointing into the 
phenanthrene bay area. In forming the 5-exo-dig isomer, this clash would be somewhat 
alleviated. 
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Figure 43. NMR spectra of compounds 238a (A) and 218a (B) (300 MHz, CDCl3), indicating characteristic feature 
of phenanthrene core. 
The preparative separation yielded enough substance to attempt the deprotection of 218a to 
give Monbarbatain A. Based upon previously reported conditions,[262] it was decided to try 
first conservative conditions, treating 218a with BCl3 at –20 °C in CH2Cl2 and quenching the 
reaction at this temperature after 30 minutes (Scheme 74).  
 
Scheme 74. Attempted deprotection of 218a to give 157a. Reagents and conditions: (a) 218a (1.0 equiv.), BCl3 (8 
equiv.), CH2Cl2, –20 °C, 30 min. 
On analysis by NMR, a large mixture of products could be seen. Comparison of the spectrum 
to that reported for Monbarbatain A by Yang et al[215] showed that only traces of the natural 
product 156a were present in the mixture. Attempts to purify by preparative TLC were 
unsuccessful, but analysis by HRMS confirmed the presence of not only the tri- and tetra-
deprotected 239a and 156a, but also the compounds 240a, 241a and 242a, where one or 
both methoxy groups were also removed (Figure 44). 
(a) 
(b) 
7.85 ppm 9.61 ppm 
9.71 ppm 
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Figure 44. Possible products formed during the attempted deprotection reaction using BCl3. 
The results of the deprotection, although not conclusive, indicated that partial removal of the 
methoxy protecting groups had occurred, even when using relatively conservative 
deprotection conditions. In addition, because of the poor conversion in the gold catalysis step 
and occurrence of the 5-exo-dig/6-endo-dig product 238a, it was decided to evaluate and 
compare the benzyl protecting group strategy. 
7.3 Benzyl protecting group strategy 
The synthesis of the benzyl-protected terminal diyne proceeded in a similar sequence to that 
described for isopropyl protected 218a. Starting from commercially available phenol 232, 
nucleophilic substitution with benzyl bromide proceeded in excellent yields to give benzyl-
protected compound 223b, which then smoothly underwent the reductive Yamamoto 
homocoupling to give biaryl 222b (Scheme 75). Attempts to iodinate 222b using the 
procedure outlined in Scheme 69 only led to decomposition. An alternative procedure, 
adding a solution of iodine in chloroform to a suspension of biaryl 222b and silver 
trifluoroacetate in chloroform,[267] gave access to diiodide 220b in excellent yield (Scheme 
75). 
 
Scheme 75. Synthesis of diiodide 220b. Reagents and conditions: (a) 232 (1.0 equiv.), BnBr (1.0 equiv.), K2CO3 
(3.0 equiv.), MeCN, rt, 16 h; (b) 223b (1.0 equiv.), PPh3 (0.75 equiv.), NiCl2 (5 mol%), BiPy (5 mol%), Zn (1.5 
equiv.), DMAc, 90 °C, 16 h; (c) 222b (1.0 equiv.), CF3CO2Ag (2.4 equiv.), I2 (2.3 equiv.), CHCl3, rt, 3 h. 
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The synthesis of the protected aromatic aldehyde 221b was similarly straightforward. 
Because in the previous case the acetal formation did not proceed smoothly in the presence 
of the free phenol, this time the order of steps was reversed. Therefore, 2-bromo,5-
hydroxybenzaldehyde (233) was first protected as the benzyl ether, before making the acetal 
using ethylene glycol and catalytic para-toluenesulfonic acid applying a Dean-Stark 
apparatus (Scheme 76). Compound 221b was found to slowly decompose to the aldehyde 
234b if not stored in the freezer at –20 °C.  
 
Scheme 76. Synthesis of 203b by benzyl protection followed by acetal formation. Reagents and conditions: (a) 
233 (1.0 equiv.), BnBr (1.0 equiv.), K2CO3 (1.7 equiv.), MeCN, rt, 16 h; (b) 243 (1.0 equiv.), p-TSA•H2O (5 mol%), 
ethylene glycol (1.3 equiv.), toluene, reflux. 
Next, bromide 221b was converted into the organozinc derivative 235b via lithiation followed 
by transmetalation with zinc chloride. The Negishi coupling of 220b proceeded with good 
conversion. After work up, the crude product was directly mixed with tetrahydrofuran and 1M 
hydrochloric acid to cleave the acetal groups. In this case heating to 60 °C was necessary to 
give full conversion to the dialdehyde 236b (Scheme 77). 
 
Scheme 77. Synthesis of dialdehyde 236b by Negishi coupling followed by acetal deprotection. Reagents and 
conditions: (a) 221b (1.0 equiv.), nBuLi (1.0 equiv.), THF, –78 °C, 2h, then ZnCl2 (2.5 equiv.), –78 °C to rt, 1.5 h, 
directly used in next step; (b) 235b (3.0 equiv.), 220b (1.0 equiv.), Pd2(dba)3 (3 mol%), SPhos (6 mol%), THF, 70 
°C, 18 h; (c) THF, HCl (1M), 60 °C, 2 h.  
Seyferth-Gilbert homologation following the Bestmann-Ohira modification then gave 
compound 219b (Scheme 78) in good yield, which set the stage for the key gold(I)-catalyzed 
cyclisation (Table 20). 
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Scheme 78. Seyferth-Gilbert homologation of 236b to give diyne 219b. Reagents and conditions: (a) 236b (1.0 
equiv.), 185 (3.0 equiv.), K2CO3 (6.0 equiv.), MeOH/MeCN, rt, 16 h. 
Similarly, this reaction was first attempted with the non-chiral gold complex 98f. After stirring 
at room temperature for 16 h in dichloromethane, no signals which corresponded to product 
formation could be detected. The formation of a gold mirror on the inside of the reaction 
vessel also indicated decomposition of the catalyst. The chiral precatalysts 172n, 172o and 
172t were then evaluated to gauge how the steric and electronic environment could influence 
conversion and selectivity. Unfortunately, in the best case 8% of product in comparison to 
starting material could be detected in the crude 1H NMR. It seemed that the steric 
environment imposed by the benzyl protecting groups decreased the rate of reaction even 
more compared to the isopropyl group strategy. 
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Table 20. Attempted gold(I)-catalyzed cyclisation of 219b.  
 
Entr
y 
[Au] 
t 
(h) 
Comments 
1 98f 16 
No product detected. Partial decomposition of starting 
material 
2 172n 48 8% product detected 
3 172o 48 4% product detected, multiple side products 
4 172t 48 No conversion 
Reagents and conditions: 219b (1.0 equiv.), [Au] (5 mol%), AgSbF6 (5 mol%), CH2Cl2, rt. After work up, reaction 
mixtures were analyzed by NMR. 
It was clear at this stage that although the synthesis towards the starting diyne 219b was 
straightforward, the key gold(I)-catalyzed hydroarylation required further optimization. 
According to the previous experience by the Alcarazo group, even highly sterically congested 
phenanthrenes could be synthesized using cationic phosphine complexes; therefore, the 
reasons for the low conversion in this reaction are not obvious. In efforts to further 
understand this transformation, it was decided to probe the effect of installing a methoxy 
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group in place of the benzyl or isopropyl substituents at the phenanthrene core to see how 
reducing the steric bulk would influence conversion and the enantioselectivity of the reaction. 
7.4 Synthesis of dimethyl Monbarbatain A 
Starting from the cheap and commercially available 1-bromo-2,4-dimethoxybenzene (223c), 
the same synthetic sequence used above to access the diyne substrate 219 was applied 
(Scheme 79).  
 
Scheme 79. Synthesis of diyne 219c starting from bromide 223c. Reagents and conditions: (a) 223c (1.0 equiv.), 
PPh3 (0.75 equiv.), NiCl2 (5 mol%), BiPy (5 mol%), Zn (1.5 equiv.), DMAc, 90 °C, 16 h; (b) 222c (1.0 equiv.), I2 
(1.20 equiv.), HCl (0.3 equiv, 37% aqueous), H2O2 (1.2 equiv.), MeCN, rt, 16 h; (c) 235bc (3.0 equiv.), 220c (1.0 
equiv.), Pd2(dba)3 (3 mol%), SPhos (6 mol%), THF, 70 °C, 18 h; then THF, HCl (1M), rt, 2 h; (d) 236c (1.0 equiv.), 
185 (3.0 equiv.), K2CO3 (6.0 equiv.), MeOH/MeCN, rt, 16 h. 
Homocoupling followed by iodination gave the diiodo 220c in 77% overall yield. The following 
Negishi coupling was then carried out using freshly prepared benzyl-protected organozinc 
compound 235b, following the deprotection of formyl groups described above using a 
mixture of 1M HCl and THF, providing the dialdehyde 236c in 76% yield. Finally, Seyferth-
Gilbert homologation provided the diyne 219c in very good yield. With the diyne 219c in 
hand, the gold(I) catalyzed cyclization was attempted using a variety of cationic ligands 
(Table 21). Gratifyingly, the substrate modification with sterically less demanding methoxy 
group led to much improved reactivity, and in most cases full conversion was seen after 
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stirring for 144 h at 20 °C. Moreover, the 5-exo-dig/6-endo-dig isomer 238c could not be 
observed in the crude reaction mixtures. Additionally, the identity of the intermediate 237c, 
present in some reaction mixtures, could also be confirmed by full characterization after 
preparative HPLC separation. From these results, it is apparent that steric bulk in the para-
positions of the biaryl core in diyne 219 had a large bearing on the outcome of the reaction. 
Of the cationic ligands tested, the highest enantiomeric excesses were obtained for the gold 
complexes 172d (+47%) and 172b (+34%), bearing 2-naphthyl and 4-biphenyl substituents 
at the TADDOL backbone, respectively. In addition, the 2-naphthyl-substituted 
phosphoramidites (R,R,S,S)- and (S,S,S,S)-50b were evaluated. Curiously, the reactions 
were finished much faster in these cases, although 8% of a by-product, which could possibly 
be the 5-exo-dig/6-endo-dig isomer, was detected in the reaction using (S,S,S,S)-50b, and 
the enantioselectivities in both cases were diminished. However, no catalyst gave particularly 
high levels of enantioselectivity, and this may indicate that a different ligand family may be 
beneficial in this type of transformation. Interestingly, steric effects in the catalyst appear to 
override any electronic impact, with the phosphoramidites giving complete conversion in 
appreciably shorter reaction times than the other cationic phosphonites. It may therefore be 
interesting to screen additional phosphoramidites in the future. Moreover, it is also clear that 
the choice of group in the para-position of the biaryl subunit in 219 is crucial to ensuring high 
conversion, with an apparent steric clash occurring between this group and the bay area of 
the formed phenanthrene ring in 218. 
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Table 21. Gold(I)-catalyzed cyclisation of diyne 219c using cationic phosphonite-based gold complexes.  
 
Entry [Au] Ar R1 R2 t (h) 
Conversion 
(%)a 
218c: 237cb ee (%)c 
1 - - - - 44 0 - - 
2 172n Ph Mes H 20 >95 63: 8d +7 
3 172d 2-naphthyl Mes H 75 >95 96:4 +47 
4 172a 4-tBu-C6H4- Mes H 24 >95 99:1 0 
5 172e 3,5-(CF3)2-C6H3- Mes H 144 0 - - 
6 172b 4-Ph-C6H4- Mes H 144 >95 95:5 +36 
7 172c 4-CF3-C6H4- Mes H 144 >95 54:46 +3 
8 172o Ph iPr Me 40 >95 100:0 +4 
9 172q Ph Mes H 144 >95 58:42 +23 
10 172i 4-CF3-C6H4- Mes H 144 >95 56d 0 
11 209b 3,5-(CF3)2-C6H3- - - 144 >95 93: 7 12 
12 (R,R,S,S)-50b 42 >95 >99: 1 –16 
13 (S,S,S,S)-50b 23 >95 92e +23 
Reagents and conditions: 219c (1.0 equiv.), [Au] (5 mol%), AgSbF6 (5 mol%), CH2Cl2, 20 °C, t. a,bReactions were 
quenched then analyzed by NMR and HPLC to determine selectivity and conversion. cee determined by HPLC. 
dMultiple other side products observed. e8% of a single other isomer observed. 
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7.5 Summary 
To conclude, the total synthesis of the axially chiral, highly oxygenated biphenanthrene 
Monbarbatain A was attempted utilizing the newly developed chiral cationic phosphonites in 
a key gold (I)-catalyzed double hydroarylation reaction. Towards this goal, a versatile 
synthesis of a suitable diyne precursor was achieved. Two protecting group strategies, using 
either isopropyl or benzyl ethers, were then investigated. For both strategies, poor 
conversion of the gold(I) catalyzed key step limited the amount to which the final deprotection 
conditions could be evaluated. 
 
In an effort to improve conversion, reduction of steric bulk by introducing a methoxy group in 
the para positions of the central biaryl unit led to much increased conversions, and the family 
of cationic phosphonites was evaluated in this reaction towards the dimethoxy derivative of 
Monbarbatain A, resulting in a best ee of +47% for catalyst 172d. Interestingly, 
phoshoramidites tested in this transformation resulted in faster reaction times, indicating that 
the steric bulk of the catalyst overrides any electronic influence. Continued efforts in this area 
may focus on evaluating other phosphoramidites, or ligands with a reduced steric bulk. 
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8 Experimental 
8.1 General remarks 
8.1.1 General working methods 
Unless otherwise stated, all reactions were carried in dried glassware under an atmosphere 
of argon using standard Schlenk techniques, or under an atmosphere of nitrogen in a 
MBraun UNIlab plus glovebox. Dry and degassed solvents were obtained by distillation over 
the appropriate drying agents and stored under argon. Tetrahydrofuran, diethyl ether 
(Mg/anthracene), toluene, pentane (Na/K), dichloromethane, fluorobenzene, pyridine, 
diisopropylamine, (CaH2, then stored over 4 Å molecular sieves), acetonitrile (CaH2, then 
stored over 3 Å molecular sieves), methanol (Mg, then stored over 3 Å molecular sieves).[268] 
Alternatively, dry solvents were obtained using an MBraun MB-SPS-800 solvent purification 
system (tetrahydrofuran, diethyl ether, toluene, pentane, dichloromethane, acetonitrile). 
Other solvents were dried by pouring the wet solvent into a dried Schlenk flask with activated 
molecular sieves, followed by degassing under flow of argon for 30 minutes (N,N-
dimethylformamide, N,N-dimethylacetamide, chlorobenzene, chloroform: 4 Å molecular 
sieves). The water content of solvents was determined using a Karl Fischer titrator TitroLine 
R 7500 KF trace from SI Analytics. Flash chromatography was performed either on Merck 60 
(40–63 µm) or Macherey Nagel 60 (40–63 μm) silica gel. Reactions were controlled by thin 
layer chromatography (TLC) analysis, performed using Merck silica gel 60 F254 TLC plates 
or polygram SIL G/UV254 from Macherey Nagel, and visualized by UV irradiation (λ = 254 
nm) and/or phosphomolybdic acid or KMnO4 dip. When it was possible, the reactions were 
additionally followed by GC/MS measurements performed on either an Agilent Technology 
GC 6890 Series with MSD 5973 (carrier gas: helium), employing an MN Optima5 column 
(30mm × 0.25mm, 0.25µm particle size); or an Agilent Technology 7820A, with a 5977E 
MSD, employing a HP-5MS column (30mm × 0.25mm, 0.25µm particle size). 
8.1.2 Starting materials 
Unless otherwise stated, all reagents were used as received from commercial suppliers 
(ABCR, Acros Organics, Alfa Aesar, Chempur GmbH, J and K Scientific, Sigma Aldrich, 
Thermo Fisher Scientific, Tokyo Chemical Industry). Molecular sieves were dried under high 
vacuum at 150 C for two days before storing under argon and additionally dried at 650 C 
under vacuum prior to use. PCl3 was distilled prior to use and stored under argon. Sodium 
hexafluoroantimonate was dried under high vacuum at 150 C for 16 h and stored in a 
Schlenk flask under argon or a glovebox under nitrogen. Silver hexafluoroantimonate was 
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purchased from Sigma Aldrich, transferred into a glovebox and finely ground using a pestle 
and mortar. N-bromosuccinimide was crystallized from boiling water, ground using a pestle 
and mortar and dried under high vacuum. Dimethyl (1-diazo-2-oxopropyl)phosphonate (185, 
the Bestmann-Ohira reagent),[269] 1-(benzyloxy)-4-iodobenzene,[270] 1-iodo-4-
(trimethylsilyl)benzene,[271] were prepared according to literature procedures. Helicene 
precursors 186a, 186b, 186c, 181d, 159bb and 159be were prepared according to 
previously described procedures.[219,272] Helicenes 160be, bi and bl analysed by CD 
spectroscopy were prepared by L Schaaf MSc.[272] The preparation of precatalysts 98a,e-l 
can be found in the literature.[86,87] TADDOL derivatives  170a,[233] 170b,[273] 170g,[52] 170i,[272] 
170l,[233] 170q,[52] 170t,[234] were prepared according to previously described procedures. 
Compound 201b was prepared according to a literature procedure.[52] BINOL derivative 163 
was prepared by Dr. Isaac Alonso according to a literature procedure.[242] Carbenes 56a, 
56b,[274] 56d,[238] 56e,[239] 56f[240] and carbodiphosphorane 202[236] were prepared according to 
literature procedures. 
8.1.3 General analytical methods 
NMR: spectra were recorded on a Bruker AV600, AV500, AV400, DPX300, Varian Mercury 
300 or Varian Inova 500 spectrometers as stated for each case; 1H and 13C chemical shifts 
(δ) are given in ppm relative to TMS, using the solvent signals as references and converting 
the chemical shifts to the TMS scale. 31P and 19F chemical shifts (δ) are given in ppm relative 
to H3PO4 and CFCl3 respectively (external standard). Coupling constants (J) are given in Hz. 
Deuterated solvents (CDCl3, C6D6, CD3CN) were dried and distilled over CaH2 under argon 
and stored in Schlenk flasks over molecular sieves (4 Å: CDCl3, C6D6; 3 Å: CD3CN) or inside 
a glovebox. 
HRMS: mass spectrometry analysis was performed either by the department for mass 
spectrometry at the Max-Planck-Institut für Kohlenforschung using the following equipment: 
Finnigan MAT 8200 (70 eV, EI), Finnigan MAT 95 (ESI) and Bruker APEX III FT-MS (7 T 
magnet, HRMS); or by the department for mass spectrometry at the Insitut für Organische 
und Biomolekulare Chemie, Georg-August-Universität Göttingen, Göttingen using the 
following equipment: Finnigan MAT 95 (70 eV, EI), Finnigan LCQ (ESI) and APEX IV 7T 
FTICR, Bruker Daltonic (HRMS). 
IR: spectra were recorded on either Nicolet FT-7199, FT/IR-4100 (Jasco), or Bruker ALPHA 
FT-IR Platinum ATR spectrometers, wavenumbers (ṽ) in cm−1. 
HPLC: the relative ratios of products in catalysis reactions was determined by analytical 
HPLC using either a Shimadzu prominence LC-20A system with integrated downstream 
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UV/Vis PDA detector; Shimadzu Nexera-i LC 2040 3D with integrated downstream UV/Vis 
PDA detector  or a Shimadzu LC-2010-CHT with integrated downstream UV/Vis detector. 
Specific conditions, such as columns, eluent mixtures, flow rates and temperatures are 
stated for each case. System control and chromatogram analysis were carried out with 
LabSolutions software. 
Chiral HPLC: the enantiomeric excesses of the products in catalysis reactions was 
determined using either a Shimadzu prominence LC-20A system  with integrated 
downstream UV/Vis PDA detector; Shimadzu Nexera-i LC 2040 3D  with integrated 
downstream UV/Vis PDA detector  or Shimadzu LC-2010-CHT with integrated downstream 
UV/Vis detector. Specific conditions, such as columns, eluent mixtures, flow rates and 
temperatures are stated for each compound. System control and chromatogram analysis 
were carried out with LabSolutions software. When indicated, the enantiomeric excess was 
determined by the department for chromatography at the Max-Planck-Institut für 
Kohlenforschung by 2D HPLC using an Agilent 2D 1290 Infinity system. In the first dimension 
an achiral separation of the mixture of products was performed using the appropriate achiral 
column and elution conditions. The relevant peak was then transferred with a heart cut to a 
second dimension equipped with the appropriate chiral column. Specific elution conditions 
are stated for each case. Detection of both separations was performed via a diode array 
detector at the given wavelengths. System control and chromatogram analysis were carried 
out with the Agilent OpenLAB ChemStation software. 
Semi-preparative HPLC: to obtain analytically pure samples, some compounds were 
separated by semi-preparative HPLC using a Jasco modular system (pump: PU-2087Plus, 
degasser: DG-2080-54, detector: UV-2077Plus, autosampler: AS-2055Plus, hardware 
interface: LC-NetII/ADC) connected to an Advantec fraction collector CHF12SC. System 
control and analysis was performed with Galaxie 1.10 chromotography software. Compound 
237c was separated by the department for chromatography at the Max-Planck-institut für 
Kohlenforschung using a Shimadzu preparative LC-8A system connected to a Shimadzu 
FRC-10A fraction collector. Columns used for separation as well as specific conditions are 
stated for each case. 
Circular dichroism: spectra were conducted on a Jasco J-1500 spectrometer in 
tetrahydrofuran using a 1 mm quartz sample cell. 
Specific rotations: were collected using Perkin Elmer 343 or Jasco P-2000 polarimeters at 
the stated temperature under a Na/Hg lamp, λ = 589 nm (c in g/100 ml). 
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Cyclic voltammetry: Cyclic voltammetry was conducted using a standard three electrode 
setup, consisting of a glassy carbon working electrode, Ag/AgNO3 pseudo-reference 
electrode and a Pt counter electrode in combination with a VersaSTAT 4 potentiostat. 
Bu4NPF6 (0.2M in MeCN or 0.1M in CH2Cl2) was used as the electrolyte. The 
voltammograms were measured in dry degassed MeCN or CH2Cl2 and referenced to the 
Fc/Fc+ couple via addition of ferrocene directly after the sample measurement. Square wave 
voltammetry was measured using the same experimental setup as for the cyclic voltammetry 
experiments. System control and analysis was performed using VersaStudio software from 
Princeton Applied Research. 
UV/Vis: spectra were obtained using a Jasco V-630 spectrometer using a 1 cm quartz 
sample cell. 
X-ray-diffraction: Single crystal structure determination for compounds was either 
performed by the department of chemical crystallography at the Max-Planck-Institut für 
Kohlenforschung or at The University of Göttingen. Conditions at the Max-Planck-Institut für 
Kohlenforschung: The X-ray intensity data were measured on a Bruker AXS Proteum X8, 
Bruker AXS KappaCCD and Bruker AXS Apex II diffractometers. The crystal structures were 
solved by direct methods using SHELXS-97 and refined with SHELXL-2014. Conditions at 
the University of Göttingen: structures were solved by Dr. Christopher Golz. Data collection 
was done on a Bruker D8 Venture four-circle-diffractometer from Bruker AXS GmbH; 
detector: Photon II from Bruker AXS GmbH; X-ray sources: microfocus IµS Cu/Mo from 
Incoatec GmbH with mirror optics HELIOS and single-hole collimator from Bruker AXS 
GmbH. Used programs: APEX3 Suite (v2017.3-0) and therein integrated programs SAINT 
(Integration) und SADABS (Absorption correction) from Bruker AXS GmbH; structure solution 
was done with SHELXT, refinement with SHELXS;[275,275] OLEX2 was used for data 
finalization.[276] Special Utilities: SMZ1270 stereomicroscope from Nikon Metrology GmbH 
was used for sample preparation; crystals were mounted on MicroMounts or MicroLoops 
from MiTeGen; for sensitive samples the X-TEMP 2 System was used for picking of 
crystals;[277] crystals were cooled to given temperature with Cryostream 800 from Oxford 
Cryosystems. Crystal structures for compounds 169q (1520361), 172q (1520362),[272] 169r, 
172s, 172t, 188b, 160ob [245] can be found with their corresponding CCDC crystallographic 
database records. 
Theoretical methods: Optimsied geometries were calculated by Dr. Christopher Golz using 
Gaussian 09 revision E[221] and GaussView (company: Semichem Inc. 2009). Starting 
geometries were based upon previously published coordinates for [6]carbohelicene.[103] 
These were then optimized according to the B3LYP/6-31+G(d) level of theory. The optimized 
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starting geometries were confirmed as local minima by calculating the molecular vibration 
frequencies, which gave no negative frequencies. Transition states were optimized using the 
qst2 methods, again starting from the previously published coordinates. From each transition 
state, one single imaginary frequency was obtained. The energies given are corrected by 
their zero point energy value. For the log files, see digital appendix. 
8.2 Synthesis of new compounds 
8.2.1 Synthesis of helicene precursors 
General procedure A (GPA) 
Based on the Sonogashira-Hagihara procedure reported by Starý for aryl-tethered triynes.[200] 
A dry Schlenk flask equipped with a magnetic stirring bar and septum was charged with 
diyne 186[219] (1.0 equiv.), the corresponding aromatic iodide (4.0 equiv.), Pd(PPh3)4 (5.5 
mol%), CuI (9 mol%) and a mixture of iPr2NH/THF (2:1, 0.047M). The reaction mixture was 
degassed for 15 minutes under nitrogen flow and then stirred at room temperature for 3–5 h. 
The solvents were removed in vacuo and the residue directly purified by column 
chromatography. 
2,7-Bis[(4-fluorophenyl)ethynyl]-1,8-diphenylnaphthalene (159af): 
Prepared as a white solid (60.0 mg, 116 µmol, 
76% yield) from alkyne 186a (1.0 equiv, 50.0 
mg, 152 µmol), 1-fluoro-4-iodobenzene (4.0 
equiv, 135 mg, 608 µmol), Pd(PPh3)4 (5.5 
mol%, 9.7 mg, 8.3 µmol), CuI (8.9 mol%, 2.6 
mg, 13.6 µmol), iPr2NH (2.2 ml) and THF (1.1 ml) according to GPA (stirring at room 
temperature for 3 h, column chromatography: 20% toluene in petrol ether). 
1H NMR: (400 MHz, CDCl3) δ = 7.87 (d, J = 8.4 Hz, 2H), 7.66 (d, J = 8.4 Hz, 2H), 7.06 – 6.81 
(m, 18H); 13C{1H} NMR: (101 MHz, CDCl3) δ = 162.4 (d, JC-F = 249.4 Hz), 144.0, 141.3, 
133.9, 133.4 (d, JC-F = 8.3 Hz), 131.3, 130.8, 128.8, 128.4, 127.0, 126.2, 124.0, 119.5 (d, JC-F 
= 3.5 Hz), 115.5 (d, JC-F = 22.0 Hz), 93.5, 89.8 (d, JC-F = 1.5 Hz); 19F NMR: (282 MHz, CDCl3) 
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δ = -109.9 (tt, J = 8.6, 5.5 Hz); IR: (neat, cm–1) ṽ: 523, 616, 690, 746, 760, 804, 832, 1154, 
1219, 1358, 1444, 1504, 1597, 3020, 3054; HRMS: calculated m/z for C38H23F2+ [M+H]+: 
517.1762; found (ESI) 517.1767. 
2,7-Bis[(4-methoxyphenyl)ethynyl]-1,8-diphenylnaphthalene (159ag): 
Prepared as a white solid (84.0 mg, 
155 µmol, 85% yield) from alkyne 186a 
(1.0 equiv, 60.0 mg, 182 µmol), 4-
iodoanisole (4.0 equiv, 171 mg, 731 
µmol), Pd(PPh3)4 (5.5 mol%, 11.6 mg, 
10.0 µmol), CuI (8.9 mol%, 3.1 mg, 16.2 µmol), iPr2NH (2.2 ml) and THF (1.1 ml) according 
to GPA (stirring at room temperature for 3 h, column chromatography: 50% toluene in petrol 
ether). 
1H NMR: (400 MHz, CDCl3) δ = 7.84 (d, J = 8.5 Hz, 2H), 7.65 (d, J = 8.6 Hz, 2H), 7.06-6.87 
(m, 14H), 6.72 (dd, J = 8.9, 4.5 Hz, 4H), 3.75 (s, 6H) ppm; 13C{1H} NMR: (101 MHz, CDCl3) δ 
= 159.5, 143.4, 141.5, 133.6, 133.0, 131.4, 130.9, 128.7, 128.2, 127.0, 126.1, 124.4, 115.6, 
113.9, 94.5, 89.0, 55.5 ppm; IR: (neat, cm–1) ṽ = 508, 538, 692, 745, 830, 1027, 1174, 1245, 
1284, 1435, 1510, 1602, 1680, 2210, 2849, 2925, 3049; HRMS: calcd m/z for C40H29O2+ 
[M+H]+: 541.2162; found (ESI) 541.2149. 
2,7-Bis{[4-(benzyloxy)phenyl]ethynyl}-1,8-diphenylnaphthalene (159ah): 
Prepared as a white solid (77.0 mg, 
111 µmol, 73% yield) from alkyne 186a 
(1.0 equiv, 50.0 mg, 152 µmol), 1-
(benzyloxy)-4-iodobenzene (4.0 equiv, 
189 mg, 609 µmol), Pd(PPh3)4 (5.5 mol%, 
9.7 mg, 8.4 µmol), CuI (9.0 mol%, 2.6 mg, 13.7 µmol), iPr2NH (2.2 ml) and THF (1.1 ml) 
according to GPA (stirring at room temperature for 3 h, column chromatography: 60% 
toluene in petrol ether). 
1H NMR: (400 MHz, CDCl3) δ = 7.84 (d, J = 8.4 Hz, 2H), 7.65 (d, J = 8.4 Hz, 2H), 7.49-7.28 
(m, 10H), 7.07-6.88 (m, 14H), 6.79 (d, J = 8.8 Hz, 4H), 5.01 (s, 4H) ppm; 13C{1H} NMR: (101 
MHz, CDCl3) δ = 158.7, 143.5, 141.5, 136.8, 133.6, 133.0, 131.4, 130.9, 128.7, 128.7, 128.2, 
128.2, 127.5, 127.0, 126.1, 124.4, 115.9, 114.8, 94.5, 89.1, 70.1 ppm; IR: (neat, cm–1) ṽ = 
508, 538, 692, 745, 830, 1027, 1174, 1245, 1284, 1435, 1510, 1602, 1680, 2210, 2849, 
2925, 3049; HRMS: calculated m/z for C52H36NaO2+ [M+Na]+: 715.2608; found (ESI) 
715.2594. 
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2,7-Bis{[4-(trimethylsilyl)phenyl]ethynyl}-1,8-diphenylnaphthalene (159ai): 
Prepared as a white solid (50.0 mg, 80 
µmol, 53% yield) from alkyne 186a (1.0 
equiv, 50.0 mg, 152 µmol), (4-
iodophenyl)trimethylsilane (4.0 equiv, 
168 mg, 609 µmol), Pd(PPh3)4 (5.5 mol%, 
9.7 mg, 8.4 µmol), CuI (9.0 mol%, 2.6 mg, 13.7 µmol), iPr2NH (2.2 ml) and THF (1.1 ml) 
according to GPA (stirring at 70 C for 3 h, then overnight at room temperature: column 
chromatography: 10–30% toluene in hexane). 
1H NMR: (400 MHz, CDCl3) δ = 7.86 (d, J = 8.6 Hz, 2H), 7.74 – 7.65 (m, 2H), 7.37 – 7.30 (m, 
4H), 7.08 – 6.94 (m, 10H), 6.94 – 6.87 (m, 4H), 0.22 (s, 18H); 13C{1H} NMR: (101 MHz, 
CDCl3) δ =: 144.1, 141.3, 140.8, 133.9, 133.1, 131.3, 130.9, 130.6, 129.0, 128.3, 127.0, 
126.2, 124.2, 123.7, 94.7, 90.6, –1.1; IR: (neat, cm–1) ṽ = 536, 571, 295, 609, 630, 691, 716, 
759, 817, 836, 110, 1247, 1338, 1392, 1408, 1442, 1492, 1507, 1595, 2895, 2952, 3018, 
3056; HRMS: calculated m/z for C44H41Si2+ [M+H]+: 625.2741; found (ESI) 625.2752. 
2,7-Bis[(4-isopropylphenyl)ethynyl]-1,8-diphenylnaphthalene (159aj): 
Prepared as a white solid (32 mg, 56.6 
µmol, 37% yield) from alkyne 186a (1.0 
equiv, 50.0 mg, 152.2 µmol), 1-iodo-4-
isopropylbenzene (4.0 equiv, 150 mg, 
610 µmol), Pd(PPh3)4 (5.5 mol%, 9.7 mg, 
8.4 µmol), CuI (9.0 mol%, 2.6 mg, 13.7 µmol), iPr2NH (2.2 ml) and THF (1.1 ml) according to 
GPA, column chromatography (20% toluene in petrol ether). 
1H NMR: (300 MHz, CDCl3) δ = 7.85 (d, J = 8.5 Hz, 2H), 7.67 (d, J = 8.5 Hz, 2H), 7.11 – 6.84 
(m, 18H), 2.83 (hept, J = 6.9 Hz, 2H), 1.19 (d, J = 6.9 Hz, 12H) ppm; 13C{1H} NMR: (126 
MHz, CDCl3) δ = 149.0, 143.7, 141.3, 133.7, 131.4, 131.3, 130.8, 128.8, 128.1, 126.9, 126.3, 
126.0, 124.2, 120.7, 94.7, 89.5, 34.2, 24.0 ppm; IR: (neat, cm–1) ṽ =502.4, 556.4, 621.0, 
691.4, 764.6, 807.1, 834.1, 1017.3, 1026.9, 1049.1, 1070.3, 1099.2, 1260.3, 1356.7, 1440.6, 
1457.0, 1491.7, 1505.2, 1599.7, 2359.5, 2866.7, 2924.5, 2958.3, 3045.0; HRMS: calculated 
m/z for C44H36+ [M]+: 564.2817; found (EI) 564.2829. 
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2,7-Bis[(3,4-dimethylphenyl)ethynyl]-1,8-diphenylnaphthalene (159ak): 
Prepared as a white solid (52 mg, 96.8 
µmol, 64% yield) from alkyne 186a (1.0 
equiv, 50.0 mg, 152 µmol), 1-iodo-3,4-
dimethylbenzene (4.0 equiv, 141 mg, 
608 µmol), Pd(PPh3)4 (5.5 mol%, 9.7 mg, 
8.4 µmol), CuI (9.0 mol%, 2.6 mg, 13.7 µmol), iPr2NH (2.2 ml) and THF (1.1 ml) according to 
GPA (column chromatography: 20–30% toluene in petrol ether).  
1H NMR: (300 MHz, CDCl3) δ = 7.85 (d, J = 8.4 Hz, 2H), 7.65 (d, J = 8.4 Hz, 2H), 7.03 – 6.88 
(m, 12H), 6.81 – 6.71 (m, 4H), 2.19 (s, 6H), 2.14 (s, 6H) ppm; 13C{1H} NMR: (126 MHz, 
CDCl3) δ = 143.6, 141.4, 136.9, 136.4, 133.6, 132.6, 131.3, 130.9, 129.4, 128.9, 128.7, 
128.1, 126.9, 126.0, 124.3, 120.6, 94.8, 89.4, 19.9, 19.7 ppm; IR: (neat, cm–1) ṽ = 528, 577, 
634, 691, 744, 760, 806, 824, 845, 881, 1023, 1069, 1094, 1260, 1441, 1494, 1597, 2854, 
2914, 2968, 3051; HRMS: calculated m/z for C42H32+ [M] +: 536.2504; found (EI) 536.2508. 
2,7-Bis{[4-(triisopropylsilyloxymethyl)phenyl]ethynyl}-1,8-diphenylnaphthalene (159al): 
Prepared as a white solid (52 mg, 60.9 
µmol, 45% yield) from alkyne 186a (1.0 
equiv, 50.0 mg, 152 µmol), [(4-
iodobenzyl)oxy]triisopropylsilane (4.0 
equiv, 237 mg, 607 µmol), Pd(PPh3)4 (5.5 
mol%, 9.7 mg, 8.4 µmol), CuI (9.0 mol%, 2.6 mg, 13.7 µmol), iPr2NH (2.2 ml) and THF (1.1 
ml) according to GPA (column chromatography: 30% toluene in hexane). 
1H NMR: (300 MHz, CDCl3) δ = 7.86 (d, J = 8.5 Hz, 2H), 7.67 (d, J = 8.5 Hz, 2H), 7.21 – 7.13 
(m, 4H), 7.05 – 6.86 (m, 14H), 4.76 (s, 4H), 1.24 – 0.96 (m, 42H) ppm; 13C{1H} NMR: (126 
MHz, CDCl3) δ = 143.8, 141.8, 141.3, 133.8, 131.3, 131.2, 130.8, 128.9, 128.2, 126.9, 126.1, 
125.5, 124.2, 121.7, 94.6, 89.7, 64.9, 18.3, 12.3 ppm; IR: (neat, cm–1) ṽ = 528, 565, 659, 763, 
797, 851, 882, 1012, 1066, 1093, 1204, 1254, 1370, 1642, 1516, 2865, 2926; HRMS: 
calculated m/z for C58H68O2NaSi2+: [M+Na]+: 875.4650; found 875.4633. 
2,7-Bis{[4-(methoxymethyl)phenyl]ethynyl}-1,8-diphenylnaphthalene (159am): 
Prepared as a white solid (65.0 mg, 114 
µmol, 75% yield) from alkyne 186a (1.0 
equiv, 50.0 mg, 152 µmol), 1-iodo-4-
(methoxymethyl)benzene (6.57 equiv, 248 
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mg, 1.00 mmol), Pd(PPh3)4 (5.5 mol%, 9.7 mg, 8.4 µmol), CuI (9.0 mol%, 2.6 mg, 13.7 µmol), 
iPr2NH (2.2 ml) and THF (1.1 ml) according to GPA (stirring at 70 °C for 3 h, then overnight 
at room temperature; column chromatography: 10–30% toluene in hexane). 
1H NMR: (300 MHz, CDCl3) δ = 7.86 (d, J = 8.5 Hz, 2H), 7.67 (d, J = 8.6 Hz, 2H), 7.21 – 7.10 
(m, 4H), 7.07 – 6.87 (m, 14H), 4.38 (s, 4H), 3.34 (s, 6H) ppm; 13C{1H} NMR: (126 MHz, 
CDCl3) δ = 143.9, 141.2, 138.2, 133.8, 131.5, 131.2, 130.8, 128.8, 128.2, 127.4, 126.9, 
126.1, 124.0, 122.6, 94.4, 90.2, 74.4, 58.3 ppm; IR: (neat, cm–1) ṽ = 525.5, 696.3, 760.8, 
806.1, 821.5, 844.7, 912.2, 965.2, 1026.9, 1071.3, 1088.6, 1183.1, 1201.4, 1356.7, 1440.6, 
1490.7, 1510.0, 1597.7, 2820.4, 2854.1, 2922.6, 3049.9; HRMS: calcd m/z for C42H33O2+ 
[M+H]+: 569.2475; found (ESI) 569.2474. 
2,7-Bis(bromoethynyl)-1,8-diphenylnaphthalene (159an): 
Prepared according to an adapted literature procedure.[278] In 
a round bottom flask equipped with a magnetic stirrer, under 
air was added alkyne 186a (1.0 equiv, 50.0 mg, 152 µmol), 
followed by acetone (1.8 ml), Once the starting material had 
dissolved, silver nitrate (0.13 equiv, 3.4 mg, 20.0 µmol) was 
added, followed by NBS (2.4 equiv, 65.8 mg, 370 µmol) in portions. The reaction mixture was 
stirred for 30 minutes at room temperature, then concentrated in vacuo. The residue was 
diluted with dichloromethane (30 ml) and successively washed extracted with Na2S2O3 (3  
15 ml, sat. aqueous) and water (15 ml). The organic phase was dried over Mg2SO4, filtered 
and concentrated in in vacuo. Purification by column chromatography (10% toluene in 
pentane) afforded compound 167an as a white solid (65.0 mg, 133 µmol, 88% yield). 
1H NMR: (300 MHz, CDCl3) δ = 7.80 (d, J = 8.5 Hz, 2H), 7.58 (d, J = 8.5 Hz, 2H), 7.00 – 6.88 
(m, 6H), 6.86 – 6.75 (m, 4H) ppm; 13C{1H} NMR: (126 MHz, CDCl3) δ = 144.6, 140.2, 134.0, 
130.6, 130.6, 129.4, 127.9, 126.8, 126.2, 123.3, 80.0, 53.9 ppm; IR: (neat, cm–1) ṽ = 577, 
608, 747, 804, 838, 1028, 1071, 1169, 1350, 1440, 1488, 1575, 1597, 2181, 2923, 3017, 
3061; HRMS: calcd m/z for C26H14Br2+ [M]+: 483.9462; found (EI) 483.9464. 
2,7-Bis(trimethylsilylethynyl)-1,8-diphenylnaphthalene (159ao): 
To a Schlenk flask equipped with magnetic stirring bar, 
was added the alkyne 186a (1.0 equiv, 50.0 mg, 152 
µmol) and THF (0.5 ml), before cooling to –78 °C and 
adding butyllithium (2.18 equiv, 0.21 ml, 336 µmol, 1.6 M 
in hexanes) and allowing to stir at –78 °C for one hour. 
To the reaction mixture was then added chlorotrimethylsilane (2.20 equiv, 36.0 mg, 331 
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µmol), allowing to stir for 30 minutes, before warming to room temperature and stirring for 
another 3 h. The reaction was quenched by addition ammonium chloride (saturated, 
aqueous, 15 ml), then extracted with diethyl ether (3  20 ml). The combined organic layers 
were dried over MgSO4, filtered and concentrated in vacuo. After purification by column 
chromatography (10% toluene in petrol ether), the product was isolated as a white solid (39.0 
mg, 82.4 µmol, 54%). 
1H NMR: (301 MHz, CDCl3) δ = 7.78 (d, J = 8.5 Hz, 2H), 7.62 – 7.53 (m, 2H), 6.99 – 6.84 (m, 
6H), 6.84 – 6.74 (m, 4H), –0.07 (d, J = 0.5 Hz, 18H); 13C{1H} NMR: (126 MHz, CDCl3) δ = 
144.8, 140.9, 134.0, 130.9, 130.7, 129.1, 127.9, 126.8, 126.0, 123.7, 105.0, 99.4, –0.1 ppm; 
IR: (neat, cm–1) ṽ = 630, 692, 757, 837, 861, 1022, 1183, 1246, 1324, 1352, 1402, 1438, 
1500, 1597, 2152, 2846, 2896, 2955, 3020, 3054; HRMS: calcd m/z for C32H33Si2+ [M+H]+: 
473.2115; found (ESI) 473.2122. 
2,7-Bis[(triisopropylsilyl)ethynyl]-1,8-diphenylnaphthalene (159ap):  
In a Schlenk flask equipped with magnetic stirring bar, 
was added the alkyne 186a (1.0 equiv, 50.0 mg, 152 
µmol), and THF (0.5 ml), before cooling to –78 °C 
before cooling to –78 °C and adding butyllithium (2.2 
equiv, 0.21 ml, 336 µmol, 1.6 M in hexanes) and 
allowing to stir at -78 °C for one hour. To the reaction was then added 
chlorotriisopropylsilane (2.2 equiv, 65.0 mg, 337 µmol) allowing stirring for 30 minutes, before 
warming to room temperature and stirring for another 3 h. The reaction was quenched by 
addition ammonium chloride (saturated, aqueous, 15 ml), then extracted with diethyl ether (3 
 20 ml). The combined organic layers were dried over MgSO4, filtered and concentrated in 
vacuo. After purification by column chromatography (10% toluene in petrol ether) the product 
was isolated as a white solid (38.0 mg, 59.2 µmol, 39%). 
1H NMR: (301 MHz, CDCl3) δ = 7.77 (d, J = 8.4 Hz, 2H), 7.60 (d, J = 8.4 Hz, 2H), 6.90 – 6.72 
(m, 10H), 0.88 (d, J = 3.0 Hz, 41H) ppm; 13C{1H} NMR: (126 MHz, CDCl3) δ = 144.2, 141.0, 
133.9, 131.0, 130.8, 129.9, 127.8, 127.0, 126.0, 124.1, 106.8, 95.8, 18.8, 11.4 ppm; IR: 
(neat, cm–1) ṽ = 565, 604, 624, 658, 676, 748, 842, 878, 919, 994, 1017, 1071, 1183, 1253, 
1382, 1460, 1494, 1597, 2156, 2859, 2888, 2939, 3056; HRMS: calcd m/z for C44H57Si2+ 
[M+H]+: 641.3993; found (ESI) 641.3981. 
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2',7'-Diethynyl-2,1':8',2''-ternaphthalene (186d): 
Compound 186d was prepared in four steps from 2',7'-dimethyl-
2,1':8',2''-ternaphthalene (181d).[219] To a dry round bottom flask 
equipped with a stirring bar was added 181d (1.0 equiv, 321 mg, 
786 µmol), followed by benzene (16 ml), N-bromosuccinimide (2.2 
equiv, 308 mg, 1.731 mmol), benzoyl peroxide (6.7 mol%, 12.7 mg, 
52.4 µmol). The suspension was heated vigorously at reflux for 7 h, 
before cooling to 0°C and filtering. The filtrate was concentrated in vacuo, taken up with 
chloroform and precipitated with hexanes. The resulting precipitate was filtered and the 
filtrate concentrated in vacuo, affording crude 2',7'-bis(bromomethyl)-2,1':8',2''-
ternaphthalene (182d) (395 mg, 695 µmol, 89% crude yield), which was used in the next step 
without further purification. The compound 182d (1.0 equiv, 395 mg, 694.7 µmol) was 
transferred to a round bottom flask; calcium carbonate (5.5 equiv, 384 mg, 3.84 mmol), 
dioxane (2 ml) and water (0.5 ml) were added, and the reaction mixture was stirred under 
reflux for 48 h, and then filtered hot, washing the filter cake with hot dioxane. The filtrate was 
concentrated in vacuo and acidified with aqueous hydrochloric acid (2M), whereupon a 
precipitate formed. The solid was filtered off, washed with water and dried under high 
vacuum, affording crude [2,1':8',2''-ternaphthalene]-2',7'-diyldimethanol (183d) (273 mg, 620 
µmol, 89% crude yield), which was used without further purification. In a Schlenk flask 
equipped with stirring bar, compound 183d (1.0 equiv, 273 mg, 620 µmol) was dissolved in 
anhydrous dichloromethane (7.6 ml). The suspension was vigorously stirred at 40 °C, before 
adding pyridinium chlorochromate (3.0 equiv, 402 mg, 1.86 mmol) in one portion. The 
mixture was refluxed for 1 hour, before pouring into diethyl ether (50 ml). Trituration afforded 
a solid, which was removed by filtration over a pad of silica, eluting with diethyl ether. The 
filtrate was concentrated in vacuo, affording crude [2,1':8',2''-ternaphthalene]-2',7'-
dicarbaldehyde (184d) as an orange solid (266 mg, 609.3 µmol, 98% crude yield), which was 
used in the next step without further purification. To a Schlenk flask, equipped with stirring 
bar, was added dimethyl (1-diazo-2-oxopropyl)phosphonate (185) (3.0 equiv, 352 mg, 
1.83 mmol), then methanol (1.2 ml) and tetrahydrofuran (1.2 ml). The solution was 
transferred to a pre-prepared second Schlenk flask containing 184d (1.0 equiv, 266 mg, 
609.3 µmol) and potassium carbonate (4.0 equiv, 337 mg, 2.44 mmol). The resulting mixture 
was stirred overnight at room temperature, before removing the solvent in vacuo and 
dissolving the residue in dichloromethane. The organic layer was washed with brine, 
extracting the aqueous layer twice with dichloromethane. The combined organic phases 
were combined, dried over Na2SO4 and concentrated in vacuo, before purifying by column 
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chromatography (20–30% toluene in petrol ether), affording 186d as a white solid (66 mg, 
154 µmol, 25% yield, 20% yield over four steps), syn/anti = 44:55. 
1H NMR: (400 MHz, CDCl3) δ = 7.88 (d, J = 8.5 Hz, 1H, anti), 7.88 (d, J = 8.6 Hz, 0.81H, 
syn), 7.68 (d, J = 8.4 Hz, 1H, anti), 7.68 (d, J = 8.7 Hz, 0.81H, syn), 7.53 – 7.47 (m, 1H, anti), 
7.34 – 7.28 (m, 2H, anti), 7.24 – 7.12 (m, 6H), 7.11 (d, J = 8.9 Hz, 1H, anti), 7.06 (ddd, J = 
8.0, 6.5, 1.2 Hz, 0.81H, syn), 6.90 (dd, J = 8.4, 1.6 Hz, 1H, anti), 6.86 (dd, J = 8.3, 1.7 Hz, 
0.81H, syn), 6.81 (d, J = 8.2 Hz, 1H, anti), 2.77 (s, 1H, anti), 2.76 (s, 0.81H, syn) ppm; 
13C{1H} NMR: (101 MHz, CDCl3) δ = 144.6, 144.5, 138.2, 138.0, 134.4, 134.4, 132.6, 132.3, 
131.8, 131.8, 131.7, 131.5, 130.0, 130.0, 129.9, 129.4, 128.9, 128.4, 128.3, 128.1, 127.5, 
127.4, 127.3, 127.0, 126.2, 125.8, 125.4, 125.4, 125.4, 125.3, 123.0, 123.0, 83.4, 83.4, 82.3, 
82.2 ppm; IR: (neat, cm–1) ṽ = 591, 635, 647, 737, 756, 771, 715, 839, 895, 962, 1012, 1129, 
1254, 1321, 1500, 1602, 3018, 3052, 3276; HRMS: calculated m/z for C34H20+ [M]+: 
428.1565; found (EI) 428.1569. 
2',7'-Bis(p-tolylethynyl)-2,1':8',2''-ternaphthalene (159db): 
Prepared as a white solid [42.6 mg, 69.9 
µmol, >99% yield; mixture of syn and anti 
(45:55) isomers] from alkyne 186d (1.0 
equiv, 30.0 mg, 70.0 µmol), 4-iodotoluene 
(4.0 equiv, 61.1 mg, 280 µmol), Pd(PPh3)4 
(5.6 mol%, 4.5 mg, 3.9 µmmol), CuI (9.0 
mol%, 1.2 mg, 6.3 µmol), iPr2NH (1:0 ml) and THF (0.5 ml) according to GPA, stirring at 
room temperature for 4 h, column chromatography (5% ethyl acetate in petrol ether),  
1H NMR: (301 MHz, CDCl3) δ = 7.92 (d, J = 8.5 Hz, 1H, anti), 7.91 (d, J = 8.6 Hz, 0.81H, 
syn), 7.72 (d, J = 8.5 Hz, 1H, anti), 7.72 (d, J = 8.4 Hz, 0.81H, syn), 7.52 (dd, J = 8.2, 1.1 Hz, 
1H, anti), 7.39 – 7.27 (m, 4H), 7.26 – 7.13 (m, 4H), 7.09 (dd, J = 6.8, 1.4 Hz, 0.81H, syn), 
7.07 (dd, J = 8.4, 1.6 Hz, 1H, anti), 7.00 (dd, J = 8.3, 1.7 Hz, 0.81H, syn), 6.90 (d, J = 8.4 Hz, 
1H, anti), 6.87 – 6.79 (m, 4H), 6.70 (dd, J = 8.2, 1.7 Hz, 2H, anti), 6.66 (dd, J = 8.1, 1.8 Hz, 
1.62H, syn), 2.19 (s, 3H, anti), 2.19 (s, 2.43H, syn) ppm; 13C{1H} NMR: (76 MHz, CDCl3) δ = 
143.3, 143.2, 138.7, 138.4, 138.0, 138.0, 133.8, 133.7, 132.5, 132.2, 131.8, 131.6, 131.5, 
131.2, 131.1, 131.1, 131.0, 130.3, 129.5, 129.3, 128.8, 128.8, 128.7, 128.7, 128.6, 128.5, 
128.1, 128.1, 127.4, 127.3, 127.0, 126.7, 125.8, 125.4, 125.1, 125.1, 125.0, 124.9, 124.0, 
120.0, 120.0, 94.7, 94.7, 89.4, 89.4, 21.3, 21.3 ppm; IR: (neat, cm–1) ṽ = 523, 668, 704, 740, 
810, 843, 891, 1017, 1338, 1437, 1512, 1597, 1907, 2210, 2854, 2916, 3014, 3051; HRMS: 
calculated m/z for C48H32Na+ [M+Na] +: 631.2396; found (ESI) 631.2375. 
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Alternative four-step sequence to access helicene precursors 159 
 
1,8-Dibromonaphthalene-2,7-diyl Bis(trifluoromethanesulfonate) (189):  
Prepared over two steps according to adapted literature 
procedures.[226], [279] In a dried 500 ml three-necked round bottom 
flask equipped with magnetic stirring bar was added 2,7-
dihydroxynaphthalene (1.0 equiv, 2.50 g, 15.6 mmol), followed by acetonitrile (160 ml) under 
an argon atmosphere. The solution was cooled to 10 °C, before adding N-bromosuccinimide 
(2.0 equiv, 5.56 g, 31.2 mmol) portionswise via argon trouser. On completion of the addition, 
the reaction was allowed to stir for 2 h at 10 °C. The yellow solution was quenched by 
addition of H2SO4 (2M, 200 ml). The mixture was transferred to a separatory funnel, rinsing 
the flask with dichloromethane and distilled water (200 ml), then extracted with 
dichloromethane (3  650 ml). The combined organic layers were combined, dried over 
MgSO4 and directly filtered through a silica plug. The filtrate was evaporated and dried under 
high vacuum to give an orange/brown solid (4.90 g), which on analysis by 1H NMR (DMSO-
d6) contained approximately 70% of the desired 1,8-dibromonaphthalene-2,7-diol (190). The 
crude product was thoroughly dried under high vacuum then transferred to a pre-dried 
Schlenk flask, equipped with magnetic stirring bar, and the system was purged with argon 
before adding dry dichloromethane (90 ml). The mixture was cooled to 0 °C, then pyridine 
(3.0 equiv. 3.65 g, 46.1 mmol) followed by triflic anhydride (2.50 equiv. 10.9 g, 38.6 mmol) 
were added dropwise. The reaction was allowed to stir at 0 °C for 30 minutes, then quenched 
by careful addition of NaHCO3 solution (sat. aqueous) and extracted with dichloromethane. 
The organic layers were combined and washed with aqueous hydrochloric acid (10%). The 
organic layer was dried over MgSO4 and evaporated to give the crude product, which could 
be purified by column chromatography (5 to 7% ethyl acetate in pentane) to give the product 
189 as an off-white solid (2.38 g, 4.09 mmol, 26% yield over two steps). 
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1H NMR: (400 MHz, CDCl3) δ = 7.97 (d, J = 9.2 Hz, 2H), 7.56 (d, J = 9.0 Hz, 2H) ppm; 
13C{1H} NMR: (126 MHz, CDCl3) δ = 148.4, 134.0, 131.3, 130.9, 121.9, 118.8 (q, J = 320.3 
Hz), 115.9 ppm; IR (neat, cm–1) ṽ = 507, 569, 583, 640, 693, 728, 772, 845, 877, 995, 1131, 
1178, 1203, 1248, 1327, 1429; HRMS calcd. m/z for C12H3Br2F6O6S2+ [M–H]+: 578.7637; 
found (ESI) 578.7622. 
General procedure B (GPB) 
In a dried Schlenk flask equipped with magnetic stirrer and septum was added triflate 189 
(1.0 equiv.), followed by the alkyne (8.0–10.0 equiv.), Et3N (0.37M) and DMF (0.37M). The 
mixture was degassed under argon flow for 15 minutes, before adding PdCl2(dppf) (5 mol%) 
and CuI (10 mol%) and allowing to stir at room temperature for 3 h. The volatiles were 
removed in vacuo and the crude product purified by column chromatography. 
1,8-Dibromo-2,7-bis[(trimethylsilyl)ethynyl]naphthalene (188a): 
Prepared as a white solid (77 mg, 160.9 µmol, 47% 
yield) using triflate 189 (1.0 equiv, 200 mg, 344 µmol), 
(trimethylsilyl)acetylene (10 equiv, 338 mg, 3.44 mmol), 
PdCl2(dppf) (5.0 mol%, 12.6 mg, 17.2 µmol) and CuI (10.1 mol%, 6.6 mg, 34.6 µmol) in Et3N 
(1.0 ml) and DMF (1.0 ml) according to GPB after column chromatography (5% 
dichloromethane in pentane). 
1H NMR: (600 MHz, CDCl3) δ = 7.66 (d, J = 8.5 Hz, 2H), 7.51 (d, J = 8.5 Hz, 2H), 0.30 (s, 
18H) ppm; 13C{1H} NMR: (126 MHz, CDCl3) δ = 135.3, 130.4, 130.2, 128.2, 128.1, 123.7, 
104.8, 102.4, –0.1 ppm; IR: (neat, cm–1) ṽ = 597, 634, 697, 758, 833, 1137, 1180, 1218, 
1245, 1286, 1334, 1409, 1427, 1490, 1599, 2099, 2151, 2899, 2958; HRMS: calcd m/z for 
C20H22Br2Si2+ [M]+: 475.9627; found (EI) 475.9627. 
1,8-Dibromo-7-[(trimethylsilyl)ethynyl]naphthalen-2-yl Trifluoromethanesulfonate 
(191): 
In a dried Schlenk flask equipped with magnetic stirrer and 
septum was added triflate 189 (1.0 equiv, 318 mg, 546 µmol), 
followed by Et3N (1.5 ml) and DMF (1.5 ml), before degassing 
under argon flow for 20 minutes. (Trimethylsilyl)acetylene (2.0 equiv, 158 µl, 109 mg, 1.11 
mmol), PdCl2(PPh3)2 (5.0 mol%, 19.2 mg, 27.3 µmol) and CuI (10.0 mol%, 10.4 mg, 54.6 
µmol) were then added, and the reaction mixture allowed to stir at room temperature for one 
hour. The mixture was diluted with aqueous hydrochloric acid (1M, 50 ml) and extracted with 
dichloromethane (3  50 ml). The organic phases were combined, dried and concentrated in 
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vacuo, before the residue was purified by column chromatography (5% dichloromethane in 
pentane), to afford the product 191 as a white solid (95 mg, 179 µmol, 33% yield).  
1H NMR: (300 MHz, CDCl3) δ = 7.77 (d, J = 9.1 Hz, 1H), 7.69 (d, J = 8.6 Hz, 1H), 7.53 (d, J = 
8.4 Hz, 1H), 7.37 (d, J = 8.9 Hz, 1H), 0.25 (s, 9H) ppm; 13C{1H} NMR: (126 MHz, CDCl3) δ = 
147.6, 134.4, 131.0, 130.6, 130.4, 129.3, 128.3, 123.9, 122.4, 120.8, 119.9, 117.3, 115.2, 
114.8, 104.3, 103.8, –0.2 ppm; IR: (neat, cm–1) ṽ = 585, 624, 666, 702, 759, 840, 869, 984, 
1138, 1183, 1204, 1251, 1327, 1409, 1424, 1487, 1602, 2156, 2553, 2365, 2904, 2958; 
HRMS: calcd m/z for C16H14Br2F3O3SSi+ [M+H]+: 530.8726; found (ESI) 530.8726. 
1,8-Dibromo-2,7-bis(p-tolylethynyl)naphthalene (188b): 
Prepared as a yellow/gold crystalline solid 
(108 mg, 210 µmol, 82% yield) using triflate 
189 (1.0 equiv, 150 mg, 258 µmol), 4-
ethynyltoluene (7.70 equiv, 230 mg, 1.98 
mmol), Pd2Cl2(dppf) (5.0 mol%, 9.4 mg, 12.8 
µmol), CuI (10.0 mol%, 4.9 mg, 25.7 µmol), Et3N (0.7 ml) and DMF (0.7 ml) according to 
GPB after column chromatography (10–15% dichloromethane in pentane). Crystals suitable 
for X-ray crystallographic analysis were grown by slowly cooling a hot saturated solution in 
ethyl acetate. 
1H NMR: (300 MHz, CDCl3) δ = 7.72 (d, J = 8.6 Hz, 2H), 7.58 (d, J = 8.5 Hz, 2H), 7.53 (dd, J 
= 7.9, 1.6 Hz, 4H), 7.23 – 7.17 (m, 4H), 2.40 (dd, J = 867.7, 0.8 Hz, 6H) ppm; 13C{1H} NMR: 
(126 MHz, CDCl3) δ = 139.2, 135.1, 131.7, 130.6, 130.1, 129.3, 128.8, 128.4, 123.3, 120.0, 
96.7, 89.9, 21.8 ppm; IR: (neat, cm–1) ṽ = 523, 573, 692, 765, 809, 819, 844, 1131, 1245, 
1344, 1509, 1591, 2205, 2852, 2912, 2950, 3023, 3069; HRMS: calcd m/z for C28H19Br2+ 
[M+H]+: 512.9848; found (ESI) 512.9831. 
1,8-Dibromo-2,7-bis((4-methoxyphenyl)ethynyl)naphthalene (188c): 
Prepared as a white solid (830 mg, 1.52 
mmol, 86% yield) using triflate 189 (1.0 
equiv, 1.03 g, 1.77 mmol), 4-
ethynylanisole (7.5 equiv, 1.86 g, 14.1 
mmol), Pd2Cl2(dppf) (5.0 mol%, 64.4 mg, 
88 µmol), CuI (9.9 mol%, 33.5 mg, 175.8 µmol), Et3N (4.8 ml) and DMF (4.8 ml) according to 
GPB after column chromatography (20–50% dichloromethane in pentane). 
 8. Experimental  
152 
1H NMR: (300 MHz, CDCl3) δ = 7.70 (d, J = 8.6 Hz, 2H), 7.61 – 7.53 (m, 6H), 6.92 (dd, J = 
8.7, 2.4 Hz, 4H), 3.85 (s, 6H) ppm; 13C{1H} NMR: (75 MHz, CDCl3) δ = 160.7, 135.4, 133.9, 
131.1, 130.5, 129.4, 128.9, 123.4, 115.6, 114.7, 97.0, 89.8, 55.9 ppm; IR: (neat, cm–1) ṽ = 
530, 804, 821, 846, 1031, 1137, 1243, 1294, 1439, 1506, 1563, 1596, 2178, 2197, 2836, 
2928, 2964, 3007, 3051; HRMS: calcd m/z for C28H18Br2NaO2+ [M+Na]+: 566.9566; found 
(ESI) 566.9537. 
General procedure C (GPC) 
Under argon, to a dried Schlenk flask equipped with a magnetic stirring bar was added the 
diyne 188 (1.0 equiv), followed by the boronic acid derivative (4.0 equiv.), cesium carbonate 
(3.0 equiv.), THF and H2O (10:1, 0.05M). The mixture was degassed via three freeze-pump-
thaw cycles, then Pd2(dba)3 (4 mol%), Sphos (8 mol%) were added, a glass stopper fitted 
onto the Schlenk flask and the reaction mixture stirred at 60 C for the stated amount of time. 
When the reaction had reached completion, it was allowed to cool to room temperature and 
filtered through a plug of silica, eluting with ethyl acetate. The solvents were removed in 
vacuo and the crude product purified by column chromatography. 
2,2'-[2,7-Bis(p-tolylethynyl)naphthalene-1,8-diyl]dithiophene (159eb): 
Prepared as an off-white solid (13 mg, 24.9 
µmol, 51% yield) using diyne 188b (1.0 
equiv, 25.0 mg, 48.6 µmol), 2-thienylboronic 
acid (4.3 equiv, 26.8 mg, 209 µmol), cesium 
carbonate (3.22 equiv, 51.1 mg, 157 µmol), 
THF (1 ml), H2O (0.1 ml), Pd2(dba)3 (4.3 mol%, 1.9 mg, 2.1 µmol), Sphos (8.4 mol%, 1.7 mg, 
4.1 µmol) according to GPE. The mixture was heated for 1 h; column chromatography: 15% 
dichloromethane in pentane.  
1H NMR: (300 MHz, CDCl3) δ = 7.86 (d, J = 8.5 Hz, 2H), 7.65 (d, J = 8.4 Hz, 2H), 7.18 (dd, J 
= 5.1, 1.2 Hz, 2H), 7.04 (s, 8H), 6.75 (dd, J = 5.1, 3.5 Hz, 2H), 6.59 (dd, J = 3.5, 1.2 Hz, 2H), 
2.30 (s, 6H) ppm; 13C{1H} NMR: (126 MHz, CDCl3) δ = 141.6, 138.2, 135.1, 133.6, 133.1, 
131.4, 129.3, 129.0, 128.8, 128.5, 126.7, 126.2, 125.0, 120.1, 95.5, 88.6, 21.6 ppm; IR: 
(neat, cm–1) ṽ = 512, 524, 686, 694, 811, 844, 1018, 1091, 1260, 1510, 1591, 2330, 2360, 
2858, 2915, 2960; HRMS: calcd m/z for C36H25S2+ [M+H]+: 521.1392; found (EI) 521.1385. 
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2,2'-[2,7-Bis(p-tolylethynyl)naphthalene-1,8-diyl]difuran (159fb): 
Prepared as a red/orange solid (40.0 mg, 
81.8 µmol, 88% yield) using alkyne 188b (1.0 
equiv, 47.8 mg, 92.9 µmol), 2-furanylboronic 
acid (4.0 equiv, 41.6 mg, 372 µmol), cesium 
carbonate (3.0 equiv, 90.8 mg, 279 µmol), 
THF (2 ml), H2O (0.2 ml), Pd2(dba)3 (4.0 mol%, 3.4 mg, 3.7 µmol), Sphos (8.2 mol%, 3.1 mg, 
7.6 µmol) according to GPC. The mixture was heated for 1 h; column chromatography: 30% 
dichloromethane in pentane. 
1H NMR: (300 MHz, CDCl3) δ = 7.87 (d, J = 8.5 Hz, 2H), 7.66 (d, J = 8.5 Hz, 2H), 7.31 (dd, J 
= 1.8, 0.8 Hz, 2H), 7.21 (dd, J = 8.1, 1.9 Hz, 4H), 7.13 – 7.03 (m, 4H), 6.21 (dd, J = 3.3, 1.8 
Hz, 2H), 6.13 (dd, J = 3.3, 0.8 Hz, 2H), 2.33 (s, 6H); 13C{1H} NMR: (126 MHz, CDCl3) δ = 
150.8, 140.8, 138.6, 133.3, 133.2, 131.7, 131.6, 129.6, 129.1, 129.0, 126.5, 120.2, 111.2, 
109.8, 94.8, 88.3, 21.8; IR: (neat, cm–1) ṽ = 526, 613, 730, 814, 846, 991, 1071, 1152, 1201, 
1342, 1494, 1510, 1597, 2208, 2855, 2917, 2958, 3056, 3115; HRMS: calcd m/z for 
C36H25O2+ [M+H]+:489.1849; found (ESI) 489.1852. 
3,3'-[2,7-Bis(p-tolylethynyl)naphthalene-1,8-diyl]dithiophene (159gb): 
Prepared as a light yellow solid (23 mg, 
44.1 µmol, 57% yield) using alkyne 188b 
(1.0 equiv, 40.0 mg, 77.7 µmol), 3-
thienylboronic acid (4.0 equiv, 39.8 mg, 311 
µmol), cesium carbonate (3.0 equiv, 75.9 
mg, 233 µmol), THF (1.7 ml), H2O (170 µl), Pd2(dba)3 (4.0 mol%, 2.8 mg, 3.1 µmol), Sphos 
(8.1 mol%, 2.6 mg, 6.3 µmol) according to GPC. The mixture was heated for 1 h; column 
chromatography: 20% toluene in pentane.  
1H NMR: (300 MHz, C6D6) δ = 7.77 (d, J = 8.5 Hz, 2H), 7.53 (d, J = 8.5 Hz, 2H), 7.35 (dd, J = 
8.1, 1.8 Hz, 4H), 6.91 – 6.83 (m, 4H), 6.77 (dd, J = 4.7, 3.2 Hz, 2H), 6.70 – 6.60 (m, 4H), 
2.01 (s, 6H) ppm; 13C NMR: (75 MHz, C6D6) δ = 141.1, 138.7, 138.0, 133.6, 131.6, 130.6, 
129.0, 128.7, 128.5, 126.8, 125.1, 124.5, 123.0, 120.7, 95.0, 89.6, 20.9 ppm; IR: (neat, cm–1) 
ṽ = 524, 659, 766, 788, 812, 842, 1020, 1034, 1082, 1258, 1331, 1413, 1510, 1585, 2846, 
2915, 2958, 2990; HRMS: calcd m/z for C36H24S2+ [M]+:520.1319; found (EI) 52.1324. 
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3,3'-[2,7-Bis(p-tolylethynyl)naphthalene-1,8-diyl]difuran (159hb): 
Prepared as a purple solid (17.0 mg, 34.7 
µmol, 45% yield) using alkyne 188b (1.0 
equiv, 40.0 mg, 77.7 µmol), 3-furanylboronic 
acid (4.0 equiv, 34.8 mg, 311 µmol), cesium 
carbonate (3.0 equiv, 75.9 mg, 233 µmol), 
THF (1.7 ml), H2O (0.17 ml), Pd2(dba)3 (4.0 mol%, 2.8 mg, 3.1 µmol), Sphos (8.1 mol%, 2.6 
mg, 6.3 µmol) according to GPC. The mixture was heated for 1 h; column chromatography: 
20% toluene in pentane.  
1H NMR: (300 MHz, CDCl3) δ = 7.83 (d, J = 8.5 Hz, 2H), 7.67 (d, J = 8.5 Hz, 2H), 7.33 (t, J = 
1.7 Hz, 2H), 7.21 (dd, J = 8.1, 1.8 Hz, 4H), 7.16 – 7.05 (m, 6H), 6.27 (dd, J = 1.8, 0.8 Hz, 
2H), 2.36 (s, 6H) ppm; 13C{1H} NMR: (126 MHz, CDCl3) δ = 141.4, 141.0, 138.4, 133.7, 
133.5, 133.2, 131.4, 129.1, 128.9, 128.4, 125.0, 125.0, 120.4, 113.6, 94.7, 89.3, 21.7 ppm; 
IR: (neat, cm–1) ṽ = 525, 593, 668, 722, 793, 813, 871, 1021, 1066, 1161, 1347, 1442, 1497, 
1510, 1567, 1594, 2208, 2858, 2920, 2958, 3031, 3113, 3140; HRMS: calcd m/z for 
C36H24NaO2+ [M+Na]+: 511.1669; found (ESI) 511.1670. 
{[2,7-Bis(p-tolylethynyl)naphthalene-1,8-diyl]bis(4,1-phenylene)}bis(trimethylsilane) 
(159ib): 
Prepared as a white solid (37.3 mg, 57.1 
µmol, 37% yield) using alkyne 188b (1.0 
equiv, 80.0 mg, 156 µmol), 4-
(trimethylsilyl)phenylboronic acid (4.0 equiv, 
120.0 mg, 618 µmol), cesium carbonate (3.0 
equiv, 152.0 mg, 467 µmol), THF (3.4 ml), 
H2O (0.34 ml), Pd2(dba)3 (4.0 mol%, 5.7 mg, 6.2 µmol), Sphos (8.0 mol%, 5.1 mg, 12.4 µmol) 
according to GPC. The mixture was heated for 16 h. Column chromatography (10-15% 
toluene in pentane) was followed by crystallization from hexanes affording the product 159ib. 
Crystals suitable for X-ray crystallographic analysis were grown by slowly cooling a hot 
saturated hexane solution. 
1H NMR: (300 MHz, CDCl3) δ = 7.84 (d, J = 8.6 Hz, 2H), 7.64 (d, J = 8.5 Hz, 2H), 7.13 (dd, J 
= 8.1, 1.5 Hz, 4H), 6.98 – 6.93 (m, 4H), 6.90 (dd, J = 8.2, 1.5 Hz, 4H), 6.83 (dd, J = 8.2, 1.7 
Hz, 4H), 2.27 (s, 6H), 0.26 (s, 18H) ppm; 13C{1H} NMR: (126 MHz, CDCl3) δ = 143.9, 142.0, 
138.1, 137.2, 133.6, 131.7, 131.4, 130.9, 130.6, 128.8, 128.6, 128.0, 124.2, 120.3, 94.6, 
89.6, 21.7, –0.6 ppm; IR: (neat, cm–1) ṽ = 524, 631, 721, 753, 814, 837, 1093, 1121, 1244, 
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1381, 1508, 2919, 2953, 3018, 3054; HRMS: calcd. m/z for C46H44NaSi2+ [M+Na]+: 675.2874; 
found (ESI) 675.2863. 
1,8-Bis[4-(benzyloxy)phenyl]-2,7-bis(p-tolylethynyl)naphthalene (159jb) 
Prepared as a white solid (52.0 mg, 72.1 
µmol, 46% yield) using alkyne 188b (1.0 
equiv, 80.0 mg, 156 µmol), 4-
(benzyloxy)phenylboronic acid (4.0 equiv, 
141.0 mg, 618 µmol), cesium carbonate (3.0 
equiv, 152.0 mg, 467 µmol), THF (3.4 ml), 
H2O (0.34 ml), Pd2(dba)3 (4.0 mol%, 5.7 mg, 6.2 µmol), Sphos (8.0 mol%, 5.1 mg, 12.4 µmol) 
according to GPC. The mixture was heated for 16 h; column chromatography: 35% toluene, 
then 40–60% toluene in pentane). 
1H NMR: (300 MHz, C6D6) δ = 7.78 (d, J = 8.5 Hz, 2H), 7.53 (d, J = 8.5 Hz, 2H), 7.34 – 7.26 
(m, 4H), 7.25 – 7.17 (m, 6H), 7.14 – 7.04 (m, 4H), 6.86 (dd, J = 8.8, 2.3 Hz, 4H), 6.79 – 6.69 
(m, 4H), 6.60 (dd, J = 8.8, 2.3 Hz, 4H), 4.77 (s, 4H), 1.91 (s, 6H) ppm; 13C{1H} NMR: (75 
MHz, C6D6) δ = 157.7, 144.1, 138.2, 138.0, 134.8, 134.4, 132.8, 132.3, 131.8, 129.3, 129.2, 
128.9, 128.7, 127.8, 127.6, 125.1, 121.2, 113.9, 95.4, 90.6, 70.3, 21.3 ppm; IR: (neat, cm–1) ṽ 
= 531, 697, 737, 804, 817, 851, 1004, 1030, 1171, 1241, 1275, 1373, 1456, 1502, 1605, 
2857, 2911, 2953, 3031; HRMS: calcd m/z for C54H40NaO2+ [M+Na]+: 743.2921; found (ESI) 
743.2932. 
1,8-Bis[4-(methoxymethyl)phenyl]-2,7-bis(p-tolylethynyl)naphthalene (159kb): 
Prepared as a white solid (50.0 mg, 83.7 
µmol, 54% yield) using alkyne 188b (1.0 
equiv, 80.0 mg, 156 µmol), 4-
(methoxymethyl)phenylboronic acid (4.0 
equiv, 103.0 mg, 621 µmol), cesium 
carbonate (3.0 equiv, 152.0 mg, 467 µmol), 
THF (3.4 ml), H2O (0.34 ml), Pd2(dba)3 (4.0 mol%, 5.7 mg, 6.2 µmol), Sphos (8.0 mol%, 5.1 
mg, 12.4 µmol) according to GPC. The mixture was heated for 16 h; column 
chromatography: 40% ethyl acetate in pentane, then crystallization by layering pentane over 
a toluene solution. 
1H NMR: (400 MHz, CDCl3) δ = 7.85 (d, J = 8.5 Hz, 2H), 7.66 (d, J = 8.5 Hz, 2H), 7.00 – 6.96 
(m, 4H), 6.96 – 6.86 (m, 12H), 4.36 (s, 4H), 3.34 (s, 6H), 2.27 (s, 6H) ppm; 13C{1H} NMR: (75 
MHz, CDCl3) δ = 143.4, 140.9, 138.3, 135.8, 133.8, 131.4, 131.4, 131.1, 129.0, 128.9, 128.3, 
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126.3, 124.3, 120.3, 94.7, 89.6, 74.6, 57.8, 21.6 ppm; IR: (neat, cm–1) ṽ = 521, 611, 729, 
817, 849, 918, 1085, 1178, 1207, 1329, 1358, 1404, 1448, 1514, 2820, 2846, 2899, 2995, 
3046; HRMS: calcd. m/z for C44H36NaO2+ [M+Na]+: 619.2608; found (ESI) 619.2603. 
1,8-Bis[4-(methoxymethyl)phenyl]-7,14-di(p-tolyl)-2,9-bis(p-tolylethynyl)pentaleno[2,1-
a:5,4-a']dinaphthalene (192): 
Isolated as a dark red solid (1.7 mg, 1.78 µmol, 
2% yield) by recrystallizing the remainder of the 
mother liquor from toluene/pentane. 
1H NMR: (400 MHz, CDCl3) δ = 7.44 (d, J = 8.6 
Hz, 2H), 7.34 (d, J = 8.4 Hz, 2H), 7.18 – 7.11 
(m, 6H), 7.10 – 6.96 (m, 14H), 6.91 – 6.85 (m, 
4H), 6.57 – 6.50 (m, 4H), 4.49 (s, 4H), 3.46 (s, 
6H), 2.37 (s, 6H), 2.32 (s, 6H) ppm; 13C{1H} 
NMR: (126 MHz, CDCl3) δ = 148.3, 147.3, 144.8, 142.1, 140.3, 140.2, 140.0, 138.2, 137.2, 
137.2, 135.9, 135.6, 133.1, 131.2, 130.3, 128.8, 128.7, 128.5, 128.4, 127.9, 126.2, 122.1, 
120.6, 119.2, 93.1, 90.5, 74.9, 58.2, 21.7, 21.7 ppm; IR: (neat, cm–1) ṽ = 522, 727, 814, 
1017, 1093, 1185, 1223, 1258, 1372, 1444, 1512, 1580, 2333, 2360, 2822, 2849, 2920, 
3029; HRMS: calcd m/z for C72H54NaO2+ [M+Na]+: 973.4016; found (ESI) 973.4001. 
1,8-Di([1,1'-biphenyl]-4-yl)-2,7-bis(p-tolylethynyl)naphthalene (159lb): 
Prepared as a purple solid (25.0 mg, 37.8 
µmol, 24% yield) using alkyne 188b (1.0 
equiv, 80.0 mg, 156 µmol), 4-
biphenylboronic acid (4.0 equiv, 124 mg, 
626 µmol), cesium carbonate (3.0 equiv, 
152.0 mg, 467 µmol), THF (3.4 ml), H2O 
(0.34 ml), Pd2(dba)3 (4.0 mol%, 5.7 mg, 6.2 µmol), Sphos (8.0 mol%, 5.1 mg, 12.4 µmol) 
according to GPC. The mixture was heated for 16 h; column chromatography: 40% toluene 
in pentane. 
Literature corresponded to those previously reported.[184] 
1H NMR: (400 MHz, CDCl3) δ = 7.89 (d, J = 8.4 Hz, 2H), 7.70 (d, J = 8.4 Hz, 2H), 7.41 – 7.38 
(m, 4H), 7.36 – 7.31 (m, 6H), 7.20 (d, J = 8.0 Hz, 4H), 7.00 (d, J = 8.0 Hz, 4H), 6.93 (d, J = 
7.9 Hz, 4H), 6.87 (d, J = 7.9 Hz, 4H), 2.25 (s, 6H) ppm; 13C NMR: (101 MHz, CDCl3) δ: = 
143.4, 141.6, 140.7, 139.0, 138.3, 133.7, 131.7, 131.4, 131.2, 129.0, 128.7, 128.7, 128.4, 
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127.4, 127.0, 125.8, 124.2, 120.2, 95.1, 89.7, 21.6 ppm; IR: (neat, cm–1) ṽ = 509, 566, 578, 
612, 641, 693, 721, 735, 758, 823, 890, 963, 1021, 1073, 1107,  1153, 1181, 1209, 1261, 
1278, 1305, 1360, 1378, 1403, 1429,  1446, 1486, 1511, 1579, 1598, 2859, 2874, 2915, 
2944, 2964, 3021; HRMS: calcd m/z for C52H36+ [M]+: 660.2817; found (EI) 660.2819. 
1,8-bis(3,5-Dimethoxyphenyl)-2,7-bis(p-tolylethynyl)naphthalene (159mb): 
Prepared as an off-white solid (62.0 mg, 98.6 
µmol, 63% yield) using alkyne 188b (1.0 
equiv, 80.0 mg, 156 µmol), 3-5-dimethoxy-
phenylboronic acid (3.0 equiv, 84.9 mg, 467 
µmol), cesium carbonate (3.0 equiv, 152.0 
mg, 467 µmol), THF (3.4 ml), H2O (0.34 ml), Pd2(dba)3 (4.0 mol%, 5.7 mg, 6.2 µmol), Sphos 
(8.0 mol%, 5.1 mg, 12.4 µmol) according to GPC. The mixture was heated for 16 h; column 
chromatography: 0 to 1% ethyl acetate in toluene, then precipitation from 
dichloromethane/pentane. 
1H NMR: (300 MHz, CDCl3) δ = 7.84 (d, J = 8.5 Hz, 2H), 7.66 (d, J = 8.5 Hz, 2H), 7.06 – 6.97 
(m, 8H), 6.19 – 6.13 (m, 6H), 3.68 (s, 12H), 2.30 (s, 6H) ppm; 13C{1H} NMR: (75 MHz, 
CDCl3) δ = 159.1, 143.2, 142.7, 138.3, 133.8, 131.5, 130.9, 129.1, 128.9, 128.3, 123.8, 
120.4, 110.0, 99.3, 94.8, 89.5, 55.2, 21.6 ppm; IR: (neat, cm–1) ṽ = 521, 697, 924, 1062, 
1152, 1201, 1365, 1417, 1454, 1516, 1591, 2836, 2911, 2935, 2984; HRMS: calcd m/z for 
C44H37O4+ [M+H]+: 629.2686; found (ESI) 629.2683. 
1,8-Bis(3,5-dimethylphenyl)-2,7-bis(p-tolylethynyl)naphthalene (159nb): 
Prepared as an off-white solid (30.0 mg, 53.1 
µmol, 34% yield) using alkyne 188b (1.0 
equiv, 155.5 µmol), 3-5-
dimethylphenylboronic acid (3.0 equiv, 70.2 
mg, 468 µmol), cesium carbonate (3.0 equiv, 
152.0 mg, 466.5 µmol), THF (3.4 ml), H2O (0.34 ml), Pd2(dba)3 (4.0 mol%, 5.7 mg, 6.2 µmol), 
Sphos (8.0 mol%, 5.1 mg, 12.4 µmol) according to GPC. The mixture was heated for 16 h; 
column chromatography: 20 to 40% toluene in pentane, then precipitation from 
dichloromethane/pentane. 
1H NMR: (300 MHz, CDCl3) δ = 7.80 (d, J = 8.5 Hz, 2H), 7.64 (d, J = 8.4 Hz, 2H), 7.07 – 6.92 
(m, 8H), 6.62 – 6.58 (m, 2H), 6.57 – 6.51 (m, 4H), 2.29 (s, 6H), 2.15 (q, J = 0.6 Hz, 12H) 
ppm; 13C{1H} NMR: (101 MHz, CDCl3) δ = 144.2, 140.8, 138.1, 135.5, 133.9, 131.7, 131.4, 
129.1, 129.0, 128.8, 127.8, 127.5, 123.6, 120.6, 94.3, 90.0, 21.6, 21.3 ppm; IR: (neat, cm–1) ṽ 
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= 524, 709, 741, 809, 847, 1036, 1336, 1374, 1442, 1512, 1599, 1907, 2855, 2915, 2950, 
3023; HRMS: calcd. m/z for C44H36+ [M]+: 564.2817; found (EI) 564.2838. 
2,7-Bis((4-methoxyphenyl)ethynyl)-1,8-diphenylnaphthalene (159ag): 
Prepared as a white solid (52.0 mg, 96.1 
µmol, 53% yield) using diyne 188c (1.0 
equiv, 100 mg, 183 µmol), phenylboronic 
acid (4.0 equiv, 89.3 mg, 732 µmol), 
cesium carbonate (3.0 equiv, 179 mg, 
549 µmol), THF (4 ml), H2O (0.4 ml), Pd2(dba)3 (4.0 mol%, 6.7 mg, 7.3 µmol), Sphos (8.0 
mol%, 6.0 mg, 14.6 µmol) according to GPC. The mixture was heated for 16 h; column 
chromatography: 50% toluene in hexanes, then crystallization from 
dichloromethane/pentane. 
Analytical data corresponded to those reported above in this thesis. 
2,7-Bis[(4-methoxyphenyl)ethynyl]-1,8-di-p-tolylnaphthalene (159pg): 
Prepared as a white solid (52.0 mg, 91.4 
µmol, 50% yield) using diyne 188c (1.0 
equiv, 100 mg, 183 µmol), p-tolylboronic 
acid (4.0 equiv, 99.5 mg, 731.8 µmol), 
cesium carbonate (3.0 equiv, 179 mg, 
549 µmol), THF (4 ml), H2O (0.4 ml), 
Pd2(dba)3 (4.0 mol%, 6.7 mg, 7.3 µmol), Sphos (8.0 mol%, 6.0 mg, 14.6 µmol) according to 
GPC. The mixture was heated for 16 h; column chromatography: 50% toluene in hexanes, 
then crystallization from dichloromethane/pentane. 
1H NMR: (300 MHz, CDCl3) δ = 7.82 (d, J = 8.5 Hz, 2H), 7.63 (d, J = 8.4 Hz, 2H), 6.95 (dd, J 
= 9.0, 2.3 Hz, 4H), 6.76 (s, 8H), 6.71 (dd, J = 9.0, 2.5 Hz, 4H), 3.76 (s, 6H), 2.28 (s, 6H) ppm; 
13C{1H} NMR: (101 MHz, CDCl3) δ = 159.5, 143.7, 138.6, 135.2, 133.0, 131.1, 128.6, 128.1, 
127.4, 124.2, 115.8, 113.9, 94.3, 89.3, 55.4, 21.3 ppm; IR: (neat, cm–1) ṽ = 529, 770, 809, 
833, 1028, 1104, 1174, 1250, 1287, 1442, 1458, 1507, 1602, 2172, 2203, 2836, 2920, 2958, 
3001; HRMS: calcd m/z for C42H32NaO2+ [M+Na]+: 591.2295; found (ESI) 591.2284. 
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[{2,7-bis[(4-methoxyphenyl)ethynyl]naphthalene-1,8-diyl}bis(4,1-
phenylene)]bis(trimethylsilane) (159ig): 
Prepared as a white solid (31.0 mg, 45.2 
µmol, 25% yield) using alkyne 188c (1.0 
equiv, 100.0 mg, 183 µmol), 4-
(trimethylsilyl)phenylboronic acid (4.0 
equiv, 142 mg, 732 µmol), cesium 
carbonate (3.0 equiv, 179 mg, 549 µmol), 
THF (4 ml), H2O (0.4 ml), Pd2(dba)3 (4.0 mol%, 6.7 mg, 7.3 µmol), Sphos (8.0 mol%, 6.0 mg, 
14.6 µmol) according to GPC. The mixture was heated for 16 h; column chromatography: 
50% toluene in hexanes, then crystallization from dichloromethane/pentane. 
1H NMR: (300 MHz, CDCl3) δ = 7.85 (d, J = 8.5 Hz, 2H), 7.65 (d, J = 8.4 Hz, 2H), 7.15 (dd, J 
= 8.0, 1.3 Hz, 4H), 6.95 – 6.86 (m, 8H), 6.70 (dd, J = 8.9, 2.5 Hz, 4H), 3.77 (s, 6H), 0.28 (s, 
18H) ppm; 13C{1H} NMR: (101 MHz, CDCl3) δ = 159.5, 143.7, 142.2, 137.2, 133.0, 131.7, 
130.7, 128.5, 128.1, 124.3, 115.6, 113.8, 94.4, 89.0, 55.4, –0.7 ppm; IR: (neat, cm–1) ṽ = 
527, 631, 810, 826, 1031, 1248, 1283, 1509, 1566, 1601, 2202, 2213, 2831, 2893, 2948, 
2994, 3061; HRMS: calcd m/z for C46H44NaO2Si2+ [M+Na]+: 707.2772; found (ESI) 707.2772. 
1,8-Bis(3,5-dimethylphenyl)-2,7-bis[(4-methoxyphenyl)ethynyl]naphthalene (159ng): 
Prepared as a white solid (43.0 mg, 72.0 
µmol, 39% yield) using diyne 188c (1.0 
equiv, 100 mg, 183 µmol), 3,5-
dimethylphenylboronic acid (4.0 equiv, 
110 mg, 733 µmol), cesium carbonate 
(3.0 equiv, 179 mg, 549 µmol), THF (4 ml), H2O (0.4 ml), Pd2(dba)3 (4.0 mol%, 6.7 mg, 7.3 
µmol), Sphos (8.0 mol%, 6.0 mg, 14.6 µmol) according to GPC. The mixture was heated for 
16 h; column chromatography: 60% toluene in hexanes, then crystallization by slowly cooling 
a hot ethyl acetate solution to –20 C. 
1H NMR: (400 MHz, CDCl3) δ = 7.79 (d, J = 8.4 Hz, 2H), 7.62 (d, J = 8.4 Hz, 2H), 7.00 (dd, J 
= 8.9, 2.5 Hz, 4H), 6.74 (dd, J = 8.9, 2.4 Hz, 4H), 6.61 (s, 2H), 6.54 (s, 4H), 3.77 (s, 6H), 2.15 
(s, 12H) ppm; 13C{1H} NMR: (101 MHz, CDCl3) δ = 159.5, 143.8, 140.9, 135.5, 132.9, 129.1, 
128.6, 127.8, 127.5, 123.7, 115.9, 113.9, 94.2, 89.4, 55.4, 21.3 ppm; IR: (neat, cm–1) ṽ = 
532, 701, 829, 849, 1025, 1107, 1169, 1243, 1288, 1512, 1602, 2199, 2831, 2918, 2964, 
3007; HRMS: calcd m/z for C44H36NaO2+ [M+Na]+: 619.2608; found (ESI) 619.2595. 
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1,8-Bis(4-fluorophenyl)-2,7-bis[(4-methoxyphenyl)ethynyl]naphthalene (159qg): 
Prepared as a white solid (23.0 mg, 39.8 
µmol, 34% yield) using diyne 188c (1.0 
equiv, 64.3 mg, 118 µmol), 4-
fluorophenylboronic acid (4.0 equiv, 66.0 
mg, 472 µmol), cesium carbonate (2.8 
equiv, 107 mg, 328 µmol), THF (2.6 ml), 
H2O (0.26 ml), Pd2(dba)3 (4.0 mol%, 4.3 mg, 4.69 µmol), Sphos (8.1 mol%, 3.9 mg, 9.49 
µmol) according to GPC. The mixture was heated for 16 h; column chromatography: 60% 
toluene in hexanes, then crystallization from dichloromethane/pentane. 
1H NMR: (400 MHz, CDCl3) δ = 7.85 (d, J = 8.5 Hz, 2H), 7.65 (d, J = 8.4 Hz, 2H), 6.99 (dd, J 
= 8.5, 2.4 Hz, 4H), 6.87 (ddd, J = 8.9, 2.4 Hz, JH-F = 5.6 Hz, 4H), 6.78 – 6.70 (m, 8H), 3.77 (s, 
6H) ppm; 13C{1H} NMR: (101 MHz, CDCl3) δ = 161.3 (d, JC-F = 245.2 Hz), 159.6, 141.6, 137.4 
(d, JC-F = 3.6 Hz), 133.4, 132.8, 132.7 (d, JC-F = 8.6 Hz), 131.1, 128.6, 128.4, 124.6, 115.2, 
113.9, 113.8 (d, JC-F = 21.9 Hz), 94.8, 88.5, 55.3 ppm; 19F NMR: (376 MHz, CDCl3) δ = –
116.6 (tt, J = 8.9, 5.5 Hz) ppm; IR: (neat, cm–1) ṽ = 519, 568, 774, 799, 840, 1016, 1031, 
1152, 1177, 1218, 1245, 1288, 1500, 1512, 1593, 2162, 2211, 2842, 2904, 2939, 2967; 
HRMS: calcd m/z for C40H26F2O2+ [M]+: 576.1901; found (EI) 576.1906. 
2,7-Bis[(4-chlorophenyl)ethynyl]-1,8-bis(4-methoxyphenyl)naphthalene (159be): 
Prepared as a white solid (105 mg, 172 
µmol, 63% yield) from diyne 186c[219] (1.0 
equiv, 107 mg, 275 µmol), 1-chloro-4-
iodobenzene (4.0 equiv, 252 mg, 1.07 
mmol), Pd(PPh3)4 (5.0 mol%, 16.0 mg, 
13.8 µmol), CuI (9.5 mol%, 5.0 mg, 26.3 
µmol), iPr2NH (4.9 ml) and THF (2.4 ml) according to GPA; stirring at room temperature for 3 
h, column chromatography: 60% toluene in pentane. 
1H NMR: (400 MHz, CDCl3) δ = 7.85 (d, J = 8.5 Hz, 2H), 7.65 (d, J = 8.5 Hz, 2H), 7.03 (dd, J 
= 8.6, 2.1 Hz, 4H), 6.97 (dd, J = 8.9, 2.5 Hz, 4H), 6.83 (dd, J = 8.3, 2.0 Hz, 4H), 6.75 (dd, J = 
8.9, 2.3 Hz, 4H), 3.77 (s, 6H) ppm; 13C{1H} NMR: (101 MHz, CDCl3) δ = 159.8, 141.4, 140.0, 
133.5, 132.9, 132.7, 132.5, 130.9, 128.7, 128.7, 127.2, 124.5, 115.2, 114.1, 95.3, 88.6, 55.4; 
IR: (neat, cm–1) ṽ = 524, 774, 821, 837, 1014, 1033, 1041, 1088, 1167, 1240, 1256, 1286, 
1485, 1509, 1604, 20165, 2197, 2836, 2928, 2958, 2994, 3067; HRMS: calcd. m/z for 
C40H27Cl2O2+ [M+H]+: 609.1383; found (ESI) 609.1380. 
8. Experimental 
161 
8.2.2 Synthesis of chiral cationic phosphonites 
{[(3aS,8aS)-2,2-Dimethyl-4,4,8,8-tetraphenyltetrahydro-6 λ4-[1,3]dioxolo[4,5-
e][1,3,2]dioxaphosphepin-6-ylidene](triphenyl-λ4-
phosphaneyl)methyl}triphenylphosphonium Hexafluoroantimonate (169l): 
A dried Schlenk flask equipped with magnetic stirring bar was 
charged with the corresponding diol (S,S)-170l[233] (1.0 equiv, 
300 mg, 643 µmol), THF (5 ml) and triethylamine (2.19 equiv, 
143 mg, 1.41 mmol), before cooling to –78 °C. In a second dried 
Schlenk flask, a solution of phosphorus trichloride (1.1 equiv, 
97.3 mg, 709 µmol) in THF (5 ml) was prepared and added dropwise to the solution of the 
TADDOL 170l. The resulting white suspension was stirred at –78 °C for 1 h, then at room 
temperature for 1 h, before filtering the liquid phase into a separate dried Schlenk flask. The 
solvent was removed in vacuo and the crude chlorophosphite dried under high vacuum, 
before dissolving in THF (5 ml). A solution of hexaphenylcarbodiphosphorane (202)[236] (1.0 
equiv, 342 mg, 637 µmol) in THF (5 ml), prepared in a dried Schlenk flask, was added via 
canula at room temperature, whereby a white precipitate formed immediately. The reaction 
was allowed to stir overnight, before filtering and washing with diethyl ether (3  15 ml). The 
white solid was taken up in acetonitrile (5 ml), and sodium hexafluoroantimonate (2.58 equiv, 
430 mg, 1.66 mmol) was added. The resulting suspension was stirred overnight, before 
removing solvent in vacuo and extracting the solid with dichloromethane (3  20 ml), filtering 
into a dried Schlenk flask. The combined washings were concentrated in vacuo, and the pure 
product was obtained by recrystallization from dichloromethane/pentane as a white powder 
(400 mg, 315 µmol, 49% yield). 
[𝜶]𝟐𝟎
𝑫 : +73.1 (c = 1.00, CH2Cl2); 1H NMR: (400 MHz, CD3CN) δ = 7.61 – 7.49 (m, 18H), 7.35 
– 7.28 (m, 12H), 7.27 – 7.20 (m, 3H), 7.21 – 7.12 (m, 7H), 7.12 – 7.02 (m, 6H), 6.98 – 6.92 
(m, 2H), 6.38 – 6.34 (m, 2H), 4.80 (dd, J = 8.3 Hz, JH-P = 5.9 Hz, 1H), 4.66 (d, J = 8.2 Hz, 
1H), 0.90 (s, 3H), 0.21 (s, 3H) ppm; 13C{1H} NMR: (101 MHz, CD3CN) δ = 146.6, 146.0 (d, 
JC-P = 1.6 Hz), 142.1 (d, JC-P = 2.5 Hz), 141.7, 135.7 – 135.2 (m), 133.9, 130.3, 130.0, 130.0 
– 129.8 (m), 129.1, 128.9, 128.8, 128.7, 128.7, 128.4, 128.3, 128.2, 127.8, 127.7, 125.8 (dd, 
JC-P = 92.8, 2.6 Hz), 112.9, 86.0, 84.5 (d, JC-P = 13.4 Hz), 80.9 (d, JC-P = 31.8 Hz), 80.1 (d, JC-
P = 3.5 Hz), 27.6, 26.1, 22.1 (td, JC-P = 84.6, 70.4 Hz) ppm; 31P{1H} NMR: (162 MHz, CD3CN) 
δ = 179.5 (t, J = 91.8 Hz), 20.4 (d, J = 91.9 Hz) ppm; 19F NMR: (282 MHz, CD3CN) δ = –
123.9 (sext, JF-121Sb = 1938.0 Hz), –123.9 (oct, JF-123Sb = 1062.1 Hz) ppm; IR: (neat, cm–1) ṽ = 
499, 654, 692, 742, 797, 877, 994, 1096, 1164, 1212, 1437, 1484, 1587, 3044, 3057; HRMS: 
calcd m/z for C68H58O4P3+ [M–SbF6]+: 1031.3542; found (ESI) 1031.3546. 
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{[(5R,6R)-5,6-Dimethoxy-4,4,7,7-tetra(4-tert-butylphenyl)-1,3,2λ4-dioxaphosphepan-2-
ylidene)(triphenyl-λ4-phosphaneyl]methyl}triphenylphosphonium 
Hexafluoroantimonate (169m): 
A dried Schlenk flask equipped with magnetic stirring bar was 
charged with the corresponding diol 170g[234] (1.0 equiv, 400 mg, 589 
µmol), molecular sieves (4 Å, powdered, 100 mg), toluene (30 ml) 
and triethylamine (3.31 equiv, 197 mg, 1.95 mmol) before cooling to 
0 ° and adding phosphorus trichloride (1.32 equiv, 107 mg, 779 
µmol) dropwise via syringe. The mixture was stirred at 0 °C for a few 
minutes, then at 60 °C for one hour, where a white suspension 
formed. On cooling, the mixture was filtered and solvent removed in vacuo. The crude 
chlorophosphite was dried under high vacuum, then dissolved in THF (10 ml) and added via 
cannula to a solution of hexaphenylcarbodiphosphorane (202)[236] (0.99 equiv, 314 mg, 585 
µmol) in THF (10 ml). The resulting mixture was allowed to stir overnight at room 
temperature and monitored by 31P NMR. A second portion of 
hexaphenylcarbodiphosphorane (0.99 equiv, 314 mg, 585 µmol) as a solution in THF (5 ml) 
was then added, and the reaction mixture allowed to stir at room temperature for 24 h, then 
heated at 60 °C for an additional four more hours, whereby full conversion of the 
chlorophosphite was detected by 31P NMR. The resulting white precipitate was filtered into a 
dried Schlenk flask and the residual solid was washed with diethyl ether (2  10 ml). The 
combined washings gave a second precipitate, which was again filtered, and the resulting 
slightly yellow solution was evaporated to dryness, affording a pale yellow solid. To the crude 
solid was added acetonitrile (5 ml) and sodium hexafluoroantimonate (2.78 equiv, 425 mg, 
1.64 mmol) and the resulting suspension stirred overnight, before removing solvent in vacuo 
and extracting with dichloromethane (3  15 ml). The combined washings were evaporated 
and the crude residue purified by column chromatography (2% ethyl acetate in 
dichloromethane), affording a white solid (310 mg, 209 µmol, 35% yield). 
[𝜶]𝟐𝟎
𝑫 : -42.1 (c = 1.04, CH2Cl2); 1H NMR: (400 MHz, CD3CN) δ = 7.64 – 7.56 (m, 6H), 7.51 – 
7.39 (m, 12H), 7.39 – 7.29 (m, 12H), 7.21 – 7.17 (m, 2H), 7.15 – 7.07 (m, 8H), 6.88 – 6.79 
(m, 2H), 6.76 – 6.66 (m, 2H), 6.50 – 6.37 (m, 2H), 4.29 (dd, J = 6.8 Hz, JH-P = 8.5 Hz, 1H), 
3.84 (d, J = 6.9 Hz, 1H), 2.70 (s, 3H), 2.40 (s, 3H), 1.34 (s, 9H), 1.30 (s, 9H), 1.26 (s, 9H), 
1.20 (s, 9H) ppm; 13C{1H} NMR: (151 MHz, CD3CN) δ = 151.2, 151.1, 150.9, 150.8, 143.0, 
142.9 (d, JC-P = 1.4 Hz), 134.0, 140.0 (d, JC-P = 1.7 Hz), 135.7 – 135.4 (m), 133.7, 130.0 – 
129.9 (m), 129.8, 129.1, 129.1, 129. 0, 129.0, 126.0 (dd, JC-P = 92.9, 2.3 Hz), 125.6, 125.0, 
124.8, 124.1, 87.5, 84.3 (d, JC-P = 15.5 Hz), 81.7 (d, JC-P = 31.6 Hz), 81.6, 59.5, 58.8, 35.1, 
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35.0, 35.0, 35.0, 31.7, 31.6, 31.6, 31.5, 20.8 (td, JC-P = 84.1, 71.4 Hz) ppm; 31P{1H} NMR: 
(162 MHz, CD3CN) δ = 175.1 (t, J = 100.7 Hz), 20.6 (d, J = 100.7 Hz) ppm; 19F NMR: (282 
MHz, CD3CN) δ = –123.9 (sext, JF-121Sb = 1928.2 Hz), –123.9 (oct, JF-123Sb = 1043.3 Hz) ppm; 
IR: (neat, cm–1) ṽ = 500, 522, 654, 691, 745, 842, 897, 995, 1097, 1269, 1437, 1482, 2867, 
2903, 2957; HRMS: calcd m/z for C83H90O4P3+ [M–SbF6]+: 1243.6046; found (ESI) 
1243.6043. 
General procedure D (GPD) for the preparation of cationic phosphonites 
A dried Schlenk flask, equipped with magnetic stirring bar and rubber septum, was charged 
with molecular sieves (4 Å, powdered) and the corresponding diol, before drying under 
vacuum for 30 minutes and purging with argon. Toluene was added through the septum and 
the mixture cooled to 0 °C, before adding phosphorus trichloride, then pyridine. The mixture 
was stirred at 0 °C for a few minutes, then heated at 60 °C for one hour, then allowed to cool 
down to room temperature and filtered via cannula into a separate, dried Schlenk flask. The 
solvent was removed in vacuo, and the crude chlorophosphite dried under high vacuum, 
before dissolving in diethyl ether and cooling to –78 °C. In a separate Schlenk flask, a 
solution of the appropriate amount of the carbene in diethyl ether was prepared and added 
slowly, dropwise to the chlorophosphite via syringe, or cannula for a larger scale. The 
resulting suspension was allowed to stir at –78 °C for a few minutes, before adding sodium 
hexafluoroantimonate as a solid and allowing to warm to room temperature overnight. The 
liquid phase was then filtered off and the remaining solid washed twice with diethyl ether. 
The crude product was taken up in dichloromethane and filtered into a separate Schlenk 
flask, before removing the solvent in vacuo and purifying the crude product by column 
chromatography at –10 °C. 
2-{(3aS,8aS)-2,2-Dimethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-
e][1,3,2]dioxaphosphepin-6-yl}-1,3-dimesityl-1H-imidazol-3-ium Hexafluoroantimonate 
(169n): 
Prepared as a white solid (912 mg, 881 µmol, 69% yield) from 
chiral diol (S,S)-170l[233] (1.0 equiv, 600 mg, 1.29 mmol), 
molecular sieves (4 Å, powdered, 150 mg), pyridine (3.0 equiv, 
313 mg, 3.96 mmol), phosphorus trichloride (1.80 equiv, 315 
mg, 2.29 mmol) with 1,3-bis(2,4,6-trimethylphenyl)-1,3-
dihydro-2H-imidazol-2-ylidene (56b)[274] (1.0 equiv, 392 mg, 1.29 mmol) and sodium 
hexafluoroantimonate (2.49 equiv, 832 mg, 3.22 mmol) according to GPD after column 
chromatography (0 to 1.5% ethyl acetate in dichloromethane) at –10 °C. 
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[𝜶]𝟐𝟎
𝑫 : +87.1 (c = 1.03, CH2Cl2); 1H NMR: (400 MHz, CD3CN) δ = 7.78 (s, 2H), 7.44 – 7.34 
(m, 9H), 7.35 – 7.28 (m, 5H), 7.27 – 7.21 (m, 4H), 7.08 (s, 2H), 6.93 – 6.85 (m, 2H), 6.63 (d, 
J = 8.0 Hz, 2H), 5.16 (dd, J = 8.0 Hz, JH-P = 5.6 Hz 1H), 4.66 (d, J = 8.5 Hz, 1H), 2.47 (s, 6H), 
2.08 (s, 6H), 1.71 (s, 6H), 1.31 (s, 3H), 0.00 (s, 3H) ppm; 13C{1H} NMR: (101 MHz, CD3CN) δ 
= 145.3 (d, JC-P = 64.2 Hz), 144.7, 143.9 (d, JC-P = 4.5 Hz), 142.8, 139.8 (d, JC-P = 2.6 Hz), 
139.2, 135.9, 135.9, 132.0, 130.9, 130.7, 130.2, 129.9, 129.7, 129.7, 129.6, 129.3, 129.3, 
129.2, 129.2, 129.0, 128.6, 128.4, 128.2, 113.7, 87.3 (d, JC-P = 11.6 Hz), 86.4 (d, JC-P = 7.2 
Hz), 83.1 (d, JC-P = 3.2 Hz), 81.2 (d, JC-P = 28.7 Hz), 27.6, 24.8, 21.3, 18.1, 17.8, 17.8 ppm; 
31P{1H} NMR: (162 MHz, CD3CN) δ = 145.3 ppm; 19F NMR: (282 MHz, CD3CN) δ = –124.0 
(sext, JF-121Sb = 1930.0 Hz), –124.0 (oct, JF-123Sb = 1050.0 Hz) ppm; IR (neat, cm–1) ṽ = 654, 
701, 733, 875, 983, 1086, 1113, 1221, 1372, 1447, 1481, 1605, 2918, 2995, 3058, 3169; 
HRMS calcd m/z for C52H52N2O4P+: 799.3659 [M–SbF6]+; found (ESI) 799.3656. 
2-{(3aS,8aS)-2,2-Dimethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-
e][1,3,2]dioxaphosphepin-6-yl}-1,3-diisopropyl-4,5-dimethyl-1H-imidazol-3-ium 
Hexafluoroantimonate (169o): 
Prepared as a white solid (400 mg, 439 µmol, 51% yield) from 
chiral diol (S,S)-170l[233] (1.0 equiv, 400 mg, 857 µmol), 
molecular sieves (4 Å, powdered, 100 mg), pyridine (3.60 
equiv, 245 mg, 3.10 mmol), phosphorus trichloride (1.1 equiv, 
126 mg, 917 µmol) with 1,3-bis(isopropyl)-4,5-dimethyl-1,3-
dihydro-2H-imidazol-2-ylidene 56d[238] (1.0 equiv, 155 mg, 860 µmol), sodium 
hexafluoroantimonate (1.51 equiv, 333 mg, 1.29 mmol) according to GPD after column 
chromatography (0 to 2% ethyl acetate in dichloromethane) at –10 °C. 
[𝜶]𝟐𝟎
𝑫 : +87.6 (c = 1.03, CH2Cl2); 1H NMR: (400 MHz, CD3CN, 70 °C) δ = 7.88 – 7.80 (m, 2H), 
7.57 – 7.50 (m, 2H), 7.50 – 7.43 (m, 3H), 7.43 – 7.27 (m, 13H), 5.57 (dd, J = 8.5, JH-P = 4.3 
Hz, 1H), 5.46 (bs, 2H), 5.20 (d, J = 8.6 Hz, 1H), 2.40 (s, 6H), 1.61 – 1.43 (m, 15H), 0.34 (s, 
3H) ppm; 13C{1H} NMR: (101 MHz, CD3CN, 70 °C) δ = 146.6, 145.1 (d, JC-P = 4.7 Hz), 141.8 
(d, JC-P = 57.6 Hz), 141.1 (d, JC-P = 1.9 Hz), 140.9 (d, JC-P = 3.3 Hz), 132.9, 130.3, 130.1, 
130.0, 129.9, 129.9, 129.9, 129.7, 129.7, 129.5, 129.4, 129.0, 128.9, 128.6, 128.6, 114.1, 
87.6 (d, JC-P = 12.9 Hz), 87.0 (d, JC-P = 7.9 Hz), 84.5 (d, JC-P = 3.9 Hz), 83.6 (d, JC-P = 25.9 
Hz), 54.4, 54.2, 28.2, 25.4, 22.6, 22.6, 22.4, 22.3, 11.2 ppm; 31P{1H} NMR: (162 MHz, 
CD3CN) δ = 138.7 ppm; 19F NMR: (282 MHz, CD3CN) δ = –124.1 (sext, JF-121Sb = 1933.1 Hz), 
–124.1 (oct, JF-123Sb = 1048.8 Hz) ppm; IR: (neat, cm–1) ṽ = 501, 654, 700, 740, 873, 990, 
1087, 1164, 1215, 1374, 1447, 1614, 2937, 2988, 3060; HRMS: calcd m/z for C42H48N2O4P+ 
[M–SbF6]+: 675.3346; found (ESI) 675.3351. 
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2-{(3aR,8aR)-2,2-Dimethyl-4,4,8,8-tetra(biphen-4-yl)tetrahydro-[1,3]dioxolo[4,5-
e][1,3,2]dioxaphosphepin-6-yl}-1,3-di[(2,6-diisopropyl)phenyl]-1H-imidazol-3-ium 
Hexafluoroantimonate (169p): 
Prepared as a white solid (300 mg, 211 µmol, 41% yield) from 
the corresponding chiral diol 170b[234] (1.0 equiv, 400 mg, 519 
µmol), molecular sieves (4 Å, powdered, 100 mg), pyridine 
(2.9 equiv, 117 mg, 1.48 mmol), phosphorus trichloride (1.3 
equiv, 94.4 mg, 687 µmol) with 1,3-bis[(2,6-
diisopropyl)phenyl]-1,3-dihydro-2H-imidazol-2-ylidene (56a)[274] 
(1.0 equiv, 204 mg, 524 µmol) and sodium hexafluoroantimonate (3.24 equiv, 434 mg, 
1.68 mmol) according to GPD, adding the carbene to the chlorophosphite at –40 °C and after 
allowing warming to room temperature overnight, further stirring for 24 hours. Column 
chromatography (40% ethyl acetate in hexanes) at –10 °C, Crystals suitable for X-ray 
crystallographic analysis were grown by layering a dichloromethane solution with pentane. 
[𝜶]𝟐𝟎
𝑫 : –141.3 (c = 1.01, CH2Cl2); 1H NMR: (400 MHz, CD3CN) δ = 0 8.04 (s, 2H), 7.89 (t, J = 
7.8 Hz, 2H), 7.69 – 7.60 (m, 10H), 7.59 – 7.55 (m, 2H), 7.55 – 7.51 (m, 4H), 7.51 – 7.43 (m, 
10H), 7.43 – 7.38 (m, 4H), 7.36 (d, J = 8.4 Hz, 4H), 7.32 (d, J = 8.6 Hz, 2H), 7.09 – 7.04 (m, 
2H), 6.46 – 6.40 (m, 2H), 5.00 (d, J = 8.2 Hz, 1H), 4.89 (dd, J = 8.2 Hz, JH-P = 4.3 Hz, 1H), 
2.56 (p, J = 6.7 Hz, 2H), 2.48 (p, J = 6.8 Hz, 2H), 1.28 (s, 3H), 1.24 (d, J = 6.7 Hz, 6H), 1.12 
(d, J = 6.7 Hz, 6H), 0.99 (d, J = 6.8 Hz, 6H), 0.54 (d, J = 6.7 Hz, 6H), 0.36 (s, 3H) ppm; 
13C{1H} NMR: (101 MHz, CD3CN) δ = 147.36 (d, JC-P = 72.7 Hz), 146.3, 145.8, 143.4, 142.6 
(d, JC-P = 3.0 Hz), 142.2, 142.1, 141.4, 141.2, 140.7, 140.6, 140.6, 140.2, 138.0 (d, JC-P = 3.1 
Hz), 137.9, 133.6, 132.0, 130.5, 130.0, 129.9, 129.9, 129.8, 129.8, 129.6, 129.2, 129.1, 
128.8, 128.8, 128.7, 128.4, 128.2, 127.8, 127.8, 127.7, 127.7, 127.6, 127.0, 126.8, 126.8, 
126.0, 114.2, 87.1 (d, JC-P = 2.2 Hz), 86.8 (d, JC-P = 13.1 Hz), 83.0 (d, JC-P = 26.3 Hz), 81.2 (d, 
JC-P = 3.5 Hz), 30.3, 30.2, 29.9, 27.5, 26.2, 25.6, 25.3, 23.2, 21.0 ppm; 31P{1H} NMR: (162 
MHz, CD3CN) δ = 153.0 ppm; 19F NMR: (282 MHz, CD3CN) δ = –124.02 (sext, JF-121Sb = 
1927.4 Hz), –124.04 (oct, JF-123Sb = 1050.1 Hz) ppm; IR: (neat, cm–1) ṽ = 654, 696, 744, 759, 
802, 846, 877, 985, 1096, 1209, 1367, 1446, 1486, 1599, 1731, 2871, 2930, 2965, 3030; 
HRMS: calcd m/z for C82H80N2O4P+ [M–SbF6]+: 1187.5850; found (ESI) 1187.5856. 
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2-[(5R,6R)-5,6-Dimethoxy-4,4,7,7-tetraphenyl-1,3,2-dioxaphosphepan-2-yl]-1,3-
dimesityl-1H-imidazol-3-ium Hexafluoroantimonate (169q): 
Prepared as a white solid (466 mg, 455 µmol, 79% yield) from the 
corresponding diol (R,R)-170q[234] (1.25 equiv, 326 mg, 717 
µmol), molecular sieves (4 Å, powdered, 150 mg), pyridine (3.8 
equiv, 169 mg, 2,14 mmol), phosphorus trichloride (1.3 equiv, 
105 mg, 765 µmol) with 1,3-bis(2,4,6-trimethylphenyl)-1,3-
dihydro-2H-imidazol-2-ylidene (56b)[274] (1.0 equiv, 175 mg, 575 µmol) and sodium 
hexafluoroantimonate (3.8 equiv, 567 mg, 2.19 mmol) according to GPD after column 
chromatography (0 to 0.5% ethyl acetate in dichloromethane) at –10 °C. Crystals suitable for 
X-ray crystallographic analysis were grown by layering a dichloromethane solution with 
pentane. 
[𝜶]𝟐𝟎
𝑫 : –44.7 (c = 1.04, CH2Cl2); 1H NMR: (400 MHz, CD3CN) δ = 7.73 (s, 2H), 7.48 – 7.30 
(m, 12H), 7.29 – 7.21 (m, 4H), 7.13 (s, 2H), 7.06 – 7.01 (m, 2H), 6.84 – 6.75 (m, 4H), 4.58 
(dd, J = 7.0 Hz, JH-P = 7.0 Hz, 1H), 3.98 (d, J = 7.3 Hz, 1H), 3.34 (s, 3H), 2.50 (s, 6H), 2.23 
(s, 3H), 2.00 (s, 6H), 1.59 (s, 6H) ppm; 13C{1H} NMR: (101 MHz, CD3CN) δ = 145.4 (d, JC-P = 
66.4 Hz), 144.2 (d, JC-P = 4.5 Hz), 143.8, 142.8, 139.5 (d, JC-P = 2.9 Hz), 139.3, 135.9, 132.1, 
130.8, 130.8, 130.2, 129.8, 129.7, 129.4, 129.3, 129.2, 129.1, 129.1, 129.0, 128.9, 128.8, 
128.7, 127.5, 89.1 (d, JC-P = 4.5 Hz), 87.2 (d, JC-P = 14.5 Hz), 84.78 (d, JC-P = 1.9 Hz), 81.0 (d, 
JC-P = 28.9 Hz), 61.1, 60.0, 21.4, 17.9, 17.4, 17.3 ppm; 31P{1H} NMR: (162 MHz, CD3CN) δ = 
144.5 ppm; 19F NMR: (282 MHz, CD3CN) δ = –123.8 (sext, JF-121Sb = 1934.6 Hz), –123.8 (oct, 
JF-123Sb = 1049.8 Hz) ppm; IR: (neat, cm–1) ṽ = 654, 699, 840, 902, 955, 1016, 1134, 1187, 
1234, 1377, 1445, 1483, 1607, 2918, 2973, 3057, 3133, 3155; HRMS: calcd m/z for 
C51H52N2O4P+ [M–SbF6]+: 787.3659; found (ESI) 787.3658. 
2-[(5R,6R)-5,6-dimethoxy-4,4,7,7-tetraphenyl-1,3,2-dioxaphosphepan-2-yl]-1,3-
diisopropyl-4,5-dimethyl-1H-imidazol-3-ium Hexafluoroantimonate (169r) 
Prepared as a white solid (375 mg, 417 µmol, 66% yield) from 
the corresponding diol (R,R)-170q[234] (1.11 equiv, 320 mg, 703.9 
µmol), molecular sieves (4 Å, powdered, 100 mg), pyridine (3.32 
equiv, 166 mg, 2.10 mmol), phosphorus trichloride (1.27 equiv, 
110 mg, 801 µmol) with 1,3-bis(isopropyl)-4,5-dimethyl-1,3-dihydro-2H-imidazol-2-ylidene 
56d[238] (1.0 equiv, 114 mg, 632 µmol), sodium hexafluoroantimonate (1.68 equiv, 273 mg, 
1.06 mmol) according to GPD after column chromatography (0 to 2% ethyl acetate in 
dichloromethane) at –10 °C. Crystals suitable for X-ray crystallographic analysis were grown 
by layering a dichloromethane solution with pentane. 
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[𝜶]𝟐𝟎
𝑫 : -54.1 (c = 1.05, CH2Cl2); 1H NMR: (400 MHz, CD3CN, 70 °C) δ = 7.88 – 7.81 (m, 2H), 
7.56 – 7.47 (m, 5H), 7.47 – 7.28 (m, 11H), 7.25 – 7.18 (m, 2H), 5.41 (s, 2H), 4.95 (dd, J = 7.5 
Hz, JH-P = 5.7 Hz, 1H), 4.56 (d, J = 7.6 Hz, 1H), 3.63 (s, 3H), 2.65 (s, 3H), 2.35 (s, 6H), 1.48 
(bs, 6H), 1.41 (d, J = 7.0 Hz, 6H) ppm; 13C{1H} NMR: (101 MHz, CD3CN, 70 °C) δ = 146.3, 
145.6 (d, JC-P = 4.4 Hz), 142.0 (d, JC-P = 62.0 Hz), 141.3 (d, JC-P = 3.4 Hz), 140.9 (d, JC-P = 1.4 
Hz), 132.8, 130.3, 130.1, 130.1, 130.1, 129.8, 129.7, 129.7, 129.5, 129.3, 129.3, 129.2, 
128.9, 128.8, 128.5, 90.0 (d, JC-P = 5.5 Hz), 87.2 (d, JC-P = 15.7 Hz), 86.7 (d, JC-P = 2.4 Hz), 
84.0 (d, JC-P = 25.3 Hz), 61.6, 61.1, 54.2, 54.1, 22.5, 22.5, 22.3, 22.3, 11.2 ppm; 31P{1H} 
NMR: (162 MHz, CD3CN) δ = 138.1 ppm; IR: (neat, cm–1) ṽ = 484, 654, 698, 829, 938, 996, 
1112, 1184, 1280, 1375, 1446, 1615, 2833, 2938, 2981; HRMS: calcd m/z for C41H48N2O4P+ 
[M–SbF6]+: 663.3346; found (ESI) 663.3339. 
(2R,3R)-1,1,4,4-Tetrakis[3,5-bis(trifluoromethyl)phenyl]-2,3-dimethoxybutane-1,4-diol 
[(R,R)-170s]: 
Prepared according to a modified literature procedure.[234] A pre-dried 
three-necked flask, equipped with magnetic stirring bar and dropping 
funnel was charged with activated magnesium (5.0 equiv, 536 mg, 22.05 
mmol) and a spatula tip of elemental iodine. THF (20 ml) was added, and 
the mixture allowed stirring for a few minutes. Under stirring, a solution of 
1,3-bis(trifluoromethyl)-5-bromobenzene (5.0 equiv, 6.46 g, 22.0 mmol) in 
THF (20 ml) was added slowly dropwise, using an ice bath to periodically 
cool the reaction mixture. After the addition was complete, the dropping 
funnel was replaced with a reflux condenser, and the suspension was stirred at reflux for an 
additional 2 h. On cooling to 0 °C, (2R,3R)-diethyl-2,3-dimethoxysuccinate (1.0 equiv, 1.03 g, 
4.40 mmol) was added via syringe as a solution in THF (4.5 ml). On completion of the 
addition, the mixture was stirred at reflux for 2 h. On cooling, a saturated aqueous solution of 
ammonium chloride (50 ml) was slowly added, then aqueous hydrochloric acid (1M, 5 ml). 
The mixture was transferred to a separatory funnel and extracted with diethyl ether (3  100 
ml). The combined organic phases were dried (MgSO4) and concentrated in vacuo. After 
purification of the crude product by column chromotography (15% MTBE in hexanes), 
compound 170s was obtained as a white solid (3.15 g, 3.15 mmol, 72% yield). 
[𝜶]𝟐𝟎
𝑫 : –17.8 (c = 1.02, CH2Cl2); 1H NMR: (400 MHz, CDCl3) δ = 8.08 (s, 4H), 7.95 (s, 4H), 
7.91 (s, 2H), 7.85 (s, 2H), 4.25 (s, 2H), 4.25 (s, 2H), 2.44 (s, 6H) ppm; 13C{1H} NMR: (101 
MHz, CDCl3) δ = 146.6, 144.8, 132.7 (q, JC-F = 34.0 Hz), 132.0 (q, JC-F = 33.9 Hz), 127.3 – 
127.0 (m), 126.7 – 126.4 (m), 123.1 (q, JC-F = 272.9 Hz), 123.0 (q, JC-F = 272.7 Hz), 122.7 – 
122.2 (m), 84.1, 78.7, 60.7 ppm; 19F NMR: (282 MHz, CDCl3) δ = –63.10, –63.2; IR: (neat, 
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cm–1) ṽ = 651, 705, 844, 893, 909, 990, 1075, 1123, 1164, 1267, 1369, 1623, 3467; HRMS: 
calcd. m/z for C38H22F24NaO4+ [M+Na]+: 1021.1027; found (ESI) 1021.1031. 
4-[(5R,6R)-5,6-dimethoxy-4,4,7,7-tetra[3,5-di(trifluoromethyl)phenyl-1,3,2-
dioxaphosphepan-2-yl]-1,3-dimesityl-1H-imidazol-3-ium Hexafluoroantimonate (203a): 
Prepared as a white solid (180 mg, 115 µmol, 29% yield) from 
diol (R,R)-170s (1.0 equiv, 400 mg, 401 µmol), molecular sieves 
(4 Å, powdered, 100 mg), pyridine (3.1 equiv, 98 mg, 1.24 
mmol), phosphorus trichloride (1.43 equiv, 79 mg, 575 µmol) 
with 1,3-bis(isopropyl)-4,5-dimethyl-1,3-dihydro-2H-imidazol-2-
ylidene (56b)[274] (1.0 equiv, 122 mg, 401 µmol), sodium 
hexafluoroantimonate (3.0 equiv, 311 mg, 1.20 mmol) according 
to modified GPD. The product was partially soluble in diethyl ether and could be directly 
filtered from the inorganic salts, which were further washed with diethyl ether (3  10 ml). The 
ether washings were combined, concentrated under vacuum and purified by column 
chromatography (0.5% ethyl acetate in dichloromethane) at –10 °C. Crystals suitable for X-
ray crystallographic analysis were grown by layering a dichloromethane solution with 
pentane. 
[𝜶]𝟐𝟎
𝑫 : –19.0 (c = 1.03, CH2Cl2); 1H NMR: (500 MHz, CD3CN) δ = 8.85 (s, 1H), 8.38 (s, 1H), 
8.21 (s, 2H), 8.19 (s, 1H), 8.10 (s, 1H), 8.07 (s, 2H), 8.06 (s, 1H), 8.03 (s, 1H), 7.72 (s, 2H), 
7.66 (s, 2H), 7.24 (s, 1H), 7.23 (s, 1H), 6.85 (s, 1H), 6.69 (s, 1H), 4.91 (dd, J = 7.7 Hz, JH-P = 
6.2 Hz, 1H), 3.67 (d, J = 7.6 Hz, 1H), 3.54 (s, 3H), 2.40 (s, 3H), 2.40 (s, 3H), 2.21 (s, 3H), 
2.19 (s, 3H), 2.17 (s, 3H), 1.87 (s, 6H) ppm; 13C{1H} NMR: (126 MHz, CD3CN) δ = 145.9 (d, 
JC-P = 3.8 Hz), 145.1, 143.3, 143.1, 141.8, 141.7, 141.5, 135.8 (d, JC-P = 23.1 Hz), 135.4, 
135.2, 133.0 (q, JC-F = 33.6 Hz), 132.4 (q, JC-F = 33.6 Hz), 132.2 (q, JC-F = 33.6 Hz), 131.7 (q, 
JC-F = 33.6 Hz), 131.3, 130.8, 130.5, 130.5, 129.9 – 129.7 (m), 129.6, 129.5 – 129.2 (m), 
128.7 – 128.4 (m), 125.1 – 124.7 (m), 124.3 (q, JC-F = 272.0 Hz), 124.3 (q, JC-F = 272.0 Hz), 
124.2 (q, JC-F = 272.0 Hz), 124.3 – 124.0 (m), 124.0 – 123.6 (m), 87.9, 85.8 (d, JC-P = 4.4 Hz), 
84.8 (d, JC-P = 10.0 Hz), 82.0 (d, JC-P = 25.7 Hz), 61.7, 61.6, 21.2, 21.0, 17.5, 17.5, 17.4, 17.4, 
17.3 ppm; 31P{1H} NMR: (202 MHz, CD3CN) δ = 145.9 ppm; 19F NMR: (470 MHz, CD3CN) δ 
= –63.1, –63.4, –63.6, –124. 0 (sext, JF-121Sb = 1947.2 Hz), –124. 0 (oct, JF-123Sb = 1040.0 Hz) 
ppm; IR: (neat, cm–1) ṽ = 656, 682, 707, 811, 848, 899, 970, 1032, 1052, 1130, 1172, 1277, 
1372, 1469, 1515, 1553, 1612, 2837, 2926, 2966, 3133; HRMS: calcd m/z for 
C59H44F24N2O4P+ [M–SbF6]+: 1331.2650; found (ESI) 1331.2660. 
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1,3-Dimesityl-5-{(3a'R,8a'R)-4',4',8',8'-tetraphenyltetrahydrospiro[cyclohexane-1,2'-
[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin]-6'-yl}-1H-imidazol-3-ium 
Hexafluoroantimonate (203b): 
Prepared as a white solid (90 mg, 84 µmol, 21% yield) from 
the corresponding diol (R,R)-170t[234] (1.0 equiv, 200 mg, 
395  µmol), molecular sieves (4 Å, powdered, 100 mg), 
pyridine (3.14 equiv, 97.8 mg, 1.24 mmol), phosphorus 
trichloride (1.0 equiv, 55.1 mg, 401 µmol) with 1,3-bis(2,4,6-trimethylphenyl)-1,3-dihydro-2H-
imidazol-2-ylidene (56b)[274] (1.0 equiv, 120 mg, 394 µmol) and sodium hexafluoroantimonate 
(1.5 equiv, 153 mg, 591 µmol) according to modified GPD. As the intermediate 
chlorophosphite 171t was not soluble in diethyl ether, it was dissolved in THF (4 ml), and the 
carbene solution in an equal volume of diethyl ether was added. The resulting white 
suspension was filtered, the filtrate evaporated and washed with diethyl ether (2  10 ml). 
The remaining solid was purified by column chromatography (1% ethyl acetate in 
dichloromethane) at –10 °C affording 203b. 
[𝜶]𝟐𝟎
𝑫 : –50.1 (c = 1.04, CH2Cl2); 1H NMR: (400 MHz, CD3CN) δ = 8.85 (dd, J = 1.5 Hz, JH-P = 
1.5 Hz, 1H), 8.32 (dd, J = 1.5 Hz, JH-P = 1.2 Hz, 1H), 7.54 – 7.52 (m, 1H), 7.52 – 7.50 (m, 
1H), 7.45 – 7.43 (m, 1H), 7.43 – 7.40 (m, 1H), 7.38 – 7.28 (m, 10H), 7.28 – 7.25 (m, 2H), 
7.25 – 7.22 (m, 4H), 7.22 – 7.18 (m, 2H), 7.15 – 7.11 (m, 1H), 7.09 – 7.06 (m, 1H), 5.26 (dd, 
J = 8.6, Hz, JH-P = 4.1 Hz, 1H), 4.75 (d, J = 8.6 Hz, 1H), 2.40 (s, 3H), 2.39 (s, 3H), 2.28 (s, 
3H), 2.17 (s, 3H), 2.02 (s, 3H), 1.94 (s, 3H), 1.89 – 1.78 (m, 1H), 1.78 – 1.68 (m, 1H), 1.64 – 
1.45 (m, 2H), 1.26 – 1.16 (m, 1H), 1.16 – 0.94 (m, 2H), 0.87 – 0.75 (m, 1H), 0.37 – 0.23 (m, 
1H), 0.20 – 0.07 (m, 1H) ppm; 13C{1H} NMR: (101 MHz, CD3CN) δ = 146.3, 144.8 (d, JC-P = 
4.5 Hz), 143.4, 142.8, 141.0, 140.6 (d, JC-P = 2.6 Hz), 140.3 (d, JC-P = 1.8 Hz), 138.0 (d, JC-P = 
25.8 Hz), 136.5, 135.8, 135.6, 135.5, 131.5, 130.9, 130.8, 130.6, 130.6, 130.0 (d, JC-P = 8.3 
Hz), 129.9, 129.5, 129.3, 129.3, 129.1, 129.0, 129.0, 128.9, 128.8, 128.8, 128.5, 128.1, 
127.8, 113.9, 85.5 (d, JC-P = 9.5 Hz), 84.8 (d, JC-P = 5.3 Hz), 84.0 (d, JC-P = 3.9 Hz), 83.4 (d, 
JC-P = 22.0 Hz), 37.8, 34.9, 25.3, 24.7, 24.7, 21.3, 21.2, 17.8, 17.8, 17.8, 17.8, 17.7, 17.6 
ppm; 31P{1H} NMR: (162 MHz, CD3CN) δ = 143.1 ppm; IR: (neat, cm–1) ṽ = 654, 699, 738, 
823, 939, 1001, 1030, 1124, 1447, 1551, 1670, 2860, 2934, 3059, 3128; HRMS: calcd m/z 
for C55H56N2O4P+ [M–SbF6]+: 839.3972; found (ESI) 839.3979. 
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2-{(5R,6R)-5,6-Dimethoxy-4,4,7,7-tetrakis[4-(trifluoromethyl)phenyl]-1,3,2-
dioxaphosphepan-2-yl}-1,3-dimesityl-4,5-dimethyl-1H-imidazol-3-ium 
Hexafluoroantimonate (169s): 
Prepared as a white solid (215 mg, 162 µmol, 67% yield) from 
the corresponding diol (R,R)-170i[219] (1.05 equiv, 184 mg, 253 
µmol), molecular sieves (4 Å, powdered, 100 mg), pyridine (3.16 
equiv, 60 mg, 759 µmol), phosphorus trichloride (1.2 equiv, 38 
mg, 0.28 mmol) with 1,3-bis(2,4,6-trimethylphenyl)-4,5-dimethyl-
1,3-dihydro-2H-imidazol-2-ylidene (56e)[240] (1.0 equiv, 80 mg, 
241 µmol), sodium hexafluoroantimonate (2.1 equiv, 131 mg, 506 µmol) according to GPD 
after column chromatography (1% ethyl acetate in dichloromethane) at –10 °C. Crystals 
suitable for X-ray crystallographic analysis were grown by layering a dichloromethane 
solution with pentane. 
[𝜶]𝟐𝟐
𝑫 : –24.2 (c = 1.04, CH2Cl2); 1H NMR: (300 MHz, CD3CN) δ = 7.74 – 7.64 (m, 6H), 7.64 – 
7.57 (m, 2H), 7.53 (d, J = 8.3 Hz, 2H), 7.28 (s, 2H), 7.21 (d, J = 8.4 Hz, 2H), 7.14 (s, 2H), 
6.98 (d, J = 5.3 Hz, 2H), 6.95 (d, J = 5.4 Hz, 2H), 4.64 (dd, J = 7.8 Hz, JH-P = 6.8 Hz, 1H), 
3.84 (d, J = 7.6 Hz, 1H), 3.39 (s, 3H), 2.49 (s, 6H), 2.28 (s, 3H), 1.95 (s, 6H), 1.93 (s, 6H), 
1.56 (s, 6H) ppm; 13C{1H} NMR: (126 MHz, CD3CN) δ = 147.5 (d, JC-P = 4.6 Hz), 147.0, 
143.1, 143.1 (d, JC-P = 2.1 Hz), 143.1 (d, JC-P = 1.5 Hz), 141.0 (d, JC-P = 58.0 Hz), 136.2, 
136.2, 136.0, 136.0, 134.3, 131.5 (q, JC-F = 32.7 Hz), 131.3 (q, JC-F = 32.5 Hz), 131.3, 131.2, 
131.0, 130.9 (q, JC-F = 32.2 Hz), 130.9 (q, JC-F = 32.3 Hz), 130.1 (d, JC-P = 1.6 Hz), 130.0, 
130.0, 129.7, 129.7, 129.4, 126.6 (q, JC-F = 3.8 Hz), 126.4 (q, JC-F = 3.8 Hz), 126.0 (q, JC-F = 
3.8 Hz), 125.2 (q, JC-F = 271.4 Hz), 125.1 (q, JC-F = 272.0 Hz), 125.1 (q, JC-F = 272.0 Hz), 
125.0 (q, JC-F = 271.6 Hz), 124.7 (q, JC-F = 3.8 Hz), 88.0 (d, JC-P = 5.4 Hz), 86.3 (d, JC-P = 15.2 
Hz), 85.0 (d, JC-P = 1.8 Hz), 80.5 (d, JC-P = 29.1 Hz), 61.4, 60.5, 21.3, 18.0, 17.5, 17.5, 9.2 
ppm; 31P{1H} NMR: (121 MHz, CD3CN) δ = 144.3 ppm; 19F NMR: (282 MHz, CD3CN) δ = –
63.1, –63.1, –63.3, –63.3, –123.9 (sext, J = 1937.0 Hz), –123.9 (oct, J = 1043.0 Hz) ppm; IR: 
(neat, cm–1) ṽ = 656, 854, 934, 999, 1017, 1069, 1117, 1167, 1324, 1406, 1445, 1483, 1617, 
2834, 2930; HRMS: calcd m/z for C57H52F12N2O4P+ [M–SbF6]+: 1087.3468; found (ESI) 
1087.3472. 
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4,5-Dichloro-2-{(5R,6R)-5,6-dimethoxy-4,4,7,7-tetrakis[4-(trifluoromethyl)phenyl]-1,3,2-
dioxaphosphepan-2-yl}-1,3-dimesityl-1H-imidazol-3-ium Hexafluoroantimonate(169t): 
Prepared as a pale orange solid (55 mg, 30% yield) from the 
corresponding diol (R,R)-170i[219] (1.0 equiv, 95 mg, 130 µmol), 
molecular sieves (4 Å, powdered, 100 mg), pyridine (3.2equiv, 
33 mg, 417 µmol), phosphorus trichloride (1.20 equiv, 21 mg, 
153 µmol) with 1,3-bis(2,4,6-trimethylphenyl),4,5-dichloro-1,3-
dihydro-2H-imidazol-2-ylidene (56f)[239] (1.0 equiv, 48 mg, 
129 µmol), sodium hexafluoroantimonate (2.10 equiv, 69 mg, 
267 µmol) according to modified GPD. After allowing warming to room temperature 
overnight, the mixture was stirred for a further 48 hours at room temperature. Column 
chromatography (1% ethyl acetate in dichloromethane) at –10 °C afforded compound 169t. 
[𝜶]𝟐𝟐
𝑫 : –32.9 (c = 1.02, CH2Cl2); 1H NMR: (400 MHz, CD3CN) δ = 7.75 – 7.65 (m, 6H), 7.62 
(d, J = 8.3 Hz, 2H), 7.44 (d, J = 8.2 Hz, 2H), 7.28 (s, 2H), 7.24 – 7.14 (m, 4H), 6.97 (d, J = 
8.1 Hz, 2H), 6.95 (d, J = 7.8 Hz, 2H), 4.62 (dd, J = 7.0 Hz, JH-P = 7.8 Hz, 1H), 3.90 (d, J = 7.4 
Hz, 1H), 3.35 (s, 3H), 2.49 (s, 6H), 2.31 (s, 3H), 1.95 (s, 6H), 1.68 (s, 6H) ppm; 13C{1H} 
NMR: (101 MHz, CD3CN) δ = 147.0 (d, JC-P = 3.3 Hz), 146.4, 144.6, 144.3 (d, JC-P = 75.1 Hz), 
142.6, 142.5 – 142.4 (m), 136.7, 136.7, 136.4, 136.4, 131.7 (q, JC-F = 32.9 Hz), 131.5 (q, JC-F 
= 32.8 Hz), 131.5, 131.2 (q, JC-F = 32.5 Hz), 131.0 (q, JC-F = 32.4 Hz), 130.8, 129.9, 129.8, 
129.8, 129.8, 129.5, 128.9 (d, JC-P = 1.0 Hz), 126.7 (q, JC-F = 3.7 Hz), 126.5, 126.5 (q, JC-F = 
3.9 Hz), 126.2 (q, JC-F = 4.0 Hz), 125.2 (q, JC-F = 271.3 Hz), 125.1 (q, JC-F = 271.6 Hz), 125.1 
(q, JC-F = 271.3 Hz), 125.0 (q, JC-F = 271.5 Hz), 124.9 (q, JC-F = 3.7 Hz), 88.9 (d, JC-P = 4.7 
Hz), 87.0 (d, JC-P = 14.9 Hz), 84.5 (d, JC-P = 1.4 Hz), 80.5 (d, JC-P = 29.0 Hz), 61.4, 60.5, 21.4, 
18.2, 17.7, 17.7 ppm; 31P{1H} NMR: (162 MHz, CD3CN) δ = 147.7 ppm; 19F NMR: (376 MHz, 
CD3CN) δ = –63.1, –63.2, –63.3, –63.3, –123.9 (oct, J = 1050.7 Hz), –123.9 (sext, J = 1935.3 
Hz) ppm; IR: (neat, cm–1) ṽ = 654, 822, 853, 929, 961, 997, 1017, 1069, 1117, 1168, 1323, 
1411, 1481, 1568, 1617, 2834, 2926, 2965; HRMS: calcd m/z for C55H46Cl2F12N2O4P+ [M–
SbF6]+: 1127.2375; found (ESI) 1127.2378. 
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4,5-Dichloro-1,3-dimesityl-2-{(3aS,8aS)-4,4,8,8-tetrakis[4-(tert-butyl)phenyl]-2,2-
dimethyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl}-1H-imidazol-3-ium 
Hexafluoroantimonate (169u): 
Prepared as a pale orange solid (110 mg, 83 µmol, 31% yield) 
from the corresponding diol (S,S)-170a[233] (1.0 equiv, 189 mg, 
273 µmol), molecular sieves (4 Å, powdered, 100 mg), 
pyridine (3.15 equiv, 67 mg, 847 µmol), phosphorus trichloride 
(1.16 equiv, 42.8 mg, 312 µmol) with 1,3-bis(2,4,6-
trimethylphenyl),4,5-dichloro-1,3-dihydro-2H-imidazol-2-
ylidene (56f)[239] (1.0 equiv, 100 mg, 269 µmol), sodium hexafluoroantimonate (2.0 equiv, 141 
mg, 545 µmol) according to modified GPD (after allowing warming to room temperature 
overnight, the mixture was stirred for a further 24 hours at room temperature). Column 
chromatography (1% ethyl acetate in dichloromethane) at –10 °C, followed by precipitating a 
saturated diethyl ether solution with pentane gave the product 169u. 
[𝜶]𝟐𝟎
𝑫 : +65.0 (c = 0.955, CH2Cl2); 1H NMR: (400 MHz, CD3CN) δ = 7.49 – 7.38 (m, 4H), 7.38 
– 7.32 (m, 4H), 7.31 (s, 2H), 7.29 – 7.23 (m, 4H), 7.16 (s, 2H), 6.79 (d, J = 8.2 Hz, 2H), 6.50 
(d, J = 8.2 Hz, 2H), 5.09 (dd, J = 8.2 Hz, JH-P = 4.8 Hz, 1H), 4.63 (d, J = 8.5 Hz, 1H), 2.51 (s, 
6H), 2.11 (s, 6H), 1.74 (s, 6H), 1.34 (s, 27H), 1.32 (s, 3H), 1.31 – 1.27 (m, 9H), –0.03 (s, 3H) 
ppm; 13C{1H} NMR: (101 MHz, CD3CN) δ = 153.2, 153.0, 152.9, 152.7, 145.8 (d, JC-P = 76.1 
Hz), 144.0, 141.6, 141.0 (d, JC-P = 4.5 Hz), 136.8, 136.7, 136.6 (d, JC-P = 2.5 Hz), 136.1, 
131.5, 131.2, 129.9, 129.1, 129.1, 129.0, 128.4, 128.1, 126.5, 126.2, 126.2, 125.9, 125.1, 
113.8, 87.7 (d, JC-P = 11.2 Hz), 86.8 (d, JC-P = 7.6 Hz), 83.2 (d, JC-P = 2.6 Hz), 81.5 (d, JC-P = 
28.5 Hz), 35.3, 35.3, 35.2, 31.4, 27.6, 24.6, 21.6, 18.4, 18.2, 18.2 ppm; 31P{1H} NMR: (162 
MHz, CDCl3) δ = 148.9 ppm; 19F NMR: (376 MHz, CD3CN) δ = –123.97 (sext, J = 1930.3 
Hz), –123.98 (oct, J = 1051.0 Hz) ppm; IR: (neat, cm–1) ṽ = 562, 598, 655, 841, 877, 955, 
979, 1088, 1112, 1201, 1379, 1411, 1473, 1512, 1566, 1606, 28623, 2907, 2958; HRMS: 
calcd. m/z for C68H82Cl2N2O4P+ [M–SbF6]+: 1091.5384; found (ESI) 1091.5385. 
Synthesis of (S)-2-(Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,3-dimesityl-
1H-imidazol-3-ium Hexafluoroantimonate (208a) and (S)-4-(Dinaphtho[2,1-d:1',2'-
f][1,3,2]dioxaphosphepin-4-yl)-1,3-dimesityl-1H-imidazol-3-ium Hexafluoroantimonate 
(208b): 
From the corresponding diol (S)-207[242] (1.0 equiv, 200 mg, 456 µmol), molecular sieves (4 
Å, powdered, 50 mg), pyridine (3.0 equiv, 108 mg, 1.37 mmol), phosphorus trichloride (1.5 
equiv, 94 mg, 684 µmol) with 1,3-bis(2,4,6-trimethylphenyl)-1,3-dihydro-2H-imidazol-2-
ylidene (56b)[274] (1.0 equiv, 139 mg, 457 µmol) and sodium hexafluoroantimonate (3.0 equiv, 
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353 mg, 1.36 mmol), a mixture of C-2 and C-4 adducts 208a and 208b was obtained 
according to GPD, along with several other unidentified compounds. Crystallization from 
dichloromethane/pentane separated the C-2 and C-4 adducts (fraction 1: 208a; fraction 2: 
208b).  
208a: 
Further purification by column chromatography at –10 °C (2% 
ethyl acetate in dichloromethane) afforded the product 208a as 
a white solid (40 mg, 40 µmol, 9% yield). Crystals suitable for X-
ray crystallographic analysis were grown by layering a 
dichloromethane solution with toluene. 
[𝜶]𝟐𝟎
𝑫 : +151.2 (c = 1.02, CH2Cl2); 1H NMR: (400 MHz,CD3CN) δ = 8.12 (d, J = 8.4 Hz, 1H), 
8.12 (s, 1H), 7.97 (d, J = 2.0 Hz, 1H), 7.91 (dd, J = 8.4, 2.7 Hz, 1H), 7.66 – 7.61 (m, 2H), 
7.61 – 7.55 (m, 2H), 7.55 – 7.44 (m, 9H), 7.42 (ddd, J = 8.5, 6.9, 2.3 Hz, 1H), 7.27 (ddd, J = 
8.6, 7.0, 1.5 Hz, 1H), 7.13 (s, 1H), 7.12 – 7.05 (m, 1H), 6.96 (s, 1H), 6.70 (dd, J = 8.7, 2.0 Hz, 
1H), 6.64 (d, J = 8.6 Hz, 1H), 6.55 (s, 1H), 5.37 (s, 1H), 2.36 (s, 3H), 1.84 (s, 3H), 1.71 (s, 
3H), 1.39 (s, 3H), 1.35 (s, 3H), 1.01 (s, 3HH) ppm; 13C{1H} NMR: (101 MHz, CD3CN) δ = 
146.0, 145.9, 145.7 (d, JC-P = 118.0 Hz), 145.4, 143.2, 141.1, 137.6, 137.5, 136.7 (d, JC-P = 
2.4 Hz), 135.1 (d, JC-P = 3.6 Hz), 134.2 (d, JC-P = 2.5 Hz), 133.4 (d, JC-P = 1.0 Hz), 133.3, 
133.0, 132.9, 132.9, 132.4, 132.3, 132.1, 132.0, 130.5, 130.5, 130.5, 130.3, 130.2, 130.1 (d, 
JC-P = 2.2 Hz), 129.9, 129.7, 129.5, 129.3, 129.1, 129.1, 128.8, 128.5, 128.3, 127.8, 127.6, 
127.4, 127.2, 127.2, 127.1, 125.0 (d, JC-P = 5.7 Hz), 124.0 (d, JC-P = 3.6 Hz), 21.1, 21.1, 18.6, 
17.9, 17.8, 17.2, 15.5 ppm; 31P{1H} NMR: (162 MHz, CD3CN) δ = 142.0 ppm; IR: (neat, cm–1) 
ṽ = 652, 701, 76, 821, 854, 962, 1145, 1192, 1313, 1407, 1446, 1481, 1605, 2920, 3054, 
3152; HRMS: calcd m/z for C53H44N2O2P+ [M–SbF6]+: 771.3135; found (ESI) 771.3134. 
208b: 
Evaporation of the second fraction, followed by column 
chromatography at –10 °C (0 to 1.5% ethyl acetate in 
dichloromethane), affording a white solid (15 mg, 15 µmol, 
3% yield). 
1H NMR: (400 MHz, CD3CN) δ = 8.52 (t, J = 1.7 Hz, JH-P =1.7 
Hz, 1H), 8.21 (s, 1H), 8.17 (s, 1H), 8.09 (d, J = 12.0 Hz, 1H), 8.07 (d, J = 12.5 Hz, 1H), 7.64 
– 7.50 (m, 6H), 7.49 – 7.44 (m, 3H), 7.41 – 7.35 (m, 4H), 7.35 – 7.29 (m, 2H), 7.24 (d, J = 8.6 
Hz, 1H), 7.14 (s, 1H), 7.05 (d, J = 1.7 Hz, 1H), 7.03 (s, 1H), 6.95 (s, 1H), 6.90 (s, 1H), 2.32 
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(s, 3H), 2.27 (s, 3H), 2.12 (s, 3H), 1.86 (s, 3H), 1.40 (s, 3H), 1.20 (s, 3HH) ppm; 13C{1H} 
NMR: (151 MHz, CD3CN) δ = 146.3 (d, JC-P = 1.7 Hz), 145.1 (d, JC-P = 6.6 Hz), 143.1, 142.6, 
140.2, 137.6, 137.3, 136.5 (d, JC-P = 63.7 Hz), 135.6, 135.5 (d, JC-P = 2.4 Hz), 135.2, 134.5, 
134.2 (d, JC-P = 2.1 Hz), 133.6, 133.0, 132.9, 132.8, 132.5, 132.4, 132.4, 130.8, 130.5, 130.5, 
130.4, 130.4, 130.4, 130.3, 130.2, 130.0, 129.6, 129.6, 129.4, 129.4, 129.1, 128.9, 127.8, 
127.7, 127.4, 127.2, 127.1, 127.0, 125.2 (d, JC-P = 2.8 Hz), 124.6 (d, JC-P = 19.6 Hz), 21.0, 
20.9, 18.1, 17.4, 17.2, 17.2, 16.5 ppm; 31P{1H} NMR: (243 MHz, CD3CN) δ = 146.2 ppm; IR: 
(neat, cm–1) ṽ = 517, 655, 701, 753, 852, 961, 1077, 1124, 1193, 1405, 1497, 1606, 2853, 
2923, 3126; HRMS: calcd m/z for C53H44N2O2P+ [M–SbF6]+: 771.3135; found (ESI) 771.3146. 
(S)-2-(2,6-Diphenyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,3-dimesityl-
4,5-dimethyl-1H-imidazol-3-ium Hexafluoroantimonate (208c): 
Compound 208c was prepared as a white solid (300 mg, 290 
µmol, 73% yield) from the corresponding diol (S)-207[242] (1.06 
equiv, 185 mg, 422 µmol), molecular sieves (4 Å, powdered, 50 
mg), pyridine (3.4 equiv, 108 mg, 1.36 mmol), phosphorus 
trichloride (1.15 equiv, 63.0 mg, 459 µmol) with 1,3-bis(2,4,6-
trimethylphenyl)4,5-dimethyl-1,3-dihydro-2H-imidazol-2-ylidene (56e)[240] (1.0 equiv., 133 mg, 
400 µmol) and sodium hexafluoroantimonate (1.5 equiv, 164 mg, 634 µmol) according to 
GPD after column chromatography (1–1.5% ethyl acetate in dichloromethane). Crystals 
suitable for X-ray crystallographic analysis were grown by layering a dichloromethane 
solution with toluene. 
[𝜶]𝟐𝟎
𝑫 : +188.4 (c = 1.00, CH2Cl2); 1H NMR: (300 MHz, CD3CN) δ = 8.14 (dt, J = 7.9, 0.5 Hz, 
1H), 8.13 (s, 1H), 7.98 (s, 1H), 7.95 (dt, J = 8.2, 0.5 Hz, 1H), 7.70 – 7.63 (m, 2H), 7.59 (ddd, 
J = 8.1, 6.9, 1.0 Hz, 1H), 7.54 – 7.46 (m, 8H), 7.44 (ddd, J = 8.1, 6.8, 1.0 Hz, 1H), 7.30 (ddd, 
J = 8.2, 6.9, 1.2 Hz, 1H), 7.16 (s, 1H), 7.13 (ddd, J = 7.1, 5.4, 1.3 Hz, 1H), 6.97 (s, 1H), 6.72 
(dd, J = 8.0, 0.6 Hz, 1H), 6.67 (dd, J = 7.9, 0.6 Hz, 1H), 6.58 (s, 1H), 5.42 (s, 1H), 2.38 (s, 
3H), 1.83 (s, 6H), 1.72 (s, 6H), 1.35 (s, 3H), 1.33 (s, 3H), 0.96 (s, 3H) ppm; 13C{1H} NMR: 
(101 MHz, CD3CN) δ = 146.2 (d, JC-P = 11.3 Hz), 145.8, 143.2, 142.9 (d, JC-P = 112.7 Hz), 
141.2, 137.9, 137.3 (d, JC-P = 2.6 Hz), 135.4 (d, JC-P = 3.6 Hz), 135.3, 134.9 (d, JC-P = 2.2 Hz), 
134.4 (d, JC-P = 2.6 Hz), 133.7, 133.5, 133.4, 133.0, 132.9, 132.9, 132.3, 132.1, 130.6, 130.6, 
130.5, 130.5, 130.2, 129.9, 129.6, 129.5, 129.4, 129.2, 129.1, 129.1, 128.9, 128.9, 127.8, 
127.6, 127.5, 127.3, 127.2, 127.0, 125.1 (d, JC-P = 5.9 Hz), 124.0 (d, JC-P = 2.9 Hz), 21.2, 
21.2, 18.9, 18.1, 18.0, 17.3, 15.5, 9.0 ppm; 31P{1H} NMR: (122 MHz, CD3CN) δ = 142.4 ppm; 
19F NMR: (282 MHz, CD3CN) δ = –124.0 (oct, JF-123Sb = 1048.4 Hz), –124.0 (sext, JF-121Sb = 
1926.5 Hz) ppm; IR: (neat, cm–1) ṽ = 495, 567, 653, 701, 752, 818, 854, 961, 1172, 1405, 
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1607, 2919, 3032, 3053; HRMS: calcd m/z for C55H48N2O2P+ [M–SbF6]+: 799.3448; found 
(ESI) 799.3454 
8.2.3 Synthesis of gold(I) complexes 
General procedure E (GPE) for the preparation of gold(I) complexes 
A dried Schlenk flask equipped with a magnetic stirring bar and rubber septum was charged 
with the cationic phosphonite and dichloromethane, and then cooled to –20 °C. To the 
Schlenk flask was then added (dimethyl sulfide)gold(I) chloride as a solid. The resulting 
solution was allowed to stir at –20 °C for a few minutes, before warming to room temperature 
and stirring for between 30 minutes and one hour. The solvent was removed in vacuo and 
the product dried under high vacuum.  
{(3aS,8aS)-6-[Bis(triphenylphosphonio)methylene]-2,2-dimethyl-4,4,8,8-
tetraphenyltetrahydro-6λ5-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl}gold Chloride 
Hexafluoroantimonate (172l): 
Prepared as a white solid (118 mg, 78.6 µmol, >99% yield) 
from compound 169l (1.0 equiv, 92.0 mg, 72.5 µmol), 
chloro(dimethyl sulfide)gold(I) (1.0 equiv, 21.4 mg, 72.6 µmol) 
in dichloromethane (1.5 ml) according to GPE. 
[𝜶]𝟐𝟎
𝑫 : +78.7 (c = 1.03, CH2Cl2); 1H NMR: (300 MHz, CD3CN) δ = 7.81 (d, J = 7.6 Hz, 2H), 
7.70 – 7.61 (m, 8H), 7.61 – 7.50 (m, 13H), 7.44 – 7.31 (m, 15H), 7.31 – 7.21 (m, 3H), 7.16 (t, 
J = 7.4 Hz, 1H), 7.06 (t, J = 7.6 Hz, 2H), 6.88 (t, J = 7.7 Hz, 2H), 6.59 (d, J = 7.6 Hz, 2H), 
6.14 (d, J = 7.9 Hz, 2H), 5.52 (d, J = 7.8 Hz, 1H), 5.23 (d, J = 7.9 Hz, 1H), 0.96 (s, 3H), 0.28 
(s, 3HH) ppm; 13C{1H} NMR: (101 MHz, CD3CN) δ = 145.7 (d, JC-P = 4.8 Hz), 143.6, 139.9 (d, 
JC-P = 6.6 Hz), 139.2, 136.2 – 135.2 (m), 134.7, 130.7, 130.6, 130.6 – 130.3 (m), 130.0, 
129.9, 129.8, 129.4, 129.4, 129.1, 129.0, 128.6, 128.2, 127.9, 125.2 (dd, JC-P = 93.4, 2.7 Hz), 
115.0, 94.6 (d, JC-P = 13.8 Hz), 90.8, 80.8 (d, JC-P = 11.6 Hz), 79.8 (d, JC-P = 2.5 Hz), 27.6, 
26.1, 25.6 (td, JC-P = 86.6, 71.5 HzH) ppm; 31P{1H} NMR: (162 MHz, CD3CN) δ = 132.5 (t, J = 
38.2 Hz), 22.9 (d, J = 38.1 Hz) ppm; 19F NMR: (282 MHz, CD3CN) δ = –124.0 (sext, JF-121Sb = 
1942.1 Hz), –124.0 (oct, JF-123Sb = 1049.7 Hz) ppm; IR: (neat, cm–1) ṽ = 499, 544, 654, 693, 
473, 885, 976, 1095, 1163, 1437, 1483, 2674, 2923, 3003, 3041; HRMS: calcd m/z for 
C68H58AuClO4P3+ [M–SbF6]+: 1263.2897; found (ESI) 1263.2900. 
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{(5S,6S)-5,6-Dimethoxy-4,4,7,7-tetra(4-tert-butylphenyl)-2-[(triphenyl-λ4-
phosphaneyl)(triphenylphosphonio)methylene]-1,3,2λ5-dioxaphosphepan-2-yl}gold 
Chloride Hexafluoroantimonate (172m): 
To a solution of compound 169m (1.0 equiv, 43.0 mg, 29.0 µmol) 
in acetonitrile (2 ml) at –20 °C, was added solid chloro(dimethyl 
sulfide)gold(I) (1.0 equiv, 8.6 mg, 29.1 µmol) according to 
modified GPE. The reaction mixture was allowed to stir at –20°C 
for 30 minutes, then at room temperature for one hour. The 
solvent was removed in vacuo, affording the product as a white 
solid (49.0 mg, 28.6 µmol, 99% yield). 
[𝜶]𝟐𝟎
𝑫 : –27.8 (c = 1.02, CH2Cl2);1H NMR: (400 MHz, CD3CN) δ = 7.66 – 7.61 (m, 6H), 7.48 – 
7.41 (m, 14H), 7.36 – 7.31 (m, 12H), 7.21 (d, J = 8.5 Hz, 2H), 7.19 – 7.14 (m, 6H), 7.02 (d, J 
= 8.6 Hz, 2H), 6.57 (d, J = 8.5 Hz, 2H), 6.46 (d, J = 8.6 Hz, 2H), 4.91 (dd, J = 6.6 Hz, JH-P = 
2.7 Hz, 1H), 4.43 (d, J = 6.6 Hz, 1H), 2.73 (s, 3H), 2.61 (s, 3H), 1.37 (s, 9H), 1.35 (s, 9H), 
1.30 (s, 9H), 1.26 (s, 9H) ppm; 13C{1H} NMR: (101 MHz, CD3CN) δ = 152.5, 152.5, 152.4, 
152.0, 142.1 (d, JC-P = 5.1 Hz), 139.9 (d, JC-P = 1.5 Hz), 137.7 (d, JC-P = 5.5 Hz), 137.1 (d, JC-P 
= 2.0 Hz), 135.8 – 135.2 (m), 134.6, 130.6 – 130.2 (m), 130.1, 130.1, 129.8, 129.2, 129.0, 
126.3, 126.1, 125.6 (ddd, JC-P = 97.7, 4.7, 2.1 Hz), 125.0, 124.7, 96.2 (d, JC-P = 13.0 Hz), 91.5 
(d, JC-P = 1.5 Hz), 81.2 (d, JC-P = 11.1 Hz), 80.5, 59.6, 59.3, 35.3, 35.2, 35.1, 35.0, 31.5, 31.5, 
31.4, 23.7 (td, JC-P = 87.5, 72.5 Hz) ppm; 31P{1H} NMR: (202 MHz, CD3CN) δ = 129.1 (t, J = 
35.5 Hz), 22.5 (d, J = 35.3 Hz) ppm; 19F NMR: (282 MHz, CD3CN) δ = –123.3 (sext, JF-121Sb = 
1925.1 Hz), –125.9 (oct, JF-123Sb = 1054.6 Hz) ppm; IR: (neat, cm–1) ṽ = 501, 526, 655, 746, 
918, 987, 1098, 1190, 1270, 1364, 1438, 1481, 2867, 2903, 2958;HRMS: calcd m/z for 
C83H90AuClO4P3+ [M–SbF6]+: 1475.5401; found (ESI) 1475.5407. 
{2-[(3aS,8aS)-2,2-Dimethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxa-
phosphepin-6-yl]-1,3-dimesityl-1H-imidazol-3-ium}gold Chloride Hexafluoroantimonate 
(172n) 
Prepared as a white solid (118 mg, 93.0 µmol, 96% yield) from 
compound 169n (1.0 equiv, 100 mg, 96.5 µmol), 
chloro(dimethyl sulfide)gold(I) (1.0 equiv, 28.4 mg, 96.4 µmol) 
in dichloromethane (3 ml) according to GPE. 
[𝜶]𝟐𝟎
𝑫 : +41.7 (c = 1.03, CH2Cl2);1H NMR: (300 MHz, CD3CN) δ = 7.93 (d, JH-P = 2.4 Hz, 2H), 
7.52 – 7.30 (m, 14H), 7.23 – 7.19 (m, 2H), 7.18 (s, 2H), 7.14 (s, 2H), 6.99 – 6.89 (m, 2H), 
6.80 – 6.73 (m, 2H), 6.28 (dd, J = 8.6 Hz, JH-P = 2.0 Hz, 1H), 4.95 (d, J = 8.6 Hz, 1H), 2.40 (s, 
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6H), 2.03 (s, 6H), 2.00 (s, 6H), 1.43 (s, 3H), 0.00 (s, 3H) ppm; 13C{1H} NMR: (75 MHz, 
CD3CN) δ = 143.9, 142.0, 141.9 (d, JC-P = 8.5 Hz), 138.4 (d, JC-P = 6.5 Hz), 138.3 (d, JC-P = 
102.4 Hz), 136.5 (d, JC-P = 1.9 Hz), 135.9, 135.8, 132.3, 132.2, 131.7, 131.6, 131.6, 131.3, 
131.0, 130.8, 130.7, 130.1, 130.0 (bs), 130.0, 129.9, 129.8, 129.4, 129.3, 129.1, 128.7, 
114.4, 93.7, 92.2 (d, JC-P = 2.2 Hz), 83.2, 80.7 (d, JC-P = 13.4 Hz), 27.6, 24.3, 21.4, 18.7, 18.4 
ppm; 31P{1H} NMR: (122 MHz, CD3CN) δ = 109.6 ppm; 19F NMR: (282 MHz, CD3CN) δ = –
123.9 (sext, JF-121Sb = 1933.7 Hz), –123.9 (oct, JF-123Sb = 1053.2 Hz) ppm; IR: (neat, cm–1) ṽ = 
654, 699, 740, 910, 936, 1093, 1161, 1216, 1254, 1375, 1448, 1479, 1605, 2921, 2992, 
3067, 3156; HRMS: calcd m/z for C52H52AuClN2O4P+ [M–SbF6]+: 1031.3013; found (ESI 
1031.3019. 
{2-[(3aS,8aS)-2,2-Dimethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxa-
phosphepin-6-yl]-1,3-diisopropyl-4,5-dimethyl-1H-imidazol-3-ium}gold Chloride 
Hexafluoroantimonate (172o): 
Prepared as a white solid (100 mg, 87.4 µmol, 99% yield) 
from compound 169o (1.0 equiv, 80.0 mg, 87.7 µmol), 
chloro(dimethyl sulfide)gold(I) (1.0 equiv, 25.9 mg, 87.9 
µmol) in dichloromethane (1.5 ml) according to GPE. 
[𝜶]𝟐𝟎
𝑫 : +26.8 (c = 1.01, CH2Cl2); 1H NMR: (300 MHz, CD3CN) δ = 7.90 – 7.79 (m, 2H), 7.62 – 
7.51 (m, 5H), 7.51 – 7.38 (m, 9H), 7.38 – 7.30 (m, 4H), 6.57 (dd, J = 8.6 Hz, JH-P = 1.8 Hz, 
1H), 5.79 (pd, J = 7.0 Hz, JH-P = 2.8 Hz, 2H), 5.19 (d, J = 8.5 Hz, 1H), 2.44 (s, 6H), 1.59 (s, 
7H), 1.57 (d, J = 7.0 Hz, 6H), 1.52 (d, J = 7.0 Hz, 6H), 0.22 (s, 3H) ppm; 13C{1H} NMR: (101 
MHz, CD3CN) δ = 142.9 (d, J = 8.4 Hz), 142.8, 138.8 (d, J = 6.3 Hz), 137.7 (d, J = 1.3 Hz), 
134.8 (d, J = 4.5 Hz), 133.6 (d, J = 122.5 Hz), 130.9, 130.8, 130.3, 130.1, 130.0, 130.0, 
129.9, 129.8, 129.3, 129.1, 129.0, 128.6, 114.5, 92.5, 91.5 (d, J = 2.7 Hz), 83.3, 81.1 (d, J = 
12.3 Hz), 54.1, 54.0, 27.6, 24.5, 21.1, 21.1, 11.7 ppm; 31P{1H} NMR: (162 MHz, CD3CN) δ = 
110.6 ppm; 19F NMR: (282 MHz, CD3CN) δ = –124.0 (sext, JF-121Sb = 1935.1 Hz), –124.0 (oct, 
JF-123Sb= 1049.9 Hz) ppm; IR: (neat, cm–1) ṽ = 530, 602, 655, 699, 740, 911, 954, 1089, 
1212, 1377, 1448, 1611, 2887, 2939, 2990, 3060; HRMS: calcd m/z for C42H48AuClN2O4P+ 
[M–SbF6]+: 907.2700; found (ESI) 907.2709. 
{2-[(5S,6S)-5,6-Dimethoxy-4,4,7,7-tetraphenyl-1,3,2-dioxaphosphepan-2-yl)-1,3-
dimesityl-1H-imidazol-3-ium}gold Chloride Hexafluoroantimonate (172q): 
Prepared as a pale yellow solid (90.5 mg, 72.0 µmol, 94%) from 
compound 169q (1.0 equiv, 78.4 mg, 76.5 µmol), chloro(dimethyl 
sulfide)gold(I) (1.0 equiv, 22.6 mg, 76.7 µmol) in 
 8. Experimental  
178 
dichloromethane (1.5 ml) according to GPE. The solvent was removed in vacuo and the 
resulting residue re-precipitated from dichloromethane/ pentane. The solid was filtered and 
dried in vacuo to afford product 172q. Crystals suitable for X-ray crystallographic analysis 
were grown by layering a dichloromethane solution with pentane. 
[𝜶]𝑫
𝟐𝟎: –47.3 (c = 1.14, CH2Cl2); 1H NMR: (400 MHz, CD3CN) δ = 7.88 (d, JH-P = 2.2 Hz, 2H), 
7.50 (tt, J = 7.4, 1.3 Hz, 1H), 7.47 – 7.36 (m, 6H), 7.36 – 7.30 (m, 6H), 7.30 – 7.16 (m, 1H), 
7.21 (s, 2H), 7.04 (s, 2H), 7.00 – 6.96 (m, 2H), 6.91 – 6.88 (m, 2H), 6.85 – 6.82 (m, 2H), 5.40 
(dd, J = 7.6 Hz, JH-P = 2.4 Hz, 1H), 4.32 (d, J = 7.6 Hz, 1H), 3.58 (s, 3H), 2.35 (s, 6H), 2.32 
(s, 3H), 2.09 (s, 6H), 1.76 (s, 6H) ppm; 13C{1H} NMR: (101 MHz, CD3CN) δ = 143.6, 142.3 (d, 
JC-P = 8.5 Hz), 141.0, 138.7 (d, JC-P = 101.5 Hz), 138.1 (d, JC-P = 6.9 Hz), 136.0, 135.9, 135.6, 
132.0, 131.5, 131.2, 131.1, 131.1, 130.6, 130.3, 130.0, 130.0 (bs), 129.9, 129.8, 129.7, 
129.6, 129.5, 129.2, 128.9, 127.7, 95.4 (d, JC-P = 4.2 Hz), 93.3, 84.9, 80.8 (d, JC-P = 11.5 Hz), 
61.7, 60.7, 21.3, 18.8, 18.0 ppm; 31P{1H} NMR: (162 MHz, CD3CN) δ = 108.6 ppm; 19F NMR: 
(282 MHz, CD3CN) δ = –124.0 (oct, JF−123Sb = 1044.9 Hz), –124.1 (sext, JF−121Sb = 1929.9 Hz) 
ppm; IR: (neat, cm–1) ṽ = 617, 654, 734, 789, 865, 939, 1030, 1129, 1183, 1264, 1365, 1445, 
1479, 1605, 2836, 2919, 3060, 3150; HRMS: calculated m/z for C51H52AuClN2O4P+ [M–
SbF6]+: 1019.3013; found (ESI) 1019.3016. 
{4-[(5R,6R)-5,6-dimethoxy-4,4,7,7-tetra[3,5-di(trifluoromethyl)phenyl-1,3,2-
dioxaphosphepan-2-yl]-1,3-dimesityl-1H-imidazol-3-ium}gold Chloride 
Hexafluoroantimonate (209a): 
Prepared as a white solid (45.0 mg, 24.0 µmol, 93% yield) from 
compound 203a (1.0 equiv, 40.7 mg, 25.9 µmol), chloro(dimethyl 
sulfide)gold(I) (1.0, equiv, 7.6 mg, 25.8 µmol) in dichloromethane 
(1.5 ml) according to GPE. 
[𝜶]𝟐𝟎
𝑫 : -4.9 (c = 1.01, CH2Cl2); 1H NMR: (400 MHz, CD3CN) δ = 
9.02 (dd, J = 1.5 Hz, JH-P = 3.9 Hz, 1H), 8.76 (dd, J = 1.5 Hz, JH-P 
1.0 Hz, 1H), 8.18 (s, 1H), 8.14 (s, 1H), 8.13 (s, 2H), 8.09 – 7.91 
(m, 4H), 7.88 (s, 2H), 7.78 (s, 2H), 7.25 (s, 2H), 7.04 (s, 1H), 
7.03 (s, 1H), 5.11 (d, J = 7.3 Hz, 1H), 4.31 (d, J = 7.2 Hz, 1H), 3.52 (s, 3H), 2.66 (s, 3H), 2.41 
(s, 3H), 2.30 (s, 3H), 2.20 (s, 3H), 2.08 (s, 3H), 2.03 (s, 3H), 1.93 (s, 3) ppm; 13C{1H} NMR: 
(101 MHz, CD3CN) δ = 144.6, 143.5, 143.5, 143.5, 143.4, 143.2 (d, JC-P = 5.0 Hz), 139.6 (d, 
JC-P = 51.8 Hz), 135.8, 135.7, 135.3, 134.9, 134.0, 133.9, 133.1 (q, JC-F = 33.8 Hz), 132.8 (q, 
JC-F = 33.8 Hz), 132.3 (q, JC-F = 33.6 Hz), 131.5 (q, JC-F = 33.6 Hz), 131.4, 131.0, 130.8, 
130.7, 130.6, 130.3 – 130.1 (m), 129.9 – 129.8 (m), 129.6 – 129.5 (m), 129.0 – 128.9 (m), 
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128.9, 125.6 – 125.5 (m), 125.1 – 124.9 (m), 124.8 – 124.6 (m), 124.1 (q, JC-F = 272.1 Hz), 
123.9 (q, JC-F = 272.4 Hz), 123.9 (q, JC-F = 272.6 Hz), 91.9, 87.9, 83.9, 81.0, 61.6, 61.3, 21.2, 
21.1, 18.5, 17.9, 17.5, 17.4; 31P{1H} NMR: (162 MHz, CD3CN) δ = 109.9 ppm; 19F NMR: (282 
MHz, CD3CN) δ = –63.2, –63.3, –63.3, –63.4, –124.1 (sext, JF-121Sb = 1925.0 Hz), –124.1 
(oct, JF-123Sb = 1057.5 Hz) ppm; IR: (neat, cm–1) ṽ = 655, 682, 847, 901, 963, 1025, 1134, 
1169, 1310, 1373, 1469, 1549, 1611, 1626, 2838, 2929, 3128; HRMS: calcd. m/z for 
C59H44AuClN2O4F24P+ [M–SbF6]+: 1563.2004; found (ESI) 1563.2017. 
{4-[(5R,6R)-5,6-dimethoxy-4,4,7,7-tetra[3,5-di(trifluoromethyl)phenyl-1,3,2-
dioxaphosphepan-2-yl]-1,3-dimesityl-1H-imidazol-3-ium}gold Chloride 
Hexafluoroantimonate (209b): 
Prepared as a white solid (60.0 mg, 45.8 µmol, 97% yield) 
from compound 203b (1.0 equiv, 51.0 mg, 47.4 µmol), 
chloro(dimethyl sulfide)gold(I) (1.0 equiv, 13.9 mg, 47.1 µmol) 
in dichloromethane (1.5 ml) according to GPE. Crystals 
suitable for X-ray crystallographic analysis were grown by 
layering a dichloromethane solution with pentane. 
[𝜶]𝟐𝟎
𝑫 : –30.0 (c = 1.02, CH2Cl2); 1H NMR: (300 MHz, CD3CN) δ = 8.99 (dd, J = 1.5 Hz, JH-P = 
3.4 Hz, 1H), 8.58 (dd, J = 1.2 Hz, JH-P = 1.2 Hz, 1H), 7.56 – 7.47 (m, 2H), 7.44 – 7.35 (m, 
13H), 7.35 – 7.33 (m, 2H), 7.31 (s, 1H), 7.29 (s, 4H), 7.28 – 7.23 (m, 3H), 7.22 (s, 1H), 7.14 
(s, 1H), 7.06 (s, 1H), 6.13 (dd, J = 8.6 Hz, JH-P = 1.9 Hz, 1H), 4.92 (d, J = 8.5 Hz, 1H), 2.41 
(s, 6H), 2.30 (s, 3H), 2.19 (s, 3H), 2.10 (s, 3H), 2.02 (s, 3H), 1.91 – 1.80 (m, 1H), 1.80 – 1.67 
(m, 1H), 1.67 – 1.41 (m, 2H), 1.26 – 0.92 (m, 3H), 0.85 – 0.68 (m, 1H), 0.36 – 0.21 (m, 1H), 
0.19 – 0.04 (m, 1H) ppm; 13C{1H} NMR: (101 MHz, CD3CN) δ = 144.0, 143.5, 143.3 (d, JC-P = 
8.6 Hz), 143.1, 143.0 (d, JC-P = 4.8 Hz), 139.1 (d, JC-P = 6.5 Hz), 137.8 (d, JC-P = 2.0 Hz), 
136.6, 136.4, 135.5, 135.4, 133.8 (d, JC-P = 15.2 Hz), 131.7, 131.3, 131.0, 130.9, 130.7, 
130.3, 130.1 (d, JC-P = 74.1 Hz), 130.1, 129.8, 129.8, 129.7, 129.6, 129.6, 129.5, 129.0, 
128.8, 128.6, 128.3, 114.9, 90.4, 89.8 (d, JC-P = 3.5 Hz), 83.4 (d, JC-P = 1.8 Hz), 81.8 (d, JC-P = 
11.6 Hz), 37.6, 34.7, 25.1, 24.6, 24.6, 21.3, 21.1, 19.1, 18.2, 17.9, 17.9; 31P{1H} NMR: (162 
MHz, CD3CN) δ = 106.8 ppm; 19F NMR: (282 MHz, CD3CN) δ = –123.9 (oct, JF-123Sb = 1054.1 
Hz), –123.9 (sext, JF-121Sb = 1927.7 Hz) ppm; IR: (neat, cm–1) ṽ = 533, 611, 654, 698, 909, 
945, 981, 1124, 1447, 1553, 2859, 2936, 3058, 3128; HRMS: calcd m/z for 
C55H56AuClN2O4P+ [M–SbF6]+: 1071.3326; found (ESI) 1071.3341. 
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[2-{(5R,6R)-5,6-Dimethoxy-4,4,7,7-tetrakis[4-(trifluoromethyl)phenyl]-1,3,2-
dioxaphosphepan-2-yl}-1,3-dimesityl-4,5-dimethyl-1H-imidazol-3-ium]gold Chloride 
Hexafluoroantimonate (172s): 
Prepared as a white solid (65.0 mg, 41.7 µmol, 91% yield) from 
compound 169s (1.0 equiv, 60.7 mg, 45.8 µmol), chloro(dimethyl 
sulfide)gold(I) (1.0, equiv, 13.5 mg, 45.8 µmol) in 
dichloromethane (2.0 ml) according to GPE. Crystals suitable for 
X-ray crystallographic analysis were grown by layering a 
dichloromethane solution with pentane. 
[𝜶]𝟐𝟐
𝑫  : –49.7 (c = 0.990, CH2Cl2); 1H NMR: (400 MHz, CD3CN) δ = 7.78 – 7.73 (m, 2H), 7.73 
– 7.68 (m, 4H), 7.68 – 7.64 (m, 2H), 7.51 (bs, 2H), 7.26 (s, 2H), 7.22 (d, J = 8.2 Hz, 2H), 7.16 
(s, 2H), 7.06 (d, J = 7.7 Hz, 2H), 6.96 (d, J = 7.7 Hz, 2H), 5.54 (dd, J = 8.0 Hz, JH-P = 2.1 Hz, 
1H), 4.17 (d, J = 8.0 Hz, 1H), 3.69 (s, 3H), 2.38 (s, 9H), 2.00 (s, 6H), 1.96 (s, 6H), 1.81 (s, 
6H) ppm; 13C{1H} NMR: (126 MHz, CD3CN) δ = 145.6 (d, JC-P = 8.7 Hz), 144.6 (d, JC-P = 1.1 
Hz), 144.1, 141.7 (d, JC-P = 7.6 Hz), 140.0 (t, JC-P = 1.4 Hz, JC-F = 1.4 Hz), 137.3, 137.3, 
136.0, 135.9, 134.1 (d, JC-P = 112.5 Hz), 132.5 (q, JC-F = 32.6 Hz), 132.2 (q, JC-F = 32.8 Hz), 
132.2, 131.8 (q, JC-F = 32.6 Hz), 131.8, 131.3 (q, JC-F = 32.6, 31.9 Hz), 130.8, 130.7 (bs), 
130.5, 130.0 (d, JC-P = 1.1 Hz), 129.7, 127.2 (q, JC-F = 3.8 Hz), 126.9 (q, JC-F = 3.8 Hz), 126.3 
(q, JC-F = 3.8 Hz), 125.0 (q, JC-F = 271.6 Hz), 124.9 (q, JC-F = 3.8 Hz), 124.9 (q, JC-F = 271.6 
Hz), 124.9 (q, JC-F = 271.7 Hz), 124.8 (q, JC-F = 271.7 Hz), 93.1 (d, JC-P = 3.0 Hz), 91.5 (d, JC-P 
= 1.6 Hz), 85.3, 80.8 (d, JC-P = 11.5 Hz), 62.1, 61.4, 21.3, 18.8, 18.2, 9.9; 31P{1H} NMR: (162 
MHz, CD3CN) δ = 109.0 ppm; 19F NMR: (376 MHz, CD3CN) δ = –63.2, –63.3, –63.3, –63.4, –
123.9 (oct, JF-123Sb = 1050.4 Hz), –123.9 (sext, JF-121Sb = 1932.5 Hz) ppm; IR: (neat, cm–1) ṽ = 
656, 793, 932, 1015, 1069, 1092, 1259, 1325, 1407, 1141, 1479, 1617, 2846, 2918, 2963; 
HRMS: calcd m/z for C57H52AuClF12N2O4P+ [M–SbF6]+: 1319.2822; found (ESI) 1319.2829. 
[4,5-Dichloro-2-{(5R,6R)-5,6-dimethoxy-4,4,7,7-tetrakis[4-(trifluoromethyl)phenyl]-1,3,2-
dioxaphosphepan-2-yl}-1,3-dimesityl-1H-imidazol-3-ium]gold Chloride 
Hexafluoroantimonate(172t): 
Prepared as a as a white solid (60.0 mg, 37.5 µmol, 92% yield) 
from compound 169t (1.0 equiv, 47.2 mg, 34.6 µmol), 
chloro(dimethyl sulfide)gold(I) (1.0, equiv, 10.2 mg, 34.6 µmol) in 
dichloromethane (2.0 ml) according to GPE. The solvent was 
removed in vacuo and the resulting solid re-precipitated from 
dichloromethane/pentane, filtered off and dried in vacuo to afford 
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the product 172t. Crystals suitable for X-ray crystallographic analysis were grown by layering 
a dichloromethane solution with pentane. 
[𝜶]𝟐𝟑
𝑫 : –60.8 (c = 0.950, CH2Cl2); 1H NMR: (400 MHz, CD3CN) δ = 7.77 (d, J = 8.3 Hz, 2H), 
7.75 – 7.65 (m, 6H), 7.44 (bs, 2H), 7.31 (s, 2H), 7.18 (d, J = 8.3 Hz, 2H), 7.15 (s, 2H), 7.09 
(d, J = 8.3 Hz, 2H), 6.98 (d, J = 8.2 Hz, 2H), 5.42 (dd, J = 7.8 = Hz, JC-P = 1.7 Hz, 1H), 4.25 
(d, J = 7.9 Hz, 1H), 3.66 (s, 3H), 2.43 (s, 3H), 2.37 (s, 6H), 2.14 (s, 6H), 1.84 (s, 6H) ppm; 
13C{1H} NMR: (101 MHz, CD3CN) δ = 145.5, 145.0 (d, JC-P = 8.4 Hz), 144.1, 141.2 (d, JC-P = 
7.3 Hz), 139.4, 137.4 (d, JC-P = 98.2 Hz), 136.6, 136.5, 132.8 (q, JC-F = 32.8 Hz), 132.5 (q, JC-
F = 32.6 Hz), 132.3, 131.9, 131.5 (q, JC-F = 32.4 Hz), 130.8, 130.6, 130.5, 129.8, 129.2 (d, JC-
P = 3.3 Hz), 129.0, 127.3 (q, JC-F = 3.8 Hz), 127.1 (q, JC-F = 3.6 Hz), 126.5 (q, JC-F = 3.8 Hz), 
125.1 (q, JC-F = 3.8 Hz), 125.0 (q, JC-F = 271.6 Hz), 124.9 (q, JC-F = 272.0 Hz), 124.9 (q, JC-F = 
271.9 Hz), 124.8 (q, JC-F = 271.8 Hz), 94.5 (d, JC-P = 3.2 Hz), 92.6, 85.1, 80.8 (d, JC-P = 11.0 
Hz), 62.1, 61.5, 21.3, 19.2, 18.5 ppm; 31P{1H} NMR: (162 MHz, CD3CN) δ = 111.2 ppm; 19F 
NMR: (376 MHz, CD3CN) δ = –63.2, –63.3, –63.4, –63.4, –123.9 (sext, JF-121Sb = 1929.4 Hz), 
–123.9 (oct, JF-123Sb = 1045.7 Hz) ppm; IR: (neat, cm–1) ṽ = 594, 824, 932, 1017, 1071, 1121, 
1168, 1324, 1381, 1410, 1471, 1565, 1615, 2844, 2929, 2997; HRMS: calcd m/z for 
C55H46AuCl3F12N2O4P+ [M–SbF6]+: 1359.1729; found (ESI) 1359.1720. 
[4,5-Dichloro-1,3-dimesityl-2-{(3aS,8aS)-4,4,8,8-tetrakis[4-(tert-butyl)phenyl]-2,2-
dimethyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl}-1H-imidazol-3-
ium]gold Chloride Hexafluoroantimonate (172u): 
Prepared as a white solid (64.0 mg, 40.9 µmol, 49% yield) 
from compound 169u (1.0 equiv, 110 mg, 82.7 µmol), 
chloro(dimethyl sulfide)gold(I) (1.0, equiv, 24.4 mg, 82.8 
µmol) in dichloromethane (2.0 ml) according to GPE. The 
solvent was removed in vacuo and the residue purified by 
column chromatography (0.5% ethyl acetate in 
dichloromethane) at –10 °C.  
[𝜶]𝟐𝟎
𝑫 : +36.6 (c = 0.94, CH2Cl2); 1H NMR: (300 MHz, CDCl3) δ = 7.44 – 7.35 (m, 4H), 7.31 (s, 
4H), 7.24 (d, J = 8.4 Hz, 2H), 7.19 (d, J = 8.3 Hz, 2H), 7.12 – 7.06 (m, 4H), 6.84 (dd, J = 8.7, 
4.0 Hz, 2H), 6.65 – 6.59 (m, 2H), 6.31 (dd, J = 8.6 Hz, JH-P = 2.0 Hz, 1H), 4.81 (d, J = 8.6 Hz, 
1H), 2.47 (s, 6H), 2.04 (s, 6H), 2.00 (s, 6H), 1.39 (s, 3H), 1.37 (s, 9H), 1.35 (s, 9H), 1.32 (s, 
9H), 1.31 (s, 9H), –0.03 (s, 3H); 13C{1H} NMR: (126 MHz, CDCl3) δ = 153.5, 153.1, 152.6, 
152.2, 143.6, 138.2 (d, JC-P = 81.3 Hz), 137.8, 137.6, 135.4, 135.4, 134.1 (d, JC-P = 6.3 Hz), 
132.3, 131.2, 130.8, 128.7, 128.6 (bs), 128.5, 128.1, 127.8, 127.7, 127.1 (d, JC-P = 2.3 Hz), 
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125.8, 125.8, 125.1, 124.1, 113.1, 93.4, 92.3, 82.0, 79.8 (d, JC-P = 13.9 Hz), 34.8, 34.6, 31.3, 
31.3, 27.5, 23.8, 21.6, 18.5, 18.1 ppm; 31P{1H} NMR (162 MHz, CDCl3) δ = 109.3 ppm; IR: 
(neat, cm–1) ṽ = 565, 602, 656, 728, 818, 929, 1019, 1093, 1212, 1264, 1373, 1403, 1471, 
1506, 1569, 1609, 2863, 2907, 2955; HRMS: calcd m/z for C68H82AuCl3N2O4P+ [M–SbF6]+: 
1323.4738; found (ESI) 1232.4736. 
{(S)-2-(2,6-Diphenyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,3-dimesityl-
4,5-dimethyl-1H-imidazol-3-ium}gold Chloride Hexafluoroantimonate (210a): 
Prepared as a white solid (68.0 mg, 53.6 µmol, 99% yield) 
from compound 208c (1.0 equiv, 56.0 mg, 54.0 µmol), 
chloro(dimethyl sulfide)gold(I) (1.0 equiv, 15.9 mg, 53.9 µmol) 
in dichloromethane (1.5 ml) according to GPE. 
[𝜶]𝟐𝟎
𝑫 : +32.1 (c = 1.01, CH2Cl2); 1H NMR: (400 MHz, CD3CN) δ 
= 8.20 (s, 2H), 8.20 (d, J = 7.8 Hz, 2H), 8.12 (s, 1H), 7.99 (d, J = 8.2 Hz, 1H), 7.73 – 7.61 (m, 
5H), 7.56 – 7.44 (m, 7H), 7.37 (ddd, J = 8.3, 6.8, 1.2 Hz, 1H), 7.19 (dt, J = 7.5, 1.0, 0.9 Hz, 
1H), 7.08 (s, 2H), 7.05 (s, 2H), 6.89 (d, J = 8.1 Hz, 1H), 6.77 (s, 1H), 6.69 (d, J = 8.7 Hz, 1H), 
5.61 (s, 1H), 2.36 (s, 3H), 1.85 (s, 6H), 1.76 (s, 3H), 1.66 (s, 3H), 1.55 (s, 3H), 1.52 (s, 3H), 
1.15 (s, 3H) ppm; 13C{1H} NMR: (101 MHz, CD3CN) δ = 145.2 (d, JC-P = 16.7 Hz), 144.7 (d, 
JC-P = 6.5 Hz), 144.4, 142.6, 138.0 (d, JC-P = 2.4 Hz), 137.2 (d, JC-P = 2.5 Hz), 136.8, 136.2, 
136.1, 135.4, 135.0 (d, JC-P = 0.9 Hz), 134.0 (d, JC-P = 1.2 Hz), 133.9, 133.9 (d, JC-P = 53.5 
Hz), 133.8 (d, JC-P = 3.2 Hz), 133.6 (d, JC-P = 1.8 Hz), 133.5, 133.1 (d, JC-P = 1.6 Hz), 133.0 
(d, JC-P = 2.2 Hz), 132.7 (d, JC-P = 2.9 Hz), 132.6, 132.5 (d, JC-P = 0.6 Hz), 131.9, 130.8, 
130.8, 129.9, 129.7, 129.6, 129.6, 129.6, 129.5, 129.4, 129.4, 128.9 (d, JC-P = 4.1 Hz), 128.5, 
128.3, 128.2, 127.9, 127.7, 127.6, 125.2 (d, JC-P = 4.4 Hz), 122.3 (d, JC-P = 4.0 Hz), 21.5, 
21.1, 20.1, 18.7, 17.8, 17.8, 16.1, 9.9, 9.8, 9.6 ppm; 31P{1H} NMR: (122 MHz, CD3CN) δ = 
112.8 ppm; 19F NMR: (282 MHz, CD3CN) δ = –123.9 (sext, JF-121Sb= 1931.2 Hz), –123.9 (oct, 
JF-123Sb = 1050.5 Hz) ppm; IR: (neat, cm–1) ṽ = 562, 604, 682, 837, 985, 1001, 1144, 1185, 
1228, 1308, 1398, 1449, 1497, 2921, 2962, 3034, 3056; HRMS: calcd m/z for 
C55H48AuClN2O2P+ [M–SbF6]+: 1031.2802; found (ESI) 1031.2808. 
Attempted preparation of the gold complex with ligand 169p. Isolation of compounds 
[2-(dihydroxyphosphaneyl)-1,3-bis(2,6-diisopropylphenyl)-1H-imidazol-3-ium]gold 
chloride hexafluoroantimonate (175b) and 1,3,4-tri([1,1'-biphenyl]-4-yl)-7-
phenylnaphthalen-2-ol (174b): 
To a dried Schlenk flask equipped with magnetic stirring bar was added 169p (1.00 equiv, 
52.0 mg, 36.5 µmol) followed by dichloromethane (1 ml) under argon. The solution was 
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cooled to –20 C, and chloro(dimethyl sulfide)gold(I) (1.00 equiv, 10.8 mg, 36.6 µmol) was 
added. The reaction mixture was allowed to stir at –20 °C for a few minutes, before warming 
to room temperature and stirring for an additional 30 minutes. The solvent was removed in 
vacuo, and the residue crystallized from dichloromethane/toluene. 
Compound 175b: 
Isolated as a white solid (9.0 mg, 9.7 µmol, 27% yield), by filtering off the 
solid followed by then washing with pentane and drying under high 
vacuum.  
1H NMR: (400 MHz, CD3CN) δ = 7.76 (d, JH-P = 1.8 Hz, 2H), 7.60 (t, J = 
7.8 Hz, 2H), 7.36 (d, J = 7.9 Hz, 4H), 2.34 (p, J = 6.8 Hz, 4H), 1.25 (d, J = 6.8 Hz, 12H), 1.12 
(d, J = 6.9 Hz, 12H) ppm; 13C{1H} NMR: (101 MHz, CD3CN) δ = 147.0 (d, JC-P = 76.3 Hz), 
146.1, 133.0, 131.8, 128.6, 125.5, 30.2, 25.5, 23.2 ppm; 31P{1H} NMR: (162 MHz, CD3CN) δ 
= 83.3 (bs) ppm 19F NMR: (376 MHz, CD3CN) δ = –124.0 (sext, JF-121Sb = 1940.7 Hz), –124.1 
(oct, JF-123Sb = 1038.8 Hz) ppm; IR: (neat, cm–1) ṽ = 557, 652, 747, 799, 880, 1025, 1061, 
1098, 1258, 1455, 2871, 2928, 2964, 3138, 3168; HRMS: calcd m/z for C54H75Au2Cl2N4O4P2+ 
[2M–2SbF6–H]+: 1369.3966; found (ESI) 1369.3970. 
Compound 174b 
The combined washings were concentrated in vacuo and 
washed with acetonitrile affording 174b as a white powder (9.0 
mg, 13.2 µmol, 36% yield). 
1H NMR: (400 MHz, CDCl3) δ = 7.92 – 7.88 (m, 1H), 7.88 – 
7.82 (m, 2H), 7.77 – 7.70 (m, 3H), 7.70 – 7.65 (m, 3H), 7.65 – 
7.60 (m, 2H), 7.60 – 7.48 (m, 10H), 7.48 – 7.27 (m, 14H), 5.33 
(s, 1H) ppm; 13C{1H} NMR: (101 MHz, CDCl3) δ = 147.9, 141.3, 
141.0, 140.8, 140.7, 140.6, 140.1, 139.9, 139.4, 137.7, 136.5, 
135.0, 134.1, 132.5, 131.7, 131.7, 131.5, 129.9, 129.0, 128.9, 128.9, 128.8, 128.5, 128.0, 
127.7, 127.5, 127.4, 127.4, 127.3, 127.2, 127.1, 127.1, 127.0, 126.5, 126.3, 125.7, 125.3, 
120.9 ppm; IR: (neat, cm–1) ṽ = 693, 761, 831, 1007, 1075, 1094, 1260, 1386, 1485, 1598, 
2852, 2922, 2961, 3027, 3054, 3521; HRMS: calcd m/z for C52H36NaO+ [M+Na]+: 699.2658; 
found (ESI) 699.2658. 
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8.2.4 Achiral synthesis of helicenes 
General procedure F (GPF) for racemic synthesis of helicenes: 
To a dried Schlenk flask equipped with magnetic stirrer was added the substrate (1.0 equiv.), 
followed by the gold precatalyst (5 mol%). A septum was fitted to the Schlenk flask and the 
contents dried under high vacuum for 30 minutes, before performing three argon purge 
cycles. Dichloromethane (0.05M) was added via syringe through the septum and the reaction 
mixture was allowed to stir at room temperature for 2 minutes at room temperature, before 
adding a solution of AgSbF6 (5 mol%, 0.05M solution in dichloromethane) through the 
septum. The septum was exchanged for a greased glass stopper and the reaction mixture 
was allowed to stir at the specified temperature for the specified amount of time. The reaction 
mixture was filtered through a short pad of silica eluting with dichloromethane, and the 
solvent was removed in vacuo, before drying under high vacuum. The conversion and ratio 
of isomers was determined by NMR and/or HPLC. 
General procedure G (GPG) for racemic synthesis of helicenes when using a catalyst 
loading less than 5 mol%: 
In a dried Schlenk equipped with magnetic stirrer was added the precursor 159 (1.0 equiv), a 
septum was fitted to the Schlenk and the contents dried under high vacuum for 30 minutes, 
before performing three argon purge cycles. Dichloromethane (0.05M) was added via syringe 
through the septum and the reaction was allowed to stir at room temperature for 2 minutes. 
Separately in a glovebox, a stock solution of the gold pre-catalyst (0.006 to 0.01M in 
dichloromethane) was prepared by weighing the gold catalyst into a volumetric flask (2 ml), 
adding dichloromethane and transferring to a Schlenk. The required amount was added to 
the reaction via micro syringe, followed by a solution of silver hexafluoroantimonate (0.01 to 
0.0125M in dichloromethane). The reaction was stirred for the specified amount of time at 
room temperature, before filtering through a short pad of silica, eluting with dichloromethane. 
The solvent was removed in vacuo before drying under high vacuum. The conversion and 
ratio of isomers was determined by NMR and HPLC.  
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Table 22. Screening for racemic synthesis of [6]carbohelicenes.  
 
Entry 159 R1 Yield (%)a 160: 188: 187b 
1 159af 4-F(C6H4) >99 81: 19: 0 
  2a 159ag 4-MeO(C6H4) 98 92: 8: 0 
3 159ah 4-BnO(C6H4) 98 93: 7: 0 
4 159ai 4-TMS(C6H4) >99 83: 17: 0 
4 159aj 4-(iPr)(C6H4) >99 87: 13: 0 
5 159ae 4-Cl(C6H4) 99 82: 18: 0 
6 159ak 3,4-(Me)2(C6H3) >99 92: 8: 0 
7 159al 4-CH2OTIPS(C6H4) - - 
8 159am 4-MeOCH2(C6H4) 97c 22: 9: 69 
9 159an Br 50d 212an 
10 159ao TMS 85e n.d 
11 159ap TIPS traces - 
Reagents and conditions (a) 159 (1 equiv.), 98 (5 mol%), AgSbF6 (5 mol%), CH2Cl2, rt, 1 h. Yields determined of 
mixtures of inseparable isomers after work up. Conversion and selectivity determined by NMR and/ or HPLC. 
aReaction using 66a. bDecomposition was observed. c36% 159am observable in reaction mixture.  dIsolated yield 
after crystallisation. e80% 159ao observable in reaction mixture. 
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Table 23. Screening of different Au(I) complexes in the achiral synthesis of [6]helicene 160ae. 
 
 
Entry [Au] R1 R2 
mol
% 
Conversion 
(%)a 
160: 188: 
187b 
1 PPh3·AuCl 5 49 22: 19: 59 
2 P(OPh)3·AuCl 5 >95 65:34: 1 
3 SPhos·AuCl 5 10 0: 0: 100 
4 98f Cy Mes 5 >95 83: 17: 0 
5 98e Ph Mes 5 >95 44: 32: 22 
6 98i 
3,5-
(CF3)2(C6H3) 
Mes 5 >95 31: 69: 0 
7 98g Cy 
2,6-
(MeO)2(C6H3) 
5 >95 67: 33: 0 
8 98h 
3,5-
(CF3)2(C6H3) 
2,6-
(MeO)2(C6H3) 
5 >95 45: 55: 0 
9 98a Ph Me 5 >95 82: 18: 0 
10c 98b Cy Me 5 >95 79: 21: 0 
11d 98f Cy Mes 5 >95 84: 16: 0 
12d 98a Ph Me 5 >95 76: 17: 7 
13 98f Cy Mes 2 >95 83:17:0 
14 98f Cy Mes 1.5 >95 78: 17: 5 
15 98a Ph Me 1.5 22 6: 0: 94 
Reagents and conditions (a) 159ae (1.0 equiv, 0.025 mmol), L·AuCl (x mol%), AgSbF6 (x mol%), CH2Cl2, rt, 45 
min. aCombined conversion of 159ae to 160ae, 188ae and 187ae.bSelectivities determined by HPLC and/ or 
NMR. cReaction performed by Tim Johannson. dReactions conducted at 0 °C, stirring for 2 h. 
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Table 24. Achiral synthesis of hexahelicenes using 98f 
 
Entry 159 R2 t (h) Conversion (%)a 
Yield 
(%)a 
160: 188: 187b 
1c 159eb 2-thienyl 1 >95 59 100: 0: 0 
2d 159fb 2-furanyl 1 >95 46 100: 0: 0 
3 159gb 3-thienyl 2 >95 34f 48: 3: 49 
4e 159gb 3-thienyl 2 >95 72 100: 0: 0 
5 159hb 3-furanyl 2 88 42f n.dg 
6e 159hb 3-furanyl 2 >95 56 100: 0: 0 
7 159ib 4-TMS(C6H4) 2 68 9f n.d.h 
8 159jb 4-BnO(C6H4 2 >95 52i 84: 16k 
9 159nb 3,5-Me2(C6H3) 6 >95 93 100: 0: 0 
10 159mb 3,5-(MeO)2(C6H3) 2 >95 91 100: 0: 0 
Reagents and conditions (a) 159 (1.5 mol%), AgSbF6 (1.5 mol%), CH2Cl2 (0.05 M), rt, t. aIsolated yields. 
bSelectivity determined by NMR and/ or HPLC. c5 mol % catalyst loading, followed by re-run with 5 mol % catalyst 
loading, then  with 10 mol % catalyst loading were necessary to give full conversion.dTwo runs at 5 mol % catalyst 
loading were necessary to give full conversion. e5 mol % catalyst loading used. fYield calculated using 1,4-
dioxane as internal standard. gMultiple unidentifiable side products apparent in reaction mixture. hMessy reaction 
mixture, 9 % desilylated helicene 160ab identified. iYield calculated using hexamethylcyclotrisiloxane as internal 
standard. kMultiple other impurities identifiable in reaction mixture. 
(5E,10E)-5,10-Bis(bromomethylene)-5,10-dihydrofluoreno[3,4-c]fluorene (160an): 
Prepared using 159an (1.0 equiv, 12.2 mg, 25.1 µmol), 
precatalyst 98f (5.1 mol%, 1.1 mg, 1.27 µmol), 
dichloromethane (0.5 ml) and AgSbF6 (4.8 mol%, 1.2 µmol, 25 
μl of a 0.05M solution in dichloromethane) according to GPF; 
stirring at room temperature for 2 h. After work up, the product 
was obtained by crystallisation from hot toluene as an orange solid (6.4 mg, 13.2 µmol, 53% 
yield).  
1H NMR: (400 MHz, CDCl3) δ = 8.68 – 8.63 (m, 2H), 7.80 (d, J = 8.4 Hz, 2H), 7.72 (d, J = 8.4 
Hz, 2H), 7.59 (s, 2H), 7.35 – 7.29 (m, 4H), 7.25 – 7.20 (m, 2H) ppm; 13C NMR: (101 MHz, 
CDCl3) δ = 142.5, 140.0, 139.3, 136.4, 135.6, 134.4, 128.7, 128.7, 128.2, 127.6, 126.4, 
124.9, 122.8, 118.4, 107.4 ppm; IR: (neat, cm–1) ṽ = 584, 600, 646, 700, 741, 770, 838, 
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1258, 1315, 1453, 1594, 1607, 3056; HRMS: calcd m/z for C26H14Br2+ [M]+: 483.9462; found 
(EI) 483.9462. 
rac-5,12-Di-p-tolylchryseno[3,4-c]chrysene (160db): 
Prepared using 159db (1.0 equiv, 15.0 mg, 14.7 
µmol), precatalyst 98f (5.1 mol%, 1.1 mg, 1.27 
µmol), dichloromethane (0.5 ml) and AgSbF6 (4.8 
mol%, 1.2 µmol, 25 μl of a 0.05M solution in 
dichloromethane) according to GPF; stirring at 
room temperature for 2 h. After work up, the 
product was obtained by crystallisation from hot 
toluene as a brown solid (7.2 mg, 11.8 µmol, 48% yield).  
Analytical data corresponded to those reported for (+)-160db in this thesis. 
rac-11,12-Dithia-1,8-di-p-tolyl-11,12-dihydrocyclopenta[c]indeno[4,5-g]phenanthrene 
(160eb): 
To a dried Schlenk flask equipped with magnetic 
stirrer was added the substrate 159eb (1.0 equiv, 
10.0 mg, 19.2 µmol), followed by the gold 
precatalyst 98f (4.8 mol%, 0.8 mg, 0.93 µmol). A 
septum was fitted to the Schlenk flask and the 
contents dried under high vacuum for 30 minutes, before performing three argon purge 
cycles. Dichloromethane (0.4 ml) was added via syringe through the septum and the reaction 
mixture was allowed to stir at room temperature for 2 minutes. A solution of AgSbF6 (4.9 
mol%, 0.95 µmol, 19 µl of a 0.05M solution in dichloromethane) was added through the 
septum and the reaction was allowed to stir at room temperature for 1 h. The reaction was 
filtered through a short pad of silica eluting with dichloromethane, and the solvent was 
removed in vacuo. 1H NMR showed 50% conversion had occurred. The crude product was 
resubmitted to the reaction conditions, using gold precatalyst 98f (4.8 mol%, 0.8 mg, 0.93 
µmol), dichloromethane (0.4 ml) and AgSbF6 (4.9 mol%, 0.95 µmol, 19 µl of a 0.05M solution 
in dichloromethane). The reaction mixture was stirred for 1 h. at room temperature, before 
filtering through a silica plug eluting with dichloromethane. 1H NMR showed that conversion 
was incomplete (proportion 160eb:187eb:159eb = 51:24:24); therefore, the mixture was 
submitted to the same reaction conditions again, this time using gold precatalyst 98f (9.6 
mol%, 1.6 mg, 1.85 µmol), dichloromethane (0.4 ml) and AgSbF6 (9.9 mol%, 1.90 µmol, 38 µl 
of a 0.05M solution in dichloromethane). After stirring for one h at room temperature and 
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workup, the product was purified by column chromatography (20% dichloromethane in 
pentane), affording the compound 160eb as a yellow solid (5.9 mg, 11.3 µmol, 59% yield). 
1H NMR: (300 MHz, CDCl3) δ = 8.07 (d, J = 8.4 Hz, 2H), 7.98 (s, 2H), 7.88 (d, J = 8.4 Hz, 
2H), 7.78 – 7.68 (m, 4H), 7.45 (d, J = 5.5 Hz, 2H), 7.42 – 7.35 (m, 4H), 7.23 (d, J = 5.6 Hz, 
2H), 2.50 (s, 6H) ppm; 13C{H} NMR: (126 MHz, cdcl3) δ = 139.3, 137.9, 137.5, 137.4, 137.2, 
132.6, 131.3, 129.4, 129.4, 128.2, 125.6, 125.3, 124.5, 124.3, 124.0, 123.0, 21.5 ppm; IR: 
(neat, cm–1) ṽ = 588, 700, 755, 801, 817, 880, 1018, 1261, 1452, 1509, 2847, 2918, 2955; 
HRMS: calcd m/z for C36H24S2+ [M]+: 520.1319; found (EI) 520.1311. 
rac-11,12-Dioxa-1,8-di-p-tolyl-11,12-dihydrocyclopenta[c]indeno[4,5-g]phenanthrene 
(160fb): 
To a dried Schlenk flask equipped with magnetic 
stirrer was added the substrate 159fb (1.0 equiv, 
12.2 mg, 25.0 µmol), followed by the gold 
precatalyst 98f (5.1 mol%, 1.1 mg, 1.27 µmol). A 
septum was fitted to the Schlenk flask and the 
contents dried under high vacuum for 30 minutes, before performing three argon purge 
cycles. Dichloromethane (0.5 ml) was added via syringe through the septum, and the 
reaction mixture was allowed to stir at room temperature for 2 minutes. A solution of AgSbF6 
(5.0 mol%, 1.25 µmol, 25 µl of a 0.05M solution in dichloromethane) was added through the 
septum, and the resulting mixture was allowed to stir at room temperature for 1 h. The 
reaction mixture was filtered through a short pad of silica eluting with dichloromethane, and 
the solvent was removed in vacuo. 1H NMR showed a mixture of products (proportion 
160fb:188fb:159fb = 28:5:67); therefore, the crude product was resubmitted to the reaction 
conditions, using gold precatalyst 98f (5.1 mol%, 1.1 mg, 1.27 µmol), dichloromethane (0.5 
ml) and AgSbF6 (5.0 mol%, 1.25 µmol, 25 µl of a 0.05M solution in dichloromethane). The 
reaction mixture was stirred for 1 hour at room temperature, before the work-up as indicated 
above and purification by column chromatography (20% dichloromethane in pentane), 
affording the product 160fb as a yellow solid (5.6 mg, 11.5 µmol, 46% yield). 
1H NMR: (300 MHz, CDCl3) δ = 8.09 (d, J = 8.5 Hz, 2H), 7.96 (s, 2H), 7.88 (d, J = 8.5 Hz, 
2H), 7.83 – 7.75 (m, 4H), 7.43 (d, J = 2.1 Hz, 2H), 7.42 – 7.36 (m, 4H), 7.06 (d, J = 2.1 Hz, 
2H), 2.49 (s, 6H); 13C{H} NMR: (126 MHz, CDCl3) δ = 152.6, 143.3, 137.3, 137.0, 134.1, 
131.5, 129.4, 128.6, 127.8, 125.3, 123.5, 121.5, 119.5, 117.5, 106.5, 21.4; IR: (neat, cm–1) ṽ 
= 578, 717, 729, 759, 798, 824, 874, 906, 1003, 1017, 1043, 1091, 1226, 1260, 1304, 1363, 
1477, 1504, 2852, 2920, 2966, 3039, 3142; HRMS: calcd m/z for C36H24O2+ [M]+: 488.1776; 
found (EI) 488.1764. 
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rac-9,14-Dithia-1,8-di-p-tolyl-11,12-dihydrocyclopenta[c]indeno[4,5-g]phenanthrene 
(160gb):  
Prepared using 159gb (1.0 equiv, 9.0 mg, 17.3 
µmol), precatalyst 98f (4.7 mol%, 0.7 mg, 0.81 
µmol), dichloromethane (0.35 ml) and AgSbF6 (5.4 
mol%, 0.93 µmol, 49 µl of a 0.05M solution in 
dichloromethane) according to GPF; stirring at 
room temperature for 2 h. The product was obtained after purification by column 
chromatography (25% toluene in pentane) as a yellow solid (6.5 mg, 12.5 µmol, 72% yield). 
1H NMR: (300 MHz, CDCl3) δ = 8.07 (d, J = 8.3 Hz, 2H), 7.96 (s, 2H), 7.91 (d, J = 8.4 Hz, 
2H), 7.89 – 7.81 (m, 4H), 7.45 – 7.37 (m, 4H), 7.19 (d, J = 5.6 Hz, 2H), 7.10 (d, J = 5.6 Hz, 
2H), 2.50 (s, 6H) ppm; 13C{H} NMR (126 MHz, CDCl3) δ = 138.1, 138.0, 137.6, 137.3, 135.9, 
132.3, 131.8, 129.6, 128.6, 127.8, 126.9, 126.1, 125.8, 125.0, 124.4, 123.6, 21.6 ppm; IR: 
(neat, cm–1) ṽ = 586, 681, 749, 793, 816, 898, 1014, 1093, 1260, 1334, 1518, 1740, 2849, 
2914, 2953, 3044; HRMS: calcd m/z for C36H24S2+ [M]+: 520.1319; found (EI) 520.1324. 
rac-9,14-Dioxa-1,8-di-p-tolyl-11,12-dihydrocyclopenta[c]indeno[4,5-g]phenanthrene 
(160hb):  
Prepared using 159hb (1.0 equiv, 5.9 mg, 12.1 
µmol), precatalyst 98f (4.8 mol%, 0.5 mg, 0.58 
µmol), dichloromethane (0.24 ml) and AgSbF6 (5.0 
mol%, 0.60 µmol, 12 µl of a 0.05M solution in 
dichloromethane) according to GPF; stirring at 
room temperature for 2 h. The product was obtained after purification by column 
chromatography (25% toluene in pentane) as a yellow solid (3.3 mg, 6.75 µmol, 56% yield). 
1H NMR: (300 MHz, CDCl3) δ = 8.10 (d, J = 8.4 Hz, 2H), 8.10 (s, 2H), 8.01 (dd, J = 7.9, 2.0 
Hz, 4H), 7.88 (d, J = 8.5 Hz, 2H), 7.55 (dd, J = 2.2, 0.4 Hz, 2H), 7.47 – 7.39 (m, 4H), 6.63 (d, 
J = 2.2 Hz, 2H), 2.51 (s, 6H) ppm; 13C{H} NMR: (126 MHz, CDCl3) δ = 150.5, 142.5, 137.8, 
133.3, 131.7, 130.8, 129.4, 128.7, 127.9, 126.4, 125.2, 125.0, 124.9, 124.3, 123.4, 110.9, 
21.4 ppm; IR: (neat, cm–1) ṽ = 572, 737, 768, 819, 833, 895, 1047, 1134, 1191, 1240, 1373, 
1444, 1602, 1659, 1738, 2852, 2921; HRMS: calcd m/z for C36H24O2+ [M]+: 488.1776; found 
(EI) 488.1768. 
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rac-9,11,14,16-Tetramethoxy-1,8-di-p-tolylhexahelicene (168mb):  
Prepared using 159mb (1.0 equiv, 15.7 mg, 25.0 
µmol), precatalyst 98f (1.50 mol%, 0.37 µmol, 107 
μl, 3.5  10–3M), dichloromethane (0.5 ml) and 
AgSbF6 (1.3 mol%, 0.31 µmol, 25 μl, 1.25  10–2M) 
according to GPG; stirring at room temperature for 
2 h. The product was obtained as a yellow solid 
(14.3 mg 22.7 µmol, 91% yield). 
1H NMR: (400 MHz, CDCl3) δ = 7.99 (d, J = 8.2 Hz, 2H), 7.90 (d, J = 8.2 Hz, 2H), 7.67 (s, 
2H), 7.51 – 7.27 (m, 4H), 7.26 – 7.21 (m, 4H), 6.99 (d, J = 2.4 Hz, 2H), 6.33 (d, J = 2.4 Hz, 
2H), 3.46 (s, 6H), 3.15 (s, 6H), 2.47 (s, 6H) ppm; 13C{H} NMR: (101 MHz, CDCl3) δ = 157.7, 
157.7, 142.5, 137.3, 135.4, 134.0, 133.4, 131.3, 128.1, 127.8, 127.8, 127.0, 126.9, 126.9, 
124.5, 116.9, 100.8, 99.5, 55.5, 54.6, 21.4 ppm; IR: (neat, cm–1) ṽ = 706, 820, 938, 1017, 
1061, 1104, 1161, 1203, 1263, 1329, 1605, 2842, 2923, 2960; HRMS: calcd m/z for 
C44H37O4+ [M+H]+: 629.2686; found (ESI) 629.2673. 
rac-9,11,14,16-Tetramethyl-1,8-di-p-tolylhexahelicene (168nb):  
Prepared using 159nb (1.0 equiv, 5.7 mg, 10.1 
µmol), precatalyst 98f (1.50 mol%, 0.15 µmol, 35 
μl, 4.4  10–3M), dichloromethane (0.2 ml) and 
AgSbF6 (1.5 mol%, 0.15 µmol, 12 μl, 1.25  10–2M) 
according to GPG; stirring at room temperature for 
2 h. The product was obtained as a yellow solid 
(5.3 mg, 9.4 µmol, 93% yield). 
1H NMR: (300 MHz, CDCl3) δ = 7.98 (d, J = 8.2 Hz, 2H), 7.87 (d, J = 8.2 Hz, 2H), 7.72 (s, 
2H), 7.55 (d, J = 7.7 Hz, 2H), 7.42 (s, 2H), 7.32 (d, J = 8.2 Hz, 2H), 7.27 (t, J = 1.3 Hz, 4H), 
6.81 (d, J = 1.8 Hz, 2H), 2.49 (s, 6H), 2.03 (s, 6H), 1.83 (s, 6H) ppm; 13C{H} NMR: (75 MHz, 
CDCl3) δ = 142.3, 138.9, 136.3, 134.0, 133.6, 132.9, 131.6, 131.2, 129.9, 129.8, 129.0, 
128.3, 128.3, 128.2, 128.0, 127.7, 127.2, 126.7, 126.1, 124.2, 25.3, 21.3, 20.7 ppm; IR: 
(neat, cm–1) ṽ = 525, 634, 728, 824, 862, 1028, 1264, m1360, 1433, 1446, 1509, 1609, 2852, 
2912, 2967, 3018; HRMS: calcd m/z for C44H36Na+ [M+Na]+: 587.2709; found (ESI) 
587.2704. 
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8.2.5 Enantioselective synthesis of helicenes 
General procedure H (GPH) for the enantioselective synthesis of helicenes 
To a dried Schlenk flask equipped with magnetic stirrer was added the substrate (1.0 equiv.), 
followed by the gold precatalyst (10 mol%). A septum was fitted to the Schlenk flask and the 
contents dried under high vacuum for 30 minutes, before performing three argon purge 
cycles. The reaction solvent (0.05M) was added via syringe through the septum and the 
reaction mixture was allowed to stir at room temperature for 2 minutes, before transferring to 
a pre-cooled isopropanol bath and stirred for 15 minutes to reach the required temperature. 
A solution of AgSbF6 (10 mol%, 0.05M solution in dichloromethane) was added through the 
septum, the septum was exchanged for a greased glass stopper and the reaction mixture 
was allowed to stir at the stated temperature for the indicated time. The reaction mixture was 
filtered through a short pad of silica eluting with dichloromethane, and the solvent was 
removed in vacuo, before drying under high vacuum. The entire sample was then re-
dissolved in a known amount of CDCl3, before an aliquot was taken for NMR and HPLC 
measurements. The conversion and ratio of isomers was determined by NMR and/or HPLC. 
The enantiomeric excess was determined by HPLC. In the case an internal standard was 
used to determine yield or conversion by 1H NMR, the entire sample was dissolved in CDCl3 
or CD2Cl2 and the internal standard (4.0 equiv.) was added, an aliquot was removed for NMR 
measurement. 
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(P)-1,8-Bis(4-fluorophenyl)hexahelicene (160af): 
Prepared using 159af (1.0 equiv, 12.8 mg, 24.7 µmol), 
precatalyst 172i (10 mol%, 3.8 mg, 2.44 µmol), 
fluorobenzene (0.5 ml) and AgSbF6 (10 mol%, 2.45 
µmol, 49 µl of a 0.05M solution in dichloromethane) 
according to GPH; stirring at –20 °C for 96 h. The 
crude product was obtained as a yellow powder in 
90% yield (mixture of 160af:188af:187af = 92:7:1, 92% conversion).  
In order to obtain a pure sample for characterization, the mixture was purified by semi-
preparative HPLC, affording 2.6 mg (5.0 µmol, 20% yield) of 160af. Separation conditions: 
250  4.6 mm YMC pack PVA-SIL 5 µm column, hexanes/MTBE = 96/4 (v/v), 18.9 ml•min–1, 
2.4 MPa, 333 nm; HPLC: 250  4.6 mm YMC-Pack PVA SIL-NP, 5 µm, hexanes/MTBE = 
96/4 (v/v), 1.0 ml•min−1, 2.6 MPa, 303 K, 246 nm; helicene 160af: tR = 14.51 min, isomers 
188af (E/Z): tR = 15.15 and 18.50 min, intermediate 187af: tR = 13.96 min, starting material 
159af: , tR = 12.16 min; Enantiomeric excess: +90%. Conditions for 2D separation: 50  4.6 
mm Agilent Eclipse Plus C18 1.8 µm column, CH3CN/H2O = 85/15 (v/v), 1.0 ml•min–1, 15.5 
MPa, 308 K, 333 nm helicene 160af tR = 10.84 min; then 150  4.6 mm Chiralpak IC-3 
column, 3 µm, CH3CN/H2O = 90/10 (v/v), 1.0 ml•min−1, 10.3 MPa, 298 K, 333 nm; major 
enantiomer: tR = 4.25 min, minor enantiomer: tR = 5.02 min. 
[𝜶]𝑫
𝟏𝟗.𝟓 : +1065.4 (c = 0.08, CH2Cl2); 1H NMR: (400 MHz, CDCl3) δ = 8.05 (d, J = 8.2 Hz, 2H), 
7.99 (d, J = 8.2 Hz, 2H), 7.89 (s, 2H), 7.84 – 7.77 (m, 4H), 7.68 (ddd, J = 8.8, 2.6 Hz, JH-F = 
5.3 Hz, 4H), 7.28 (td, J = 8.5, 2.4 Hz, JH-F = 8.5 Hz, 4H), 7.18 (ddd, J = 8.2, 6.9, 1.3 Hz, 2H), 
6.74 (ddd, J = 8.3, 6.8, 1.4 Hz, 2H) ppm; 13C{1H} NMR: (126 MHz, CDCl3) δ = 162.6 (d, JC-F = 
246.5 Hz), 138.7, 136.6 (d, JC-F = 3.3 Hz), 133.5, 131.9 (d, JC-F = 7.9 Hz), 130.9, 130.6, 
130.5, 128.2, 127.8, 127.6, 127.3, 126.9, 125.8, 125.7, 124.7, 123.9, 115.5 (d, JC-F = 21.3 
Hz) ppm; 19F NMR: (376 MHz, CDCl3) δ = -115.1 (tt, JF-H = 8.6, 5.3 Hz) ppm; IR: (neat, cm–1) 
ṽ: 115, 506, 517, 572, 608, 734, 766, 766, 836, 887, 1215, 1401, 1498, 1508, 1605, 1766, 
1893, 2249, 2859, 2929, 3026; HRMS: calcd m/z for C38H22F2Na+ [M+Na]+: 539.1582; found 
(ESI) 539.1560; UV/Vis: (THF): λmax (log ε) = 230 (4.79), 251 (4.76), 269 (4.69), 321 (4.44), 
333 (4.48), 357 (4.29) nm. 
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(P)-1,8-Bis(4-methoxyphenyl)hexahelicene (160ag): 
Prepared using 159ag (1.0 equiv, 13.4 mg, 
24.7 µmol), precatalyst 172i (10 mol%, 3.8 mg, 
2.44 µmol), fluorobenzene (0.5 ml) and AgSbF6 
(10 mol%, 2.45 µmol, 49 µl of a 0.05M solution 
in dichloromethane) according to GPH; stirring 
at –20 °C for 96 h. The crude product was 
obtained as a yellow powder in 90% yield (mixture of 160ag:188ag = 96:4).  
HPLC: 50  4.6 mm Agilent Eclipse Plus C18 1.8 µm column, CH3CN/H2O = 80/20 (v/v), 
1.0 ml•min−1, 19.3 MPa, 308 K, 193 nm; helicene 160ag: tR = 15.67 min, isomers 188ag 
(E/Z): tR= 16.61 min; Enantiomeric excess: +81%. The ee was determined by chiral HPLC: 
150  4.6 mm Chiralpak IC-3 3 µm column, CH3CN/H2O = 80/20 (v/v), 1.0 ml•min−1, 17.2 
MPa, 308 K, 193 nm; major enantiomer: tR = 9.90 min, minor enantiomer: tR = 14.00 min. 
[𝜶]𝑫
𝟐𝟒: +1099.1 (c = 0.518, CH2Cl2); 1H NMR: (300 MHz, CDCl3) δ = 8.03 (d, J = 8.2 Hz, 2H), 
7.98 (d, J = 8.3 Hz, 2H), 7.94-7.86 (m, 4H), 7.81 (ddd, J = 8.5, 1.3, 0.6 Hz, 2H), 7.66 (dd, J = 
8.7, 2.5 Hz, 4H), 7.22-7.09 (m, 6H), 6.74 (ddd, J = 8.3, 6.8, 1.4 Hz, 2H), 3.96 (s, 6H) ppm; 
13C{1H} NMR: (126 MHz, CDCl3) δ = 159.2, 139.3, 133.2, 133.0, 131.3, 130.9, 130.8, 130.5, 
128.2, 127.5, 127.3, 127.1, 126.5, 125.9, 125.6, 124.5, 124.0, 114.0, 55.6 ppm; IR: (neat, 
cm–1) ṽ = 521, 581, 608, 727, 834, 765, 888, 1031, 1103, 1174, 1243, 1286, 1395, 1460, 
1509, 1560, 2828, 2900, 2926, 2996, 3030; HRMS: calcd m/z for C40H28O2+ [M]+: 540.2089; 
found (EI) 540.2096; UV/Vis: (THF): λmax (log ε) = 233 (5.03), 249 (4.94), 269 (4.85), 323 
(4.60), 336 (4.65) nm. 
(P)-1,8-bis[4-(benzyloxy)phenyl]hexahelicene (160ah): 
Prepared using 159ah (1.0 equiv, 17.1 mg, 
24.7 µmol), precatalyst 172i (10 mol%, 3.8 mg, 
2.44 µmol), dichloromethane (0.5 ml) and 
AgSbF6 (10 mol%, 2.45 µmol, 49 µl of a 0.05M 
solution in dichloromethane) according to GPH; 
stirring at –20 °C for 96 h. The crude product was 
obtained as a yellow powder, 98% yield (mixture of 160ah:188ah = 95:5).  
HPLC: 50  4.6 mm Agilent Eclipse Plus C18 1.8 µm column, CH3CN/H2O = 85/15 (v/v), 
1.0 ml•min−1, 24.3 MPa, 308 K, 250 nm; helicene 160ah: tR = 29.32 min, isomers 188ah 
(E/Z): tR = 30.81 min; Enantiomeric excess: +99%. Conditions for 2D separation: 50  4.6 
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mm Agilent Eclipse Plus C18 1.8 µm column, CH3CN/H2O = 95/5 (v/v), 1.0 ml•min−1, 12.6 
MPa, 308 K, 250 nm, helicene 160ah: tR = 5.02 min; then 150  4.6 mm Chiralpak IC-3 
column, 3 µm, CH3CN/H2O = 90/10 (v/v), 1.0 ml•min−1, 10.3 MPa, 298 K, 250 nm; major 
enantiomer: tR = 6.92  min, minor enantiomer: tR = 8.08 min. 
[𝜶]𝑫
𝟐𝟒.𝟓 : +882.0 (c = 0.254, CH2Cl2); 1H NMR: (300 MHz, CDCl3) δ = 8.03 (d, J = 8.2 Hz, 2H), 
7.98 (d, J = 8.3 Hz, 2H), 7.92 – 7.87 (m, 4H), 7.79 (dd, J = 8.5, 0.7 Hz, 2H), 7.65 (dd, J = 8.8, 
2.5 Hz, 4H), 7.59 – 7.51 (m, 4H), 7.50 – 7.36 (m, 6H), 7.24 – 7.11 (m, 6H), 6.73 (ddd, J = 8.4, 
6.8, 1.3 Hz, 2H), 5.21 (s, 4H); 13C{1H} NMR: (126 MHz, CDCl3) δ = 158.4, 139.3, 137.1, 
133.3, 133.2, 131.3, 130.9, 130.8, 130.5, 128.7, 128.2, 128.1, 127.7, 127.5, 127.4, 127.2, 
126.5, 125.9, 125.6, 124.5, 124.0, 114.9, 70.4; IR: (neat, cm–1) ṽ = 750, 833, 879, 958, 1170, 
1246, 1287, 1384, 1454, 1509, 1607, 2859, 2914, 3027, 3057; HRMS: calcd m/z for 
C52H36NaO2+ [M+Na]+: 715.2608; found (ESI) 715.2590; UV/Vis: (THF): λmax (log ε) = 233 
(4.94), 250 (4.86), 267 (4.79), 323 (4.52), 338 (4.58) nm. 
(P)-1,8-Bis[4-(trimethylsilyl)phenyl]hexahelicene (160ai): 
Prepared using 159ai (1.0 equiv, 15.4 mg, 
24.6 µmol), precatalyst 172i (10 mol%, 3.8 mg, 
2.44 µmol), fluorobenzene (0.5 ml) and AgSbF6 
(10 mol%, 2.45 µmol, 49 µl of a 0.05M solution 
in dichloromethane) according to GPH; stirring 
at –20 °C for 96 h. The crude product was 
obtained as a yellow powder in 76% yield (mixture of 160ai:188ai:187ai = 84: 13: 3).  
In order to obtain a pure sample for characterization, the mixture was purified by semi-
preparative HPLC, obtaining 5.1 mg (8.16 µmol, 33% yield) of 160ai. Separation conditions: 
250  20 mm YMC-Pack PVA SIL, 5 µm, hexanes/ MTBE = 97/3, 18.9 ml•min−1, 4.2 MPa, 
295 K, 246 nm; HPLC: 250  4.6 mm YMC-Pack PVA SIL, 5 µm, hexanes/MTBE = 94/6, 1.0 
ml•min−1, 3.6 MPa, 303 K, 246 nm; helicene 160ai tR = 6.28 min, isomers 188ai (E/Z): tR = 
8.17 and 4.48 min, intermediate 187ai: tR = 5.90; Enantiomeric excess: +87%. The ee was 
determined by chiral HPLC: 150 × 4.6 mm Chiralpak AS-3R column, 3 µm, CH3CN/H2O = 
90/10 (v/v), 1.0 ml•min−1, 10.0 MPa, 308 K, 246 nm; major enantiomer: tR = 4.37 min, minor 
enantiomer: tR = 5.19 min.  
[𝜶]𝑫
𝟐𝟐: 1125.0 (c = 0.23, CH2Cl2); 1H NMR: (500 MHz, CDCl3) δ = 8.04 (d, J = 8.2 Hz, 2H), 
7.99 (d, J = 8.2 Hz, 2H), 7.93 – 7.88 (m, 4H), 7.81 (dd, J = 8.5, 0.6 Hz, 2H), 7.77 – 7.69 (m, 
8H), 7.17 (ddd, J = 8.2, 6.8, 1.3 Hz, 2H), 6.74 (ddd, J = 8.4, 6.8, 1.3 Hz, 2H), 0.39 (s, 18H) 
ppm; 13C{1H} NMR: (126 MHz, CDCl3) δ = 141.2, 139.7, 139.6, 133.6, 133.4, 131.0, 130.5, 
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130.5, 129.6, 128.2, 127.7, 127.5, 127.4, 126.8, 126.0, 125.7, 124.7, 124.0, –0.8 ppm; IR: 
(neat, cm–1) ṽ = 610, 696, 722, 746, 769, 825, 1025, 1095, 1246, 1310, 1399, 1594, 2844, 
2917, 2951, 3010, 3046; HRMS: calcd m/z for C44H40NaSi2+ [M+Na]+: 647.2561; found (ESI) 
647.2538; UV/Vis: (THF): λmax (log ε) = 227 (5.14), 250 (5.00), 268 (4.92), 308 (4.47), 322 
(4.63), 335 (4.68), 358 (4.52) nm. 
(P)-1,8-Bis(4-isopropylphenyl)hexahelicene (160aj): 
Prepared using 159aj (1.0 equiv, 13.9 mg, 24.6 
µmol), precatalyst 172i (10 mol%, 3.8 mg, 2.44 
µmol), fluorobenzene (0.5 ml) and AgSbF6 (10 
mol%, 2.45 µmol, 49 µl of a 0.05M solution in 
dichloromethane) according to GPH; stirring at –20 
°C for 96 h. The crude product was obtained as a 
yellow powder in 99% yield (mixture of 160aj:188aj:187aj = 87:8:5).  
HPLC: 50  4.6 mm Agilent Eclipse Plus C18 1.8 µm column, CH3CN/H2O = 95/5 (v/v), 
1.0 ml•min−1, 28.9 MPa, 308 K, 190 nm; helicene 160aj: tR = 11.11 min, isomers 188aj (E/Z): 
tR = 11.41 min and 12.09 min; intermediate 187aj: tR = 8.88 min; Enantiomeric excess: 
+87%. The ee was determined by chiral HPLC: 150  4.6 mm Chiralpak IC-3 column, 3 µm, 
CH3CN/H2O = 80/20 (v/v), 1.0 ml•min−1, 10.0 MPa, 308 K, 246 nm; major enantiomer: tR= 
13.97 min, minor enantiomer: tR = 15.89 min.  
1H NMR: (400 MHz, CDCl3) δ = 8.03 (d, J = 8.2 Hz, 2H), 7.98 (d, J = 8.2 Hz, 2H), 7.95 – 7.89 
(m, 4H), 7.80 (dd, J = 8.6, 1.1 Hz, 2H), 7.65 (dd, J = 8.2, 1.9 Hz, 4H), 7.45 (dd, J = 8.1, 1.8 
Hz, 4H), 7.17 (ddd, J = 8.2, 6.8, 1.3 Hz, 2H), 6.73 (ddd, J = 8.3, 6.8, 1.4 Hz, 2H), 3.08 (p, J = 
6.9 Hz, 2H), 1.40 (d, J = 7.0 Hz, 12H) ppm; 13C{1H} NMR: (126 MHz, CDCl3) δ = 148.2, 
139.7, 138.1, 133.3, 131.0, 130.7, 130.5, 130.2, 128.2, 127.6, 127.4, 127.3, 126.7, 126.6, 
126.0, 125.6, 124.6, 124.0, 34.1, 24.3 ppm; IR: (neat, cm–1) ṽ = 536.1, 591.1, 612.3, 748.2, 
771.4, 810.9, 835.0, 886.1, 1019.2, 1051.0, 110.2, 1364.4, 1410.7, 1457.0, 1509.0, 1604.5, 
2359.5, 2861.8, 2923.6, 2955.4, 3020.0, 3037.3; HRMS: calcd m/z for C44H36+ [M]+: 
564.2817; found (EI) 564.2838. 
(P)-1,8-Bis(4-chlorophenyl)hexahelicene (160ae): 
Prepared using 159ae[219] (1.0 equiv, 13.6 mg, 
24.8 µmol)., precatalyst 172i (10 mol%, 3.8 mg, 
2.44 µmol), fluorobenzene (0.5 ml) and AgSbF6 
(10 mol%, 2.45 µmol, 49 µl of a 0.05M solution in 
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dichloromethane) according to GPH; stirring at –20 °C for 96 h. The crude product was 
obtained as a yellow powder in 99% yield (mixture of 160ae:188ae:187ae = 81:3:16; 30% 
conversion).  
HPLC: 250  4.6 mm YMC-Pack PVA SIL, 5 µm, hexanes/MTBE = 98/2, 1.0 ml•min−1, 5.5 
MPa, 303 K, 195 nm; helicene 160ae: tR = 12.85 min, isomers 188ae tR = 17.27 min, 
intermediate 187ae: tR = 12.11 min, starting material 159ae: tR = 10.26 min; Enantiomeric 
excess: +97%. 150  4.6 mm Chiralpak IC-3 column, 3 µm, CH3CN/H2O = 90/10 (v/v), 1.0 
ml•min−1, 16.3 MPa, 308 K, 193 nm; major enantiomer: tR= 5.68 min, minor enantiomer: tR = 
7.36 min. 
1H NMR: (300 MHz, CDCl3) δ = = 8.06 (d, J = 8.2 Hz, 2H), 8.00 (d, J = 8.2 Hz, 2H), 7.89 (s, 
2H), 7.85 – 7.74 (m, 4H), 7.70 – 7.62 (m, 4H), 7.61 – 7.53 (m, 4H), 7.18 (ddd, J = 8.3, 6.9, 
1.3 Hz, 2H), 6.74 (ddd, J = 8.4, 6.9, 1.4 Hz, 2H) ppm; 13C{1H} NMR: (126 MHz, CDCl3) δ = = 
138.97, 138.31, 133.50, 133.39, 131.44, 130.65, 130.33, 130.17, 128.62, 128.08, 127.66, 
127.43, 127.23, 126.70, 125.72, 125.47, 124.65, 123.73, 77.24, 76.99, 76.74 ppm; IR: (neat, 
cm–1) ṽ = 580, 594, 609, 717, 747, 772, 831, 887, 1012, 1085, 1255, 1361, 1408, 140, 1600, 
3014, 3036, 3073; HRMS: calcd m/z for C38H22Cl2+ [M]+: 548.1099; found (EI) 548.1099. 
(P)-1,8-Bis(3,4-dimethylphenyl)hexahelicene (160ak) 
Prepared using 159ak (1.0 equiv, 13.3 mg, 
24.8 µmol), precatalyst 172i (10 mol%, 3.8 mg, 
2.44 µmol), fluorobenzene (0.5 ml) and AgSbF6 
(10 mol%, 2.45 µmol, 49 µl of a 0.05M solution in 
dichloromethane) according to GPH; stirring at –20 
°C for 96 h. The crude product was obtained as a 
yellow powder in 99% yield (mixture of 160ak: 188ak, 95: 5).  
HPLC: 50  4.6 mm Agilent Eclipse Plus C18 1.8 µm column, CH3CN/H2O = 95/5 (v/v), 
1.0 ml•min−1, 19.8 MPa, 308 K, 190 nm; helicene 160ak: tR = 7.89 min, isomers 188ak (E/Z): 
tR = 8.62 min and 9.08 min; Enantiomeric excess: +78%. The ee was determined by chiral 
HPLC: 150  4.6 mm Chiralpak IC-3 column, 3 µm, CH3CN/H2O = 80/20 (v/v), 1.0 ml•min−1, 
15.9 MPa, 308 K, 246 nm; major enantiomer: tR= 12.75 min, minor enantiomer: tR = 16.37 
min.  
1H NMR: (500 MHz, CDCl3) δ = 8.06 – 7.96 (m, 4H), 7.93 – 7.88 (m, 4H), 7.81 (dd, J = 8.6, 
1.1 Hz, 2H), 7.51 (d, J = 1.8 Hz, 2H), 7.48 – 7.44 (m, 2H), 7.36 (d, J = 7.6 Hz, 2H), 7.17 (ddd, 
J = 8.2, 6.8, 1.3 Hz, 2H), 6.75 (ddd, J = 8.4, 6.8, 1.4 Hz, 2H), 2.44 (s, 6H), 2.43 (s, 6H) ppm; 
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13C{1H} NMR: (126 MHz, CDCl3) δ = 139.8, 138.3, 136.8, 135.9, 133.3, 131.5, 131.0, 130.8, 
130.5, 129.8, 128.2, 127.8, 127.6, 127.4, 127.3, 126.6, 126.1, 125.6, 124.6, 124.0, 20.1, 19.8 
ppm; IR: (neat, cm–1) ṽ = 587.2, 609.4, 622.9, 730.9, 747.3, 765.6, 812.8, 881.3, 906.4, 
1020.2, 1069.3, 1123.3, 1255.4, 1307.5, 1364.4, 1446.4, 1494.6, 1601.6, 2851.2, 2916.8, 
3043.1; HRMS: calcd m/z for C42H32+ [M]+: 536.2504; found (EI) 536.2507. 
(P)-1,8-Bis[4-{[(triisopropylsilyl)oxy]methyl}phenyl]hexahelicene (160al): 
Prepared using 160al (1.0 equiv, 21.1 mg, 
24.7 µmol), precatalyst 172i (10 mol%, 3.8 mg, 
2.44 µmol), fluorobenzene (0.5 ml) and 
AgSbF6 (10.7 mol%, 2.65 µmol, 53 µl of a 
0.05M solution in dichloromethane) according 
to GPH. The crude product was obtained as a 
yellow solid in 98% yield (mixture of 160al:188al:187al = 87:13:0).  
HPLC: the selectivity was determined by HPLC: 250  4.6 mm YMC-Pack PVA SIL, 5 µm, 
hexanes/MTBE = 94/6 (v/v), 1.0 ml•min−1, 3.9 MPa, 303 K, 250 nm; helicene 160al: tR = 6.85 
min, isomers 188al: tR = 6.50, 8.25 min. Enantiomeric excess: +86%. Conditions for 2D 
chiral separation: Agilent 50  4.6 mm Zorbax Eclipse Plus C8, 1.8 µm, pure MeOH, 1.0 
ml•min−1, 19.5 MPa, 308 K, 250 nm; helicene 160al: tR = 3.55 min; then 150  4.6 mm 
Chiralpak AS-3R column, 3 µm, CH3CN/H2O = 90/10 (v/v), 1.0 ml•min−1, 10.6 MPa, 298 K, 
254 nm; major enantiomer: tR= 10.18 min, minor enantiomer: tR = 11.90 min 
1H NMR: (300 MHz, CDCl3) δ = = 8.04 (d, J = 8.2 Hz, 2H), 7.99 (d, J = 8.3 Hz, 2H), 7.94 – 
7.88 (m, 4H), 7.83 – 7.78 (m, 2H), 7.71 (dd, J = 8.1, 1.8 Hz, 4H), 7.63 – 7.56 (m, 4H), 7.17 
(ddd, J = 8.2, 6.9, 1.3 Hz, 2H), 6.75 (ddd, J = 8.4, 6.8, 1.4 Hz, 2H), 5.02 (s, 4H), 1.30 – 1.15 
(m, 42H) ppm; 13C{1H} NMR: (126 MHz, CDCl3) δ = = 141.0, 139.6, 139.2, 133.3, 130.9, 
130.7, 130.5, 130.1, 128.1, 127.6, 127.3, 127.2, 126.6, 125.9, 125.9, 125.6, 124.6, 124.0, 
65.2, 18.4, 12.4 ppm; IR: (neat, cm–1) ṽ = 610, 657, 681, 747, 768, 798, 881, 999, 1012, 
1066, 1092, 1119, 1258, 1368, 1464, 2857, 2891, 2937, 3046; HRMS: calcd m/z for 
C58H72NO2Si2+ [M+NH4]+: 870.5096; found (ESI) 870.5073. 
(5E,10E)-5,10-Bis(bromomethylene)-5,10-dihydrofluoreno[3,4-c]fluorene (160an): 
Prepared using 159an (1.0 equiv, 12.2 mg, 25.1 µmol), 
precatalyst 172i (9.7 mol%, 3.8 mg, 2.44 µmol), fluorobenzene 
(0.5 ml) and AgSbF6 (10 mol%, 2.50 µmol, 50 μl of a 0.05M 
solution in dichloromethane) according to GPH. The crude 
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product was obtained as a yellow solid in 62% NMR yield.  
Analytical data corresponded to those reported above for the synthesis of 160an using 
precatalyst 98f. 
(+)-5,12-Di-p-tolylchryseno[3,4-c]chrysene (160db): 
Prepared using 159db (1.0 equiv, 15.0 mg, 
24.6 µmol), precatalyst 172i (10 mol%, 3.8 mg, 
2.44 µmol), fluorobenzene (0.5 ml) and AgSbF6 
(10 mol%, 2.45 µmol, 49 µl of a 0.05M solution in 
dichloromethane) according to GPH; stirring at –20 
°C for 96 h. The crude mixture was obtained as a 
yellow powder in 99% combined yield and 
contained 68% of the desired product, as well as other unidentified side products. 
In order to obtain a pure sample for characterization, the mixture was purified by semi-
preparative HPLC. Separation conditions: 250  20 mm YMC-Pack PVA SIL, 5 µm, 
hexanes/MTBE = 99/1 (v/v), 18.9 ml•min−1, 4.4 MPa, 295 K, 280 nm, affording 5.2 mg, (8.54 
µmol, 35% yield) of 160db; Enantiomeric excess: +46%. The ee was determined by chiral 
HPLC: 150 × 4.6 mm Chiralpak IC-3 column, 3 µm, CH3CN/H2O = 80/20 (v/v), 1.0 ml•min−1, 
15.5 MPa, 308 K, 333 nm; major enantiomer: tR= 17.89 min, minor enantiomer: tR = 19.50 
min.  
[𝜶]𝟐𝟐
𝑫 : +365.5 (c = 0.215, CH2Cl2); 1H NMR: (300 MHz, CDCl3) δ = 8.07 (d, J = 8.3 Hz, 2H), 
8.03 (d, J = 8.3 Hz, 2H), 7.98 (s, 2H), 7.92 (d, J = 8.9 Hz, 2H), 7.68 (d, J = 5.9 Hz, 2H), 7.56 
(d, J = 9.1 Hz, 2H), 7.43 (d, J = 7.4 Hz, 2H), 7.36 – 7.22 (m, 8H), 7.09 (ddd, J = 8.4, 6.6, 1.7 
Hz, 2H), 6.69 (d, J = 9.1 Hz, 2H), 2.53 (s, 6H) ppm; 13C{H} NMR: (126 MHz, CDCl3) δ = 
142.3, 139.0, 136.7, 133.4, 132.6, 130.6, 130.5, 130.1, 129.7, 129.7, 129.6, 129.2, 128.8, 
128.5, 128.0, 127.6, 127.5, 127.1, 126.9, 125.9, 125.3, 125.0, 124.2, 123.9, 21.4; IR: (neat, 
cm–1) ṽ = 585.3, 713, 743, 795, 826, 888, 1017, 1039, 1258, 1444, 1512, 1910, 2854, 2919, 
2950, 309, 3042; HRMS: calcd m/z for C48H32+ [M]+: 608.2504; found (EI) 608.2497; UV/Vis: 
(THF): λmax (log ε) = 257 (4.46), 280 (4.65), 304 (4.57), 319 (4.54), 334 (4.50), 349 (4.45), 
369 (4.26) nm. 
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 (P)-10,15-Dimethoxy-1,8-di-p-tolylhexahelicene (160bb): 
Prepared using 159bb (1.0 equiv, 12.9 mg, 
22.7 µmol), precatalyst 172y (9.8 mol%, 3.6 mg, 
2.23 µmol), fluorobenzene (0.46 ml) and AgSbF6 
(10.1 mol%, 2.30 µmol, 46 µl of a 0.05M solution in 
dichloromethane) according to GPH. Purification 
by column chromatography (50% toluene in petrol 
ether) afforded the product mixture (10.8 mg, 83% yield) in proportion 160bb:188bb:187bb = 
96: 4: 0 as a yellow solid.  
HPLC: The selectivity was determined by HPLC: Agilent 50  4.6 mm Zorbax Eclipse Plus 
C18, 1.8 µm, MeCN/H2O = 90/10 (v/v), 1.0 ml•min−1, 20.3 MPa, 308 K, 254 nm; helicene 
160bb: tR = 9.55 min, isomers 188bb: tR = 10.21 and 18.54 min. Enantiomeric excess: 
+78%. The ee was determined by chiral HPLC: 150  4.6 mm Chiralpak IC-3 column, 3 µm, 
MeCN/H2O = 80/20 (v/v), 1.0 ml•min−1, 15.4 MPa, 308 K, 254 nm; major enantiomer: tR= 
11.48 min, minor enantiomer: tR = 14.46 min.  
[𝜶]𝟐𝟒
𝑫 : (86% ee) +1367 (c = 0.525, CH2Cl2); UV/Vis: (THF): λmax (log ε) = 266 (4.79), 279 
(4.64), 337 (4.59), 365 (4.30). Fluorescence: (THF ʎex 337): ʎmax (Irel) 434 (0.99), 457 (0.66). 
Analytical data corresponded to that previously reported.[219] 
1H-NMR: (400 MHz, CDCl3) δ = 7.94 (AA’BB’, 4H), 7.87 (s, 2H), 7.75 (d, J= 9.3 Hz, 2H), 7.62 
(d, J= 8.0 Hz, 4H), 7.39 (d, J= 7.8 Hz, 4H), 7.28 (d, J= 2.7 Hz, 2H), 6.44 (dd, J= 9.3, 2.7 Hz, 
2H), 3.69 (s, 6H), 2.52 (s, 6H) ppm; 13C{H}-NMR: (101 MHz, CDCl3) δ = 157.3, 139.0, 138.0, 
137.2, 133.5, 132.2, 130.0, 129.9, 129.9, 129.3, 127.9, 127.2, 127.2, 126.4, 125.4, 123.5, 
115.1, 106.23, 55.2, 21.5 ppm, IR: (neat, cm−1) ν˜: 3035, 3021, 2996, 2967, 2943, 2923, 
2873, 2859, 2838, 1558, 1498, 1469, 1449, 1428, 1404, 1374, 1327, 1288, 1262, 1230, 
1199, 1180, 1150, 1090, 1078, 1032, 959, 898, 887, 870, 850, 824, 796, 756, 736, 721, 694, 
671, 612, 584, 550, 521,  503, HRMS: calculated m/z for C42H32O2Na+: 591.229449; found 
(ESI) 591.229610. 
(P)-1,8-Bis(4-chlorophenyl)-10,15-dimethoxyhexahelicene (160be): 
Prepared using 159be (1.0 equiv, 15.2 mg, 24.9 
µmol), precatalyst 172y (10 mol%, 4.0 mg, 2.48 
µmol), fluorobenzene (0.5 ml) and AgSbF6 (10 
mol%, 2.50 µmol, 50 µl of a 0.05M solution in 
dichloromethane) according to GPH. Purification by 
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column chromatography (50% toluene in petrol ether) afforded the product mixture (14.1 mg, 
23.1 µmol, 93% yield) in proportion 160be:188be = 95: 5 as a yellow solid.  
HPLC: 250 x 4.6 mm YMC-Pack PVA SIL, 5 µm, hexanes/MTBE = 92/8 (v/v), 1.0 ml•min−1, 
5.4 MPa, 303 K, 250 nm; helicene 160be: tR = 11.83 min, isomers 188be: tR = 16.23 min; 
Enantiomeric excess: +85%. The ee was determined by chiral HPLC: 150 × 4.6 mm 
Chiralpak IC-3 column, 3 µm, MeCN/H2O = 75/25 (v/v), 1.0 ml•min−1, 18.4 MPa, 308 K, 254 
nm; major enantiomer: tR= 28.94 min, minor enantiomer tR = 46.10 min.  
[𝜶]𝟐𝟒
𝑫 : (+85% ee) +1257 (c = 0.760, CH2Cl2). 
Analytical data corresponded to those previously reported.[272] 
1H-NMR: (500 MHz, CDCl3): δ = 7.96 (d, J = 8.2 Hz, 2H), 7.94 (d, J = 8.2 Hz, 2H), 7.85 (s, 
2H), 7.73 (d, J = 9.3 Hz, 2H), 7.66 (dd, J = 8.4, 2.2 Hz, 4H), 7.56 (dd, J = 8.4, 2.2 Hz, 4H), 
7.17 (d, J = 2.7 Hz, 2H), 6.44 (dd, J = 9.3, 2.7 Hz, 2H), 3.69 (s, 6H) ppm; 13C{H}-NMR: (126 
MHz, CDCl3) δ : 157.4, 139.4, 137.7, 133.8, 133.6, 131.9, 131.5, 130.0, 129.7, 128.9, 128.2, 
127.5, 127.4, 126.6, 125.3, 123.3, 115.4, 105.8, 55.3 ppm; IR: (neat, cm-1) ν˜: 2923, 2855, 
2358, 1613, 1504, 1488, 1458, 1429, 1398, 1373, 1329, 1261, 1230, 1193, 1132, 1090, 
1036, 1013, 956, 891, 851, 826, 797, 749, 736, 720, 688, 632, 611, 595, 582, 528; HRMS: 
calculated m/z for C40H27O2Cl2+ [M+H+]: 609.1382; found (ESI) 609.1346; UV/Vis: (THF): λmax 
(log ε) = 265 (4.85), 282 (4.61), 336 (4.52), 366 (4.27) nm. 
(P)-10,15-Diphenyl-1,8-di-p-tolylhexahelicene (160cb): 
Prepared using 159cb (1.0 equiv, 11.6 mg, 
17.6 µmol), precatalyst 172y (10 mol%, 2.8 mg, 
1.74 µmol), fluorobenzene (0.35 ml) and AgSbF6 
(9.9 mol%, 1.76 µmol, 35 µl of a 0.05M solution in 
dichloromethane) according to GPH. Purification by 
column chromatography (50% toluene in petrol 
ether) afforded the product mixture (11.5 mg, 17.4 µmol, 99% yield) in proportion 
160cb:188cb = 98: 3 as a yellow solid.  
HPLC: Agilent 50  4.6 mm Zorbax Eclipse Plus C18, 1.8 µm, pure MeCN, 1.0•ml•min−1, 
14.9 MPa, 308 K, 266 nm; helicene 160cb: tR = 6.13 min, isomer 188cb: tR = 6.86 min; 
Enantiomeric excess: +75%. The ee was determined by chiral HPLC: 150  4.6 mm 
Chiralpak IC-3 column, 3 µm, MeCN/H2O = 90/10 (v/v), 1.0 ml•min−1, 12.3 MPa, 308 K, 266 
nm; major enantiomer: tR= 8.32 min, minor enantiomer: tR = 12.03 min.  
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[𝛼]21
𝐷  = +1304 (c = 0.495, CH2Cl2). 
Analytical data corresponded to those previously reported.[219] 
1H-NMR: (400 MHz, CDCl3) δ = 8.15 (d, J = 2.0 Hz, 2H), 8.06 (d, J = 8.2 Hz, 2H),  8.01 (d, J 
= 8.2 Hz, 2H), 7.94 (s, 2H), 7.90 (d, J = 8.8 Hz, 2H), 7.67 (d, J = 8.0 Hz, 4H), 7.42-7.39 (m, 
8H), 7.33-7.28 (m, 4H), 7.27-7.23 (m, 2H), 6.99 (dd, J = 8.8, 2.0 Hz, 2H), 2.53 (s, 6H) ppm; 
13C{H}-NMR: (101 MHz, CDCl3) δ = 143.4, 141.1, 139.9, 138.1, 137.7, 137.4, 133.4, 131.1, 
131.0, 130.2, 129.8, 129.4, 128.8, 128.7, 127.5, 127.5, 127.4, 127.3, 127.2, 124.1, 124.0, 
123.8, 21.5 ppm; IR: (neat, cm−1) ν˜: 3021, 2964, 2944, 2915, 2874, 2859, 1598, 1579, 1511, 
1486, 1446, 1429, 1403, 1378, 1360, 1305, 1278, 1261, 1209, 1181, 1153, 1107, 1073, 
1021, 963, 890, 823, 758, 735, 721, 693, 641, 612, 578, 566, 509; HRMS: calculated for 
C52H36+: 660.281700; found (EI) 660.281253. 
(P)-10,15-Dichloro-1,8-di-p-tolylhexahelicene (160ob): 
Prepared using 159ob (1.0 equiv, 14.4 mg, 
24.9 µmol), precatalyst 172y (10 mol%, 4.0 mg, 
2.48 µmol), fluorobenzene (0.5 ml) and AgSbF6 
(10 mol%, 2.50 µmol, 50 µl of a 0.05M solution in 
dichloromethane) according to GPH. The crude 
mixture was obtained as a yellow powder in 76% 
NMR yield (using 1,4-dioxane as an internal standard), conversion 94%, proportion 
160ob:188ob:187ob = 86:7: 7. 
In order to obtain a pure sample for characterization, the mixture was purified by semi-
preparative HPLC, obtaining 7.8 mg of 160ob (13.5 µmol, 54% yield). Separation conditions: 
250  20 mm YMC-Pack PVA SIL, 5 µm, hexanes/MTBE = 99/1 (v/v), 18.9 ml•min−1, 4.5 
MPa, 295 K, 210 nm; HPLC: The ratio of isomers was determined by HPLC: Agilent 50  4.6 
mm Zorbax Eclipse Plus C18, 1.8 µm, MeCN = 100, 1.0 ml•min−1, 17.5 MPa, 308 K, 260 nm; 
helicene 160ob: tR = 5.12 min, isomers 188ob: tR = 5.59 and 5.98 min, intermediate 187ob: 
tR = 3.26 min, starting material 159ob: tR = 2.54 min. Enantiomeric excess: +92%. The ee 
was determined by chiral HPLC: 150  4.6 mm Chiralpak IC-3 column, 3 µm, pure CH3CN, 
1.0 ml•min−1, 10.4 MPa, 308 K, 210 nm; major enantiomer: tR= 3.67 min, minor enantiomer: tR 
= 4.46 min.  
[𝜶]𝟐𝟑
𝑫 : (92% ee) +1684 (c = 0.390, CH2Cl2). 1H NMR: (400 MHz, CDCl3) δ = 8.03 (d, J = 8.2 
Hz, 2H), 7.98 (d, J = 8.2 Hz, 2H), 7.92 (s, 2H), 7.86 (d, J = 2.3 Hz, 2H), 7.70 (d, J = 9.1 Hz, 
2H), 7.58 (dd, J = 8.1, 1.9 Hz, 4H), 7.47 – 7.38 (m, 4H), 6.74 (dd, J = 9.1, 2.3 Hz, 2H), 2.53 
8. Experimental 
203 
(s, 6H) ppm; 13C{1H} NMR: (101 MHz, CDCl3) δ = = 139.1, 137.8, 136.9, 133.6, 132.0, 131.8, 
131.1, 130.1, 129.6, 129.5, 128.8, 127.8, 127.7, 127.5, 127.1, 125.4, 125.3, 123.6, 21.5 ppm; 
IR: (neat, cm–1) ṽ = 576, 611, 736, 793, 823, 884, 933, 1025, 1104, 1182, 1258, 1296, 1360, 
1426, 1488, 1512, 1599, 2858, 2920, 2960, 3020; HRMS: calcd m/z for C40H26Cl2+ [M]+: 
576.1412; found (EI) 576.1423; UV/Vis: (THF): λmax (log ε) = 235 (4.64), 257 (4.78), 262 
(4.76), 276 (4.68), 327 (4.46), 337 (4.53), 362 (4.30) nm; Fluorescence: (THF ʎex 337): ʎmax 
(Irel) 429 (0.99), 454 (0.67). 
(P)-10,15-Bis(benzyloxy)-1,8-di-p-tolylhexahelicene (160jb): 
Prepared using 159jb (1.0 equiv, 18.0 mg, 25.0 
µmol), precatalyst 172y (9.9 mol%, 4.0 mg, 2.48 
µmol), fluorobenzene (0.5 ml) and AgSbF6 (10 
mol%, 2.50 µmol, 50 µl of a 0.05M solution in 
dichloromethane) according to GPH. The product 
(16.6 mg, 23.0 µmol, 92% yield) was obtained as a 
yellow powder, proportion 160jb:188jb = 97: 3.  
The ratio of isomers was determined by 1H NMR. Enantiomeric excess: +88%. The ee was 
determined by chiral HPLC: 150  4.6 mm Chiralpak IC-3 column, 3 µm, CH3CN = 100, 1.0 
ml•min−1, 11.1 MPa, 308 K, 255 nm; major enantiomer: tR= 2.97 min, minor enantiomer: tR = 
3.65 min.  
[𝜶]𝟐𝟐
𝑫 : (88% ee) +1261 (c = 0.510, CH2Cl2). 1H NMR: (400 MHz, CDCl3) δ = = 7.95 – 7.89 (m, 
4H), 7.84 (s, 2H), 7.72 (d, J = 9.2 Hz, 2H), 7.55 – 7.50 (m, 4H), 7.36 (d, J = 7.8 Hz, 4H), 7.33 
– 7.25 (m, 12H), 6.49 (dd, J = 9.3, 2.7 Hz, 2H), 4.97 (d, J = 11.7 Hz, 2H), 4.91 (d, J = 11.7 
Hz, 2H), 2.51 (s, 6H) ppm; 13C{1H} NMR: (101 MHz, CDCl3) δ = = 156.3, 139.0, 137.9, 137.2, 
137.0, 133.5, 132.1, 130.0, 130.0, 129.9, 129.4, 128.6, 128.0, 127.9, 127.8, 127.2, 127.2, 
126.5, 125.5, 123.5, 115.8, 107.6, 69.9, 21.5 ppm; IR: (neat, cm–1) ṽ = 611, 692, 724, 824, 
887, 1019, 1179, 1226, 1263, 1377, 1442, 1501, 1610, 2861, 2915, 3029.HRMS: calcd m/z 
for C54H40NaO2+ [M+Na]+: 743.2921; found (ESI) 743.2905; UV/Vis: (THF): λmax (log ε) = 230 
(4.69), 266 (4.86), 280 (4.68), 338 (4.56), 366 (4.28); Fluorescence: (THF ʎex 338): ʎmax (Irel) 
435 (0.97), 458 (0.63). 
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(P)-9,11,14,16-Tetramethyl-1,8-di-p-tolylhexahelicene (160nb): 
Prepared using 159nb (1.0 equiv, 14.1 mg, 
25.0 µmol), precatalyst 172y (9.9 mol%, 4.0 mg, 
2.48 µmol), fluorobenzene (0.5 ml) and AgSbF6 
(10 mol%, 2.50 µmol, 50 µl of a 0.05M solution in 
dichloromethane) according to GPH. The product 
(12.7 mg, 22.5 µmol, 90% yield) was isolated as a 
yellow solid, proportion 160nb:188nb = 97:3. 
HPLC: The selectivity of the reaction was determined by HPLC: Agilent 50  4.6 mm Zorbax 
Eclipse Plus C8, 1.8 µm, MeCN/H2O = 90/10 (v/v), 1.0 ml•min−1, 8.6 MPa, 308 K, 2  5 nm; 
helicene 160nb: tR = 6.80 min, isomers 188nb: tR = 8.91 and 12.97 min. Enantiomeric 
excess: +87%. The ee was determined by chiral HPLC: 150  4.6 mm Chiralpak AS-3R 
column, 3 µm, MeOH/H2O = 95/5 (v/v), 1.0 ml•min−1, 15.9 MPa, 308 K, 255 nm; major 
enantiomer: tR = 10.43 min, minor enantiomer: tR = 14.78 min. 
Analytical data corresponded to those reported above for the synthesis of 160nb using 
precatalyst 98f. 
[𝜶]𝟐𝟒
𝑫 : (87% ee) +1174 (c = 0.225, CHCl3). UV/Vis: (THF): λmax (log ε) = 260 (4.74), 273 
(4.72), 313 (4.36), 328 (4.43), 346 (4.42), 362 (4.35); Fluorescence: (THF ʎex 346): ʎmax (Irel) 
436 (1.0), 458 (0.63). 
(P)-10,15-Bis(trimethylsilyl)-1,8-di-p-tolylhexahelicene (160ib): 
Prepared using 159ib (1.0 equiv, 16.3 mg, 
25.0 µmol), precatalyst 172y (9.9 mol%, 4.0 mg, 
2.48 µmol), fluorobenzene (0.5 ml) and AgSbF6 
(10 mol%, 2.50 µmol, 50 µl of a 0.05M solution in 
dichloromethane) according to GPH; stirring at –20 
°C for 96 h. The crude product mixture was 
obtained as a yellow powder in 87% NMR yield (using 1,4-dioxane as internal standard), 
proportion 160ib:188ib = 89:11.  
In order to obtain a purer sample for characterization, the mixture was purified by semi-
preparative HPLC, obtaining 8.3 mg (12.7 µmol, 51% yield) of 160ib. Separation conditions: 
250  20 mm YMC-Pack PVA SIL, 5 µm, hexanes/MTBE = 99/1 (v/v), 18.9 ml•min−1, 4.5 
MPa, 295 K, 210 nm. HPLC: 250  4.6 mm YMC-Pack PVA SIL, 5 µm, hexanes/MTBE = 
99/1 (v/v), 1.0 ml•min−1, 3.9 MPa, 303 K, 210 nm; helicene 160ib: tR = 9.91 min, isomers 
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188ib: tR = 10.49 and 10.91 min; Enantiomeric excess: +62%. The ee was determined by 
chiral HPLC: 150 × 4.6 mm Chiralpak IC-3 column, 3 µm, CH3CN/H2O = 80/20 (v/v), 1.0 
ml•min−1, 15.8 MPa, 308 K, 255 nm; major enantiomer: tR= 16.24 min, minor enantiomer: tR = 
22.68 min.  
[𝜶]𝟐𝟓
𝑫 : +923 (c = 0.415, CH2Cl2); 1H NMR: (300 MHz, CDCl3) δ = 8.13 (d, J = 24.1 Hz, 2H), 
8.03 (d, J = 8.2 Hz, 2H), 7.97 (d, J = 8.1 Hz, 2H), 7.88 (s, 2H), 7.74 (dd, J = 8.4, 0.6 Hz, 2H), 
7.65 (dd, J = 8.0, 1.8 Hz, 4H), 7.47 – 7.38 (m, 4H), 6.80 (dd, J = 8.4, 1.3 Hz, 2H), 2.53 (s, 
6H), 0.12 (s, 18H) ppm; 13C{H} NMR: (75 MHz, CDCl3) δ = 139.7, 137.8, 137.3, 137.2, 133.3, 
131.4, 131.3, 130.8, 130.3, 129.6, 129.2, 128.6, 127.6, 127.5, 127.3, 127.1, 126.8, 124.2, 
21.5, –1.0 ppm; IR: (neat, cm–1) ṽ = 612, 752, 802, 823, 854, 1017, 1077, 1105, 1123, 1250, 
1258, 1512, 2953, 3018; HRMS: calcd m/z for C36H44Si2+ [M]+: 652.2982; found (EI) 
652.2993; UV/Vis: (THF): λmax (log ε) = 237 (4.72), 258 (4.86), 272 (4.76), 311 (4.35), 326 
(4.51), 339 (4.55), 362 (4.38) nm. 
11,12-Dithia-1,8-di-p-tolyl-11,12-dihydrocyclopenta[c]indeno[4,5-g]phenanthrene 
(160eb) using 172y: 
Prepared using 159eb (1.0 equiv, 13.0 mg, 
25.0 µmol), precatalyst 172y (9.9 mol%, 4.0 mg, 
2.48 µmol), fluorobenzene (0.5 ml) and AgSbF6 
(10 mol%, 2.50 µmol, 50 µl of a 0.05M solution in 
dichloromethane) according to GPH; stirring at –
20 °C for 96 h. The crude product mixture was obtained as a yellow powder in 21% NMR 
yield (using 1,4-dioxane as internal standard), proportion 160eb:188eb:187eb = 81:0:19, 
27% conversion.  
The ratio of isomers was determined by 1H NMR. Enantiomeric excess: +24%. The ee was 
determined by chiral HPLC: 150 × 4.6 mm Chiralpak IA-3 column, 3 µm, hexane/CH2Cl2 = 
90/10 (v/v), 1.0 ml•min−1, 6.6 MPa, 303 K, 330 nm; major enantiomer: tR= 5.13 min, minor 
enantiomer: tR = 6.68 min.  
Analytical data corresponded to those reported above for 160eb made using 98f. 
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11,12-Dioxa-1,8-di-p-tolyl-11,12-dihydrocyclopenta[c]indeno[4,5-g]phenanthrene 
(160fb) using 172y: 
Prepared using 159fb (1.0 equiv, 12.2 mg, 
25.0 µmol), precatalyst 172y (9.9 mol%, 4.0 mg, 
2.48 µmol), fluorobenzene (0.5 ml) and AgSbF6 
(10 mol%, 2.50 µmol, 50 µl of a 0.05M solution in 
dichloromethane) according to GPH; stirring at –
20 °C for 96 h. The crude product mixture was obtained as a yellow powder in 5% NMR yield 
(using 1,4-dioxane as internal standard), proportion 160fb:188fb:187fb = >99:0:0, 8% 
conversion.  
The ratio of isomers was determined by 1H NMR. Enantiomeric excess: +24%. The ee was 
determined by chiral HPLC: 150 × 4.6 mm Chiralpak IA-3 column, 3 µm, hexane/MTBE = 
70/30 (v/v), 1.0 ml•min−1, 6 MPa, 303 K, 330 nm; major enantiomer: tR= 4.88 min, minor 
enantiomer: tR = 7.48 min.  
Analytical data corresponded to those reported above for 160fb made using 98f. 
9,14-Dithia-1,8-di-p-tolyl-11,12-dihydrocyclopenta[c]indeno[4,5-g]phenanthrene 
(160gb) using 172y:  
Prepared using 159gb (1.0 equiv, 11.1 mg, 
21.3 µmol), precatalyst 172y (9.9 mol%, 4.0 mg, 
2.10 µmol), fluorobenzene (0.5 ml) and AgSbF6 
(10.1 mol%, 2.15 µmol, 43 µl of a 0.05M solution in 
dichloromethane) according to GPH; stirring at –20 
°C for 96 h. The crude product mixture was obtained as a yellow powder in 16% NMR yield 
(using 1,4-dioxane as internal standard), proportion 160gb:188gb:187gb = 38:0:62, 53% 
conversion.  
The ratio of isomers was determined by 1H NMR. Enantiomeric excess: 0%. The ee was 
determined by chiral HPLC: 150 × 4.6 mm Chiralpak IA-3 column, 3 µm, hexane/CH2Cl2 = 
95/5 (v/v), 1.0 ml•min−1, 5.8 MPa, 298 K, 330 nm; major enantiomer: tR= 8.70 min, minor 
enantiomer: tR = 13.59 min.  
Analytical data corresponded to those reported above for 160gb made using 98f. 
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9,14-Dioxa-1,8-di-p-tolyl-11,12-dihydrocyclopenta[c]indeno[4,5-g]phenanthrene 
(160hb) using 172y:  
Prepared using 159hb (1.0 equiv, 8.9 mg, 
18.2 µmol), precatalyst 172y (9.9 mol%, 2.9 mg, 
1.79 µmol), fluorobenzene (0.5 ml) and AgSbF6 
(10 mol%, 18.2 µmol, 36 µl of a 0.05M solution in 
dichloromethane) according to GPH; stirring at –20 
°C for 96 h. The crude product mixture was obtained as a yellow powder in 33 isolated yield, 
proportion 160gb:188gb:187gb = >99:0:0.  
The ratio of isomers was determined by 1H NMR. Enantiomeric excess: 0%. The ee was 
determined by chiral HPLC: 150 × 4.6 mm Chiralpak IA-3 column, 3 µm, hexane/CH2Cl2 = 
92/8 (v/v), 1.0 ml•min−1, 6.1 MPa, 330 K, 330 nm; major enantiomer: tR= 8.34 min, minor 
enantiomer: tR = 15.25 min.  
Analytical data corresponded to those reported above for 160hb made using 98f. 
(P)-1,8-Bis(4-methoxyphenyl)hexahelicene-2-carbonitrile (217a): 
Prepared using 216a[257] (1.0 equiv, 8.0 mg, 
14.1 µmol), precatalyst 172y (10.1 mol%, 2.3 
mg, 1.43 µmol), fluorobenzene (0.28 ml) and 
AgSbF6 (9.9 mol%, 1.40 µmol, 28 µl of a 0.05M 
solution in dichloromethane) according to GPH, 
(stirring at 5 °C for 72 h) as a yellow solid in 
57% NMR yield; 67% conversion.  
In order to obtain a pure sample for characterization, the mixture was purified by semi-
preparative HPLC, obtaining 3.6 mg (6.36 µmol, 45% yield) of 217a. Separation conditions: 
250 x 20 mm YMC-Pack PVA SIL, 5 µm, heptane/THF = 90/10 (v/v), 18.9 ml•min−1, 5.6 MPa, 
295 K, 246 nm. Enantiomeric excess: +89%. The ee was determined by chiral HPLC: 150  
4.6 mm Chiralpak AS-3R column, 3 µm, MeCN/H2O = 75/25 (v/v), 1.0 ml•min−1, 12.8 MPa, 
308 K, 239 nm; major enantiomer: tR= 12.28 min, minor enantiomer: tR = 15.14 min.  
[𝜶]𝟐𝟑
𝑫 : +1129 (c = 0.17, CH2Cl2); 1H NMR: (400 MHz, CDCl3) δ = 8.48 (d, J = 8.3 Hz, 1H), 
8.19 (d, J = 8.4 Hz, 1H), 8.08 (d, J = 8.2 Hz, 1H), 8.05 (d, J = 8.3 Hz, 1H), 7.90 (dd, J = 8.1, 
1.1 Hz, 1H), 7.90 (s, 1H), 7.80 – 7.74 (m, 1H), 7.73 – 7.67 (m, 2H), 7.63 (dd, J = 8.5, 2.5 Hz, 
2H), 7.61 (d, J = 9.6 Hz, 2H), 7.22 – 7.15 (m, 4H), 7.12 (ddd, J = 13.9, 8.6, 2.5 Hz, 2H), 6.82 
(ddd, J = 8.3, 6.8, 1.3 Hz, 1H), 6.73 (ddd, J = 8.3, 6.8, 1.3 Hz, 1H), 3.97 (s, 3H), 3.95 (s, 3H) 
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ppm; 13C{H} NMR: (126 MHz, CD2Cl2) δ = 160.6, 159.7, 147.5, 140.2, 133.8, 132.8, 132.0, 
131.8, 131.6, 131.5, 131.2, 130.5, 130.4, 129.5, 129.2, 129.2, 129.0, 128.6, 128.4, 128.1, 
128.0, 127.8, 127.5, 127.5, 126.7, 126.6, 126.4, 126.0, 125.0, 124.3, 123.8, 118.2, 114.4, 
114.2, 109.3, 55.8, 55.7 ppm; IR: (neat, cm–1) ṽ = 610, 702, 765, 793, 864, 1013, 1084, 
1175, 1257, 1444, 1511, 1606, 2853, 2923, 2961; HRMS: calcd m/z for C41H27NO2 + [M]+: 
565.2042; found (EI) 565.2045. 
Compound 217b: 
Prepared using 216b[257] (1.0 equiv, 11.3 mg, 
18.2 µmol), precatalyst 172y (9.9 mol%, 2.9 mg, 
1.80 µmol), fluorobenzene (0.36 ml) and AgSbF6 
(9.9 mol%, 1.80 µmol, 36 µl of a 0.05M solution 
in dichloromethane) according to GPH; stirring 
at 5 °C for 72 h. Purification by column 
chromatography (toluene) afforded the product as a yellow solid (9.1 mg, 14.6 µmol, 81% 
yield). 
Enantiomeric excess: +51%. The ee was determined by chiral HPLC: 150  4.6 mm 
Chiralpak IC-3 column, 3 µm, MeCN/H2O = 90/10 (v/v), 1.0 ml•min−1, 12.9 MPa, 308 K, 247 
nm; major enantiomer: tR= 7.05 min, minor enantiomer: tR = 8.05 min.  
[𝜶]𝟐𝟐
𝑫 : +596 (c = 0.445, CH2Cl2); 1H NMR: (400 MHz, CDCl3) δ = 8.37 (d, J = 8.4 Hz, 1H), 
8.13 (d, J = 8.4 Hz, 1H), 8.02 (d, J = 8.2 Hz, 1H), 7.93 (d, J = 8.2 Hz, 1H), 7.72 (s, 1H), 7.57 
– 7.48 (m, 2H), 7.40 (s, 1H), 7.38 – 7.34 (m, 1H), 7.33 (s, 1H), 7.28 (dd, J = 8.6, 2.3 Hz, 1H), 
7.12 – 7.08 (m, 2H), 7.07 – 6.98 (m, 2H), 6.84 (s, 1H), 6.80 (s, 1H), 3.94 (s, 3H), 3.93 (s, 3H), 
2.03 (s, 3H), 1.98 (s, 3H), 1.82 (s, 6H) ppm; 13C{H} NMR: (101 MHz, CDCl3) δ = 160.0, 
158.9, 146.6, 139.3, 137.4, 137.1, 135.9, 134.5, 134.0, 133.5, 133.4, 133.2, 132.5, 131.6, 
131.5, 131.0, 131.0, 130.8, 130.3, 129.6, 129.0, 128.5, 128.3, 128.2, 128.0, 127.9, 127.4, 
127.3, 127.3, 127.2, 126.4, 124.1, 123.5, 118.3, 114.1, 114.0, 113.8, 113.5, 110.5, 55.5, 
55.5, 25.4, 25.0, 21.0, 20.8 ppm; IR: (neat, cm–1) ṽ = 532, 733, 830, 1036, 1174, 1247, 1287, 
1442, 1510, 1604, 2211, 2833, 2932, 2966; HRMS: calcd m/z for C45H35NO2+ [M]+: 621.2668; 
found (EI) 621.2673; UV/Vis: (THF): λmax (log ε) = 247 (4.75), 289 (4.71), 343 (4.28), 355 
(4.30), 373 (4.28) nm. 
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8.3 Towards the total synthesis of Monbarbatain A 
1-Bromo-4-isopropoxy-2-methoxybenzene (223a): 
Prepared according to a literature procedure.[280] In a high pressure tube, 
equipped with a magnetic stirring bar, a suspension of 4-bromo-3-
methoxyphenol (232) (1.0 equiv, 1.88 g, 9.26 mmol), K2CO3 (3.80 equiv, 4.83 
g, 34.9 mmol) and 2-bromopropane (1.27 equiv, 1.45 g, 11.8 mmol) in DMF 
(20 ml) was stirred at 100 °C. After three hours, 2-bromopropane (0.64 equiv, 730 mg, 5.94 
mmol) was added again and the reaction was stirred at 80 °C over night. For the work up, 
water (160 ml) was added, the aqueous layer was separated and extracted with MTBE (3  
70 ml). The combined organic layers were washed with water (5  50 ml), aqueous NaOH 
solution (1M, 50 ml) and dried over Na2SO4. The solvents were removed under reduced 
pressure to afford the product 223a as a yellow oil (2.11 g, 8.61 mmol, 93% yield). 
Analytical data corresponded to that described in the literature.[280] 
4-(Benzyloxy)-1-bromo-2-methoxybenzene (223b): 
In a round bottom flask, equipped with a magnetic stirring bar, 4-bromo-3-
methoxyphenol (232) (1.0 equiv, 2.30 g, 11.32 mmol), benzyl bromide (1.0 
equiv, 1.94 g, 11.34 mmol), K2CO3 (3.0 equiv, 4.7 g, 34.0 mmol) and 
acetonitrile (38 ml) were added under air. The reaction mixture was stirred at 
room temperature for 16 h, before diluting with ethyl acetate (200 ml) and washing with water 
(200 ml). The aqueous phase was extracted with ethyl acetate (2  200 ml); the combined 
organic phases were dried over MgSO4, filtered and concentrated in vacuo. The product 
(3.31 g, 11.29 mmol, >99% yield) was used without further purification. 
Analytical data corresponded to those of the literature.[281] 
General procedure I (GPI) 
 
Following an adapted literature procedure,[260] to a dried Schlenk flask, equipped with 
magnetic stirring bar were added NiCl2 (5 mol%), PPh3 (0.75 equiv), 2-2'-bipyridine (5 mol%), 
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Zn dust (1.5 equiv) and the aromatic bromide 223. The mixture was dried under high vacuum 
for 20 minutes, purging with argon, before adding dimethylacetamide (0.088M) and stirring at 
the specified temperature for the indicated time. The suspension was then diluted with 
chloroform and filtered through Celite®. The filtrate was washed with aqueous hydrochloric 
acid (1M) and water, before drying over Na2SO4, filtering and removing volatiles in vacuo. 
The product was obtained by column chromatography. 
4,4'-Diisopropoxy-2,2'-dimethoxy-1,1'-biphenyl (222a): 
Prepared as a colorless solid (370 mg, 1.12 mmol, 40% yield) from 
compound 223a (1.0 equiv, 1.36 g, 5.55 mmol) using NiCl2 (5.6 mol%, 
40 mg, 309 µmol), PPh3 (0.75 equiv, 1.09 g, 4.16 mmol), 2-2'-bipyridine 
(4.6 mol%, 40.0 mg, 256 µmol), Zn dust (1.5 equiv, 550 mg, 8.41 mmol) 
in dimethylacetamide (6.5 ml) according to GPI (stirring at 90 °C for 16 
h; column chromatography: 8–10% ethyl acetate in petrol ether). 
1H NMR: (300 MHz, CDCl3) δ = 7.16 – 7.08 (m, 2H), 6.56 – 6.48 (m, 4H), 4.58 (hept, J = 6.1 
Hz, 2H), 3.75 (s, 6H), 1.38 (d, J = 6.1 Hz, 12H) ppm; 13C NMR: (126 MHz, CDCl3) δ = 158.1, 
157.9, 131.7, 119.8, 105.7, 100.5, 69.7, 55.6, 22.2 ppm; IR: (neat, cm–1) ṽ = 790, 828, 986, 
1036, 1113, 1127, 1158, 1196, 1269, 1305, 1415, 1455, 1490, 1576, 1609, 2977; HRMS: 
calcd m/z for C20H27O4 [M+H]+: 331.1904, found: (ESI) 331.1903.  
4,4'-Bis(benzyloxy)-2,2'-dimethoxy-1,1'-biphenyl (222b): 
Prepared as a colorless solid (1.84 g, 4.31 mmol, 76% yield) from 
compound 223b (1.0 equiv, 3.31 g, 11.3 mmol) using NiCl2 (5.1 mol%, 
75 mg, 579 µmol), PPh3 (0.75 equiv, 2.22 g, 8.46 mmol), 2-2'-bipyridine 
(5.0 mol%, 88 mg, 563.4 µmol), Zn dust (1.53 equiv, 1.13 g, 17.28 
mmol) in dimethylacetamide (11.3 ml) according to GPI (stirring at 90 °C 
for 16 h; column chromatography: 10–60% ethyl acetate in petrol ether). 
1H NMR: (300 MHz, CDCl3) δ = 7.55 – 7.31 (m, 10H), 7.21 – 7.12 (m, 2H), 6.72 – 6.58 (m, 
4H), 5.11 (s, 4H), 3.76 (s, 6H) ppm; 13C NMR: (75 MHz, CDCl3) δ = 159.3, 158.1, 137.1, 
131.9, 128.6, 127.9, 127.6, 120.4, 105.0, 99.8, 70.2, 55.7 ppm; IR: (neat, cm–1) ṽ = 537, 640, 
699, 827, 1021, 1133, 1189, 1286, 1382, 1457, 1492, 1573, 1606, 2876, 2929, 2954, 2997; 
HRMS: calcd m/z for C28H26NaO4 [M+Na]+: 449.1723, found (ESI) 449.1724. 
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2,2',4,4'-Tetramethoxy-1,1'-biphenyl (222c): 
Prepared as a colorless solid (5.0 g, 18.2 mmol, 79% yield) from 1-
bromo-2,4-dimethoxybenzene (223c) (1.0 equiv, 10.0 g, 46.10 mmol) 
using NiCl2 (5.0 mol%, 299 mg, 2.31 mmol), PPh3 (0.749 equiv, 9.06 g, 
34.5 mmol), 2-2'-bipyridine (5.0 mol%, 360 mg, 2.31 mmol), Zn dust 
(1.50 equiv, 4.52 g, 69.13 mmol) in dimethylacetamide (45 ml) according 
to GPI (stirring at 90 °C for 16 h; column chromatography: 20% ethyl 
acetate in petrol ether). 
Analytical data corresponded to those reported.[282] 
General procedure J (GPJ) 
 
Following an adapted literature procedure,[259] to a round bottom flask, equipped with a 
magnetic stirrer, iodine (1.2 equiv.) in acetonitrile (0.5M), aqueous hydrochloric acid (37%), 
hydrogen peroxide (1.2 equiv., 35%) and the corresponding biaryl 222 (1.0 equiv) were 
added under air. The reaction mixture was stirred for 16 h at room temperature, monitoring 
the reaction by GCMS until completion and adding more equivalents of the reagents if 
necessary. The reaction mixture was then quenched by addition of water, sodium thiosulfate 
and sodium bicarbonate as saturated aqueous solutions. The phases were separated and 
the aqueous layer was extracted with dichloromethane. The combined organic layers were 
dried over Na2SO4, filtered and concentrated in vacuo. The product was used in the next step 
without further purification. 
5,5'-Diiodo-4,4'-diisopropoxy-2,2'-dimethoxy-1,1'-biphenyl (220a): 
Prepared as a light yellow solid (150 mg, 258 µmol, 88% yield) from 
compound 222a (1.0 equiv, 97 mg, 293 µmol) using iodine (1.21 equiv, 
45 mg, 177 µmol), aqueous hydrochloric acid (0.3 equiv, 88.0 µmol, 
7.30 µl of a 37% aq. solution) and hydrogen peroxide (1.2 equiv, 352 
µmol, 30.3 µl of a 35% aq. solution) in acetonitrile (0.6 ml) according to 
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modified GPJ: after stirring at room temperature for 16 h, iodine (0.7 equiv, 26 mg, 102 
µmol), aqueous hydrochloric acid (0.6 equiv, 176 µmol, 14.6 µl of a 37% aq. solution) and 
hydrogen peroxide (0.6 equiv, 176 µmol, 15.2 µl of a 35% aq. solution) were added, and the 
reaction mixture was stirred at room temperature for an additional 4 h. 
1H NMR: (300 MHz, CDCl3) δ = 7.54 (s, 2H), 6.48 (s, 2H), 4.58 (hept, J = 6.1 Hz, 2H), 3.75 
(s, 6H), 1.43 (d, J = 6.1 Hz, 12H) ppm; 13C NMR: (101 MHz, CDCl3) δ = 158.5, 157.4, 140.8, 
121.4, 99.5, 77.1, 72.8, 56.1, 22.4; IR: (neat, cm–1) ṽ = 619, 807, 881, 990, 1023, 1108, 
1132, 1170, 1196, 1255, 1347, 1370, 1482, 1589, 2935, 2971; HRMS: calcd m/z for 
C20H25I2O4 [M+H]+: 582.9837, found (ESI) 582.9827. 
4,4'-Bis(benzyloxy)-5,5'-diiodo-2,2'-dimethoxy-1,1'-biphenyl (220b): 
According to a literature procedure,[232] to a round bottom flask, 
equipped with magnetic stirring bar under air was added compound 
222b (1.0 equiv, 1.62 g, 3.79 mmol), followed by chloroform (105 ml) 
and silver trifluoroacetate (2.4 equiv, 2.01 g, 9.10 mmol). The mixture 
was allowed to stir at room temperature for 5 minutes, before adding a 
solution of iodine (2.3 equiv, 2.21 g, 8.72 mmol) in chloroform (484 ml) 
dropwise over 3 h, giving a pale red solution with a white precipitate. 
The mixture was filtered, washing with chloroform and the organic phase was washed 
successively with sodium thiosulfate (saturated aqueous), sodium bicarbonate (saturated, 
aqueous) and water and brine. The organic phase was dried (Mg2SO4) and concentrated in 
vacuo, then purified by column chromatography (50 to 100% dichloromethane in petrol 
ether). Any residual pink colour from the chromatographed compounds was extracted with 
sodium thiosulfate and water. Compound 202b was obtained as a white solid (2.19 g, 3.23 
mmol, 85% yield).  
1H NMR: (300 MHz, CDCl3) δ = 7.56 (s, 2H), 7.56 – 7.50 (m, 4H), 7.47 – 7.29 (m, 6H), 6.51 
(s, 2H), 5.19 (s, 4H), 3.72 (s, 6H) ppm; 13C{H} NMR: (126 MHz, CDCl3) δ = 158.5, 157.8, 
140.9, 136.6, 128.8, 128.1, 127.2, 121.3, 98.0, 75.1, 71.4, 56.0 ppm; IR: (neat, cm−1) ṽ = 591, 
619, 629, 696, 724, 813, 1009, 1170, 1194, 1217, 1267, 1309, 1366, 1385, 1440, 1459, 
1552, 1584, 2845, 2928, 2966, 3004; HRMS: calcd m/z for C28H24I2O4Na+ [M+Na]+: 
700.9656, found (ESI) 700.9656. 
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5,5'-Diiodo-2,2',4,4'-tetramethoxy-1,1'-biphenyl (220c): 
Prepared as a light yellow solid (9.34 g, 17.8 mmol, 97% yield) from 
compound 222c (1.0 equiv, 5.00 g, 18.23 mmol) using iodine (1.2 equiv, 
2.78 g, 10.9 mmol) aqueous hydrochloric acid (0.3 equiv, 5.47 mmol, 
0.46 ml of a 37% aq. solution) and hydrogen peroxide (1.2 equiv, 
21.9 mmol, 1.88 ml of a 35% aq. solution) in acetonitrile (44 ml) 
according to GPJ. 
1H NMR: (400 MHz, CDCl3) δ = 7.54 (s, 2H), 6.48 (s, 2H), 3.93 (s, 6H), 3.79 (s, 6H) ppm; 13C 
NMR: (101 MHz, CDCl3) δ = 158.6, 158.6, 140.8, 120.8, 95.9, 77.5, 77.4, 56.6, 56.1 ppm; IR: 
(neat, cm–1) ṽ = 455, 620, 809, 1021, 1168, 1204, 1250, 1348, 1438, 1457, 1590, 2838, 
2939, 3001; HRMS: calcd m/z for C16H16I2NaO4+ [M+Na]+: 548.9030; found (ESI) 548.9033. 
General procedure K (GPK) 
 
According to a literature procedure,[283] to a round bottom flask equipped with magnetic 
stirrer, the respective aldehyde (1.0 equiv.), p-TsOH•H2O (5 mol%), ethylene glycol (1.3 
equiv.) and toluene (0.45M) were added under air. Using a Dean-Stark apparatus equipped 
with a reflux condenser, the reaction mixture was heated to reflux for 24 h. After washing with 
a saturated aqueous solution of NaHCO3 and extracting the aqueous layer with 
dichloromethane, the combined organic layers were dried over Na2SO4, and the solvents 
were removed in vacuo. Purification by column chromatography afforded the product. 
4-Bromo-3-(1,3-dioxolan-2-yl)phenol (234) 
Prepared as yellow crystals (2.80 g, 11.43 mmol, 50% yield) from compound 
233 (1.0 equiv, 4.56 g, 22.7 mmol), p-TsOH•H2O (5 mol%, 216 mg, 1.13 
mmol) and ethylene glycol (1.3 equiv, 1.83 g, 29.5 mmol) and toluene (50 ml) 
according to GPK; column chromatography: 20–30% ethyl acetate in petrol 
ether. 
Analytical data corresponded to those described in the literature.[283] 
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2-(2-Bromo-5-isopropoxyphenyl)-1,3-dioxolane (221a) 
To a high pressure tube equipped with magnetic stirring bar was added 
compound 234 (1.00 equiv, 1.75 g, 7.14 mmol), K2CO3 (3.5 equiv, 3.41 g, 
24.7 mmol), iso-propyl bromide (1.3 equiv, 1.15 g, 9.35 mmol) and DMF (7 
ml), before stirring at 100 °C overnight. On cooling, iso-propyl bromide (0.13 
equiv, 0.24 g, 1.95 mmol) was added, and the suspension was stirred again for 2 h at 100 
°C. The reaction mixture was poured into water (100 ml), and the aqueous phase was 
extracted with MTBE (3  40 ml). The combined organic layers were washed with water (2  
50 ml), an aqueous solution of NaOH (1M, 50 ml) and dried over Na2SO4, before filtering and 
concentrating in vacuo. Purification by column chromatography (10% ethyl acetate in petrol 
ether) afforded the product 221a (1.91 g, 6.65 mmol, 93% yield) as a colorless oil. 
1H NMR: (300 MHz, CDCl3) δ = 7.42 (d, J = 8.8 Hz, 1H), 7.14 (d, J = 3.1Hz, 1H), 6.76 (dd, J 
= 8.8, 3.1 Hz, 1H), 6.04 (s, 1H), 4.54 (hept, J = 6.1 Hz, 1H), 4.29 – 3.97 (m, 4H), 1.32 (d, J = 
6.1 Hz, 6H) ppm; 13C-NMR: (126 MHz, CDCl3) δ = 157.4, 137.6, 133.7, 118.3, 115.4, 112.9, 
102.6, 70.5, 65.6, 22.2 ppm; IR: (neat, cm–1) ṽ = 635, 811, 880, 941, 1027, 1081, 1111, 
1177, 1231, 1287, 1384, 1469, 1574, 1595, 2886, 2977, 3073; HRMS: calcd m/z for 
C12H15BrO3+ [M]+: 286.0205, found (EI) 286.0205. 
5-(Benzyloxy)-2-bromobenzaldehyde (243): 
To a round bottom flask equipped with a magnetic stirring bar, 2-bromo-5-
hydroxybenzaldehyde (1.0 equiv, 10.0 g, 49.8 mmol), acetonitrile (60 ml) and 
K2CO3 (1.7 equiv, 11.7 g, 84.7 mmol) were added under air. The suspension was 
allowed to stir for a few minutes before adding benzyl bromide (1.05 equiv, 8.93 g, 
52.2 mmol) and allowed to stir at room temperature for 4 hours. The mixture was diluted with 
water and extracted with dichloromethane. The organic layers were combined, dried over 
Na2SO4, filtered and concentrated in vacuo. The product 243 was obtained as colorless oil 
(14.5 g, 49.8 mmol, >99% yield) and used without further purification. 
Analytical data corresponded to those of the literature.[284] 
2-[5-(Benzyloxy)-2-bromophenyl]-1,3-dioxolane (221b): 
Prepared as a yellow solid (13.7 g, 40.9 mmol, 82% yield) from compound 
243 (1.0 equiv, 14.5 g, 49.8 mmol) using p-TsOH•H2O (5.2 mol%, 490 mg, 
2.58 mmol) and ethylene glycol (1.35 equiv, 4.16 g, 67.0 mmol) in toluene 
(110 ml) according to GPK; column chromatography: 5–10% ethyl acetate in 
hexanes. Compound 221b was stored in at –20 °C to avoid decomposition. 
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Analytical data corresponded to those reported.[285] 
General procedure L (GPL) 
 
Following an adapted literature procedure,[266] in a dried Schlenk flask equipped with a 
magnetic stirring bar, the aryl bromide 221 (3.0 equiv.) was dissolved in THF (0.5M) before 
cooling to –78°C and adding nbutyllithium (3.4 equiv, 1.6M in hexanes) dropwise. The light 
yellow solution was allowed to stir at –78 °C for 2 h, before adding a freshly prepared 
solution of ZnCl2 in THF (7.4 equiv, 1M) at –78 °C. The reaction mixture was stirred for 30 
min at –78 °C and for 1.5 h at room temperature. Then Pd2(dba)3 (3 mol%), SPhos (6 mol%) 
and the aromatic iodide 220 (1.0 equiv) were added, before stirring at 70°C for 18 h. On 
cooling, the reaction mixture was diluted with ethyl acetate and filtered through Celite®, 
washing with ethyl acetate. The filtrate was washed with NaHCO3, extracting the aqueous 
layers with ethyl acetate. The combined organic layers were dried over Na2SO4, filtered and 
concentrated in vacuo. 
The crude product was dissolved in THF (0.015M) and stirred with 1M aqueous hydrochloric 
acid at the specified temperature for the indicated time. Dichloromethane was then added, 
the layers were separated, and the organic layer was washed with water and brine. The 
aqueous layer was extracted with dichloromethane. The combined organic layers were dried 
over MgSO4, filtered and the volatiles removed in vacuo, before purification by column 
chromatography. 
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4,4'',4''',6'-Tetraisopropoxy-4',6''-dimethoxy-[1,1':3',1'':3'',1'''-quaterphenyl]-2,2'''-dicarb-
aldehyde (236a): 
Prepared as a yellow solid (120 mg, 183 µmol, 51% yield 
over three steps) from compounds 220a (1.0 equiv, 208 
mg, 357 µmol), 221a (3.07 equiv, 310 mg, 1.08 mmol) in 
THF (2 ml), nBuLi (3.36 equiv, 1.20 mmol, 0.75 ml of a 
1.6M solution in hexanes), ZnCl2 (7.28 equiv, 2.6 mmol, 
2.6 ml of a 1M solution in THF), Pd2(dba)3 (3.1 mol%, 10 
mg, 10.9 µmol), SPhos (6.1 mol%, 9 mg, 21.9 µmol) 
according to GPL [stirring in THF (25 ml) and aqueous hydrochloric acid (25 ml, 1M) at room 
temperature for 2 h, column chromatography: 5–30% ethyl acetate in petrol ether]. 
1H NMR: (300 MHz, CDCl3) δ = 9.87 (s, 2H), 7.46 (d, J = 2.8 Hz, 2H), 7.29 (d, J = 8.5 Hz, 
2H), 7.21 (s, 2H), 7.12 (dd, J = 8.5, 2.8 Hz, 2H), 6.61 (s, 2H), 4.66 (hept, J = 6.0 Hz, 2H), 
4.41 (hept, J = 6.0 Hz, 2H), 3.85 (s, 6H), 1.37 (d, J = 6.0 Hz, 12H), 1.25 (d, J = 6.0 Hz, 12H); 
13C NMR: (126 MHz, CDCl3) δ = = 157.1, 155.6, 155.03, 134.2, 133.3, 129.8, 127.8, 125.4, 
125.2, 117.4, 114.7, 111.4, 99.1, 71.8, 69.9, 57.0, 22.7, 22.3; IR: (neat, cm–1) ṽ = 598, 734, 
821, 913, 984, 1042, 1109, 1162, 1193, 1240, 1270, 1385, 1481, 1601, 1686, 2972; HRMS: 
calcd m/z for C40H47O8+ [M+H]+: 655.3265, found (ESI) 655.3256. 
4,4'',4''',6'-tetrakis(benzyloxy)-4',6''-dimethoxy-[1,1':3',1'':3'',1'''-quaterphenyl]-2,2'''-
dicarbaldehyde (236b): 
Prepared as a yellow solid (950 mg, 1.12 mmol, 45% yield 
over three steps) using compounds 220b (1.0 equiv, 1.69 
g, 2.49 mmol), 221b (3.0 equiv, 2.50 g, 7.46 mmol) in THF 
(15 ml), nBuLi (3.08 equiv, 7.68 mmol, 4.8 ml of a 1.6M 
solution in hexanes), ZnCl2 (6.83 equiv, 17 mmol, 17 ml of 
a 1M solution in THF), Pd2(dba)3 (3.0 mol%, 68.4 mg, 74.6 
µmol), SPhos (6.0 mol%, 61 mg, 149 µmol) according to 
GPL [stirring in THF (75 ml) and aqueous hydrochloric acid (400 ml, 1M) at 60 °C for 2 h, 
column chromatography: 20–30% ethyl acetate in petrol ether]. 
1H NMR: (500 MHz, CDCl3) δ = 9.86 (s, 2H), 7.50 (d, J = 2.8 Hz, 2H), 7.42 – 7.36 (m, 4H), 
7.36 – 7.28 (m, 6H), 7.21 (ddt, J = 18.7, 8.9, 4.8 Hz, 14H), 7.12 (s, 2H), 6.59 (s, 2H), 5.07 (s, 
4H), 4.98 (s, 4H), 3.72 (s, 6H).ppm; 13C NMR: (126 MHz, CDCl3) δ = 192.9, 158.0, 157.9, 
156.0, 136.6, 136.5, 135.0, 134.9, 134.9, 133.0, 128.6, 128.5, 128.1, 127.8, 127.6, 127.0, 
121.7, 119.4, 118.7, 110.3, 97.6, 70.9, 70.2, 55.9. ppm; IR: (neat, cm–1) ṽ = 694, 731, 817, 
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999, 1014, 1163, 1190, 1236, 1269, 1382, 1452, 1483, 1603, 1681, 2747, 2839, 2934, 3030, 
3063; HRMS: calcd m/z for C56H46NaO8+ [M+Na]+: 869.3085; found (ESI) 869.3076. 
4,4'''-Bis(benzyloxy)-4',4'',6',6''-tetramethoxy-[1,1':3',1'':3'',1'''-quaterphenyl]-2,2'''-
dicarbaldehyde (236c): 
Prepared as a yellow foam (1.31 g, 1.89 mmol, 76% yield 
over three steps) from compounds 220c (1.0 equiv, 1.31 
g, 2.49 mmol), 221b (3.0 equiv, 2.50 g, 7.46 mmol) in 
THF (15 ml), nBuLi (3.40 equiv, 8.38 mmol, 5.24 ml of a 
1.6M solution in hexanes), ZnCl2 (7.30 equiv, 18.2 mmol, 
18.2 ml of a 1M solution in THF), Pd2(dba)3 (2.50 mol%, 
56.9 mg, 62.1 µmol), SPhos (6.0 mol%, 61.2 mg, 149 
µmol) according to GPL [stirring in THF (25 ml) and aqueous hydrochloric acid (100 ml, 1M) 
at room temperature for 2 h, column chromatography: 0–40% ethyl acetate in hexanes]. 
1H NMR: (400 MHz, CDCl3) δ = 9.86 (s, 2H), 7.58 (d, J = 2.8 Hz, 2H), 7.50 – 7.44 (m, 4H), 
7.44 – 7.37 (m, 4H), 7.37 – 7.32 (m, 4H), 7.27 – 7.23 (m, 2H), 7.21 (s, 2H), 6.62 (s, 2H), 5.14 
(s, 4H), 3.89 (s, 6H), 3.81 (s, 6H) ppm;; 13C NMR: (101 MHz, CDCl3) δ = 193.0, 158.2, 158.1, 
156.9, 136.6, 134.9, 134.8, 134.7, 133.0, 128.8, 128.3, 127.8, 122.0, 119.1, 118.1, 110.3, 
95.3, 70.3, 56.1, 55.7 ppm; IR: (neat, cm–1) ṽ = 455, 597, 696, 1027, 1172, 1203, 1283, 
1466, 1481, 1603, 1682, 2827, 2883, 2934; HRMS: calcd m/z for C44H38NaO8+ [M+Na]+: 
717.2459; found (ESI) 717.2460. 
General procedure M (GPM) 
 
To a dried Schlenk flask equipped with a magnetic stirring bar was added K2CO3 (6.0 equiv.), 
before drying under vacuum at 500 °C for 5 min. After cooling to room temperature, the 
aldehyde 236 (1.0 equiv.), dry methanol (0.2M) and the Ohira-Bestmann reagent (3.0 equiv.) 
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were added. A bubbler was attached to the flask, and the reaction was stirred overnight at 
room temperature. To quench the reaction, water was slowly added at 0 °C followed by 
dichloromethane. The aqueous layer was extracted with dichloromethane, the combined 
organic layers were dried over Na2SO4 and the solvents were removed under reduced 
pressure, before purifying by column chromatography. 
2,2'''-Diethynyl-4,4'',4''',6'-tetraisopropoxy-4',6''-dimethoxy-1,1':3',1'':3'',1'''-
quaterphenyl (219a): 
Prepared as a yellow solid (94.0 mg, 145.3 µmol, 79% 
yield) from aldehyde 236a (1.0 equiv, 120 mg, 183 µmol) 
using K2CO3 (6.3 equiv, 160 mg, 1.16 mmol) and the 
Ohira-Bestmann reagent (3.1 equiv, 109 mg, 567 µmol) in 
anhydrous dry methanol (1 ml) according to GPM (column 
chromatography: 20% ethyl acetate in petrol ether). 
1H NMR: (300 MHz, CDCl3) δ = 7.28 (d, J = 8.6, 0.5 Hz, 
2H), 7.26 (s, 2H), 7.07 (d, J = 2.7 Hz, 2H), 6.87 (dd, J = 8.6, 2.7 Hz, 2H), 6.61 (s, 2H), 4.55 
(hept, J = 6.1 Hz, 2H), 4.31 (hept, J = 6.1 Hz, 2H), 3.81 (s, 6H), 2.94 (d, J = 0.5 Hz, 2H), 1.35 
(d, J = 6.1 Hz, 12H), 1.22 (d, J = 6.1 Hz, 12H) ppm; 13C-NMR: (75 MHz, CDCl3) δ = 157.4, 
156.2, 155.5, 135.0, 134.4, 132.3, 123.0, 122.7, 120.1, 119.5, 116.9, 100.4, 83.9, 79.3, 72.0, 
70.2, 56.1, 22.4, 22.2 ppm; IR: neat) ṽ = 631, 118, 908, 981, 1040, 1110, 1193, 1239, 1278, 
1383, 1478, 1599, 1681, 2975, 3277; HRMS: calcd m/z for C42H47O6 [M+H]+: 647.3367, 
found(ESI) 647.3361. 
4,4'',4''',6'-Tetrakis(benzyloxy)-2,2'''-diethynyl-4',6''-dimethoxy-1,1':3',1'':3'',1'''-quarter-
phenyl (219b): 
Prepared as a white solid (383 mg, 456 µmol, 77% yield) 
from aldehyde 236b (1.0 equiv, 500 mg, 590 µmol) using 
the Ohira-Bestmann reagent (3.0 equiv, 340 mg, 1.77 
mmol) and K2CO3 (6.0 equiv, 489 mg, 3.54 mmol) in 
methanol (2 ml) according to GPM [acetonitrile (2 ml) was 
added to solubilize the substrate; column 
chromatography: 25% ethyl acetate in petrol ether]. 
1H NMR: (300 MHz, CDCl3) δ = 7.50 – 7.26 (m, 24H), 7.20 (d, J = 2.7 Hz, 2H), 6.99 (dd, J = 
8.6, 2.7 Hz, 2H), 6.65 (s, 2H), 5.08 (s, 8H), 3.78 (s, 6H), 2.97 (s, 2H) ppm; 13C NMR: (126 
MHz, CDCl3) δ = 157.3, 157.0, 156.0, 137.4, 136.7, 134.5, 134.3, 132.0, 128.5, 128.3, 127.9, 
127.4, 126.9, 122.8, 121.7, 119.7, 118.4, 115.8, 98.2, 83.6, 79.3, 70.9, 70.2, 55.9; IR: (neat, 
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cm–1) ṽ = 624, 694, 733, 816, 1002, 1022, 1162, 1191, 1234, 1283, 1379, 1452, 1485, 1599, 
2333, 2360, 2909, 2931, 3027, 3282 ppm; HRMS: calcd m/z for C58H46NaO6+ [M+Na]+: 
861.3187; found (ESI) 861.3189. 
4,4'''-Bis(benzyloxy)-2,2'''-diethynyl-4',4'',6',6''-tetramethoxy-1,1':3',1'':3'',1'''-
quaterphenyl (219c): 
Prepared as a white solid (1.05 g, 1.53 mmol, 87% yield) 
from aldehyde 236c (1.0 equiv, 1.22 g, 1.76 mmol) using 
the Ohira-Bestmann reagent (3.0 equiv, 1.02 g, 5.31 
mmol) and K2CO3 (6.0 equiv, 1.46 g, 10.6 mmol) in 
anhydrous dry methanol (5 ml) and according to GPM 
[acetonitrile (5 ml) was added to increase solubility of the 
substrate; column chromatography: 0–30% ethyl acetate 
in hexanes, then precipitation from hot ethyl acetate]. 
1H NMR: (400 MHz, CD3CN) δ = 7.48 – 7.43 (m, 4H), 7.43 – 7.31 (m, 6H), 7.23 (d, J = 8.6 
Hz, 2H), 7.15 (d, J = 2.7 Hz, 2H), 7.04 (s, 2H), 7.01 (dd, J = 8.6, 2.8 Hz, 2H), 6.72 (s, 2H), 
5.11 (s, 4H), 3.82 (s, 6H), 3.80 (s, 6H), 3.24 (s, 2H) ppm; 13C NMR: (101 MHz, CD3CN) δ = 
158.7, 158.0, 157.9, 138.0, 134.9, 134.6, 132.9, 129.4, 128.9, 128.5, 123.7, 121.2, 119.7, 
119.2, 116.7, 96.8, 84.0, 80.6, 70.5, 56.3, 56.1 ppm; IR: (neat, cm–1) ṽ = 532, 662, 695, 814, 
901, 1028, 1097, 1155, 1201, 1298, 1453, 1599, 2839, 2927, 3257, 3352; HRMS: calcd m/z 
for C46H38NaO6+ [M+Na]+: 709.2561; found (ESI) 709.2566. 
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General procedure N (GPN) 
 
In a dried Schlenk flask equipped with a magnetic stirrer was added the substrate (1.0 
equiv.), followed by the gold precatalyst (5 mol%). A septum was fitted to the Schlenk flask 
and the contents dried under high vacuum for 30 minutes, before performing three argon 
purge cycles. The reaction solvent (0.05M) was added via syringe through the septum and 
the reaction mixture was allowed to stir at room temperature for 2 minutes, before 
transferring to a pre-cooled bath and stirred for 15 minutes to reach the required 
temperature. A solution of AgSbF6 (5 mol%, 0.05M in dichloromethane) was added through 
the septum, the septum was replaced with a greased glass stopper and the reaction was 
allowed to stir at the stated temperature for the indicated time. The reaction mixture was 
filtered through a short pad of silica eluting with dichloromethane, and the solvent was 
removed in vacuo, before drying under high vacuum. The conversion and ratio of isomers 
was determined by NMR and/or HPLC. The enantiomeric excess was determined by HPLC. 
Reaction of 219a under gold catalysis: 
Prepared from compound 219a (1.0 equiv, 61.0 mg, 94.3 µmol) using precatalyst 98f (5.0 
mol%, 4.1 mg, 4.75 µmol) and AgSbF6 (5.0 mol%, 4.7 µmol, 94 µl of a 0.05 M solution in 
dichloromethane) in dichloromethane (1.9 ml) according to GPN (stirring for 45 h at room 
temperature). After purification by column chromatography (40% ethyl acetate in petrol 
ether), the crude residue was resubmitted to the reaction conditions, using precatalyst (10.0 
8. Experimental 
221 
mol%, 8.2 mg, 9.50 µmol) and AgSbF6 (10.0 mol%, 9.50 µmol, 0.19 ml of a 0.05M solution in 
dichloromethane) in dichloromethane (1.9 ml), stirring at room temperature for 18 h. The 
reaction was quenched by filtering through a silica plug, eluting with dichloromethane and 
concentrating the filtrate in vacuo. The crude mixture was purified by column 
chromatography (40% ethyl acetate in petrol ether), affording a mixture of the product 218a 
and the 6-endo-dig/5-exo-dig isomer 238a (78:21), yellow foam (28.0 mg, 43.3 µmol, 46% 
yield).  
4,4',7,7'-Tetraisopropoxy-2,2'-dimethoxy-1,1'-biphenanthrene (218a): 
To obtain samples suitable for characterization, the 
mixture of isomers was purified by preparative HPLC. 
Separation conditions: 250  20.0 mm YMC-Pack PVA-
SIL column, particle size 5 µm, hexane/MTBE = 85:15 
(v/v), 18.9 ml•min-1, 5.0 MPa, 303 K, 254 nm; HPLC: 250 
mm  4.6 mm, 5 µm YMC-pak PVA-sil column, 
hexane/MTBE = 85:15, 1 ml•min–1, 5.0 MPa, 303 K, 254 
nm; biphenanthrene 218a: tR = 20.42 min, isomer 238a: tR = 21.30 min.  
1H NMR: (300 MHz, CDCl3) δ = 9.71 (d, J = 9.4 Hz, 2H), 7.32 (d, J = 9.1 Hz, 2H), 7.21 (dd, J 
= 9.4, 2.8 Hz, 2H), 7.14 (d, J = 2.8 Hz, 2H), 7.06 (d, J = 9.1 Hz, 2H), 7.06 (s, 2H), 5.04 – 4.90 
(m, 2H), 4.71 (hept, J = 6.0 Hz, 2H), 3.75 (s, 6H), 1.65 (d, J = 6.0, 0.8 Hz, 12H), 1.39 (d, J = 
6.0, 12H) ppm; 13C NMR: (126 MHz, CDCl3) δ = 157.0, 155.5, 155.0, 134.2, 133.3, 129.7, 
127.8, 125.4, 125.2, 117.4, 117.0, 114.8, 111.4, 99.2, 71.8, 70.0, 57.0, 22.8, 22.4 ppm; IR: 
neat) ṽ = 565, 726, 827, 908, 966, 1107, 1197, 1267, 1325, 1383, 1460, 1575, 1606, 2926, 
2975; HRMS: calcd m/z for C42H47O6+ [M+H]+: 647.3367, found (ESI) 647.3351. 
1-(4,7-Diisopropoxy-2-methoxy-9-methylene-9H-fluoren-1-yl)-4,7-diisopropoxy-2-
methoxyphenanthrene (238a): 
The 5-exo-dig/6-endo-dig product 238a could also be 
isolated from the semi-preparative HPLC separation; 
however, unfortunately it decomposed before could be 
fully characterized. 
1H NMR: (300 MHz, CDCl3) δ = 9.68 (d, J = 9.8 Hz, 1H) , 
7.93 (d, J = 8.6 Hz, 1H), 7.37 (d, J = 8.9 Hz, 1H), 7.29 (d, 
J = 8.9 Hz, 1H), 7.20 (dd, J = 9.8, 2.9 Hz, 1H), 7.16 (d, J 
= 2.9 Hz, 1H), 7.02 (s, 1H), 7.01 (d, J = 2.4 Hz, 1H), 6.86 (dd, J = 8.6, 2.4 Hz, 1H), 6.67 (s, 
1H), 5.50 (s, 1H), 4.94 (hept, J = 6.0 Hz, 1H), 4.80 (hept, J = 6.0 Hz, 1H), 4.71 (hept, J = 6.1 
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Hz, 1H), 4.53 (s, 1H), 4.52 (hept, J = 6.0 Hz, 1H), 3.78 (s, 3H), 3.66 (s, 3H), 1.62 (d, J = 6.0 
Hz, 6H), 1.56 (d, J = 6.0, 6H), 1.39 (dd, J = 6.1, 1.0 Hz, 6H), 1.31 (d, J = 6.0 Hz, 6H) ppm. 
7,7'-Bis(benzyloxy)-2,2',4,4'-tetramethoxy-1,1'-biphenanthrene (218c): 
Prepared using 219c (1.0 equiv, 20.0 mg, 29.1 µmol), 
precatalyst 172d (4.9 mol%, 2.1 mg, 1.43 µmol), 
dichloromethane (0.58 ml) and AgSbF6 (5.0 mol%, 1.45 
µmol, 29 µl of a 0.05M solution in dichloromethane) 
according to GPN, affording the product mixture (19.5 mg, 
28.4 µmol, 98% yield) in proportion 218c:237c = 96: 4 as 
an off-white solid. Enantiomeric excess = +47%.  
HPLC: Conditions for 2D separation: 50  4.6 mm Agilent Eclipse Plus C8 1.8 µm column, 
CH3CN/H2O = 90/10 (v/v), 1.0 ml•min−1, 18.5 MPa, 298 K, 244 nm, 218c: tR = 1.15 min, 237c 
tR = 0.98 min; then 150  4.6 mm Chiralpak AS-3R column, 3 µm, CH3CN/H2O = 75/25 - 10’ 
– 90/10 CH3CN/H2O (v/v), 1.0 ml•min−1, 14.5 MPa, 298 K, 244 nm; major enantiomer 218c: tR 
= 8.16  min, minor enantiomer: tR = 8.92 min. 
1H NMR: (400 MHz, CDCl3) δ = 9.58 (d, J = 9.5 Hz, 2H), 7.54 – 7.46 (m, 4H), 7.45 – 7.30 (m, 
10H), 7.24 (d, J = 2.9 Hz, 2H), 7.07 (d, J = 9.2 Hz, 2H), 7.05 (s, 2H), 5.19 (s, 4H), 4.24 (s, 
6H), 3.80 (s, 6H) ppm; 13C NMR: (101 MHz, CDCl3) δ = 159.1, 156.0, 155.6, 137.2, 134.1, 
133.2, 129.7, 128.7, 128.1, 128.0, 127.7, 125.4, 125.3, 116.9, 116.0, 114.3, 109.8, 96.3, 
70.0, 56.9, 55.9 ppm; IR: (neat, cm–1) ṽ = 500, 638, 697, 742, 781, 824, 859, 963, 1024, 
1087, 1169, 1204, 1276, 1335, 1455, 1470, 1576, 1608, 2840, 2929, 2996, 3032; HRMS: 
calcd m/z for C46H39O6+ [M+H]+: 687.2741; found (ESI) 687.2739. 
7-(Benzyloxy)-1-(4'-(benzyloxy)-2'-ethynyl-4,6-dimethoxy-[1,1'-biphenyl]-3-yl)-2,4-
dimethoxyphenanthrene (237c): 
Prepared using 219c (1.0 equiv, 200 mg, 291 µmol), 
precatalyst 172n (5.0 mol%, 18.5 mg, 14:6 µmol), 
dichloromethane (5.8 ml) and AgSbF6 (5.0 mol%, 5.0 mg, 
14.6 µmol) according to GPN. After 4 h (F1) and 20 h 
(F2), a 1 ml aliquot was taken and eluted through a pad of 
silica, affording product mixtures in proportion 
218c:237c:238c = (F1) 2: 34: 64 and (F2) 42: 55: 3, 
respectively. After 44 h, the remainder of the reaction was 
quenched by eluting through a pad of silica and evaporating to dryness, affording 218c as an 
off white solid.  
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A sample of 237c suitable for analysis was obtained by semi-preparative HPLC of F2. 
Separation conditions: 150  20.0 mm YMC-ODS-A column (particle size 5 µm), 100% 
acetonitrile, 10 ml•min-1, 1.7 MPa, 308 K, 244 nm, tR = 4.60 min. 
1H NMR: (400 MHz, CDCl3) δ = 9.53 (d, J = 9.3 Hz, 1H), 7.54 – 7.48 (m, 2H), 7.47 (s, 2H), 
7.46 – 7.40 (m, 4H), 7.39 (dt, J = 2.7, 1.2 Hz, 2H), 7.38 – 7.31 (m, 4H), 7.28 (t, J = 3.2 Hz, 
1H), 7.19 (s, 1H), 7.19 (s, 1H), 7.00 (dd, J = 8.6, 2.8 Hz, 1H), 6.96 (s, 1H), 6.72 (s, 1H), 5.21 
(s, 2H), 5.06 (s, 2H), 4.17 (s, 3H), 3.90 (s, 3H), 3.88 (s, 3H), 3.75 (s, 3H), 2.99 (s, 1H) ppm; 
13C NMR: (101 MHz, CDCl3) δ = 158.8, 158.4, 157.3, 157.3, 156.1, 155.1, 137.3, 136.9, 
135.9, 134.3, 133.7, 133.1, 132.2, 129.7, 128.7, 128.7, 128.7, 128.2, 128.1, 127.7, 127.7, 
127.7, 127.6, 125.8, 125.2, 123.0, 121.1, 118.6, 117.4, 116.8, 116.3, 116.0, 115.9, 109.8, 
96.4, 96.1, 83.6, 79.3, 70.2, 70.1, 57.0, 56.1, 55.9, 55.9; IR: (neat, cm–1) ṽ = 648, 696, 729, 
907, 1027, 1088, 1163, 1201, 1277, 1350, 1454, 1578, 1605, 2240, 2841, 2929, 2999, 3033, 
3289; HRMS: calcd m/z for C46H38NaO6+ [M+Na]+: 709.2561; found (ESI) 709.2561. 
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